UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2003

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________________________ to ______________________

 

Commission file number 0-12626


EASTMAN CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
62-1539359
(I.R.S. Employer
Identification No.)

100 N. Eastman Road, Kingsport, Tennessee
(Address of principal executive offices)

37660
(Zip Code)

Registrant's telephone number, including area code:    (423) 229-2000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Common Stock, par value $0.01 per share

(including rights to purchase shares of

Common Stock or Participating Preferred Stock)

Name of each exchange on which registered

New York Stock Exchange

 


Securities registered pursuant to section 12(g) of the Act:  None

 

 

 PAGE 1 OF 234 TOTAL SEQUENTIALLY NUMBERED PAGES

EXHIBIT INDEX ON PAGE 140

 
     

 


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes    [X]    No    [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes [X] No [  ]

The aggregate market value (based upon the closing price on the New York Stock Exchange on June 30, 2003) of the 77,104,882 shares of common equity held by nonaffiliates as of December 31, 2003 was approximately $2,384,082,951 using beneficial ownership rules adopted pursuant to Section 13 of the Securities Exchange Act of 1934, as amended, to exclude common stock that may be deemed beneficially owned as of December 31, 2003 by the current directors and executive officers and Eastman Chemical Company’s ("Eastman" or the "Company") charitable foundation, some of whom might not be held to be affiliates upon judicial determination. At December 31, 2003, 77,388,646 shares of common stock of the registrant were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant's definitive Proxy Statement relating to the 2004 Annual Meeting of Stockholders (the "2004 Proxy Statement"), to be filed with the Securities and Exchange Commission, are incorporated by reference in Part III, Items 10 to 12 and 14 of this Annual Report on Form 10-K (the "Annual Report") as indicated herein.

FORWARD-LOOKING STATEMENTS

Certain statements in this Annual Report are forward-looking in nature as defined in the Private Securities Litigation Reform Act of 1995. These statements and other written and oral forward-looking statements made by the Company from time to time may relate to, among other things, such matters as planned and expected capacity increases and utilization; anticipated capital spending; expected depreciation and amortization; environmental matters; legal proceedings; exposure to, and effects of hedging of, raw material and energy costs and foreign currencies; global and regional economic, political, and business conditions; competition; growth opportunities; supply and demand, volume, price, cost, margin, and sales; earnings, cash flow, dividends and other expected financial conditions; expectations, strategies, and plans for individual products, businesses, segments and divisions as well as for the whole of Eastman; cash requirements and uses of available cash; pension expenses and funding; anticipated restructuring, divestiture, and consolidation activities; cost reduction and control efforts and targets; development, production, commercialization, and acceptance of new products, services and technologies and related costs; expected tax rate; and business, asset and product portfolio changes.

These plans and expectations are based upon certain underlying assumptions, including those mentioned with the specific statements. Such assumptions are in turn based upon internal estimates and analyses of current market conditions and trends, management plans and strategies, economic conditions and other factors. These plans and expectations and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. Certain important factors that could cause actual results to differ materially from those in the forward-looking statements are included with such forward-looking statements and in Part II--Item 7--"Management's Discussion and Analysis of Financial Condition and Results of Operations--Forward-Looking Statements and Risk Factors."


 2

     

 

TABLE OF CONTENTS

ITEM
 
 
PAGE


PART I

1.
Business
 
4-26
 
Executive Officers of the Company
 
27-28
 
 
 
 
2.
Properties
 
29-30
 
 
 
 
3.
Legal Proceedings
 
30-31
 
 
 
 
4.
Submission of Matters to a Vote of Security Holders
 
31
 
 
 
 

PART II

5.
Market for the Registrant's Common Stock and Related Stockholder Matters
 
 
32
 
 
 
 
6.
Selected Financial Data
 
33
 
 
 
 
7.
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
 
34-77
 
 
 
 
7A.
Quantitative and Qualitative Disclosures About Market Risk
 
78
 
 
 
 
8.
Financial Statements and Supplementary Data
 
79-133
 
 
 
 
9.
Changes in and Disagreements With Accountants on Accounting
 
 
 
and Financial Disclosure
 
134
 
 
 
 
9A.
Controls and Procedures
 
134


PART III

10.
Directors and Executive Officers of the Registrant
 
135
 
 
 
 
11.
Executive Compensation
 
135
 
 
 
 
12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
 
135-136
 
 
 
 
13.
Certain Relationships and Related Transactions
 
136
 
 
 
 
14.
Auditor Fees
 
136

PART IV

15.
Exhibits, Financial Statement Schedules, and Reports on Form 8-K
 
137



SIGNATURES

 
Signatures
 
138-139



3
     

  

PART I

ITEM 1. BUSINESS

CORPORATE PROFILE

Eastman Chemical Company ("Eastman" or the "Company"), a global chemical company engaged in the manufacture and sale of a broad portfolio of chemicals, plastics, and fibers, began business in 1920 for the purpose of producing chemicals for Eastman Kodak Company's ("Kodak's") photographic business. The Company was incorporated in Delaware in 1993 and became an independent entity as of December 31, 1993, when Kodak spun off its chemicals business. The Company's headquarters and largest manufacturing site are located in Kingsport, Tennessee.

Eastman is the largest producer of polyethylene terephthalate ("PET") polymers for packaging based on capacity share and is a leading supplier of raw materials for paints and coatings, inks and graphic arts, adhesives, textile sizes, and other formulated products, and of cellulose acetate fibers. Eastman has 35 manufacturing sites in 16 countries that supply major chemicals, fibers, and plastics products to customers throughout the world. In 2003, the Company had sales revenue of $5.8 billion, an operating loss of $267 million, and a net loss of $270 million. Included in 2003 results were asset impairments and restructuring charges, goodwill impairments and other operating income of $489 million, $34 million and $33 million, respectively. Loss per diluted share was $3.50.
 
The Company’s products and operations are managed and reported in six operating segments. Effective January 1, 2002, the Company implemented a divisional structure that aligned the businesses into two divisions; Eastman and Voridian. On January 1, 2003, the Company realigned the divisional structure to add the Developing Businesses Division, and reclassified its sales, operating earnings, and assets from Eastman Division. Eastman Division consists of the Coatings, Adhesives, Specialty Polymers, and Inks ("CASPI") segment, the Performance Chemicals and Intermediates ("PCI") segment and the Specialty Plastics ("SP") segment. Voridian Division contains the Polymers segment and the Fibers segment. Developing Businesses Division contains the Developing Businesses segment. See Note 20 to the Company’s consolidated financial statements for certain financial information related to the Company’s operating segments.

EASTMAN DIVISION

Business and Industry Overview

Operating in a variety of markets with varying growth prospects and competitive factors, the segments in Eastman Division manufacture a diverse portfolio of specialty chemicals and plastics that are used in a wide range of consumer and industrial markets. Eastman Division has 31 manufacturing sites in 14 countries. It is focused on providing its customers with chemicals and plastics products that meet their evolving needs. Eastman Division is comprised of the following segments: CASPI, PCI, and SP, which are more fully discussed below.

The CASPI segment generally competes in the markets for raw materials for paints and coatings, inks and graphic arts, adhesives and other formulated products. Growth in these markets in North America and Europe typically is at or slightly below economic growth in general, due to the wide variety of end uses for these applications and dependence on the economic conditions of the markets for durable goods, packaged goods, automobiles, and housing. Higher growth sub-markets exist within North America and Europe, driven primarily by increasing governmental regulation. For example, industry participants are promoting products and technologies primarily designed to reduce air emissions. Growth outside of North America and Europe is substantially higher, driven primarily by the increasing requirements of industrializing economies.

The PCI segment competes in diverse markets for its performance chemicals and intermediates chemicals offerings. Performance chemicals products are specifically developed based on product performance criteria, which make market quantification difficult. Instead, the focus in this market is on specific opportunities for value-added products and market size. Growth opportunities and other industry characteristics are a function of the level and extent to which a producer chooses to participate in niche opportunities driven by these customer specifications. For PCI intermediates products, the markets are varied, from durables to food products to pharmaceuticals and, although opportunities for differentiation on service and product offerings exist, these products compete primarily on price.

 4

     

 

 
The SP segment competes in the market for the development of plastics that meet specific performance criteria, typically determined on an application-by-application basis. Development is dependent upon a manufacturer’s ability to design products that achieve specific performance characteristics determined by the customer, while doing so either more effectively or more efficiently than alternative materials such as polycarbonate ("PC") and acrylic. Increases in market share are gained through the development of new applications, substitution of plastic for other materials, and particularly, displacement by plastic resins in existing applications. The SP segment engages in the production of specialty copolyesters and plastic sheeting and cellulose esters and cellulose plastics. The Company estimates that the market growth for copolyesters, which has historically been high due to the relatively small market size, will be higher than general economic growth due to displacement opportunities. Eastman believes that the cellulosic plastics markets will be flat, or, at best, equal to the rate of growth of the economy in general.

Strategy

The Company’s objectives for Eastman Division are to improve gross margins, emphasize growth in earnings by targeting core businesses, and build capabilities for future growth. The key elements of this strategy include:

·       Improve Gross Margins
 
The Company continues to evaluate its portfolio of products and businesses, which has resulted in the exiting of certain products and businesses. The Company expects further restructuring and divestiture actions, which could result in additional product lines or businesses being removed from its portfolio to improve overall profitability. In addition, the Company anticipates this evaluation could lead to further consolidation of manufacturing facilities to improve profitability.

The Company intends to continue to implement historically successful initiatives to eliminate inefficiencies and unnecessary costs, as well as improve manufacturing processes, all with the goal of improving the cost structure of Eastman Division segments. Among these initiatives will be continued efforts to implement selling price increases to offset raw material and energy cost increases. Also, Eastman Division will continue to expand the use of shared services across segments, including improved utilization of information technology, for productivity gains and cost savings. Eastman Division will also continue to implement a Six Sigma* quality improvement program aimed at reducing costs, improving customer satisfaction, and improving efficiency through reduction of variations and defects.

Through the restructuring, divestiture, consolidation, price increases, and cost savings actions, Eastman Division expects to improve operating earnings.

*Six Sigma is a trademark of Motorola, Inc.

·       Exploit Growth Opportunities in Core Businesses
 
Ø    Develop New Specialty Products and Expand into New Markets
 
The Company believes that it is a market leader based on sales in a number of Eastman Division’s product lines, and is focused on growth through continued innovation and displacement of competitive products with offerings that provide greater functionality or better value. Recent examples of the continued focus on the development of new and innovative products are DuraStar Ô polymer, Embrace Ô shrink film, and Provista Ô copolymer in the SP segment.

Ø    Leverage Opportunities Created by the Broad Product Line
 
Eastman Division is able to offer a broad array of complementary products that customers would otherwise need to obtain from multiple manufacturers. This integrated platform should allow Eastman Division to further benefit from advancements and developments with respect to one product line by applying them to other product lines. For example, efficiency is created through the operation of large plants that produce numerous products related to different segments. This situation allows a customer to place an order for multiple products, which may be produced by different segments, and have them delivered from the same location, reducing costs and ordering time.

 5

     

 

 
Ø    Pursue Opportunities for Business Development and Diversification
 
Eastman Division currently has in place, and continues to pursue, opportunities for joint ventures, equity investments and other alliances. These strategic initiatives are expected to diversify and strengthen businesses by providing access to new markets and high-growth areas as well as providing an efficient means of ensuring that Eastman is involved in and supportive of technological innovation in or related to the chemicals industry. The Company is committed to pursuing these initiatives in order to capitalize on new business concepts that differentiate it from other chemical manufacturers and that will provide incremental growth beyond that which is inherent in the chemicals industry and at lower capital investment requirements. For example, in 2003, Eastman entered into a joint venture with Qilu Eastman Specialty Chemical Ltd., located in Zibo City, China. When construction on this plant is complete, it will produce Texanol Ô ester alcohol coalescing aid for the paint market within the CASPI segment and Texanol Ô iso butyrate ("TXIB Ô ") plasticizer for the glove and flooring markets within the PCI segment.

CASPI SEGMENT

·       Overview

Through the CASPI segment, Eastman Division manufactures binders, liquid vehicles, pigment concentrates and additives, unsaturated polyester resins and polyester and acrylic emulsions, which are integral to the production of paints and coatings, inks and graphic arts, adhesives and other formulated products. The CASPI segment focuses on producing raw materials rather than finished products in order to develop long-term, strategic relationships and achieve preferred supplier status with its customers. In 2003, the CASPI segment had sales revenue of approximately $1.6 billion, which represented 23% of Eastman’s total sales and 41% of Eastman Division’s total sales.
 
·       Products

The CASPI segment manufactures raw materials, additives and specialty polymers, primarily for the paints and coatings, inks and graphic arts, adhesives and other markets. The CASPI segment's products consist of:
 
Ø    Coatings Additives and Solvents

Additives, such as cellulosic polymers, Texanol Ô ester alcohol and chlorinated polyolefins, enhance the performance and aesthetic appeal of paints and coatings. These products are used in architectural latex paints and industrial and automotive OEM / refinish coatings to improve film formation and durability, metallic flake orientation, and adherence to plastic substrates. Solvents, which consist of ester, ketone, glycol ether and alcohol solvents, are used in both paints and inks to maintain the formulation in liquid form for ease of application. Environmental regulations that impose limits on the emission of hazardous air pollutants continue to impact coatings formulations requiring compliant coatings raw materials. Eastman’s coatings additives and solvents are used primarily in compliant coatings, such as waterborne (latex) and high solids coatings, and additional products are under development to meet the growing demand for environmentally friendly paints. These product lines comprised 31% of the CASPI segment’s total sales for 2003.
 
Ø    Resins and Monomers

Resins and monomers products are sold primarily to the paint and coatings industry in such applications as architectural, industrial and original equipment manufacturer ("OEM"). The Company is the second largest merchant supplier of coatings resins in North America and Europe with the most comprehensive product offerings in the industry. The Company’s products include solvent-borne polymers (alkyd, polyester, and solution acrylics), waterborne polymers (latex and other waterborne polymers), resins and curatives for powder coatings (carboxyl, hydroxyl, and curing agent) and radiation-curable polymers and acrylic monomers (acrylic acid and esters of acrylic acid). In addition, these products are used in other industries such as textiles, construction, and personal care. These product lines comprised 29% of the CASPI segment’s total sales for 2003.

 6

     

 

Ø    Adhesives Raw Materials

The adhesives product line consists of hydrocarbon resins, rosins resins, resin dispersions, and polymer raw materials. These products are sold to adhesive formulators and tape and label manufacturers for use as raw materials in hot melt and pressure sensitive adhesives and as binders in nonwoven products (such as disposable diapers, feminine products and pre-saturated wipes). Eastman has a leadership position in hydrogenated gum rosins used in adhesive and chewing gum applications. Eastman offers the broadest product portfolio of raw materials for the adhesives industry, ranking as the second largest global supplier. These product lines comprised 26% of the CASPI segment’s total sales for 2003.
 
Ø    Inks and Graphic Arts

Inks and graphic arts products consist of pigments, resins, liquid components and additives, used in inks formulation for a variety of substrates and printing processes to offer such performance enhancement as durability, printability, adhesion to substrate, drying speed and security. The end use applications include brochures, newspapers, magazines, beverage cans and flexible packaging. The Company is the leading merchant supplier of ink resins in the world. These product lines comprised 14% of the CASPI segment’s total sales for 2003.
 
·       Strategy

A key element of the CASPI segment growth strategy is the continued development of innovative product offerings, building on proprietary technologies, in high-growth markets and regions that meet customers’ evolving needs and improve the quality and performance of customers’ end products. Eastman Division believes that its ability to leverage its broad product line and research and development capabilities across this segment make it uniquely capable of offering a broad array of solutions for new and emerging markets.

The CASPI segment is focused on the expansion of the coatings additives and solvents product offerings into other high-growth areas. These include areas with growth due to specific market trends and product developments, such as high solids coatings and water-based products, as well as growth in geographic areas due to the level and timing of industrial development. The Company's global manufacturing presence and future joint venture operation for coatings additives and solvents products at Zibo City, China, positions it to take advantage of areas of high industrial growth.

The CASPI segment is focused on the expansion of the adhesives raw materials product offerings into other high-growth areas. Additionally, within this group of product lines, the CASPI segment has an ongoing program to realize significant savings through the consolidation of plant operations, outsourcing and other projects that leverage best manufacturing practices, infrastructure, and business processes. For example, this effort includes the previously announced consolidation of the Savannah, Georgia facility to a modified Franklin, Virginia facility. Also, as part of the CASPI segment’s efforts to improve profitability, it commenced the consolidation of certain production assets at its plant in Jefferson, Pennsylvania, which should positively contribute to operating results. Additionally, the segment should continue to realize earnings growth in Asia through its joint venture operation in Nanjing, China.

Many of the assets associated with the inks and graphic arts and resins and monomers product groups were acquired between 1998 and 2000. Despite the Company’s efforts to improve these product lines' financial performance, they have experienced continued operating losses and deteriorating market conditions. In the third quarter of 2003, the Company decided to pursue alternative strategies regarding these product lines and assets. As a result of this change in strategy, these product lines and assets are targeted for restructuring, divestiture, or consolidation.

In the future, the Company intends to continue to leverage its resources to strengthen its innovation pipeline through improved market connect and the expanded use of proprietary products and technologies. Although sales and application development is often specialized by end-use market, developments in technology may be successfully shared across all end uses. In addition, new product offerings and manufacturing assets are shared across multiple end uses.
 

 7

     

 

 
·       Customers and Markets

As a result of the variety of end uses for its products, the customer base in the CASPI segment is broad and diverse. This segment has more than 3,000 customers around the world and 80% of its sales revenue in 2003 was attributable to approximately 250 customers. Eastman Division focuses on establishing long-term, customer service oriented relationships with its strategic customers in order to become their preferred supplier. Eastman Division anticipates significant growth potential in its ability to leverage these relationships to provide sales opportunities in previously underserved markets, as well as expand the scope of its value-added services. However, from time to time, customers decide to vertically integrate their own processes and internally develop products or diversify their sources of supply that had been provided by Eastman. Growth in these markets in North America and Europe typically coincide with economic growth in general, due to the wide variety of end uses for these applications and their dependence on the economic conditions of the markets for durable goods, packaged goods, automobiles, and housing.

·       Competition

Competition within the CASPI segment markets varies widely depending on the specific product or product group. Because of the depth and breadth of its product offerings, particularly in the coating additives and solvents and adhesives raw materials product lines, Eastman does not believe that any one of its competitors presently offers all of the products that it manufactures within the CASPI segment. However, many of the Company’s competitors within portions of its CASPI segment are substantially larger companies, such as The Dow Chemical Company ("Dow"), BASF Corporation ("BASF"), and Exxon Mobil Corporation, which may have greater financial and other resources than those of Eastman. Additionally, within each market in this segment, the Company competes with other smaller, regionally focused companies that may have advantages based on location, local market knowledge, manufacturing strength in a specific product, or other factors. At any time, any one or more of these competitors could develop additional products that compete with, or that may make obsolete, some of Eastman’s current product offerings.

Eastman does not believe that any of its competitors is dominant within the CASPI segment's markets. Further, the Company attempts to maintain competitive advantages through its level of vertical integration, breadth of product and technology offerings, low-cost manufacturing position, consistent product quality, and process and market knowledge. In addition, Eastman attempts to leverage its strong customer base and long-standing customer relationships to promote substantial recurring business, further strengthening its competitive position.

PCI SEGMENT
 
·       Overview

The Company’s PCI segment manufactures diversified products that are used in a variety of markets and industrial and consumer applications, including chemicals for agricultural intermediates, fibers, food and beverage ingredients, photographic chemicals, pharmaceutical intermediates, polymer compounding and chemical manufacturing intermediates. The PCI segment also offers custom manufacturing services through its custom synthesis business. The Company believes it has one of the industry’s broadest product offerings, ranging from custom manufacturing to high volume manufacturing of complex organic molecules for customers. In 2003, the PCI segment had sales revenue of $1.7 billion, which represented 24% of Eastman’s total sales and 43% of Eastman Division's total sales. PCI segment sales for 2003 included $495 million of interdivisional sales.

Because a portion of the PCI segment's sales are derived from higher margin, highly specialized products with niche applications, success in the PCI segment will require the Company to continue to innovate and develop new products and find new applications for its existing products. PCI intends to target high-growth specialty products, such as additives for food, personal care and pharmaceuticals, where it believes the highest returns can be generated. PCI is also concentrating its efforts on new uses for existing products, such as sucrose acetate isobutyrate ("SAIB") and specialty anhydrides. Some of Eastman Division's other products in this segment are more substitutable and price sensitive in nature, requiring the Company to operate on a lower cost basis while maintaining high quality products and customer service.
 
 

 8

     

 

 
·       Products

The PCI segment offers over 150 products to customers, many of whom are major producers in a broad range of markets. The following is a summary of key products:
 
Ø    Intermediates Chemicals

Eastman manufactures a variety of intermediates chemicals based on oxo and acetyl chemistries. Intermediates comprised approximately 77% of the PCI segment’s revenue for 2003. Approximately 73% of the revenue for intermediate chemicals are generated in North America. Sales in all regions are generated through a mix of the Company’s direct sales force and a network of distributors. The Company is the largest marketer of acetic anhydride in the United States, a critical component of analgesics and other pharmaceutical and agricultural products, and is the only U.S. producer of acetaldehyde, a key intermediate in the production of vitamins and other specialty products. Eastman manufactures the broadest range of oxo aldehyde derivatives products in the world. The PCI segment’s other intermediate products include plasticizers, glycols and polymer intermediates. Many of the products in this portion of the PCI segment are priced based on supply and demand of substitute and competing products. In order to maintain a competitive position, the Company strives to operate with a low- cost manufacturing base. Intermediate chemicals sales revenue is approximately 18% acetyl based, 30% oxo based, and 52% other intermediate chemicals.
 
Ø    Performance Chemicals

Eastman manufactures complex organic molecules such as diketene derivatives, specialty ketones, and specialty anhydrides for fiber and food and beverage ingredients, which are typically used in market niche applications. The Company also engages in custom manufacturing of complex organic chemicals where business is developed on a customer-by-customer basis after significant consultation and analysis. These niche and custom manufacturing products are typically priced based on the amount of value added rather than supply and demand factors. The Company also owns proprietary technology for the production of epoxybutene ("EpB Ô ") oxirane, an intermediate with growing use in pharmaceuticals and other small volume, high-value specialty products. Additionally, performance chemicals produces nonanoyloxybenzenesulfonate ("NOBS") bleach activator for a key customer. These product lines comprised 23% of the PCI segment’s total sales for 2003.

·       Strategy

A two-pronged strategy for success in the PCI segment focuses on continuing to develop and access markets with high-growth potential for the Company’s performance chemicals, while maintaining its competitive advantage as a low-cost, high quality and customer service oriented supplier of products to other chemicals customers. The Company engages in customer focused research and development initiatives in order to develop new products and find additional applications for existing products, both in response to, and in anticipation of, customer needs. The Company believes that this strategy will enable it to remain a leader in application-specific, higher margin PCI products. For example, Eastman has been successful in developing new applications for some of its existing PCI products such as Sustane Ô SAIB, which has long been used as a coatings additive and for inks end uses and has new applications in the U.S. as a stabilizer in citrus flavored drinks. Food and Drug Administration regulations now allow the use of SAIB for this application. In the future, the Company expects to continue to capitalize on applications such as these in biotechnology and in other industries, and intends to seek to create additional opportunities to apply its products in new and innovative ways.

In order to build on and maintain its status as a low-cost producer, Eastman continuously focuses on cost control, operational efficiency and capacity utilization to maximize earnings. The Company's highly integrated and world-scale manufacturing facilities position it to achieve its strategic goals. For example, the Kingsport, Tennessee manufacturing facilities allow the PCI segment to produce acetic anhydride and other acetyl derivatives from coal rather than natural gas or other petroleum feedstocks. Similarly, at the Longview, Texas facility, the PCI segment utilizes local ethane and propane supplies along with Eastman's proprietary oxo-technology in the world’s largest single-site, oxo-aldehyde manufacturing facility to produce a wide range of alcohols, esters and other derivatives products. These integrated facilities, combined with large scale production processes and continuous focus on additional process improvements, allow the PCI segment to remain cost competitive with, and for some products cost-advantaged over, its competitors.

 9

     

 

 
·       Customers and Markets

Because of the niche applications of the PCI segment’s performance chemical products, each individual product offering is tailored to specific end uses. Intermediates chemicals are generally more readily substitutable, and have a more identifiable potential customer base. In order to obtain a better understanding of its customers’ requirements, which in turn allows it to focus on developing application-specific products, the Company focuses on establishing long-term, partnership-oriented relationships with its customers. From time to time, customers decide to vertically integrate their own processes and internally develop products or diversify their sources of supply that had been provided by Eastman. Approximately 80% of the PCI segment’s sales revenue in 2003 was to 90 customers out of approximately 1,400 customers worldwide.

The PCI segment’s products are used in a variety of markets and end uses, including agrochemical, automotive, beverages, catalysts, nutrition, pharmaceuticals, coatings, flooring, medical devices, toys, photographic and imaging, household products, polymers, textiles and consumer and industrials. The markets for products with market-based pricing in the PCI segment are cyclical. This cyclicality is caused by periods of supply and demand imbalance, either when incremental capacity additions are not offset by corresponding increases in demand, or when demand exceeds existing supply. Demand, in turn, is based on general economic conditions, raw material and energy prices, consumer demand and other factors beyond the Company’s control. Eastman may be unable to increase or maintain its level of PCI sales in periods of economic stagnation or downturn, and future PCI results of operations may fluctuate from period to period due to these economic conditions. The Company believes many of these markets are arising from the "trough" of the cycle. Cyclicality is expected to remain a significant factor in the PCI segment, particularly in the near term, as existing capacity becomes absorbed and utilization rates increase from current levels. The Company believes that, as excess capacity is absorbed, it will be in a strong position to take advantage of the improved market conditions that accompany this cyclical upturn.
 
·       Competition

For the majority of the PCI segment's intermediates chemicals, there historically have been significant barriers to entry, primarily due to the fact that the relevant technology has been held by a small number of companies. As this technology has become more readily available, competition from multinational chemicals manufacturers has intensified. Eastman competes with these and other producers primarily based on price, as products are interchangeable, and, to a lesser extent, based on technology, marketing and other resources. Eastman’s major competitors for this part of the segment include large multinational companies such as Dow, Celanese AG, BASF, and Exxon Mobil Corporation. While some of the Company’s competitors within the PCI segment have greater financial resources than Eastman, which may better enable them to compete on price, the Company believes it maintains a strong position due to a combination of its scale of operations, breadth of product line, level of integration and technology leadership.

For performance chemicals and other niche applications, there are typically few equivalent products, as the products and their applications are very specialized. For this reason, producers compete with others only to the extent they attempt to manufacture similar or enhanced products that share performance characteristics. Barriers to entry in this market have typically been technology; cost due to raw material, integration, size or capacity issues; and customer service. On a general level, Eastman’s primary competitors for performance chemicals are multinational specialty chemical manufacturers such as Ciba Specialty Chemicals Holding Inc., Clariant International Ltd. and Lonza Group Ltd. Recently, an increasing number of producers, primarily from China and India, have been entering the market primarily on price, benefiting from low-cost labor, less stringent environmental regulations and government support. These producers may later focus on improving their product quality and customer service. Although the entry of new competitors is impacting the pricing of existing products, Eastman believes it currently maintains a competitive advantage over these competitors due to the combination of its research and development applications, low-cost manufacturing base due to vertical integration, long-term customer relations and related customer service focus, as well as the fact that these suppliers are frequently unable to produce products of consistently high quality.

 10

     

 

 

SP SEGMENT
 
·       Overview

The SP segment produces highly specialized copolyesters and cellulosic plastics that possess unique performance properties for value-added end uses such as appliances, store fixtures and displays, building and construction, electronic packaging, medical devices and packaging, personal care and cosmetics, performance films, tape and labels, biodegradeables, fibers/nonwovens, photographic and optical film, graphic arts and general packaging. In 2003, the SP segment had sales revenue of $608 million, which represented approximately 9% of Eastman’s total sales and 16% of Eastman Division’s total sales.

Specialty copolyester products within the SP segment, including modified specialty copolyesters such as Eastar Ô and Spectar Ô , have higher than industry average growth rates. Eastman’s specialty copolyesters, which generally are based on Eastman's market leading supply of cyclohexane dimethanol ("CHDM") modified polymers, typically fill a market position between polycarbonates and acrylics. While polycarbonates traditionally have had some superior performance characteristics, acrylics have been less expensive. Specialty copolyesters combine superior performance with competitive pricing and are taking market share from both polycarbonates and acrylics as their performance characteristics continue to improve and their pricing remains competitive. The specialty copolyesters market also includes environmentally friendly specialty copolyesters and plastic sheeting that allow for flexibility in designing signs and displays.

The SP segment also includes cellulosic plastics, which has historically been a steady business with strong operating margins for the Company, and also includes what Eastman believes is a market-leading position in North American cellulose esters for tape and film products and cellulose plastics for molding applications.

Eastman has the ability within its SP segment to modify its polymers and plastics to control and customize their final properties, creating numerous opportunities for new application development, including the expertise to develop new materials and new applications starting from the molecular level in the research laboratory to the final designed application in the customer’s plant. In addition, the SP segment has a long history of manufacturing excellence with strong process improvement programs providing continuing cost reduction. Manufacturing process models and information technology systems support global manufacturing sites and provide monitoring and information transfer capability that speed up the innovation process.
 
·       Products

The SP segment’s key products are:
 
Ø    Engineering and Specialty Polymers

Engineering and specialty polymers accounted for approximately 45% of the SP segment’s 2003 sales revenue. Engineering and specialty polymers include a broad line of polyesters, copolyesters, alloys, and cellulosic plastics that are sold to a diverse and highly fragmented customer base in numerous market segments on a global basis. Approximately 50% of the revenues from engineering and specialty polymers are generated in North America. Sales in all regions are generated through a mix of the Company’s direct sales force and a network of distributors. Engineering and specialty polymers products are sold into three sectors: durable goods (components used in appliances and to a lesser degree, automobiles); medical goods (disposable medical devices, healthcare equipment and instruments, and pharmaceutical packaging); and personal care and consumer goods (housewares, cosmetics, tools, toys and a variety of other uses). Engineering and specialty polymers sales revenue is approximately 50% to personal care and consumer goods markets, approximately 30% to durable goods markets, and approximately 20% to medical goods markets.

Engineering and specialty polymers products are heavily specification-driven. The Company works with original equipment manufacturing companies to enable product designers to design polymers for a specified use in a specified product. Although the average life cycle of many of these products is shrinking over time, the Company works to identify uses for the polymers in products that will have multi-year lives. In working with original equipment manufacturing companies on new consumer product designs, new polymer products are often developed for use in a particular type of end-use product. There are numerous variations of polymer products sold under ten different trade names.

 11

     

 

 
The Company competes in market niches requiring polymers with combinations of clarity, toughness and chemical resistance.
 
Ø    Specialty Film and Sheet

Approximately 30% of the SP segment’s 2003 revenue resulted from sales of specialty film and sheet products. The key markets for specialty film and sheet are packaging, displays, and building and construction. The SP segment’s specialty film and sheet annual sales revenue is approximately 50% to packaging, 45% to displays and 5% to building and construction.

Direct customers are film and sheet producers, but extensive marketing activities target customers in end-use markets. The Company is a major supplier of resins to the specialty film and sheet markets, but with less than 10% of the global specialty film and sheet market, substantial growth opportunities exist for Eastman. The growth strategy is to penetrate new market segments or geographies and offer a substitute for other materials by providing an improved or lower cost solution or design flexibility that enhances the growth potential of the company’s customers.

Specialty film and sheet is sold in the packaging markets including medical and electronic component trays, shrink label films and multilayer films. Copolyester use in these markets is relatively mature with the exception of shrink label films. Competitive materials in these markets are typically PET polymers, PVC and polystyrene. Eastman’s primary brands for these markets are Eastar Ô and Embrace Ô copolyesters.

In the display market, Spectar Ô copolyester is marketed primarily for point of purchase displays including indoor sign and store fixtures. Eastar Ô copolyester is marketed into the graphics market. Copolyester use in these markets is expected to grow above market rates. Competitive materials in these markets are typically PET polymers, PVC, polymethylmethacrylate ("PMMA"), and PC.

The building and construction market is a new focus for specialty film and sheet beginning with Kelvx Ô resin for the sign market. The Company plans to seek a number of new opportunities within this market. The use of copolyester in these markets is expected to grow significantly above market rates. Competitive materials in these markets are typically PMMA and PC.
 
Ø    Packaging, Film and Fiber

Packaging, film and fiber products, which represented approximately 25% of the SP segment’s 2003 revenue, include a range of specialty polymer products for markets such as photographic, optical film, biodegradable food service packaging and industrial film, nonwovens and tapes/labels. Customers are typically manufacturers of film and fiber products, employing a range of processing technologies, including film and sheet melt extrusion, thermoforming, solvent casting, fiber extrusion and extrusion coating. These films and fibers products are further converted to produce value-added products, such as photographic film, adhesive tape, or nonwoven articles, which are sold as branded items. Products include cellulose esters, copolyesters, specialty polyesters and concentrates/additives. Packaging, film and fiber sales consist of 75% photographic and optical film, 15% tapes and labels, and 10% biodegradable, packaging, industrial film and nonwovens. Currently, North America comprises 85% of sales revenue for packaging, film and fiber. Competition is primarily from other producers of copolyesters and cellulose esters.

 12

     

 

 
·       Strategy

The SP segment is focused on innovation and marketing and, within the past three years, has commercialized over 20 new products. Eastman Division believes that the continued differentiation of its current offerings and introduction of new products will provide access to previously underserved markets, such as its introduction of polymers with higher heat resistance and products designed to be environmentally friendly. Additionally, the SP segment develops product enhancements in order to respond to specific market needs, and expects this to result in increased market penetration for existing products. The SP model of innovation leverages a unique and growing portfolio of cellulosics and specialty copolyesters, such as Embrace Ô for shrink film, Provista Ô for retail displays, Durastar Ô for cosmetic and household applications, and Kelvx Ô resin for higher temperature sheet applications. This product portfolio is focused on substitution for other materials, such as PC, acrylic, or PVC, in applications that require clarity, toughness and chemical resistance.

The Company expects to continue to pursue profitable alliances with strategic customers to engage in branding in order to increase name recognition, to offer one of the industry’s widest varieties of products and to maintain its focus on high-growth markets, all with the intent of maximizing the return from its recognized brand position in its SP products.
 
·       Customers and Markets

The SP segment produces highly-specialized copolyesters, cellulosic plastics and compounded polyethylene plastics that possess performance properties for value-added end uses such as appliances, in-store fixtures and displays, building and construction, electronics and electronic packaging, medical packaging, personal care and cosmetics, performance films, tapes and labels, biodegradeables, fibers/nonwovens, photographic and optical, graphic arts and general packaging. The customer base in the SP segment is broad and diverse, consisting of over 900 companies worldwide in a variety of industries. Approximately 80% of the SP segment’s 2003 revenue was attributable to approximately 75 customers. The SP segment seeks to develop mutually beneficial relationships with its customers throughout various stages of product life cycles. By doing so, Eastman Division is better able to understand its customers’ needs as those customers develop new products, and more effectively bring new solutions to market. Additionally, Eastman Division builds additional brand loyalty, lengthening the time before its products compete based entirely on price.
 
·       Competition

Competition for Eastman Division’s products in the SP segment varies as a function of where the products are in their life cycle. For example, the SP segment's products in the introduction phase of the life cycle compete mainly on the basis of performance. As products begin to advance in the life cycle, and substitute products come into existence, the basis of competition begins to shift, taking into account factors such as price, customer service and brand loyalty. At maturity, where one or more competitors may have equivalent products in the market, competition is based primarily on price. Many large, well-recognized manufacturers produce substitute products of different materials, some of which may offer better performance characteristics than those of the Company, and others of which may be offered at a lower price.

 13

     

 

 
Eastman Division has a full array of products moving across the SP segment’s life cycle. For example, two commonly used plastics materials in the heavy gauge sheet market are acrylic and polycarbonate. In general, acrylics are lower in cost, but polycarbonates provide higher performance. Eastman’s products capture portions of both markets. Customers of the SP segment can select from products that offer improved performance over acrylics at a slightly higher cost, or products that are lower cost than polycarbonates while still possessing excellent performance properties. In this way, the SP segment is able to meet the industry need for low-cost, high performance plastics materials and maintain a significant advantage over its competitors. With regard to engineering and specialty polymers products, the Company competes in market niches requiring polymers with combinations of clarity, toughness and chemical resistance. Eastman’s primary competitors for engineering and specialty polymers are polymer companies such as Bayer AG, Dow, GE Plastics, and others, including PC, acrylic and clear acrylonitrile butadiene styrene ("ABS") producers in regions outside North America. Specialty film and sheet competitors include SK Chemical Industries ("SK") and Radici Chimica Deutschland GmbH ("Radici") for PETG. Competition for packaging, film and fiber products is primarily from other producers of copolyester such as, SK, KoSa, Gruppo Mossi & Ghisolfi ("M&G"), Nan Ya, and Wellman, Inc. ("Wellman"); producers of cellulose ester polymers such as Acetati and Daicel Chemical Industries, Ltd.; or producers of biodegradable polymers such as, Cargill Dow LLC, BASF, and DuPont. Intermaterial competition with other polymers such as acrylic, PVC, polystyrene, polypropylene and PC is also significant in several markets and applications. Channels to market include corporate accounts, direct sales, e-commerce, and distributors.

Eastman Division believes that it maintains competitive advantages over its competitors in the SP segment throughout the product life cycle. At product introduction, Eastman Division’s breadth of offerings combined with its research and development capabilities and customer service orientation enable it to quickly bring a wide variety of products to market. As products enter the growth phase of the life cycle, Eastman Division is able to continue to leverage its product breadth by receiving revenues from multiple sources, as well as retaining customers from long-term relationships. As products become price sensitive, Eastman Division can take advantage of its scale of operations and vertical integration to remain profitable as a low-cost manufacturer.

Eastman Division believes it has competitive advantages in copolyester and cellulose ester plastics. However, new competitors, such as SK in Asia and Radici in Europe, have entered the copolyester marketplace. These new competitors cannot yet produce the wide variety of specialty copolyesters offered by Eastman Division or the same level of technical assistance. Additionally, Eastman Division is committed to increasing the utilization of current capacity and maintaining its cost advantages obtained from its scale of operations and manufacturing experience. There can be no assurance, however, that the SP segment will be able to maintain this competitive advantage and if it is unable to do so, its results of operations could be adversely affected.

EASTMAN DIVISION GENERAL INFORMATION

Sales, Marketing and Distribution

The Company markets Eastman Division products primarily through a global sales organization, which has a presence in the United States as well as in over 35 other countries around the world. Eastman Division has a number of broad product lines which require a sales and marketing strategy that is tailored to specific customers in order to deliver high quality products and high levels of service to all of its customers worldwide. Judgment and process knowledge are critical in determining the application of Eastman Division’s products for a particular customer. Through a highly skilled and specialized sales force that is capable of providing customized business solutions for each of its three operating segments, Eastman Division is able to establish long-term customer relationships and strives to become the preferred supplier of specialty chemicals and plastics.

Eastman Division’s products are marketed through a variety of selling channels, with the majority of sales being direct and the balance sold primarily through indirect channels such as distributors. International sales tend to be made more frequently through distributors than domestic sales. Eastman Division's customers throughout the world have the choice of obtaining products and services through Eastman's website, www.eastman.com, through any of the global customer service centers, or through any of Eastman's direct sales force or independent distributors. Customers who choose to use the Company’s website can conduct a wide range of business transactions such as ordering online, accessing account and order status, and obtaining product and technical data.

 14

     

  

Eastman is an industry leader in the implementation and utilization of e-business technology for marketing products to customers and was one of the first chemical companies to offer this capability. Eastman views this as an opportunity to increase supply chain efficiency by having an enterprise resource-planning platform with connectivity to customers. These sales and marketing capabilities combine to reduce costs and provide a platform for growth opportunities for the Company by providing potential customers new methods to access Eastman’s products.

Eastman Division’s products are shipped to customers directly from Eastman's manufacturing plants as well as from distribution centers worldwide, with the method of shipment generally determined by the customer.

Intellectual Property and Trademarks

The Company considers its Eastman Division-related intellectual property portfolio to be a valuable corporate asset which it expands and vigorously protects globally through a combination of patents that expire at various times, trademarks, copyrights and trade secrets. The Company’s primary strategy regarding its Eastman Division-related intellectual property portfolio is to protect all innovations that provide its segments with a significant competitive advantage. The Company also derives value from its intellectual property by actively licensing and selling patents and expertise worldwide. In addition, when appropriate, the Company licenses technology from third parties that complement Eastman Division’s strategic business objectives. Neither Eastman Division’s business as a whole nor any particular segment is materially dependent upon any one particular patent, trademark, copyright, or trade secret. As a producer of a broad and diverse portfolio of chemicals and plastics, Eastman Division’s intellectual property and trademarks relate to a wide variety of products and processes. As the laws of many foreign countries do not protect intellectual property to the same extent as the laws of the United States, Eastman Division cannot assure that it will be able to adequately protect all of its intellectual property assets.

Research and Development

Eastman Division devotes significant resources to its research and development programs, which are primarily targeted towards three objectives:

·    improving existing products and processes to lower costs, improve product quality and reduce environmental impact;
 
·    developing new products and processes; and
 
·    developing new product lines and markets through applications research.
 
In the last several years, research and development has developed a number of new copolyesters for specific market applications and has improved the Company’s specialty polyester manufacturing expertise. There has been a significant expansion in coatings and adhesives technologies, resulting in a number of new products in the waterborne and emulsion resins area. Eastman Division has discovered and is developing Bophoz Ô , a catalyst that has the potential to provide intermediates for medicinal drugs.

VORIDIAN DIVISION

Business and Industry Overview

The Voridian Division consists of the Polymers segment and the Fibers segment. The Polymers segment contains two principal product lines – polyethyleneterephthalate ("PET") polymers and polyethylene ("PE"). The PET polymers product line is large, global in scope and has the largest capacity share of all competitors in the polyesters for packaging industry. The PE product line is primarily North American in scope and has a relatively small market share. The Fibers segment is primarily made up of acetate tow, acetate yarn, and acetyl chemical products. Voridian is one of the two largest producers of acetate tow and acetate yarn, worldwide. Globally positioned to serve its growing markets, Voridian has eight manufacturing plants in six countries as well as two contract manufacturing arrangements in Asia.

PET polymers for the packaging industry are clear, lightweight plastics used in applications such as beverage containers, edible oil and other food containers, film and sheet. Packages made from PET polymers are characterized by their light weight, high strength, durability, clarity, low cost, safety and recyclability.

 15

     

   

 
Voridian’s PE products consist of low density polyethylene ("LDPE") and linear low density polyethylene ("LLDPE") and are used in extrusion coating, film and molding applications.

Both the PET polymers and PE product lines compete to a large degree on price. Both can also be characterized as capital intensive. Success in each depends largely on attaining low cost through manufacturing scale, capacity utilization, access to reliable and inexpensive utilities, energy and raw materials, and efficient manufacturing processes.

The acetate tow market, which Voridian believes is approximately a $2 billion market annually, grew at a rate of approximately 2.0% annually from 1998 to 2003. Voridian estimates that, for 2003, the acetate tow market grew by 0.5% to 1% as compared to 2002. Three trends are contributing to the current increase in demand and are expected to do so in future years:
 
·    a decline in the use of polypropylene tow in China and its replacement by acetate tow;
 
·    requirements in the European Union, Brazil and China to reduce tar deliveries in cigarettes, resulting in cigarette filter manufacturers producing longer cigarette filters; and
 
·    an increase in production of filtered cigarettes worldwide.

If polypropylene tow usage in China were totally replaced by acetate tow over the next five years, the global market for acetate tow could grow at a rate of approximately 1% per year. Increased filter lengths due to legislated lower tar deliveries in the European Union, Brazil and China could increase the expected growth rate to 1% to 2% per year for the next few years. After polypropylene tow is replaced in China, the expected growth rate for worldwide demand is approximately 0.5% to 1.0% per year. Included within these estimates are adjustments for the expected decrease in cigarette production in the United States, which is expected to be more than offset by a greater increase in production overseas.

Voridian estimates that the market for acetate yarn was approximately $300 million in 2003. The demand for acetate yarn has declined 40% since 1998 due to the impact of business casual fashions and the substitution of polyester yarn. This decrease in demand has led to associated decreases in price and profitability throughout the market. The market demand has been steady for the past two years and is expected to continue at these levels for the next two to three years.

Strategy

Voridian participates in price sensitive markets where product performance is a requirement for involvement and low cost is the primary driver for success. As a result, the division’s strategic goals focus on maintaining quality products, operational excellence, and its global position as one of the most efficient producers of polymers and fibers in the world. The key elements of this strategy include:
 
·       Operational Efficiency

Voridian is a global leader in market share in two of its major product markets and expects to leverage its product knowledge, experience and scale to further reduce production costs and increase output. As a highly integrated major PET polymers producer and one of only a few integrated acetate fiber producers, Voridian intends to develop further efficiencies to enhance its cost position.
 
·       Superior Process Technology

Voridian has a demonstrated expertise in developing and implementing improved process technologies. Through efficient use of research and development, Voridian intends to continue that trend and to develop increasingly efficient technologies with the goal of lowering manufacturing costs and improving operating margins.
 
·       Capital Efficiency

Voridian intends to expand its production capabilities in a capital-efficient manner. Efforts will include maximizing capacity utilization at existing manufacturing facilities, reducing bottlenecks at those facilities, asset expansions utilizing improved process technologies, and smart growth through participation in strategic manufacturing alliances and contract manufacturing or toll arrangements.
 

 16

     

   

 
·       Quality and Innovation

Voridian’s product quality and innovation make it a recognized industry leader in the markets in which it participates. Through the efficient use of research and development, Voridian will continue to develop and commercialize new products where customer needs and consumer preference offer improved returns or increased market share.

POLYMERS SEGMENT
 
·       Overview

In 2003, the Polymers segment had revenues of $1.8 billion, which represented 26% of the Company’s total sales and 72% of Voridian’s total sales. The segment consists of two principal product lines, PET polymers and PE.

PET polymers production is vertically integrated back to the raw material paraxylene for a substantial majority of its capacity. Voridian’s PET polymers for packaging product line is the world’s largest based on capacity share; is the most global based on manufacturing sites; and is the broadest based on formula diversity. PET polymers for packaging are used in a wide variety of products including carbonated soft drinks, water, beer, personal care items and food containers that are suitable for both conventional and microwave oven use. Voridian has PET polymers manufacturing sites in the United States, Mexico, Argentina, Great Britain, Spain and the Netherlands. In addition, Voridian has contract manufacturing arrangements at two sites in Asia. Voridian competes primarily in North America, Latin America and Europe. The PE product lines are manufactured entirely in the United States and have a relatively small market share.
 
·       Products
 
Ø    PET Polymers

PET polymers are used in beverage and food packaging and other applications such as custom-care and cosmetics packaging, health care and pharmaceutical uses, household products and industrial. PET polymers offer fast and easy processing, superb clarity, excellent colorability and color consistency, durability and strength, impact and chemical resistance and high heat stability.
 
Ø    PE

The Polymers segment also offers a PE product line manufactured in the United States including LDPE and LLDPE. The LLDPE products are produced using the Company’s proprietary Energx Ô manufacturing technology for gas-phase polyethylene production. Voridian PE products are used primarily for extrusion coating, film and molding applications. The LDPE and LLDPE product lines accounted for approximately 20% of the Polymers segment’s sales revenue in 2003.
 
·       Strategy
 
Ø    Growth

Voridian intends to capitalize on the growth in the PET polymers industry with timely and efficient capacity additions including debottlenecking existing production processes, asset expansions, contract-manufacturing arrangements and manufacturing alliances. This smart growth strategy will rely on continuous process technology improvements from the efficient use of research and development.

 17

     

   

 
Ø    Innovation

Where driven by improved returns or increased market share, Voridian expects to continue to provide customers with innovative new products and incremental improvements in existing products. Voridian currently maintains the industry’s broadest product offering for PET polymers including: Voridian Aqua Ô polymer for the water bottle market, Heatwave Ô polymer for hotfill markets, Versatray Ô polymer for the dual ovenable tray market, Amberguard Ô polymer for the beer and pharmaceutical markets, Elegante Ô polymer for the cosmetics and personal care markets, Vitiva Ô polymer for ultraviolet (UV) light sensitive applications, and Voridian Ô polymers for a wide range of markets including carbonated soft drink and other food and beverage packaging applications.
 
Ø    Licensing

The company believes that the licensing of certain of its technologies, such as its EPTA Ô (purified terephthalic acid) technology, for PET polymers, and Energx Ô technologies, for PE, provides continuing revenue opportunities and intends to seek to expand these licensing efforts.
 
·       Customers and Markets

The largest 66 customers within the Polymers segment accounted for more than 80% of the segment’s total sales revenue in 2003. These customers are primarily PET polymer container suppliers to large volume beverage markets such as carbonated soft drinks, water and juice, with strong participation in custom areas such as food, liquor, sport and fruit beverages, health and beauty aids and household products. In 2003, the worldwide market for PET polymers, including containers, film and sheet, was over 9.5 million metric tons. Demand for PET polymers has grown briskly over the past several years, driven by its popularity as a substitute for glass and aluminum. PET polymers have already made significant inroads in soft drink and water bottles, and producers are currently targeting markets such as hot-fill and barrier containers for beer, soups and sauces. Industry analysts report that PET polymers consumption grew worldwide from 1.0 million metric tons in 1989 to approximately 8.9 million metric tons in 2002, a compound annual growth rate of 18.3%. Global demand for PET polymers is expected to grow approximately 10% annually over the next several years.

In the low-density polyethylene product line, Voridian is a significant producer of materials used in extrusion coating applications and is one of only two North American producers of acrylate copolymers. In the linear low-density polyethylene market, Voridian employs its proprietary Energx Ô technology to produce products that compete in higher strength film and packaging markets.
 
·       Competition
 
Ø    PET polymers

The strong growth in demand for PET polymers, coupled with ease of access to conventional manufacturing technology, has resulted in the presence of over 80 suppliers in this market in 2003, up from fewer than 20 in 1995. Voridian comes closest to being a global competitor with manufacturing sites in North America, Latin America and Western Europe as well as contract manufacturing arrangements in Asia. The level of competition, however, varies by region. Competition is primarily on the basis of price with product performance, quality, service and reliability being requirements for participation.

Industry pricing is strongly affected by raw material costs and capacity utilization. PET polymers global supply has exceeded demand since 1997 as a result of capacity being introduced into the market at a rate exceeding that of demand growth. While the demand for PET polymers continues to steadily increase, excess capacity, primarily in Asia, remains. Though other regions may approach a balanced supply/demand state in coming years, the excess Asian capacity is likely to impact PET polymers pricing worldwide.
 

 18

     

   

 
Ø    PE

Voridian is a niche polyethylene producer due to its size and ability to target specific markets. Competitive advantage in these markets is achieved via operating efficiencies and new product offerings. Some polyethylene producers are substantially larger than Voridian, and have greater market presence and resources devoted to polyethylene than Voridian. This may allow them, or other competitors, to price competing products at lower levels, or devote substantial resources to product development, that Voridian is unable or unwilling to match, which may at some point reduce Voridian’s polyethylene revenues.

Voridian intends to continue to develop and maintain competitive advantage through manufacturing process technology innovation, operational excellence, manufacturing integration, and the efficient execution of research and development.

FIBERS SEGMENT

·       Overview

The Fibers segment manufactures Estron Ô acetate tow and Estrobond Ô triacetin plasticizers, which are used primarily in cigarette filters; Estron Ô and Chromspun Ô acetate yarns for use in apparel, home furnishings and industrial fabrics; and acetate flake and acetyl raw materials for other acetate fiber producers. Voridian is one of the world’s two largest suppliers of acetate tow and has been a market leader in the manufacture and sale of acetate tow since it began producing the product in the early 1950’s. Voridian is also one of the world’s two largest producers of acetate yarn. In 2003, the Fibers segment had sales revenue of approximately $715 million, which represented 10% of the Company’s total sales and 28% of Voridian’s total sales.

Voridian’s long history and experience in the fibers markets are reflected in its operating expertise, both within the Company and in support of its customers’ processes. Voridian’s expertise in internal operating processes allows it to achieve a consistently high level of product quality, a differentiating factor in the industry. Further, Voridian’s fully integrated facilities allow it to reduce its dependence on necessary petrochemicals from third parties. Voridian management believes that all of these factors combine to make it a leader in performance and cost position.

Voridian’s high-quality products, technical expertise and superior customer service in the Fibers segment are its key competitive strengths. Voridian’s industry knowledge and knowledge of its Fibers segment customers’ processes allow it to assist its customers in maximizing their processing efficiencies, promoting repeat sales and mutually beneficial, long-term customer relationships. Voridian’s scale, strong customer base, long-standing customer relationships and expert technical service contribute to its market-leading position. Voridian’s goal is to build on these strengths to improve its strategic position.

·       Products

Voridian’s main products in the Fibers segment are acetate tow, acetate yarn, and acetyl chemical products.

Ø    Acetate Tow

Voridian manufactures acetate tow to customer specifications which are used to produce various filtration patterns for cigarettes.

Ø    Acetate Yarn

Voridian is a market leader offering over 300 types of acetate yarn. Chromspun Ô and Estron Ô acetate yarns are used in apparel, home furnishings and industrial applications. Voridian acetate yarn products have characteristics that allow for highly efficient mill processability. From a retail customer’s perspective, garments containing Estron Ô and Chromspun Ô yarns have a silky feel, rich color, supple drape, breathability and comfort. Chromspun Ô acetate yarn is available in more than 70 colors.

 19

     

 
 

Ø    Acetyl Chemical Products

Voridian’s acetyl chemicals are primarily comprised of acetate flake as part of its highly integrated production chain, along with acetylation-grade acetic acid and acetic anhydride for other acetate fiber producers. In addition, Voridian manufactures triacetin plasticizers for use by cigarette manufacturers as a bonding agent in cigarette filters.

·       Strategy

Voridian’s strategy in the Fibers segment is as follows:

Ø    Position for Growth
 
In the Fibers segment, Voridian focuses on high quality products, excellent customer service, operational efficiencies, and potential alliances to take advantage of global market growth.
 
Ø    Continue to Capitalize on Operating Expertise
 
The Fibers segment emphasizes incremental product and process improvements to continue to meet customers’ evolving needs and to maximize efficiencies in the supply chain through collaborative planning. The Fibers segment intends to further focus on refining its processes to lower manufacturing costs and provide additional product quality and operations improvements.
 
Ø    Maintain Cost-Effective Operations and Consistent Cash Flows
 
The Fibers segment expects to continue to operate in a cost effective manner, capitalizing on its scale and vertical integration, and intends to make further productivity and efficiency improvements through continued investments in research and development. The Company plans to reinvest in the Fibers business to continue to improve product performance and productivity in order to generate consistently strong cash flows.
 
·       Customers and Markets

The customer base in the Fibers segment is relatively concentrated, consisting of about 175 companies, primarily those involved in the production of cigarettes and in the textiles industry. The largest 20 customers within the Fibers segment, multinational as well as regional cigarette producers and textile industry fabric manufacturers, accounted for greater than 80% of the segment’s total sales revenue in 2003.

Voridian is well known for its expert technical service. Voridian periodically reviews customers’ processes and provides process training to some of its customers' employees to assist them in the efficient use of Voridian’s products. Voridian also engages in collaborative planning with its customers to maximize supply chain management. These customer-focused efforts, combined with Voridian’s long history and product quality reputation, have resulted in many long-term customer relationships, a key competitive advantage.

·       Competition

Competition in the fibers industry is based primarily on product quality, technical and customer service, reliability, long-term customer relationships and price. To be successful, Voridian is required to minimize costs and maximize production efficiency. Competitors in the fibers market include one global supplier, Celanese AG, in both the acetate tow and yarn markets, and several regional competitors in each market. The supply and demand balance at a given time affects pricing in the market. Currently, the acetate yarn market has an excess supply of products due to manufacturing capacity remaining high while demand declined, resulting in lower prices. Voridian management believes it is well positioned to respond to competitive price pressures due to its scale of operations and level of integration.

In the acetate tow market, Celanese AG has capacity in China and has announced construction of additional capacity through expansion of existing joint ventures with the government-owned China National Tobacco Corporation. Increased local production in China may diminish access to this market by Voridian and other competitors. Global capacity utilization rates and pricing for acetate tow also could be adversely affected.

 20

     

   

 
Within the acetate yarn market, product quality, technical service and global distribution are key competitive factors. Particularly with respect to textile customers, a majority of the customer base and production capacity has moved to regions where Voridian does not have manufacturing sites. This shift in the worldwide customer base requires Voridian to capitalize upon its global product distribution capability, product quality, and technical service capability.

VORIDIAN DIVISION GENERAL INFORMATION

Sales, Marketing and Distribution

Voridian primarily markets its products through direct sales channels; however, it employs contract representatives and resellers where beneficial. As part of its commitment to customer and technical service which leads to increased repeat sales, Voridian periodically provides audits of customers’ processes, as well as process training to some of its customers' employees. Voridian is committed to maintaining its high level of customer service by remaining current with customer needs, market trends and performance requirements.

Through the use of e-business platforms that improve connectivity and reduce costs, Voridian offers its customers an internet option, www.voridian.com , for placing and tracking orders, generating reports and bidding at online auctions. Voridian also provides integrated direct capabilities to customers, allowing enhanced collaborative planning to improve supply chain efficiencies.

Intellectual Property and Trademarks

The Company believes that significant advantages can be obtained through the continued focus on branding its products and, for this reason, protects its Voridian Division-related intellectual property through a combination of patents that expire at various times, trademarks, licenses, copyrights and trade secrets. The Company expects to expand its portfolio of technologies licensed to other companies in the future. To date, the Company has selectively licensed a fairly extensive portfolio of patented Voridian polyester, intermediates, and polyethylene technologies. The Company has formed an alliance to license PTA technology, trademarked EPTA, to Lurgi Oel Gas Chemie, an EPC firm headquartered in Germany and to SK, a PET and EPTA producer headquartered in South Korea. Energx Ô polyethylene technology has been licensed to Chevron-Phillips Chemical Company, headquartered in the United States, Hanwha Chemical, headquartered in South Korea, and BP Amoco ("BP"), headquartered in the United Kingdom. BP is also licensed to market and sub-license the technology to other gas-phase LLDPE producers. Additionally, the Company has formed an alliance with W.R. Grace/Davison Catalysts to further exploit Energx Ô globally. Voridian Division’s intellectual property portfolio is an important asset. However, neither its business as a whole nor any particular segment is materially dependent upon any one particular patent, trademark, copyright, or trade secret. As the laws of many foreign countries do not protect intellectual property to the same extent as the laws of the United States, Voridian Division cannot assure that it will be able to adequately protect all of its intellectual property assets.

Research and Development
 
Ø    Polymers Segment

Voridian directs its research and development programs for the Polymers segment toward five key objectives:

·       Lowering manufacturing costs through process technology innovations and process improvement efforts;

·       Developing new products and services in PET polymers through applications research and customer feedback;

·       Developing new products and processes that are compatible with Voridian’s commitment to producing more environmentally friendly products;

·       E nhancing product quality by improvement in manufacturing technology and processes; and

·       M arketing, licensing and delivering PET polymers, EPTA Ô and polyethylene product and production technologies.

 21

     

   

 
Voridian’s research and development efforts in the Polymers segment have resulted in significant improvements in manufacturing process efficiencies and are continuing to yield sustainable competitive advantage. Those efforts have also resulted in new products that have met with wide acceptance in the marketplace. In the PET polymers business, Voridian has introduced sixteen new products since the beginning of 2000 including two Voridian Aqua Ô polymer formulas for the water market, two Elegante Ô polymer formulas for the personal care/cosmetics market, AmberGuard Ô polymer for the beer market, Heatwave Ô polymer for hot-fill beverage applications that require ultra-violet (UV) protection, VersaTray Ô polymer for food packaging and cooking, suitable for both conventional and microwave oven use, and new enhanced reheat resins for the European and Asian markets. In the polyethylene business, Voridian has commercialized a group of new, higher-value polyethylene products with increased tear strength and impact performance such as Mxsten Ô and Voridian Hif o r Ô .
 
Ø    Fibers Segment

In the acetate yarn business, Voridian has commercialized Estron Plus Ô which is a combination yarn. Estron Plus Ô is a blend of Estron acetate and nylon. Garments of Estron Plus Ô offer the consumer the rich colors and luxurious feel of acetate and the durability and washability of nylon. Estron Plus Ô is featured in high fashion designer garments.

Research and development efforts for the Fibers segment are primarily focused on incremental process and product improvements, as well as cost reduction, with the goal of increasing sales and reducing costs. Recent achievements have included fiber product advancements that allow improved processability on customers’ equipment and improved packaging design. Voridian also engages in research to assist acetate tow customers in the cigarette industry in the effective use of Voridian products and in the customers’ own product development efforts.

DEVELOPING BUSINESSES DIVISION

Developing Businesses Segment
 
·       Overview

The Developing Businesses segment includes new businesses and certain investments in non-traditional growth opportunities that leverage the Company’s technology expertise, intellectual property and know-how into business models that extend to new customers and markets. The segment includes, among other new and developing businesses, Cendian Corporation ("Cendian"), a logistics provider for chemical companies; Ariel Research Corporation ("Ariel"), a provider of international chemical and regulatory compliance solutions for environmental, health and safety operations; and Eastman’s Gasification Services, a provider of consulting and operations services to third-party gasification plant operators.

Ø    Cendian Corporation
 
Launched by the Company in 2000, Cendian is an Eastman subsidiary that markets a complete logistics solution for small to mid-sized chemical manufacturers. By streamlining and automating logistics business processes, Cendian enables its customers to focus on their core business and reduce operational and capital expenses. Cendian supports substantially all of the Company's worldwide logistics requirements, as well as those of other chemical manufacturers under multi-year agreements. Cendian leverages state-of-the-art technologies with the Company's long standing distribution and logistics capabilities and strong reputation and brand in the chemicals industry to transport chemicals for its customers from their source location to any destination in the world via all modes of transportation.

 22

     

 

Ø    Ariel Research Corporation
 
In January 2002, Eastman acquired Ariel Research Corporation ("Ariel"). Ariel, headquartered in Bethesda, Maryland, is a leading provider of worldwide regulatory information and software products that enable corporations to manage product safety and stewardship functions, including requirements for workplace, environmental, and dangerous goods compliance. Ariel’s comprehensive product offerings arise from its over 14 year history of delivering improvement protocols for environmental, health and safety operations and from the successful delivery of quality and efficient improvements to environmental, health and safety operations. Its customers include major global corporations in the chemical, pharmaceutical and consumer products markets.

Ø    Eastman Gasification Services
 
The Company has launched a service business to assist owners of gasification plants, including those built as an alternative clean technology for power generation. Recognized as an industry leader in reliability and efficiency of gasification operations, Eastman has operated a coal gasification plant in Kingsport, Tennessee for approximately 20 years. The Company has leveraged its expertise in gasification by offering operations and maintenance services to third party gasification facilities. In the fourth quarter of 2002, the Company entered into a cooperative agreement with Texaco Development Corporation, a wholly- owned subsidiary of ChevronTexaco Corporation, that enables the Company to provide operation, maintenance, management and technical services, as well as parts fabrication and sales, for gasification plants of Texaco Development licensees.

In addition, Developing Businesses is evaluating and investing in additional potential growth opportunities utilizing its stage gate guidelines described below.

Strategy

Developing Businesses is expanding beyond the Company’s core business of chemicals, plastics, and fibers manufacturing to develop less capital-intensive businesses and platforms that allow it to take advantage of its long-term customer relationships, operational skills and technological capabilities. Developing Businesses uses a disciplined stage gating process in evaluating investments to weigh expected returns against investment levels at various stages of development. Those that meet the initial requirements go on to the next stage where a cross-functional team of experts from marketing, technology, business and finance determine if there is a compelling business plan, and viable means for capturing value from it.

Customers and Markets

Cendian targets its offerings to North American-based medium and smaller size chemical manufacturers with global operations. The Company is a significant customer of Cendian.

Ariel's customers include major global corporations in the chemical, pharmaceutical and consumer products markets. They include Dow, Schering Plough, General Electric and IBM.

Eastman Gasification Services serves current owners of gasification plants, as well as parties investigating or intending to build a new gasification plant.

Competition

Cendian's target market is highly fragmented, characterized by many competitors offering partial solutions for the logistics requirements of chemical manufacturers. Competition also arises from in-house capabilities.

The market for Ariel's chemical regulatory products is fragmented. Most of the services provided by Ariel are currently performed internally at most large chemical companies.

Because of the specialized nature of the Developing Businesses segment coal gasification services, there are few third party providers of similar services. Customer alternatives to these services are to use internal resources, supplemented by assistance from engineering firms or the gasification technology supplier.

 23

     

 

 
EASTMAN CHEMICAL COMPANY GENERAL INFORMATION

Sources and Availability of Raw Materials and Energy

Eastman purchases a substantial portion, estimated to be approximately 70%, of its key raw materials and energy through long-term contracts, generally of three to five years initial duration with renewal or cancellation options for each party. Most of those agreements do not require the Company to purchase materials or energy if its operations are reduced or idle. The cost of raw materials and energy is generally based on market price at the time of purchase, although derivative financial instruments, valued at quoted market prices, have been utilized to mitigate the impact of short-term market price fluctuations. Key raw materials and purchased energy include paraxylene, ethylene glycol, PTA, propane and ethane, cellulose, methanol, coal, natural gas, electricity, and a wide variety of precursors for specialty organic chemicals. The Company has multiple suppliers for most key raw materials and energy and uses quality management principles, such as the establishment of long-term relationships with suppliers and on-going performance assessment and benchmarking, as part of the supplier selection process. When appropriate, the Company purchases raw materials from a single source supplier to maximize quality and cost improvements, and has developed contingency plans that would minimize the impact of any supply disruptions from single source suppliers.

While temporary shortages of raw materials and energy may occasionally occur, these items are generally sufficiently available to cover current and projected requirements. However, their continuous availability and price are subject to unscheduled plant interruptions occurring during periods of high demand, or due to domestic or world market and political conditions, changes in government regulation, war or other outbreak of hostilities. Eastman’s operations or products may, at times, be adversely affected by these factors. The Company’s total cost of raw materials as a percent of total cost of operations was estimated to be approximately 50% in 2003.

Capital Expenditures

Capital expenditures were $230 million, $427 million, and $234 million in 2003, 2002, and 2001, respectively. Capital expenditures for 2002 included $161 million related to the purchase of certain machinery and equipment previously utilized under an operating lease.

In 2004, Eastman expects that capital expenditures and other directed investments for small acquisitions and other ventures will increase compared to 2003, but will be no more than depreciation and amortization. Efficiency of capital utilization is a key element of the Company's strategy to improve gross margins and, where appropriate, alliances, joint ventures, acquisitions of existing businesses, and tolling arrangements are used to expand available capacity using less capital.

Employees

Eastman employs approximately 15,000 men and women worldwide. Approximately 11% of the total worldwide labor force is represented by unions, mostly outside the United States.

Customers

Eastman has an extensive customer base and, while it is not dependent on any one customer, loss of certain top customers could adversely affect the Company until such business is replaced. The top 100 customers accounted for approximately 57% of the Company's 2003 sales revenue.

 24

     

   

 
Intellectual Property and Trademarks

While the Company’s intellectual property portfolio is an important Company asset which it expands and vigorously protects globally through a combination of patents that expire at various times, trademarks, copyrights, and trade secrets, neither its business as a whole nor any particular segment is materially dependent upon any one particular patent, trademark, copyright, or trade secret. As a producer of a broad and diverse portfolio of both specialty and commodity chemicals, plastics, and fibers, Eastman owns well over 1,000 active United States patents and more than 900 active foreign patents, expiring at various times over several years, and also owns over 3,000 active worldwide trademarks. The Company’s intellectual property relates to a wide variety of products and processes. As the laws of many foreign countries do not protect intellectual property to the same extent as the laws of the United States, Eastman cannot assure that it will be able to adequately protect all of its intellectual property assets.

Research and Development

For 2003, 2002 and 2001, Eastman’s research and development expense totaled $173 million, $159 million and $160 million, respectively. Research and development expenses are expected to decrease in 2004; however, the Company will continue to increase its technology efforts associated with new products and process technologies.

Seasonality

The Company typically experiences a seasonal decline in earnings in the fourth quarter. Demand in the CASPI segment is typically stronger in the second and third quarters due to increased use of coatings products in the building and construction industries, and weaker during the winter months and the holiday season because of seasonal construction downturns. The Polymers segment typically experiences stronger demand for PET polymers for beverage plastics during the second quarter due to higher consumption of beverages, while demand typically weakens during the third quarter. Seasonality in the SP segment is associated with certain segments of the photographic and adhesive tape market, coupled with the effect of a typical year-end inventory reduction by several customers.

Environmental

Eastman is subject to laws, regulations and legal requirements relating to the use, storage, handling, generation, transportation, emission, discharge, disposal and remediation of, and exposure to, hazardous and non-hazardous substances and wastes in all of the countries in which it does business. These health, safety and environmental considerations are a priority in the Company’s planning for all existing and new products and processes. The Health, Safety, Environmental and Security Committee of Eastman’s Board of Directors reviews the Company's policies and practices concerning health, safety and the environment and its processes for complying with related laws and regulations, and monitors related matters.

The Company’s policy is to operate its plants and facilities in a manner that protects the environment and the health and safety of its employees and the public. The Company intends to continue to make expenditures for environmental protection and improvements in a timely manner consistent with its policies and with the technology available. In some cases, applicable environmental regulations such as those adopted under the U.S. Clean Air Act and Resource Conservation and Recovery Act, and related actions of regulatory agencies, determine the timing and amount of environmental costs incurred by the Company.

The Company accrues environmental costs when it is probable that the Company has incurred a liability and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. This undiscounted accrued amount reflects the Company’s assumptions about remedial requirements at the contaminated site, the nature of the remedy, the outcome of discussions with regulatory agencies and other potentially responsible parties at multi-party sites, and the number and financial viability of other potentially responsible parties. Changes in the estimates on which the accruals are based, unanticipated government enforcement action, or changes in health, safety, environmental, chemical control regulations and testing requirements could result in higher or lower costs.

Other matters pertaining to health, safety, and the environment are discussed in Management's Discussion and Analysis of Financial Condition and Results of Operations and Notes 1 and 11 to the Company’s consolidated financial statements.

 25

     

 

Backlog

On January 1, 2004, Eastman’s backlog of firm sales orders was estimated to be approximately $238 million compared with approximately $233 million at January 1, 2003. The Company adjusts its inventory policy to control the backlog of products depending on customers' needs. In areas where the Company is the single source of supply, or competitive forces or customers' needs dictate, the Company may carry additional inventory to meet customer requirements.

Investment in Genencor

The Company holds an approximate 42% equity interest in Genencor International, Inc. ("Genencor"). Genencor is a publicly traded biotechnology company engaged in the discovery, development, manufacture, and marketing of biotechnology products for the industrial chemicals, agricultural, and health care markets, and a developer of integrated genomics technology. The Company, which was an early stage investor and held a 50% interest prior to Genencor's initial public offering in 2000, believes this investment provides the opportunity for a financial return. Genencor is accounted for by the equity method of accounting for investments in common stock. Genencor’s common stock is registered under the Securities Exchange Act of 1934 and is listed on the NASDAQ National Market System under the symbol GCOR. See the "Investments" section of Note 1 and Note 5 to the Company’s consolidated financial statements for more information on the accounting for this investment and its current market value.

Available Information – SEC Filings and Corporate Governance Materials

The Company makes available free of charge, through the "Investors – SEC Filings" section of its Internet website (www.eastman.com) , its annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as soon as reasonably practicable after electronically filing such material with, or furnishing it to, the Securities and Exchange Commission (the "SEC"). Once filed with the SEC, such documents may be read and/or copied at the SEC’s Public Reference Room at 450 Fifth Street N.W., Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers, including Eastman Chemical Company, that electronically file with the SEC at http://www.sec.gov .

The Company also makes available free of charge, through the "Investors – Corporate Governance" section of its internet website ( www.eastman.com ), the Corporate Governance Guidelines of its Board of Directors, the charters of each of the committees of the board, and codes of ethics and business conduct for directors, officers and employees. Such materials are also available in print upon the written request of any stockholder to Eastman Chemical Company, P.O. Box 511, Kingsport, Tennessee 37662-5075, Attention: Investor Relations.

Financial Information About Geographic Areas

For information about revenues and long-lived assets based on geographic areas, see Note 20 to the Company’s consolidated financial statements.

 26

     

 

EXECUTIVE OFFICERS OF THE COMPANY

Certain information about the Company's executive officers is provided below:

J. Brian Ferguson, age 49, is Chairman of the Board and Chief Executive Officer. Mr. Ferguson joined the Company in 1977. He was named Vice President, Industry and Federal Affairs in 1994, became Managing Director, Greater China in 1997, was named President, Eastman Chemical Asia Pacific in 1998, became President, Polymers Group in 1999, became President, Chemicals Group in 2001, and was elected to his current position in 2002.

James P. Rogers, age 52, was appointed Executive Vice President of the Company and President of Eastman Division effective November 2003. Mr. Rogers joined the Company in 1999 as Senior Vice President and Chief Financial Officer and in 2002, was also appointed Chief Operations Officer of Eastman Division. Mr. Rogers served previously as Executive Vice President and Chief Financial Officer of GAF Materials Corporation ("GAF"). He also served as Executive Vice President, Finance, of International Specialty Products, Inc., which was spun off from GAF in 1997.
 
Allan R. Rothwell, age 56, is Executive Vice President of the Company and President of Voridian Division. Mr. Rothwell joined the Company in 1969, became Vice President and General Manager, Container Plastics Business Organization in 1994, and was appointed Vice President, Corporate Development and Strategy in 1997. He was named Senior Vice President and Chief Financial Officer in 1998, became President, Chemicals Group in 1999, became President, Polymers Group in 2001, and was appointed to his current position in 2002.

Theresa K. Lee, age 51, is Senior Vice President, Chief Legal Officer and Corporate Secretary. Ms. Lee joined Eastman as a staff attorney in 1987, served as Assistant General Counsel for the health, safety, and environmental legal staff from 1993 to 1995, and served as Assistant General Counsel for the corporate legal staff from 1995 until her appointment as Vice President, Associate General Counsel and Secretary in 1997. She became Vice President, General Counsel, and Secretary of Eastman in 2000 and was appointed to her current position in 2002.

Richard A. Lorraine, age 58, joined Eastman in November 2003 as Senior Vice President and Chief Financial Officer. Mr. Lorraine served as Executive Vice President and Chief Financial Officer of Occidental Chemical Corporation from 1995 until 2003, and at ITT Automotive Group as President of the Aftermarket Group from 1990 to 1995 and Vice President and Chief Financial Officer from 1985 to 1990. Mr. Lorraine started his career with Westinghouse Electric Corporation, where he held various financial positions.

Roger K. Mowen, Jr., age 58, is Senior Vice President, Developing Businesses and Corporate Strategy. Mr. Mowen joined Eastman in 1971. He was named Vice President and General Manager, Polymer Modifiers in 1991, Superintendent of the Polymers Division in 1994, President, Carolina Operations in 1996, Vice President, Customer Demand Chain in 1998, Vice President, CustomerFirst and Chief Information Officer in 1999, Vice President, Global Customer Services Group and Chief Information Officer in 2000, and appointed Senior Vice President, Global Customer Services Group and Chief Information Officer in 2001. He was appointed to his current position in March 2003. As previously announced, Mr. Mowen is retiring from the Company effective May 31, 2004, at which time his responsibilities will be assumed by other current Eastman officers.

Gregory O. Nelson, age 52, is Senior Vice President and Chief Technology Officer. Dr. Nelson joined Eastman in 1982 as a research chemist and held a number of positions in the research and development organization. He became Director, Polymers Research Division in 1995 and was named Vice President, Polymers Technology in 1997. He was appointed to his present position in 2001 and named Senior Vice President in 2002.

Norris P. Sneed, age 48, is Senior Vice President, Human Resources, Communications and Public Affairs. Mr. Sneed joined the Company in 1979 as a chemical engineer. In 1989, he was assigned to Eastman’s Arkansas Operations where he was superintendent for different manufacturing and new business development departments. In 1997, he served as assistant to the CEO. He was named managing director for Eastman’s Argentina operations in 1999, Vice President of Organization Effectiveness in the Human Resources, Communications and Public Affairs Organization in 2001, and was appointed to his current position in June 2003.

 27

     

 

EXECUTIVE OFFICERS OF THE COMPANY

Curtis E. Espeland, age 39, is Controller of the Company. Mr. Espeland joined Eastman in 1996. At Eastman, Mr. Espeland has served as Director of Internal Auditing and Director of Financial Services, Asia Pacific, was named Assistant Controller of the Company and Controller of Eastman Division in 2002, and was appointed to his current position in December 2002. Prior to joining Eastman, he was an audit and business advisory manager with Arthur Andersen LLP.

 28

     

 

ITEM 2. PROPERTIES

PROPERTIES

At December 31, 2003, Eastman operated 35 manufacturing sites in 16 countries. Utilization of these facilities may vary with product mix and economic, seasonal, and other business conditions, but none of the principal plants are substantially idle. The Company's plants, including approved expansions, generally have sufficient capacity for existing needs and expected near-term growth. These plants are generally well maintained, in good operating condition, and suitable and adequate for their use. Unless otherwise indicated, all of the properties are owned. The locations and general character of the major manufacturing facilities are:

 
Segment using manufacturing facility

Location      
CASPI
PCI
SP
Polymers
Fibers






 
 
 
 
 
 
USA and Canada
Batesville, Arkansas      
 
x
 
x
 
 
 
Lynwood, California      
x
 
 
 
 
Columbus, Georgia      
x
 
 
 
 
Forest Park, Georgia      
x
 
 
 
 
Carpentersville, Illinois      
x
 
 
 
 
Jefferson, Pennsylvania      
x
 
 
 
 
Columbia, South Carolina
 
 
x
x
 
Roebuck, South Carolina      
x
 
 
 
 
Kingsport, Tennessee      
x
x
x
x
x
LaVergne, Tennessee      
x
 
 
 
 
Ennis, Texas      
x
 
 
 
 
Longview, Texas      
x
x
 
x
 
Franklin, Virginia*      
x
 
 
 
 
Pleasant Prairie, Wisconsin
x
 
 
 
 
Europe
Kallo, Belgium      
 
x
 
 
 
 
Sokolov, Czech Republic      
x
x
 
 
 
Hartlepool, England      
 
 
x
 
 
Workington, England      
 
 
 
x
x
Hamburg, Germany      
x
 
 
 
 
Waterford, Ireland      
x
 
 
 
 
Cola’ di Lazise, Italy      
x
 
 
 
 
Sant’ Albano, Italy      
x
 
 
 
 
Middelburg, Netherlands      
x
 
 
 
 
Rotterdam, Netherlands**
 
 
 
x
 
San Roque, Spain      
 
x
x
x
 
Molndal, Sweden      
x
 
 
 
 
Llangefni, Wales      
 
x
 
 
 
Asia Pacific
Funing, China      
 
x
 
 
 
 
Nanping, China      
x
 
 
 
 
Tianjin, China      
x
 
 
 
 
Kuantan, Malaysia**      
 
 
x
 
 
Jurong Island, Singapore**
 
x
 
 
 

Latin America
Zarate, Argentina      
 
 
 
 
x
 
Cosoleacaque, Mexico      
 
 
 
x
 
Uruapan, Mexico      
x
 
 
 
 

* indicates a location that Eastman leases from a third party.
** indicates a location that Eastman leases from a third party under a long-term ground lease.

 29

     

 

 
Eastman has a 50% interest in Primester, a joint venture that manufactures cellulose acetate at its Kingsport, Tennessee plant. The production of cellulose acetate is an intermediate step in the manufacture of acetate tow and other cellulose acetate based products. The Company also has a 50% interest in a manufacturing facility in Nanjing, China. The Nanjing facility produces Eastotac Ô hydrocarbon tackifying resins for pressure-sensitive adhesives, caulks, and sealants. Eastotac Ô hydrocarbon resins are also used to produce hot melt adhesives for packaging applications in addition to glue sticks, tapes, labels, and other adhesive applications. The Company also has a 51% interest in a manufacturing facility that is currently under construction in Zibo City, China. The Zibo City facility will produce Texanol Ô ester alcohol coalescing aid for the paint market and TXIB Ô plasticizer for the glove and flooring markets.

Eastman has distribution facilities at all of its plant sites. In addition, the Company owns or leases over 100 stand-alone distribution facilities in the United States and 17 other countries. Corporate headquarters are in Kingsport, Tennessee. The Company's regional headquarters are in Miami, Florida; Rotterdam, the Netherlands; Singapore; and Kingsport, Tennessee. Technical service is provided to the Company's customers from technical service centers in Kallo, Belgium; Kingsport, Tennessee; Kirkby, England; Pleasant Prairie, Wisconsin, Sant Albano, Italy; and Singapore. Customer service centers are located in Kingsport, Tennessee; Rotterdam, the Netherlands; Miami, Florida; and Singapore.

A summary of properties, classified by type, is contained in Note 3 to the Company’s consolidated financial statements.

ITEM 3. LEGAL PROCEEDINGS

General

From time to time, the Company and its operations are parties to, or targets of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety and employment matters, which are being handled and defended in the ordinary course of business. While the Company is unable to predict the outcome of these matters, it does not believe, based upon currently available facts, that the ultimate resolution of any such pending matters, including the sorbates litigation and the asbestos litigation described in the following paragraphs, will have a material adverse effect on its overall financial condition, results of operations or cash flows. However, adverse developments could negatively impact earnings or cash flows in a particular future period.
 
Sorbates Litigation

As previously reported, on September 30, 1998, the Company entered into a voluntary plea agreement with the U.S. Department of Justice and agreed to pay an $11 million fine to resolve a charge brought against the Company for violation of Section One of the Sherman Act. Under the agreement, the Company entered a plea of guilty to one count of price-fixing for sorbates, a class of food preservatives, from January 1995 through June 1997. The plea agreement was approved by the United States District Court for the Northern District of California on October 21, 1998. The Company recognized the entire fine as a charge against earnings in the third quarter of 1998 and paid the fine in installments over a period of five years. On October 26, 1999, the Company pleaded guilty in a Federal Court of Canada to a violation of the Competition Act of Canada and was fined $780,000 (Canadian). The plea in Canada admitted that the same conduct that was the subject of the United States guilty plea had occurred with respect to sorbates sold in Canada, and prohibited repetition of the conduct and provides for future monitoring. The Canadian fine has been paid and was recognized as a charge against earnings in the fourth quarter of 1999.
 
Following the September 30, 1998 plea agreement, the Company, along with other defendants, was sued in federal, state and Canadian courts in more than twenty putative class action lawsuits filed on behalf of purchasers of sorbates and products containing sorbates, claiming those purchasers paid more for sorbates and for products containing sorbates than they would have paid in the absence of the defendants’ price-fixing. Only two of these lawsuits have not been resolved via settlement. One of the cases has been inactive for more than a year.  In the other case, the trial court decided in October 2002 that the case would not proceed as a class action, though that decision has been appealed by the plaintiff.

 30

     

 

In addition, six states have sued the Company and other defendants in connection with the sorbates matter, seeking damages, restitution and civil penalties on behalf of consumers of sorbates in those respective states. One of those six cases has been settled; defense motions to dismiss were granted in four state cases; one of those dismissals has been appealed and none of the other three are yet final.  Seven other states have advised the Company that they intend to bring similar actions against the Company and others. A settlement with those seven states has tentatively been reached.
 
The Company has recognized charges to earnings for estimated and actual costs, including legal fees and expenses, related to the sorbates fine and litigation. While the Company intends to continue to defend vigorously the remaining sorbates actions unless they can be settled on acceptable terms, the ultimate outcome of the matters still pending and of additional claims that could be made is not expected to have a material impact on the Company's financial condition, results of operations, or cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses and charges against earnings in particular periods.
 
Asbestos Litigation      

Over the years, Eastman has been named as a defendant, along with numerous other defendants, in lawsuits in various state courts in which plaintiffs alleged injury due to exposure to asbestos at Eastman’s manufacturing sites and sought unspecified monetary damages and other relief. Historically, these cases were dismissed or settled without a material effect on Eastman’s financial condition, results of operations, or cash flows.
 
In recently filed cases, plaintiffs allege exposure to asbestos-containing products allegedly made by Eastman.  Based on its investigation to date, the Company has information that it manufactured limited amounts of an asbestos-containing plastic product between the mid-1960's and the early 1970's.  The Company's investigation has found no evidence that any of the plaintiffs worked with or around any such product alleged to have been manufactured by the Company.
 
The Company recently reached an agreement with plaintiffs' counsel to resolve many of these claims. The Company intends to defend vigorously the approximately 2000 remaining claims or to settle them on acceptable terms.
 
The Company continues to evaluate the allegations and claims made in recent asbestos-related lawsuits and its insurance coverages. Based on such evaluation to date, the Company continues to believe that the ultimate resolution of asbestos cases will not have a material impact on the Company’s financial condition, results of operations, or cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses and charges against earnings in particular periods. To date, costs incurred by the Company related to the recent asbestos-related lawsuits have not been material.
 
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

There were no matters submitted to a vote of the Company's stockholders during the fourth quarter of 2003.




31
     

    


PART II

ITEM 5.   MARKET FOR THE REGISTRANT'S COMMON STOCK AND RELATED STOCKHOLDER MATTERS

The Company's common stock is traded on the New York Stock Exchange (the "NYSE") under the symbol EMN. The following table presents the high and low closing sales prices of the common stock on the NYSE and the cash dividends per share declared by the Company's Board of Directors for each quarterly period of 2002 and 2003.


 
 
 
High
 
 
 
Low
 
Cash Dividends Declared
2002
First Quarter
$
 
48.99
$
 
37.82
$
 
0.44
 
Second Quarter
49.04
 
43.30
 
0.44
 
Third Quarter
47.82
 
38.17
 
0.44
 
Fourth Quarter
40.53
 
35.35
 
0.44
2003
First Quarter
$
 
38.40
$
 
27.89
$
 
0.44
 
Second Quarter
33.95
 
28.82
 
0.44
 
Third Quarter
36.60
 
31.46
 
0.44
 
Fourth Quarter
39.53
 
31.46
 
0.44



As of December 31, 2003, there were 77,388,646 shares of the Company's common stock issued and outstanding, which shares were held by 36,265 stockholders of record. These shares include 144,825 shares held by the Company's charitable foundation. The Company has declared a cash dividend of $0.44 per share during the first quarter of 2004. Quarterly dividends on common stock, if declared by the Company's Board of Directors, are usually paid on or about the first business day of the month following the end of each quarter. The payment of dividends is a business decision to be made by the Board of Directors from time to time based on the Company's earnings, financial position and prospects, and such other considerations as the Board considers relevant. Accordingly, while management currently expects that the Company will continue to pay the quarterly cash dividend, its dividend policy may change at any time.

For information concerning issuance of shares and option grants in 2003 under compensation and benefit plans and shares held by the Company's charitable foundation, see Notes 13 and 14 to the Company’s consolidated financial statements.

Information required by Item 201(d) of Regulation S-K is set forth under Part III — Item 12 — "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" and is incorporated herein by reference.


 32

     

 

ITEM 6.       SELECTED FINANCIAL DATA

Summary of Operating Data
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions, except per share amounts)
 
2003
 
2002
 
2001
 
2000
 
1999
 
 

 
 

 
 

 
 

 
 

 
                     
Sales
$
5,800
$
5,320
$
5,390
$
5,292
$
4,590
Operating earnings (loss)
 
(267)
 
208
 
(120)
 
562
 
202
Earnings (loss) from operations before cumulative effect of change in accounting principle
 
 
 
(273)
 
 
 
79
 
 
(175)
 
 
 
303
 
 
 
48
Net earnings (loss)
 
(270)
 
61
 
(175)
 
303
 
48
 
 
 
 
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share before
 
 
 
 
 
 
 
 
 
 
cumulative effect of change in
 
 
 
 
 
 
 
 
 
 
accounting principle
$
(3.54)
$
1.02
$
( 2.28)
$
3.95
$
0.61
Cumulative effect of change in
 
 
 
 
 
 
 
 
 
 
accounting principle, net
 
0.04
 
(0.23)
 
-
 
-
 
-





Net earnings (loss) per share
$
(3.50)
$
0.79
$
( 2.28)
$
3.95
$
0.61





 
 
 
 
 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per share before
 
 
 
 
 
 
 
 
 
 
cumulative effect of change in
 
 
 
 
 
 
 
 
 
 
accounting principle
$
(3.54)
$
1.02
$
( 2.28)
$
3.94
$
0.61
Cumulative effect of change in
 
 
 
 
 
 
 
 
 
 
accounting principle, net
 
0.04
 
(0.23)
 
-
 
-
 
-





Net earnings (loss) per share
$
(3.50)
$
0.79
$
( 2.28)
$
3.94
$
0.61





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statement of Financial Position Data
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Current assets
$
2,010
$
1,547
$
1,464
$
1,523
$
1,489
Net properties
 
3,419
 
3,753
 
3,627
 
3,925
 
3,950
Total assets
 
6,230
 
6,287
 
6,092
 
6,550
 
6,303
Current liabilities
 
1,477
 
1,247
 
960
 
1,258
 
1,608
Long-term borrowings
 
2,089
 
2,054
 
2,143
 
1,914
 
1,506
Total liabilities
 
5,187
 
5,016
 
4,710
 
4,738
 
4,544
Total stockholders’ equity
 
1,043
 
1,271
 
1,382
 
1,812
 
1,759
Dividends declared per share
 
1.76
 
1.76
 
1.76
 
1.76
 
1.76

In 2002, the Company adopted the non-amortization provisions of Statement of Financial Accounting Standards ("SFAS") No. 142. As a result of the adoption of SFAS No. 142, results for the years 2002 and 2003 do not include certain amounts of amortization of goodwill and indefinite-lived intangible assets that are included in prior years’ financial results. See Note 4 to the Company’s consolidated financial statements for additional information.

Effective January 1, 2003, the Company’s method of accounting for environmental closure and postclosure costs changed as a result of the adoption of Statement of Financial Accounting Standards ("SFAS") No. 143, "Accounting for Asset Retirement Obligations." If the provisions of SFAS No. 143 had been in effect in prior years, the impact on the Company’s financial results would have been immaterial. See Note 23 to the Company’s consolidated financial statements for additional information.

 33

     

 

ITEM 7.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management's Discussion and Analysis of Financial Condition and Results of Operations is based upon the consolidated financial statements for Eastman Chemical Company ("Eastman" or the "Company"), which have been prepared in accordance with accounting principles generally accepted in the United States of America, and should be read in conjunction with the Company's consolidated financial statements included elsewhere in this Annual Report. All references to earnings per share contained in this report are diluted earnings per share unless otherwise noted.

CRITICAL ACCOUNTING POLICIES

In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, the Company’s management must make decisions which impact the reported amounts and the related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions on which to base estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, the Company evaluates its estimates, including those related to customer programs and incentives, doubtful accounts, impaired assets, environmental costs, pensions and other postemployment benefits, goodwill and other intangibles, and litigation and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company’s management believes the critical accounting policies described below are the most important to the fair presentation of the Company’s financial condition and results. These policies require management’s more significant judgments and estimates in the preparation of the Company’s consolidated financial statements.

Customer Programs and Incentives

The Company records estimated obligations for customer programs and incentive offerings, which consist primarily of revenue or volume-based amounts that a customer must achieve over a specified period of time, as a reduction of revenue to each underlying revenue transaction as the customer progresses toward reaching goals specified in incentive agreements. These estimates are based on a combination of forecast of customer sales and actual sales volumes and revenues against established goals, the customer’s current level of purchases, and Eastman’s knowledge of customer purchasing habits and industry pricing practice. The incentive payment rate may be variable, based upon the customer reaching higher sales volume or revenue levels over a specified period of time in order to receive an agreed upon incentive payment.

Since the volume incentives and their usefulness to the Company are largely based on the overall supply and demand in the markets for the products the Company produces, significant changes in supply and demand can positively or negatively impact the effectiveness of the Company’s customer programs and incentives. This has been particularly true for the Company’s PET Polymers business.

The Company’s reserve for customer programs and incentives was $45 million, $50 million, and $44 million at December 31, 2003, 2002, and 2001, respectively, and was recorded as a reduction of trade receivables. If market conditions change, the Company could be forced to take actions to adjust customer incentive offerings to maintain market share and capacity utilization.

34
     

    

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Allowances for Doubtful Accounts

The Company maintains allowances for doubtful accounts (the "allowances") for estimated losses resulting from the inability of its customers to make required payments. The allowances are based on the relative age of each individual receivable and management’s regular assessment of the financial condition of the Company’s customers. Additionally, management regularly reviews credit limits based on payment activity and other customer related factors to determine whether or not to extend credit and what other limiting terms, such as prepayment requirements, will be levied on given customers. The Company increases the allowances based on a monthly evaluation of the aged receivables, and based on their age, writes off a certain percentage. These expectations have historically been relatively accurate with regard to most of the Company’s customers. However, under certain circumstances, such as a customers’ bankruptcy, the Company will increase the allowance to reflect the collectability of the receivable.

The Company believes, based on historical results, the likelihood of actual write offs having a material impact on financial results or earnings per share is low. However, if one of the Company’s key customers were to file for bankruptcy, or otherwise be unable to make its required payments, or there was a significant continued slow down in the economy, the Company could be forced to increase its allowances. This could result in a material charge to earnings.

The Company’s allowances were $28 million, $32 million, and $35 million at December 31, 2003, 2002, and 2001, respectively. Further information is provided in Schedule II, "Valuation and Qualifying Accounts."

Impaired Assets

The Company evaluates the carrying value of long-lived assets, including definite-lived intangible assets, when events or changes in circumstances indicate that the carrying value may not be recoverable. The carrying value of a long-lived asset is considered impaired when the total projected undiscounted cash flows from such assets are separately identifiable and are less than its carrying value.  In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. For long-lived assets to be held and used, fair value of fixed (tangible) assets and definite-lived intangible assets is determined primarily using either the projected cash flows discounted at a rate commensurate with the risk involved or appraisal. For long-lived assets to be disposed of by sale or other than by sale, fair value is determined in a similar manner, except that fair values are reduced for disposal costs.

As the Company’s assumptions related to long-lived assets are subject to change, additional write-downs may be required in the future. If estimates of fair value less costs to sell are revised, the carrying amount of the related asset is adjusted, resulting in recognition of a charge or benefit to earnings. The Company recorded fixed (tangible) asset impairments of $291 million and definite-lived intangible asset impairments of $128 million during 2003. For more information, see Note 15 to the Company’s consolidated financial statements.

Environmental Costs

The Company accrues environmental remediation costs when it is probable that the Company has incurred a liability and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. This undiscounted accrued amount reflects the Company’s assumptions about remediation requirements at the contaminated site, the nature of the remedy, the outcome of discussions with regulatory agencies and other potentially responsible parties at multi-party sites, and the number and financial viability of other potentially responsible parties. Changes in the estimates on which the accruals are based, unanticipated government enforcement action, or changes in health, safety, environmental, and chemical control regulations and testing requirements could result in higher or lower costs. Estimated future environmental expenditures for remediation costs range from the minimum or best estimate of $34 million to the maximum of $52 million at December 31, 2003.

 35

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In accordance with SFAS No. 143 "Accounting for Asset Retirement Obligations," the Company also establishes reserves for closure/postclosure costs associated with the environmental and other assets it maintains. Environmental assets include but are not limited to land fills, water treatment facilities, and ash ponds. When these types of assets are constructed, a reserve is established for the future environmental remediation anticipated to be associated with the closure of the site based on an expected life of the environmental assets. These future expenses are accreted into earnings over the estimated useful life of the assets. Currently, the Company estimates the useful life of each individual asset up to 50 years. If the Company changes its estimate of the asset retirement obligation costs or its estimate of the useful lives of these assets, the future expenses to be accreted into earnings could increase or decrease.

The Company’s reserve for environmental contingencies was $61 million, $60 million, and $54 million at December 31, 2003, 2002, and 2001, respectively, representing the minimum or best estimate for remediation costs and, for asset retirement obligation costs, the amount accrued to date over the facilities’ estimated useful lives.

For additional information see Note 1, 11 and 23 to the Company’s consolidated financial statements and Schedule II, "Valuation and Qualifying Accounts."

United States Pension and Other Postemployment Benefits

The Company maintains defined benefit pension plans that provide eligible employees with retirement benefits. Additionally, Eastman provides life insurance and health care benefits for eligible retirees and health care benefits for retirees’ eligible survivors. The costs and obligations related to these benefits reflect the Company’s assumptions related to general economic conditions (particularly interest rates), expected return on plan assets, rate of compensation increase for employees and health care cost trends. At December 31, 2003, the Company assumed a discount rate of 6.25%; an expected return on assets of 9%; a rate of compensation increase of 3.75%; and an initial health care cost trend of 10%. The cost of providing plan benefits also depends on demographic assumptions including retirements, mortality, turnover and plan participation.

The following table illustrates the sensitivity to a change in the expected return on assets and assumed discount rate for U.S. pension plans and other postretirement welfare plans:

Change in
Assumption
 
Impact on
2004 Pre-tax U.S.
Pension Expense
Impact on
December 31, 2003 Projected Benefit Obligation for U.S. Pension Plans
Impact on
December 31, 2003 Benefit Obligation for Other U.S. Postretirement Plans




 
 
 
 
25 basis point
decrease in discount
rate
 
 
+$5 Million
 
 
+$48 Million
 
 
+$28 Million
 
 
 
 
25 basis point
increase in discount
rate
 
 
-$5 Million
 
 
-$46 Million
 
 
-$27 Million
 
 
 
 
25 basis point
decrease in expected
return on assets
 
 
+$2 Million
 
 
No Impact
 
 
N/A
 
 
 
 
25 basis point
increase in expected
return on assets
 
 
-$2 Million
 
 
No Impact
 
 
N/A





 36

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The expected return on assets and assumed discount rate used to calculate the Company’s pension and other postemployment benefit obligations are established each December 31. The expected return on assets is based upon the long-term expected returns in the markets in which the pension trust invests its funds, primarily the domestic, international, and private equities markets. The assumed discount rate is based upon an index of high-quality, long-term corporate borrowing rates. If actual experience differs from these assumptions, the difference is recorded as an unrecognized gain (loss) and then amortized into earnings over a period of time, which may cause the cost of providing these benefits to increase or decrease. The charges applied to earnings in 2003, 2002, and 2001 due to the amortization of unrecognized actuarial losses were $32 million, $20 million, and $8 million, respectively.

The Company does not anticipate that a change in pension and other post-employment obligations caused by a change in the assumed discount rate will impact the cash contributions to be made to the pension plans during 2004. However, an after-tax charge or credit will be recorded directly to accumulated other comprehensive income (loss), a component of stockholders’ equity, as of December 31, 2004 for the impact on the pension’s projected benefit obligation of the change in interest rates, if any. While the amount of the change in these obligations does not correspond directly to cash funding requirements, it is an indication of the amount the Company will be required to contribute to the plans in future years. The amount and timing of such cash contributions is dependent upon interest rates, actual returns on plan assets, retirement and attrition rates of employees, and other factors.

For additional information see Note 9 to the Company’s consolidated financial statements.

Litigation and Contingent Liabilities

From time to time, the Company and its operations are parties to or targets of lawsuits, claims, investigations and proceedings, including product liability, personal injury, asbestos; patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. The Company believes the amounts reserved are adequate for such pending matters; however, results of operations could be affected by significant litigation adverse to the Company.

2003 OVERVIEW

Over the past several years, key determinants of profitability for the Company have included: generally slow economic growth, particularly for manufacturing; fluctuations in raw material and energy costs, with those costs increasing substantially in late-2002 and remaining at historically high levels during 2003; and the ability to obtain sales price increases for the Company’s products necessary to preserve or expand margins. In addition, many of the markets that Eastman serves have been impacted by substantial capacity additions that led to lower capacity utilization levels, limiting the ability to obtain sales price increases for some of the Company’s products. As a result, the Company’s gross profit has been negatively impacted.

In 2003, the Company’s gross profit was negatively impacted by approximately $100 million compared to 2002 due to higher raw material and energy costs that were partially offset by higher selling prices. In 2002, the Company’s gross profit was negatively impacted by approximately $100 million compared to 2001 due to selling prices declining more than raw material costs, partially offset by higher sales volumes. In both years, the Company implemented various cost reduction efforts to improve profitability.

Eastman has also recorded significant impairment and restructuring charges. In 2003, the Company recognized $489 million of asset impairments and restructuring charges and $34 million of goodwill impairments. In 2002 and 2001, such charges were $5 million and $396 million, respectively. These charges were primarily the result of restructuring, divestiture and consolidation actions.

The Company continues to implement a number of initiatives to improve profitability and cash flows. These include:
 
·    Continued portfolio evaluation across the Company, particularly in the Eastman Division, with the expectation that some product lines will be removed from the portfolio;

 37

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
·    Restructuring, divestiture, and consolidation actions in the CASPI segment;
 
·    Narrowing the focus for the Developing Businesses Division, resulting in improved operating results; and
 
·    Cost and working capital reduction efforts throughout the Company.

In addition, the Company has and continues to maintain a number of commitments which demonstrate financial discipline. These include:
 
·    Capital expenditures to be no more than depreciation and amortization;
 
·    The combination of sales and general administrative expenses and research and development expenses will be at or below 10 percent of sales revenue;
 
·    Priorities for use of available cash from operations are to pay the quarterly cash dividend, reduce outstanding borrowings, and fund targeted growth initiatives such as small acquisitions and other ventures.

The Company anticipates profitability and operating cash flows to improve in 2004 due to the actions being taken in the CASPI segment, improved results in the Developing Businesses segment, and generally improved economic conditions. In addition, the Company expects raw material and energy costs to increase slightly in 2004 compared with 2003, and that the ability to obtain sales price increases will be a key driver of profitability. 

RESULTS OF OPERATIONS

SUMMARY OF CONSOLIDATED RESULTS - 2003 COMPARED WITH 2002

The Company’s results of operations as presented in the Company’s consolidated financial statements appearing in this Annual Report are summarized and analyzed below:

Earnings (Loss)
 
 
 
 
 
 
 
 
 
(Dollars in millions, except per share amounts)
 
2003
 
2002


 
 
 
 
 
Operating earnings (loss)
$
(267)
$
208
Net earnings (loss) before cumulative effect of change in accounting principle
 
(273)
 
79
Net earnings (loss)
 
(270)
 
61
Earnings (loss) per share
 
 
 
 
--Basic
 
(3.50)
 
0.79
--Diluted
 
(3.50)
 
0.79
 
 
 
 
 
Asset impairments and restructuring charges, net
 
489
 
5
Goodwill impairments
 
34
 
--
Other operating income
 
(33)
 
--


 38

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Operating results for 2003 declined to a loss of $267 million compared to operating earnings for 2002 of $208 million. The decline in operating earnings was primarily attributable to asset impairments and restructuring charges and goodwill impairments of $489 million and $34 million, respectively. Other operating income related to a gain of $20 million for the sale of the Company’s high-performance crystalline plastics assets, which were formerly a part of the SP segment, and a gain of $13 million for the sale of the Company’s colorant product lines and related assets, which were formerly part of the CASPI segment. Additionally, higher raw material and energy costs partially offset by higher selling prices had a negative impact on gross profit of approximately $100 million. Continued cost reduction efforts and favorable foreign currency exchange rates had a positive impact on earnings.

Other factors impacting operating earnings for 2003 include:
 
·    a reduction in costs of approximately $40 million as a result of the previously reported change in vacation policy which was part of cost reduction measures implemented by the Company in the first quarter 2003.
·    a gain of approximately $14 million from the insurance settlement related to the previously disclosed 2002 operational disruptions at the Company’s Rotterdam, the Netherlands and Columbia, South Carolina facilities;
·    increased pension and other post-employment benefits expense of approximately $25 million.
·    lower depreciation and amortization expense of $30 million.

Operating results for 2002 were negatively impacted by several items:
 
·    approximately $39 million due to operational disruptions at the Company’s Columbia, South Carolina and Rotterdam, the Netherlands facilities;
·    costs pertaining to asset charges relating primarily to equipment dismantlement and other write-offs recorded in 2002 totaling approximately $17 million;
·    an unfavorable shift in product mix; and
·    asset impairments and restructuring charges totaling approximately $5 million (as described more fully below and in Note 15 to the Company’s consolidated financial statements).

Net earnings for 2002 included the write-down to fair value of certain technology business venture investments and a loss of $12 million due to re-measurement of an Argentine peso-denominated tax receivable.

 
 
 
(Dollars in millions)
 
 
 
2003
 
 
 
2002
 
 
Change
 
Volume Effect
 
Price Effect
Product
Mix Effect
Exchange Rate Effect









 
 
 
 
 
 
 
 
 
 
Sales
$
5,800
$
5,320
9 %
(1) %
5 %
1 %
4 %


Sales revenue increased for 2003 compared to 2002 primarily due to increased selling prices, particularly for the polymers and the PCI segments, and favorable foreign currency exchange rates, particularly for the euro, of $275 million and $192 million, respectively. The increase in selling prices was primarily in response to an increase in raw material and energy costs. The Company plans to implement additional price increases in 2004 as needed to offset additional increases in raw material and energy costs.

(Dollars in millions)
 
2003
 
2002
 
Change




 
 
 
 
 
 
 
Gross Profit
$
810
$
779
 
4 %
As a percentage of sales
 
14.0 %
 
14.6 %
 
 


Gross profit for 2003 increased compared to 2002 primarily due to higher selling prices, continued cost reduction efforts, and favorable foreign currency exchange rates that more than offset higher raw material and energy costs. The higher raw material and energy costs were primarily attributable to the following raw materials: propane, paraxylene, ethylene glycol, and natural gas. The decrease in gross profit as a percentage of sales is attributable to higher raw material and energy costs that were partially offset by selling price increases and had a negative impact on gross profit of approximately $100 million.

 39

     

  

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The Company expects that higher raw material and energy costs will continue to negatively impact gross profit during 2004, mitigated to the extent the Company is able to continue to offset this impact in part through higher selling prices for certain of its products and through various cost reduction measures.

An insurance settlement of approximately $14 million related to the previously reported 2002 operational disruptions at the Company’s plants in Rotterdam, the Netherlands and Columbia, South Carolina had a positive impact on gross profit in 2003. In 2002, the same operational disruptions had a negative impact of $39 million.

The Company continues to implement a variety of cost control measures to manage discretionary spending. Of the measures taken, a change in vacation policy favorably impacted 2003 results by approximately $40 million. This change in vacation policy is not expected to have a significant impact on 2004 results. The Company expects that the other cost control measures implemented during 2003 will continue to positively impact its results in 2004.

The Company is also working on other measures to improve its cost structure and profitability. Included in that effort is a review of the Company’s portfolio of products and businesses, primarily in the Eastman Division. The Company expects during 2004 to continue to identify and pursue implementation of restructuring, divestiture, and consolidation alternatives for certain identified portions of the CASPI segment to improve profitability.

(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
Selling and General Administrative Expenses (S&GA)
$
414
$
407
 
2 %
Research and Development Expenses (R&D)
 
173
 
159
 
9 %


 
$
587
$
566
 
 


As a percentage of sales
 
10.1%
 
10.6%
 
 

The increase in S&GA expenses for 2003 compared to 2002 was primarily due to higher costs associated with the Company’s growth initiatives, including the business-building efforts within the Developing Businesses segment.

R&D expenses for 2003 were higher compared to 2002 primarily due to the Company’s increased efforts to develop certain operational efficiencies and efforts associated with new business initiatives.

In 2004, the Company expects combined costs related to S&GA expenses and R&D expenses will be at or below 10% of sales revenue.

 40

     

  

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Impairments and Restructuring Charges, Net

Impairments and restructuring charges totaled $523 million during 2003, with non-cash asset impairments of $500 million and restructuring charges of $23 million. The following table summarizes the 2003 and 2002 charges:

(Dollars in millions)
 
2003
 
2002


Eastman Division Segments:
 
 
 
 
CASPI Segment:
 
 
 
 
Fixed asset impairments
$
195
$
2
Intangible asset impairments
 
175
 
--
Goodwill impairments
 
34
 
--
Severance charges
 
13
 
--
Site closure costs
 
3
 
3
 
 
 
 
PCI Segment:
 
 
 
 
Fixed asset impairments
 
95
 
(1)
Severance charges
 
4
 
 
 
 
 
 
 
SP Segment
 
 
 
 
Severance charges
 
1
 
--
 
 
 
 
 


Total Eastman Division
 
520
 
4
 
 
 
 
 
Voridian Division Segments:
 
 
 
 
Polymers Segment:
 
 
 
 
Fixed asset impairments
 
1
 
1
Severance charges
 
1
 
--
 
 
 
 
 
Fibers Segment:
 
 
 
 
Severance charges
 
1
 
--
 
 
 
 
 


Total Voridian Division
 
3
 
1


 
 
 
 
 
Total Eastman Chemical Company
$
523
$
5


 
 
 
 
 
Total asset impairments and restructuring charges, net
 
489
 
5
Total goodwill impairments
 
34
 
--


 
 
 
 
 
Total Eastman Chemical Company
$
523
$
5


 
·    CASPI Segment
 
2003

In the third quarter, the Company reorganized the operating structure within its CASPI segment and changed the segment’s business strategy in response to the financial performance of certain underlying product lines. Those product lines include inks and resins and monomers, as more fully described under "Item 1 – Business." Prior to the third quarter 2003, management was pursuing growth strategies aimed at significantly improving the financial performance of these product groups. However, due to the continued operating losses and deteriorating market conditions, management decided to pursue alternative strategies including restructuring, divestiture, and consolidation. This change affected both the manner in which certain assets are used and the financial outlook for these product groups, thus triggering the impairments and certain restructuring charges.

 41

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The third quarter fixed asset impairments charges of $194 million primarily related to assets associated with the above mentioned product groups, and primarily impacted manufacturing sites in the North American and European regions that were part of the Lawter International, Inc. ("Lawter"), McWhorter Technologies, Inc. ("McWhorter"), and Chemicke Zavody Sokolov ("Sokolov") acquisitions. Within these product lines, nine sites in North America and six sites in Europe were impaired. As the undiscounted future cash flows could not support the carrying value of the assets, the fixed assets were written down to fair value, as established primarily by appraisal.

The third quarter intangible asset impairments charges related to definite-lived intangible assets of approximately $128 million and indefinite-lived intangibles of approximately $47 million. The definite-lived intangibles related primarily to developed technology and customer lists, and the indefinite-lived intangibles primarily related to trademarks. These intangible assets were primarily associated with the acquisitions of Lawter and McWhorter. As the undiscounted future cash flows could not support the carrying value of the definite-lived intangible assets, these assets were written down to fair value, as established primarily by appraisal. Indefinite-lived intangible assets were written down to fair value, as established by appraisal.

Upon adoption of SFAS No. 142, "Goodwill and Other Intangible Assets," the Company defined "reporting units" as one level below the operating segment level and considered the criteria set forth in SFAS No. 142 in aggregating the reporting units. This resulted in the CASPI segment being deemed a single reporting unit. In the third quarter 2003, the reorganization of the operating structure within the CASPI segment resulted in new reporting units one level below the operating segment. Due to the change in strategy and lack of similar economic characteristics, these reporting units did not meet the criteria necessary for aggregation. As a result, the goodwill associated with the CASPI segment was reassigned to the new reporting units based upon relative fair values. The reporting unit that contained the above-mentioned product lines was assigned $34 million of goodwill out of the total CASPI segment goodwill of $333 million. Because the Company determined that this reporting unit could no longer support the carrying value of its assigned goodwill, the full amount of that goodwill was impaired. The fair value of the other reporting unit within CASPI was sufficient to support the carrying value of the remainder of the goodwill.

In the fourth quarter, the Company recognized fixed asset impairments and site closure costs of $1 million and $3 million, respectively. The fixed asset impairments relate to additional impairments associated with the CASPI reorganization, as discussed above. The site closure charges relate primarily to additional costs related to the closure of the Company’s Dusseldorf manufacturing site.

Severance charges of $13 million for 2003 are discussed in further detail below.

2002

A change in estimate for site closure costs for Philadelphia, Pennsylvania and Portland, Oregon resulted in a $1 million credit to earnings in the third quarter. In the fourth quarter, the Company recognized restructuring charges of approximately $4 million related to closure of plants in Duesseldorf, Germany; Rexdale, Canada; and LaVergne, Tennessee; and additionally recognized an asset impairment charge of approximately $2 million related to certain other European assets.
 
·    PCI Segment

2003

In the second quarter, the Company recorded an asset impairments charge of approximately $15 million related to the impairment of certain fixed assets used in certain of the PCI segment’s performance chemicals product lines that are located in Llangefni, Wales. In response to industry conditions, during the second quarter 2003 the Company revised its strategy and the earnings forecast for the products manufactured by these assets. As the undiscounted future cash flows could not support the carrying value of the asset, the fixed assets were written down to fair value, as established primarily by discounted future cash flows of the impacted assets.

 42

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
In the third and fourth quarter, the PCI segment incurred charges of $80 million related to the impairment of fixed assets used in certain commodity and performance chemicals product lines as a result of increased competition and changes in business strategy in response to a change in market conditions and the financial performance of these product lines. Within the commodity product lines, the fixed asset impairments charge related to assets at the Sokolov, Czech Republic facility. Within the specialty organic chemicals product lines, the fixed asset impairments charge related to assets located at the Kingsport, Tennessee facility.
Severance charges of $4 million for 2003 are discussed in further detail below.

2002

In the fourth quarter, a net $1 million credit to earnings was recorded due to a $2 million credit associated with previously impaired fine chemicals product lines assets, and a charge of $1 million related to impaired assets used in certain research and development activities.
 
·    SP Segment

Severance charges of $1 million for 2003 are discussed in further detail below.
 
·    Polymers Segment

2003

In the fourth quarter, an asset impairment charge of $1 million was recorded related to certain research and development assets classified as held for sale. The fair value of these assets was determined using the estimated proceeds from sale less cost to sell.

Severance charges of $1 million for 2003 are discussed in further detail below.

2002

In 2002, the Company recorded charges related to the write-down of underperforming polyethylene assets totaling approximately $1 million.

Severance Charges - 2003

In the first half of the year, severance costs of $3 million were incurred within the CASPI segment related primarily to consolidation and restructuring activities and changes in previously accrued amounts. In the third quarter, the Company recognized $14 million in restructuring charges related to the actual and probable involuntary separations of approximately 300 employees. These workforce reductions are the result of decisions made as part of the restructuring of the CASPI segment discussed above, the Company’s annual budgeting process, and site closure costs associated with the PCI segment. During the fourth quarter, severance charges were recorded in the CASPI and Fibers segment totaling $2 million and $1 million, respectively, due to the ongoing restructuring of the CASPI segment and the annual budgeting process discussed above.

During 2003, terminations related to actual and probable involuntary separations totaled approximately 500 employees. As of the end of 2003, approximately 350 of these terminations had occurred, with the remaining primarily relating to previously announced consolidation and restructuring activities of certain European CASPI manufacturing sites that will be completed in early 2004.

 43

     

  

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following table summarizes the charges and changes in estimates described above, other asset impairments and restructuring charges, the noncash reductions attributable to asset impairments and the cash reductions in shutdown reserves for severance costs and site closure costs paid:


 
(Dollars in millions)
 
Balance at
January 1, 2002
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2002
 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
2
$
(2)
$
--
$
--
Severance costs
 
10
 
2
 
--
 
(10)
 
2
Site closure costs
 
13
 
3
 
--
 
(9)
 
7





Total
$
23
$
7
$
(2)
$
(19)
$
9





 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at
January 1, 2003
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2003





 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
500
$
(500)
$
--
$
--
Severance costs
 
2
 
20
 
--
 
(12)
 
10
Site closure costs
 
7
 
3
 
--
 
(5)
 
5





Total
$
9
$
523
$
(500)
$
(17)
$
15





Substantially all severance and site closure costs are expected to be applied to the reserves within one year.
 
Other Operating Income

(Dollars in millions)
2003
 
2002


 
 
 
 
Other operating income
(33)
 
--

Other operating income for 2003 totaled approximately $33 million and reflected gains of approximately $20 million on the sale of the Company’s high-performance crystalline plastic assets in first quarter, and approximately $13 million on the sale of the Company’s colorant product lines and related assets in fourth quarter. These items were reflected within the SP and CASPI segments, respectively.

Interest Expense, Net

(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
Gross interest costs
$
133
$
132
 
 
Less: capitalized interest
 
3
 
4
 
 


Interest expense
 
130
 
128
 
2 %
Interest income
 
6
 
6
 
 


Interest expense, net
$
124
$
122
 
2 %


Slightly higher gross interest costs for 2003 compared to 2002 reflected higher average debt levels due to bond offerings in June and November, with total proceeds of $495 million, in anticipation of the maturity of $500 million of 6 3/8% bonds due January 15, 2004, that were partially offset by lower average interest rates. For more information on the new bond issues and post year-end bond retirements, see Notes 7 and 24 to the Company’s consolidated financial statements.

For 2004, the Company expects net interest expense to decrease compared to 2003 due to lower expected gross interest costs as a result of lower average interest rates on borrowings and anticipated lower average borrowings.

 44

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Other (Income) Charges, net

 (Dollars in millions)  

2003  

 

2002  

   
  
 
  
Other income
$
(28)
$
(14)
Other charges
 
18
 
16


Other (income) charges, net
$
(10)
$
2



Included in other income are the Company’s portion of earnings from its equity investments, gains on sales of non-operating assets, royalty income, net gains on foreign exchange transactions and other miscellaneous items. Included in other charges are net losses on foreign exchange transactions, the Company’s portion of losses from its equity investments, losses on sales of nonoperating assets, fees on securitized receivables and other miscellaneous items.

Other income for 2003 primarily reflects net gains on foreign exchange transactions of $13 million and the Company’s portion of earnings from its equity investment in Genencor of $10 million. Other charges for 2003 consist primarily of writedowns to fair value of certain technology business venture investments due to other than temporary declines in value of $4 million, fees on securitized receivables of $3 million, and other miscellaneous charges.

Other income for 2002 primarily reflected $9 million of earnings from the Company’s equity investment in Genencor, net of a restructuring charge of $5 million. Additionally, other income included a net gain on foreign exchange transactions of $4 million. Other charges for 2002 primarily reflected a write-down to fair value of certain technology business venture investments due to other than temporary declines in value of $8 million and fees on securitized receivables of $4 million.

For more information on the Company’s equity investment in Genencor, see "Item 1 – Business – Investments" and Notes 1 and 5 to the Company’s consolidated financial statements.

Provision (Benefit) for Income Taxes

(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
Provision (benefit) for income taxes
$
(108)
$
5
 
N/A
Effective tax rate
 
28%
 
5%
 
 


The 2003 tax rate of 28% was impacted primarily by the treatment of the asset impairments and restructuring charges resulting in a lower expected tax benefit in certain foreign jurisdictions. This, coupled with non-deductible goodwill impairments, resulted in an effective tax benefit rate lower than the statutory rate.

The 2002 effective tax rate was reduced by a net credit of $17 million resulting from the favorable resolution of prior periods’ tax contingencies, by a reduction in international taxes related to the implementation of the Company’s divisional structure, and the elimination of nondeductible goodwill and indefinite-lived intangible asset amortization resulting from the implementation of SFAS No. 142.

In both years, the Company has recorded benefits from a foreign sales corporation or extraterritorial income exclusion, and management expects these benefits to continue into 2004. The Company also expects its effective tax rate in 2004 will be between approximately 30% and 33%.

 45

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cumulative Effect of Changes in Accounting Principles, Net

(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Cumulative effect of change in accounting principles, net
$
3
$
(18)


SFAS No. 143
 
As required by Statement of Financial Accounting Standards (SFAS) No. 143, "Accounting for Asset Retirement Obligations," at January 1, 2003, the Company recognized existing asset retirement obligations adjusted for cumulative accretion to the date of adoption, asset retirement costs capitalized as an increase to the carrying amount of the associated long-lived asset and accumulated depreciation on those capitalized costs. As a result of adoption of this standard, the Company recognized an after-tax credit to earnings of $3 million during the first quarter 2003, primarily related to a reduction in certain environmental liabilities.
 
If the asset retirement obligation measurement and recognition provisions of SFAS No. 143 had been in effect on January 1, 2002, the aggregate carrying amount of those obligations on that date would have been $27 million. If the amortization of asset retirement cost and accretion of asset retirement obligation provisions of SFAS No. 143 had been in effect during 2002, the impact on "Earnings before cumulative effect of changes in accounting principle" in 2002 would have been immaterial.
 
SFAS No. 142
 
The Company adopted the provisions of SFAS No. 142, "Goodwill and Other Intangible Assets," effective January 1, 2002. The provisions of SFAS No. 142 prohibit the amortization of goodwill and indefinite-lived intangible assets; require that goodwill and indefinite-lived intangible assets be tested at least annually for impairment; require reporting units to be identified for the purpose of assessing potential future impairments of goodwill; and remove the forty-year limitation on the amortization period of intangible assets that have finite lives.
 
In connection with the adoption of SFAS No. 142, the Company completed in the first quarter 2002 the impairment test for intangible assets with indefinite useful lives other than goodwill. As a result of this impairment test, it was determined that the fair value of certain trademarks related to the CASPI segment, as established by appraisal and based on discounted future cash flows, was less than the recorded value. Accordingly, the Company recognized an after-tax impairment charge of approximately $18 million in the first quarter of 2002 to reflect lower than previously expected cash flows from certain related products. This charge is reported in the Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss), and Retained Earnings as the cumulative effect of a change in accounting principle. Additionally, the Company reclassified $12 million of its intangible assets related to assembled workforce and the related deferred tax liabilities of approximately $5 million to goodwill. During the second quarter 2002, the Company performed the transitional impairment test on its goodwill as required upon adoption of this Statement, and determined that no impairment of goodwill existed as of January 1, 2002. The Company completed its annual testing of goodwill and indefinite-lived intangible assets for impairment in the third quarter 2002 and determined that no impairment existed as of September 30, 2002. The Company plans to continue its annual testing of goodwill and indefinite-lived intangible assets for impairment in the third quarter of each year, unless events warrant more frequent testing.
 
In 2003, the Company impaired certain goodwill and indefinite-lived intangible assets in the CASPI segment as discussed in Note 15 to the Company’s consolidated financial statements. Additionally, the Company completed its annual impairment review of the remaining goodwill and indefinite-lived intangible assets. No further impairment of goodwill or indefinite-lived intangible assets was required due to this review.

 46

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SUMMARY BY OPERATING SEGMENT

The Company’s products and operations are managed and reported in three divisions comprising six operating segments. Eastman Division consists of the CASPI segment, the PCI segment and the SP segment. Voridian Division contains the Polymers segment and the Fibers segment. The Developing Businesses Division consists of the Developing Businesses segment. The divisional structure allows the Company to align costs more directly with the activities and businesses that generate them.

The Company’s divisional structure allows it to align costs more directly with the activities and businesses that generate them. Goods and services are transferred between the divisions at predetermined prices that may be in excess of cost. Accordingly, the divisional structure results in the recognition of interdivisional sales revenue and operating earnings. Such interdivisional transactions are eliminated in the Company’s consolidated financial statements. Prior to 2002, segment sales revenue reflected only actual sales to third parties and the intersegment transfer of goods and services, recorded at cost, had no impact on segment earnings.

The CASPI segment manufactures raw materials, additives and specialty polymers, primarily for the paints and coatings, inks and graphic arts, adhesives and other markets. The CASPI segment's products consist of binders and resins, liquid vehicles, additives, unsaturated polyester resins and polyester and acrylic emulsions. Binders and resins, such as alkyd and polyester resins, hydrocarbon resins and rosins and rosin esters, are used in adhesives and as key components in paints and inks to form a protective coating or film, and bind color to the substrate. Liquid vehicles, such as ester, ketone and alcohol solvents, maintain the binders in liquid form for ease of application. Additives, such as cellulosic polymers, Texanol Ô ester alcohol and chlorinated polyolefins, provide different properties or performance enhancements to the end product. Unsaturated polyester resins are used primarily in gel coats and fiberglass reinforced plastics. Polyester and acrylic emulsions are traditionally used as textile sizes to protect fibers during processing in textile manufacturing, and the technology is also used in water-based paints, coatings and inks. Additional products are developed in response to, or in anticipation of, new applications where the Company believes significant value can be achieved.

The PCI segment manufactures diversified products that are used in a variety of markets and industrial and consumer applications, including chemicals for agricultural intermediates, fibers, food and beverage ingredients, photographic chemicals, pharmaceutical intermediates, polymer compounding and chemical manufacturing intermediates. The PCI segment also offers custom manufacturing services through its custom synthesis business.

The SP segment’s key products include engineering and specialty polymers, specialty film and sheet products, and packaging film and fiber products. Included in these are highly specialized copolyesters, cellulosic plastics and compounded polyethylene plastics that possess unique performance properties for value-added end uses such as appliances, store fixtures and displays, building and construction, electronics and electronic packaging, medical packaging, personal care and cosmetics, performance films, tape and labels, biodegradeables, cups and lids, fiber and strapping, photographic and optical film, graphic arts and general packaging.

The Polymers segment manufactures and supplies PET polymers for use in beverage and food packaging and other applications such as custom-care and cosmetics packaging, health care and pharmaceutical uses, household products and industrial. PET polymers serve as source products for packaging a wide variety of products including carbonated soft drinks, water, beer and personal care items and food containers that are suitable for both conventional and microwave oven use. The Polymers segment also manufactures low-density polyethylene and linear low-density polyethylene, which are used primarily in extrusion coating, film and molding applications.

The Fibers segment manufactures Estron Ô acetate tow and Estrobond Ô triacetin plasticizers which are used primarily in cigarette filters; Estron Ô and Chromspun Ô acetate yarns for use in apparel, home furnishings and industrial fabrics; acetate flake for use by other acetate tow producers; and acetyl chemicals.

 47

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Developing Businesses segment includes new businesses and certain investments in non-traditional growth opportunities that leverage the Company’s technology expertise, intellectual property and know-how into business models that extend to new customers and markets. The segment includes, among other new and developing businesses, Cendian Corporation ("Cendian"), a logistics provider for chemical companies; Ariel Research Corporation ("Ariel"), a provider of international chemical and regulatory compliance solutions for environmental, health and safety operations; and Eastman’s gasification services.

Effective January 1, 2003, sales and operating results for developing businesses activities were moved from the CASPI, PCI and SP segments to the Developing Businesses segment. During 2002, these amounts were included within the CASPI, PCI, and SP segments. During 2001, these amounts had been split among all segments. Accordingly, the prior year amounts for sales and operating earnings have been reclassified for all periods presented. These revisions had no effect on the Company’s consolidated financial statements.

For additional information concerning an analysis of the results of the Company’s operating segments, see Note 20 to the Company’s consolidated financial statements and Exhibits 99.01 and 99.02 to this Annual Report.

 48

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EASTMAN DIVISION

CASPI Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
1,597
$
1,540
 
4 %
Volume effect
 
 
 
 
 
(6) %
Price effect
 
 
 
 
 
2 %
Product mix effect
 
 
 
 
 
3 %
Exchange rate effect
 
 
 
 
 
5 %
 
 
 
 
 
 
 
Interdivisional sales
 
--
 
--
 
N/A
 
 
 
 
 
 
 
Operating earnings (loss)
 
(358)
 
58
 
N/A
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
386
 
5
 
 
Goodwill impairments
 
34
 
--
 
 
Other operating income
 
(13)
 
--
 
 


2003 Compared With 2002

The increase in external sales revenue for 2003 compared to 2002 was primarily due to favorable shifts in foreign currency exchange rates, improved product mix, and slightly higher selling prices that more than offset a decrease in sales volume. Foreign currency exchange rates had a positive impact on sales revenue of $74 million primarily due to the strengthening of the euro. A favorable shift in product mix towards higher priced products had a positive impact on sales revenue of $48 million. Additionally, higher selling prices, as a result of increased raw material and energy costs had a positive impact on sales revenues of $29 million. The decline in sales volume, which had a negative impact on sales revenue of $93 million, was primarily attributable to forgoing sales of certain low-margin products and restructuring and divestiture actions that were taken during the year.

Operating earnings for 2003 declined significantly compared to 2002 primarily due to the asset impairments and restructuring charges and goodwill impairments related to this segment of $386 million and $34 million, respectively. Higher raw material and energy costs and lower sales volume, which were partially offset by higher selling prices, cost reduction measures, and the favorable impact of foreign currency exchange rates contributed to the decrease in operating earnings. Additionally, a gain of approximately $13 million from the sale of the segment’s colorant product lines contributed to earnings. For more information on the asset impairments and restructuring charges, see the discussion of impairments and restructuring charges above and in Note 15 to the Company’s consolidated financial statements.

For 2004, the Company expects restructuring, divestiture and consolidation activities and continuing cost reduction efforts to contribute approximately $50 million to operating results.

 49

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS


PCI Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
1,184
$
1,084
 
9 %
Volume effect
 
 
 
 
 
-- %
Price effect
 
 
 
 
 
7 %
Product mix effect
 
 
 
 
 
-- %
Exchange rate effect
 
 
 
 
 
2 %
 
 
 
 
 
 
 
Interdivisional sales
 
495
 
383
 
29 %
 
 
 
 
 
 
 
Operating loss
 
(89)
 
14
 
N/A
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
99
 
(1)
 
 

2003 Compared With 2002

The increase in external sales revenue for 2003 compared to 2002 was primarily attributable to higher selling prices and a favorable shift in foreign currency exchange rates. The increase in selling prices had a positive impact on sales revenue of $78 million and was primarily attributable to oxo chemical prices that increased in response to higher raw material and energy costs. Foreign currency exchange rates also had a positive impact on sales revenue of $23 million primarily due to the strengthening of the euro. The increase in interdivisional sales revenue for 2003 was primarily due to higher selling prices as a result of higher raw material and energy costs.

The decrease in operating earnings 2003 compared to 2002 was primarily due to asset impairments and restructuring charge of approximately $99 million. Additionally, higher raw material and energy costs were largely offset by higher selling prices and cost reduction measures. For more information on the asset impairments and restructuring charges see the discussion of impairments and restructuring charges above and Note 15 to the Company’s consolidated financial statements.

Long-term, the Company expects that aggressive management of costs in the PCI segment will help improve margins and position it to take full advantage of the upturn expected in the 2005 through 2006 timeframe. The PCI segment is aggressively identifying and implementing projects to reduce costs and improve performance.

During 2001, the Company reported that a large customer of the PCI segment did not intend to renew its contract for a custom synthesis product beyond June 30, 2002. As a consequence, impairment charges totaling approximately $70 million related to the impacted assets were recorded during 2001 as part of the restructuring of the fine chemicals product lines. Subsequently, the customer initiated discussions with the Company which resulted in two amendments to the agreement to extend the custom synthesis product contract through June 2004 based on renegotiated terms. Effective July 1, 2003, Eastman and the customer entered into a multi-year agreement in which the Company will remain the sole global supplier for the customer's custom synthesis product.

 50

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS


 

SP Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
559
$
528
 
6 %
Volume effect
 
 
 
 
 
1 %
Price effect
 
 
 
 
 
-- %
Product mix effect
 
 
 
 
 
1 %
Exchange rate effect
 
 
 
 
 
4 %
 
 
 
 
 
 
 
Interdivisional sales
 
49
 
45
 
9 %
 
 
 
 
 
 
 
Operating earnings
 
63
 
34
 
85 %
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
1
 
-
 
 
Other operating income
 
20
 
-
 
 

 
2003 Compared With 2002

External sales revenue for 2003 increased compared to 2002 primarily due to favorable shifts in foreign currency exchange rates. These shifts, primarily due to the strengthening of the euro, contributed $20 million of the increased sales revenue. Additionally, slight increases in sales volume and some improvement in product mix contributed to the overall increase in revenues.
 
Operating earnings for 2003 increased compared to 2002 primarily due to a gain of $20 million on the sale of the segment’s high-performance crystalline plastics assets, cost reduction measures, and favorable shifts in foreign currency exchange rates that were partially offset by higher raw material and energy costs.

New competitors in Asia and Europe continue to negatively impact results for copolyesters. However, the Company is committed to maintaining cost advantages obtained from its scale of operations and manufacturing experience and to increasing utilization of its current capacity. This could result in consolidation and restructuring within the segment’s manufacturing facilities.

 51

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

VORIDIAN DIVISION

Polymers Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
1,756
$
1,510
 
16 %
Volume effect
 
 
 
 
 
2 %
Price effect
 
 
 
 
 
11 %
Product mix effect
 
 
 
 
 
(1) %
Exchange rate effect
 
 
 
 
 
4 %
 
 
 
 
 
 
 
Interdivisional sales
 
68
 
55
 
23 %
 
 
 
 
 
 
 
Operating earnings (loss)
 
62
 
35
 
77 %
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
2
 
1
 
 

2003 Compared With 2002

The increase in external sales revenue for 2003 compared to 2002 was primarily due to higher selling prices, for both PET polymers and polyethylene, which had a positive impact on sales revenue of $162 million. A favorable shift in foreign currency exchange rates, particularly for the euro, also had a positive impact on sales revenue of $60 million. Additionally, new industry capacity in North America that began production earlier in 2003 than the Company had anticipated resulted in a smaller than expected increase in sales revenue from volume.

Operating earnings for 2003 increased compared to 2002 primarily due to a $14 million insurance settlement in 2003 related to 2002 operational disruptions that had a negative impact of $39 million on operating earnings in 2002. Other factors impacting operating earnings included higher selling prices, for both PET polymers and polyethylene, and the positive impact of a favorable shift in foreign currency exchange rates, primarily for the euro. The positive shifts in selling prices and foreign currency exchange rates were more than offset by higher raw material and energy costs, added PET polymers capacity in North America, which negatively impacted volumes, and asset impairments and restructuring charges of $2 million.

For 2004, the Polymers segment expects to maintain its focus on lowering costs and, for its PET polymers product lines, growing along with overall market demand growth. Longer term, the Company expects global demand for PET polymers to grow at an average rate of approximately 10% annually over the next several years.

 52

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Fibers Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
635
$
642
 
(1) %
Volume effect
 
 
 
 
 
4 %
Price effect
 
 
 
 
 
1 %
Product mix effect
 
 
 
 
 
(9) %
Exchange rate effect
 
 
 
 
 
3 %
 
 
 
 
 
 
 
Interdivisional sales
 
80
 
72
 
10 %
 
 
 
 
 
 
 
Operating earnings
 
125
 
133
 
(6) %
Asset impairments and restructuring charges, net
 
1
 
--
 
 


2003 Compared With 2002

The slight decrease in external sales revenue for 2003 compared to 2002 was primarily due to an unfavorable shift in product mix, which had a negative impact on sales revenue of $57 million. The unfavorable shift in product mix was primarily due to a decrease in sales of acetate tow in North America partially offset by increased sales of acetate tow in other parts of the world. The shift in product mix was mostly offset by increases in sales volume, primarily for acetyl chemicals, and favorable shifts in foreign currency exchange rates, primarily for the euro, of $28 million and $16 million, respectively.

The decline in operating earnings for 2003 compared to 2002 was primarily due to an unfavorable shift in product mix, primarily due to a decline of acetate tow demand in North America that was partially offset by increased acetate tow demand in other parts of the world.


 53

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

DEVELOPING BUSINESSES DIVISION

Developing Businesses Segment
 
 
 
 
 
 
 



(Dollars in millions)
 
2003
 
2002
 
Change



 
 
 
 
 
 
 
External Sales
$
69
$
16
 
>100 %
 
 
 
 
 
 
 
Interdivisional sales
 
396
 
330
 
20 %
 
 
 
 
 
 
 
Operating loss
 
(65)
 
(70)
 
7 %

2003 Compared With 2002

The increase in external sales revenue for 2003 compared to 2002 was primarily due to the continued implementation of customer contracts by Cendian and the implementation of gasification services contracts. The increase in interdivisional sales revenue for 2003 compared to 2002 was primarily due to geographic expansion of the logistics services provided by Cendian to Eastman Division and Voridian Division.

Operating results for the Developing Businesses segment improved in 2003 compared to 2002, primarily due to improved operating performance at Cendian that was partially offset by higher costs associated with other growth initiatives.

For 2004, the Company expects the operating loss in the Developing Businesses Division to be less than $45 million.

 54

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SUMMARY BY CUSTOMER LOCATION – 2003 COMPARED WITH 2002

Sales Revenue (excluding interdivisional sales)

 
 
(Dollars in millions)
 
 
 
2003
 
 
 
2002
 
 
 
Change
 
 
 
Volume Effect
 
 
 
Price Effect
 
 
Product
Mix Effect
 
Exchange
Rate
Effect







 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
United States and Canada
$
 
3,302
$
 
3,040
 
 
9 %
 
 
1 %
 
 
7 %
 
 
1 %
 
 
-- %
Europe, Middle East, and Africa
 
1,368
 
1,170
 
17 %
 
(1) %
 
-- %
 
2 %
 
16 %
Asia Pacific
 
643
 
636
 
1 %
 
(5) %
 
3 %
 
2 %
 
1 %
Latin America
 
487
 
474
 
3 %
 
(7) %
 
11 %
 
-- %
 
(1) %


 
$
5,800
$
5,320
 
 
 
 
 
 
 
 
 
 



The increase in sales revenue in the United States and Canada for 2003 compared to 2002 was primarily due to higher selling prices, particularly for the Polymers and PCI segment, which had a positive impact on sales revenue of $206 million. The higher selling prices mostly related to sales of intermediates chemicals, PET polymers, and polyethylene, and were primarily in response to increases in raw material and energy costs.
 
2003 sales revenue in Europe, the Middle East, and Africa increased compared to 2002 due to favorable shifts in foreign currency exchange rates which had a positive impact on sales revenue of $191 million, primarily due to the strengthening of the euro.

2003 sales revenue in the Asia Pacific region increased slightly compared to 2002 primarily due to higher selling prices and a favorable shift in product mix that was offset by lower sales volume. Higher selling prices, particularly for intermediates products and PET polymers, and a favorable shift in product mix contributed $22 million and $13 million, respectively, to sales revenue. Lower sales volume, particularly for the PCI and Fibers segments, had a negative impact on sales revenue of $33 million.

2003 sales revenue in Latin America increased slightly compared to 2002 primarily due to higher selling prices, primarily related to PET polymers, which had a positive impact on sales revenue of $52 million. These increases were partially offset by a decrease in sales volume, primarily attributable to lower sales of PET polymers and PCI segment intermediates chemicals, in the amount of approximately $34 million.

With a substantial portion of sales to customers outside the United States of America, Eastman is subject to the risks associated with operating in international markets. To mitigate its exchange rate risks, the Company frequently seeks to negotiate payment terms in U.S. dollars and euros. In addition, where it deems such actions advisable, the Company engages in foreign currency hedging transactions and requires letters of credit and prepayment for shipments where its assessment of individual customer and country risks indicates their use is appropriate. For more information on these practices, see Note 8 to the Company’s consolidated financial statements and Part II--Item 7A--"Quantitative and Qualitative Disclosures About Market Risk."

 55

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

SUMMARY OF CONSOLIDATED RESULTS - 2002 COMPARED WITH 2001

Earnings (Loss)
 
 
 
 
 
 
 
 
 
(Dollars in millions, except per share amounts)
 
2002
 
2001


 
 
 
 
 
Operating earnings (loss)
$
208
$
(120)
Net earnings (loss) before cumulative effect of a change in
 
 
 
 
accounting principle
 
79
 
(175)
Net earnings (loss)
 
61
 
(175)
Earnings (loss) per share
 
 
 
 
--Basic
 
0.79
 
(2.28)
--Diluted
 
0.79
 
(2.28)
 
 
 
 
Asset impairments and restructuring charges
 
5
 
396
Other operating expense
 
--
 
50
Other items
 
--
 
20

           
Operating earnings for 2002 increased compared to 2001 primarily due to a decrease in asset impairments and restructuring charges. In addition, operating earnings for 2002 were significantly impacted by lower selling prices for all of the Company’s segments. Such selling prices decreased more than raw material costs, resulting in a reduction in gross profit of approximately $100 million. Higher sales volumes and lower unit costs resulting from increased capacity utilization had a positive impact on operating earnings for 2002.

In addition, operating earnings for 2002 were negatively impacted by:
 
·    approximately $39 million due to operational disruptions at the Company’s Columbia, South Carolina and Rotterdam, the Netherlands facilities;
·    costs pertaining to asset charges relating primarily to equipment dismantlements and other write-offs recorded in the fourth quarter 2002 totaling approximately $17 million;
·    an unfavorable shift in product mix; and
·    asset impairments and restructuring charges (as described more fully below and in Note 15 to the Company’s consolidated financial statements) totaling approximately $5 million.

Operating results for 2001 were negatively impacted by:
 
·    asset impairments and restructuring charges and other operating expense totaling approximately $446 million (as described more fully below and in Notes 15 and 16 to the Company’s consolidated financial statements); and
·    the effect of amortization of goodwill and indefinite-lived intangible assets totaling approximately $20 million.

 
 
 
(Dollars in millions)
 
 
 
2002
 
 
 
2001
 
 
Change
 
Volume Effect
 
Price Effect
Product
Mix Effect
Exchange Rate Effect









 
 
 
 
 
 
 
 
 
 
Sales
$
5,320
$
5,390
(1)%
7%
(7)%
(2)%
1%


Sales revenue for 2002 declined slightly compared to 2001 primarily due to lower selling prices for all of the Company’s segments which had a negative impact on revenues of $351 million. The decline in selling prices is indicative of the Company’s inability to increase its selling prices for some of its products, and also of a persistently sluggish global economy, particularly for manufacturers. Increased sales volumes for all of the Company’s segments had a positive impact on sales revenue of $359 million.

 56

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS


(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Gross Profit
$
779
$
893
 
(13)%
As a percentage of sales
 
14.6%
 
16.6%
 
 

Decreased selling prices had a negative impact on gross profit for 2002 of $351 million that were mostly offset by decreased raw material costs. Operational disruptions at the Company’s plants in Rotterdam, the Netherlands and Columbia, South Carolina negatively impacted gross profit by approximately $39 million. Fourth quarter 2002 asset charges relating primarily to equipment dismantlements and other write-offs totaling approximately $17 million also had a negative impact on gross profit.


(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Selling and General Administrative Expenses
$
407
$
407
 
 -- %
Research and Development Expenses
 
159
 
160
 
(1)%


 
$
566
$
567
 
 


As a percentage of sales
 
10.6%
 
10.5%
 
 

S&GA expenses for 2002 were flat compared to 2001 even though costs related to the Company’s growth initiatives increased from $35 million in 2001 to approximately $50 million in 2002. This increase was offset by cost control efforts. R&D expenses for 2002 were flat compared to 2001. The combined expenditures of S&GA and R&D for both 2002 and 2001 were below the commitment by the Company to contain these expenditures at or below 11% of sales revenues.

Asset Impairments and Restructuring Charges, Net

The following table summarizes the asset impairment and restructuring charges for 2002 and 2001:

(Dollars in millions)
 
2002
 
2001


Eastman Division Segments:
 
 
 
 
CASPI Segment:
 
 
 
 
Fixed asset impairments
$
2
$
59
Severance charges
 
--
 
8
Site closure costs
 
3
 
10
 
 
 
 
PCI Segment:
 
 
 
 
Fixed asset impairments
 
(1)
 
69
Severance charges
 
--
 
3
Site closure costs
 
--
 
1
 
 
 
 
 
SP Segment
 
 
 
 
Fixed asset impairments
 
--
 
15
 
 
 
 
 
Total Eastman Division
 
4
 
165
 
 
 
 
 
Voridian Division Segments:
 
 
 
 
Polymers Segment:
 
 
 
 
Fixed asset impairments
 
1
 
123
Termination of raw material supply agreement
 
--
 
108
 
 
 
 
 
Total Voridian Division
 
1
 
231
 
 
 
 
 


Total Eastman Chemical Company
$
5
$
396



 57

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
·    CASPI Segment
 
2002

A change in estimate for site closure costs for Philadelphia, Pennsylvania and Portland, Oregon resulted in a $1 million credit to earnings in the third quarter. In the fourth quarter, the Company recognized restructuring charges of approximately $4 million related to closure of plants in Duesseldorf, Germany; Rexdale, Canada; and LaVergne, Tennessee; and additionally recognized an asset impairment charge of approximately $2 million related to certain other European assets.

2001

In the second quarter, the Company recognized a charge of approximately $20 million related to the closure of plants in Philadelphia, Pennsylvania and Portland, Oregon that were obtained in the acquisition of McWhorter Technologies, Inc. ("McWhorter"). In the third quarter, the Company recognized a charge of approximately $21 million related to the closure of a Moundville, Alabama plant that was obtained in the acquisition of Lawter International, Inc.

In the fourth quarter, the Company recognized a charge of approximately $27 million related to the closure of an operating site in Duesseldorf, Germany. Also in the fourth quarter, charges of approximately $6 million and $3 million, respectively, were recognized related to the impairment of other operating assets in Savannah, Georgia and Banbury, England.

The restructuring charges included write-downs of the fixed assets at these facilities, severance accruals for employees impacted by the plant shutdowns, and other costs associated with closing the facilities. The Philadelphia and Portland facilities were closed in 2001, and the Moundville, Duesseldorf and Banbury sites closed in 2002. The Savannah site closed in 2003. The fair value of the impacted assets was determined using the discounted estimated net cash flows related to the products produced by the impacted assets.
 
·    PCI Segment

2002

In the fourth quarter, a net $1 million credit to earnings was recorded due to a $2 million credit associated with previously impaired fine chemicals product lines assets, and a charge of $1 million related to impaired assets used in certain research and development activities.

2001

As a part of the restructuring of the Company's fine chemicals product lines, Eastman recorded restructuring charges, including related asset write-downs, totaling approximately $70 million in 2001. These charges resulted from the Company's on-going restructuring of its fine chemicals product lines to reduce costs, and from the write-down of assets determined to be impaired. The restructuring initiative and related asset impairments involve manufacturing sites within the United States at Tennessee and Arkansas, Llangefni, Wales, and Hong Kong.

Charges in the fourth quarter and the third quarter of $1 million and $6 million, respectively, pertained primarily to severance accruals for employees impacted by the plant shutdowns, closure costs and write-downs of fixed assets. Charges totaling approximately $63 million recorded during the second quarter related to certain fine chemicals product lines that did not fit the Company’s long-term strategic objectives and for assets determined to be impaired.

 58

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The impairments at the foreign sites included the write-down of fixed assets and other long-term deposits. The restructuring and asset impairments at the domestic sites primarily pertained to write-downs of fixed assets, net of the effect of a reversal of a customer deposit, related to a custom synthesis product contract. In 2001, the Company reported that a large customer of the PCI segment did not intend to renew its contract for a custom synthesis product beyond June 30, 2002. As a consequence, impairment charges totaling approximately $70 million related to the impacted assets were recorded during 2001 as part of the restructuring of the fine chemicals product lines. These assets were written down to fair value in the second quarter of 2001 using discounted estimated net cash flows from contracts that were currently in effect. Subsequently, the customer initiated discussions with the Company which resulted in two amendments to the agreement to extend the custom synthesis product contract through June 2004 based on renegotiated terms. Effective July 1, 2003, Eastman and the customer entered into a multi-year agreement in which the Company will remain the sole global supplier for the customer's custom synthesis product.

Also during 2001, PCI incurred asset impairment charges of $3 million for certain European assets. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.
 
·    SP Segment

During 2001, Specialty Plastics incurred $15 million related to deterioration of demand for certain specialty plastics products produced in Kingsport, Tennessee. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.
 
·    Polymers Segment

2002

In 2002, the Company recorded charges related to the write-down of underperforming polyethylene assets totaling approximately $1 million.

2001

During the second quarter, Eastman terminated an agreement with a supplier that guaranteed the Company’s right to buy a specified quantity of a certain raw material annually through 2007 at prices determined by the pricing formula specified in the agreement. In prior years, the Company paid a total of $239 million to the supplier and deferred those costs to be amortized over the 15-year period during which the product was to be received. The Company began amortizing those costs in 1993 and had recorded accumulated amortization of $131 million at March 31, 2001. As a result of the termination of this agreement, a charge of $108 million, representing unamortized deferred cost, was charged to the Polymers segment's earnings during the second quarter 2001 as no continuing economic benefits will be received pertaining to this contract.

Also during the second quarter, management identified and announced certain assets that were intended to be spun off at year-end 2001 related to the Company’s efforts to spin off the specialty chemicals and plastics businesses. An indirect result of these decisions would have been that the continuing operations would have been required to purchase certain raw materials and utilities that were historically produced internally for use in the manufacture of polyethylene. Considering the purchase price of these raw materials and utilities, the carrying value of certain assets used to consume ethylene at the Longview, Texas facility in the manufacture of polyethylene exceeded the expected future cash flows attributable to such assets.

Subsequent to the second quarter, the spin-off was canceled. However, management determined that the continued operation of these assets was not economically attractive. Based upon the resulting cash flows from the probable future use of these assets, an impairment loss of $103 million was charged to the Polymers segment’s earnings during the second quarter 2001. The impairment represents the excess of the carrying value over the discounted estimated future cash flows related to the products produced by the impacted assets.

 59

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Also during 2001, the Company recorded asset impairment charges related to under-utilized assets including $10 million related to the discontinuation of the precolored-green PET polymers product line in Kingsport, Tennessee; and $10 million related to cessation of production at the Company’s solid-stating facility in Toronto, Ontario. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.

The following table summarizes the charges and changes in estimates described above, other asset impairments and restructuring charges, the noncash reductions attributable to asset impairments and the cash reductions in shutdown reserves for severance costs and site closure costs paid:

 
 
Balance at
January 1, 2001
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2001





 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
373
$
(373)
$
--
$
--
Severance costs
 
--
 
16
 
--
 
(6)
 
10
Site closure costs
 
10
 
10
 
--
 
(7)
 
13





Total
$
10
$
399
$
(373)
$
(13)
$
23





 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
Balance at
January 1, 2002
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2002
 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
2
$
(2)
$
--
$
--
Severance costs
 
10
 
2
 
--
 
(10)
 
2
Site closure costs
 
13
 
3
 
--
 
(9)
 
7





Total
$
23
$
7
$
(2)
$
(19)
$
9





 
 
 
 
 
 
 
 
 
 
 

Substantially all severance and site closure costs are expected to be applied to the reserves within one year.
 
Other Operating Expense

(Dollars in millions)
 
2002
 
2001


 
 
 
 
 
Other operating expense
$
--
$
50


Other operating expenses of $50 million were recognized in 2001. These items consisted of approximately $20 million in charges associated with efforts to spin off the specialty chemicals and plastics businesses; an $18 million write-down of accounts receivable for credit risks resulting from the devaluation of the Argentine peso; a $7 million pension settlement charge; and a $5 million write-off of acquired in-process research and development related to the acquisition of the hydrocarbon resins and select portions of the rosin-based resins business from Hercules Incorporated ("Hercules Businesses"). Approximately $26 million of these items were reflected in the Polymers segment, $11 million in the CASPI segment, $7 million in the PCI segment, $4 million in the SP segment, and $2 million in the Fibers segment.

 60

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Interest Expense, Net

(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Gross interest costs
$
132
$
151
 
 
Less: capitalized interest
 
4
 
5
 
 


Interest expense
 
128
 
146
 
(12)%
Interest income
 
6
 
6
 
 


Interest expense, net
$
122
$
140
 
(13)%


Lower interest expense for 2002 compared to 2001 reflected a net reduction in borrowings and decreases in market interest rates, partially offset by a higher interest rate on the Company’s April 2002 10-year bond issue versus the interest rate on commercial paper that was outstanding during the prior period.

Other (Income) Charges, net

(dollars in millions)
 
2002
 
2001


 
 
 
 
 
Other Income
$
(14)
$
(11)
Other Charges
 
16
 
42


Other (Income) Charges, net
$
2
$
31


Included in other income are the Company’s portion of earnings from its equity investments, gains on sales of non-operating assets, royalty income, net gains on foreign exchange transactions and other miscellaneous items. Included in other charges are net losses on foreign exchange transactions, the Company’s portion of losses from its equity investments, losses on sales of nonoperating assets, fees on securitized receivables and other miscellaneous items.

Other income for 2002 primarily reflected $9 million of earnings from the Company’s equity investment in Genencor, net of a restructuring charge of $5 million. Additionally, other income included a net gain on foreign exchange transactions of $4 million. Other charges for 2002 primarily reflected a write-down to fair value of certain technology business venture investments due to other than temporary declines in value of $8 million and fees on securitized receivables of $4 million.

Other income for 2001 primarily reflected the Company’s portion of earnings from its equity investment in Genencor. Other charges for 2001 included a $12 million charge for currency losses resulting from the devaluation of the Argentine peso, an $8 million charge for sorbates civil litigation settlement costs, and other miscellaneous items.

For more information on the Company’s equity investment in Genencor, see Notes 1 and 5 to the Company’s consolidated financial statements.

Provision (Benefit) for Income Taxes

(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Provision (benefit) for income taxes
$
5
$
(116)
 
N/A
Effective tax rate
 
5.4%
 
39.8%
 
 


The 2002 effective tax rate was reduced by a net credit of $17 million resulting from the favorable resolution of prior periods’ tax contingencies, by a reduction in international taxes related to the implementation of the Company’s divisional structure, and the elimination of nondeductible goodwill and indefinite-lived intangible asset amortization resulting from the implementation of SFAS No. 142.

The 2001 effective tax rate was impacted by the significant asset impairments and restructuring charges recorded during 2001 as described above.

 61

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
In both years, the Company has recorded benefits from a foreign sales corporation or extraterritorial income exclusion.

Cumulative Effect of Changes in Accounting Principles, Net

(Dollars in millions)
 
2002
 
2001


 
 
 
 
 
Cumulative effect of change in accounting principle, net
$
(18)
$
--


In connection with the adoption of SFAS No. 142, the Company completed in the first quarter 2002 the impairment test for intangible assets with indefinite useful lives other than goodwill. As a result of this impairment test, it was determined that the fair value of certain trademarks related to the CASPI segment, as established by appraisal and based on discounted future cash flows, was less than the recorded value. Accordingly, the Company recognized an after-tax impairment charge of approximately $18 million in the first quarter 2002. This charge is reported in the Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss) and Retained Earnings as the cumulative effect of a change in accounting principle. Additionally, the Company reclassified $12 million of its intangible assets related to assembled workforce and the related deferred tax liabilities of approximately $5 million to goodwill. During the second quarter 2002, the Company performed the transitional impairment test on its goodwill as required upon adoption of this Statement, and determined that no impairment of goodwill existed as of January 1, 2002. The Company completed its annual testing of goodwill and indefinite-lived intangible assets for impairment in the third quarter 2002 and determined that no impairment existed as of September 30, 2002.

For additional information regarding the effects of changes in accounting principles, see Note 23 to the Company’s consolidated financial statements.

SUMMARY BY OPERATING SEGMENT

EASTMAN DIVISION

CASPI Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
1,540
$
1,508
 
2 %
Operating earnings (loss)
 
58
 
(25)
 
N/A
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
5
 
77
 
 
Other operating expense
 
-
 
11
 
 


2002 Compared With 2001

Sales revenue for 2002 increased moderately compared to 2001 mainly due to increased sales volumes, which had a positive impact on sales revenue of $58 million. The increase in sales volumes for 2002 was primarily due to the Hercules Businesses. Lower selling prices had a negative impact on sales revenue of $49 million.

Operating earnings for 2002 were negatively impacted by asset impairments and restructuring charges totaling approximately $5 million as described in Note 15 to the Company’s consolidated financial statements. Operating results for 2001 were negatively impacted by asset impairments and restructuring charges and other operating expense totaling approximately $88 million as more fully described in Notes 15 and 16 to the Company’s consolidated financial statements. Operating results for 2001 were also impacted by amortization of goodwill and indefinite-lived intangibles totaling approximately $20 million.

In addition to the items above, selling prices for 2002 declined more than raw material costs resulting in margin compression. Operating earnings for 2002 were also negatively impacted by fourth quarter asset charges relating primarily to equipment dismantlements and other write-offs totaling approximately $5 million.

 62

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS


PCI Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
1,467
$
1,132
 
30 %
Operating earnings (loss)
 
14
 
(60)
 
N/A
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
(1)
 
73
 
 
Other operating expense
 
--
 
7
 
 

2002 Compared With 2001

Sales revenue for 2002 increased $335 million including interdivisional sales, but declined $48 million excluding interdivisional sales. Lower selling prices had a negative impact on revenues of $65 million. Increased sales volumes had a positive impact on sales revenue of $87 million, partially offset by an unfavorable shift in product mix, which had a negative impact on revenues of $65 million. The shift in product mix was primarily due to increased sales volumes of lower unit priced products, particularly glacial acetic acid in the acetyl and intermediates product group.

In 2002, a change in estimate resulting in a credit of approximately $2 million related to the sale of operating assets and a charge of approximately $1 million related to impaired research and development assets, as more fully described in Note 15 to the Company’s consolidated financial statements, were recognized in the PCI segment. Results for 2001 were negatively impacted by asset impairments and restructuring charges totaling approximately $73 million and other operating expense totaling approximately $7 million, as more fully described in Notes 15 and 16 to the Company’s consolidated financial statements.

In addition to the items above, selling prices for 2002 declined more than raw material costs resulting in margin compression. Operating results for 2002 were also negatively impacted by fourth quarter asset charges relating primarily to equipment dismantlements and other write-offs totaling approximately $3 million.

During 2001, the Company reported that a large customer of the PCI segment did not intend to renew its contract for a custom synthesis product beyond June 30, 2002. As a consequence, impairment charges totaling approximately $70 million related to the impacted assets were recorded during 2001 as part of the restructuring of the fine chemicals product lines. Subsequently, the customer initiated discussions with the Company which resulted in two amendments to the agreement to extend the custom synthesis product contract through June 2004 based on renegotiated terms. Effective July 1, 2003, Eastman and the customer entered into a multi-year agreement in which the Company will remain the sole global supplier for the customer's custom synthesis product.

 63

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS


SP Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
573
$
535
 
7 %
Operating earnings
 
34
 
51
 
(33)%
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
-
 
15
 
 
Other operating expense
 
-
 
4
 
 

2002 Compared With 2001

Sales revenue for 2002 increased $38 million compared to 2001 including interdivisional sales, but decreased $6 million excluding interdivisional sales. The decline in sales revenue excluding interdivisional sales was attributed to a decline in selling prices, which had a negative impact on sales revenue of $19 million. The decline in selling prices was partially offset by increased sales volumes, which had a positive impact on sales revenue of $12 million.

Operating earnings for 2001 were negatively impacted by asset impairments and restructuring charges totaling approximately $15 million and other operating expense totaling approximately $4 million, as more fully described in Notes 15 and 16 to the Company’s consolidated financial statements.

In addition to the items above, operating earnings for 2002 were negatively impacted by lower selling prices, mainly for cellulosic plastics products. The decline in operating earnings for 2002 was also partially due to the recognition of technology licensing revenue of $6 million that was reflected in results for 2001. New competitors in Asia and Europe negatively impacted results for copolyesters during 2002.

VORIDIAN DIVISION

Polymers Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
1,565
$
1,587
 
(1)%
Operating earnings (loss)
 
35
 
(187)
 
N/A
 
 
 
 
 
 
 
Asset impairments and restructuring charges, net
 
1
 
231
 
 
Other operating expense
 
-
 
26
 
 

2002 Compared With 2001

The slight decrease in sales revenue for 2002 compared to 2001 was mainly due to lower selling prices, for both PET polymers and polyethylene, which had a negative impact on revenues of $207 million. Increased sales volumes, for both PET polymers and polyethylene, had a positive impact on revenues of $131 million. Interdivisional sales also had a positive impact on revenues of $55 million.

Asset impairments and restructuring charges of $1 million related to impaired polyethylene assets was recognized in the fourth quarter 2002. Results for 2001 were negatively impacted by asset impairments and restructuring charges totaling approximately $231 million and other operating expense totaling approximately $26 million, as more fully described in Notes 15 and 16 to the Company’s consolidated financial statements.

 64

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In addition to the items above, operational disruptions at the Company’s plants in Rotterdam, the Netherlands and Columbia, South Carolina negatively impacted operating earnings for 2002 by an estimated $39 million. Operating earnings for 2002 were also negatively impacted by fourth quarter asset charges relating primarily to equipment dismantlements and other write-offs totaling approximately $3 million. Operating earnings for 2002 were positively impacted by increased sales volumes for PET polymers, lower raw material costs, and better operation and utilization of polyethylene assets.

Fibers Segment
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
714
$
628
 
14 %
Operating earnings
 
133
 
147
 
(9)%
 
 
 
 
 
 
 
Other operating expense
 
-
 
2
 
 

2002 Compared With 2001

The increase in sales revenue for 2002 compared to 2001 was mainly due to interdivisional sales and higher sales volumes. Interdivisional sales had a positive impact on revenues of $73 million. Increased sales volumes had a positive impact on revenues of $69 million, largely offset by an unfavorable shift in product mix, which had a negative impact on sales revenue of $47 million. The unfavorable shift in product mix was due to increased sales volumes of lower unit priced products, particularly acetyl raw materials. Lower selling prices, primarily for acetyl raw materials, had a negative impact on sales revenue of $11 million.

Operating earnings for 2001 were negatively impacted by other operating expense totaling approximately $2 million related to costs associated with efforts to spin-off the specialty chemicals and plastics businesses as more fully described above and in Note 16 to the Company’s consolidated financial statements. Operating earnings for 2002 were negatively impacted by fourth quarter asset charges relating primarily to equipment dismantlements and other write-offs totaling approximately $3 million.

DEVELOPING BUSINESSES DIVISION

Developing Businesses Segment

(Dollars in millions)
 
2002
 
2001
 
Change



 
 
 
 
 
 
 
Sales
$
346
$
110
 
>100 %
Operating earnings (loss)
 
(70)
 
(46)
 
(52) %
 
 
 
 
 
 
 


2002 Compared With 2001

The sales revenue for 2002 compared to 2001 represents the increase of interdivisional sales and the emergence of external sales to new customers at Cendian. All sales in 2001 represent interdivisional sales that are eliminated in consolidation.

The 2002 operating loss for the Developing Businesses Segment increased compared to 2001 operating loss primarily due to Cendian’s up-front costs to implement new customers and to support anticipated growth.

 65

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
SUMMARY BY CUSTOMER LOCATION - 2002 COMPARED WITH 2001

Sales Revenue (excluding interdivisional sales)

 
 
(Dollars in millions)
 
 
 
2002
 
 
 
2001
 
 
 
Change
 
 
 
Volume Effect
 
 
 
Price Effect
 
 
Product
Mix Effect
 
Exchange
Rate
Effect







 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
United States and Canada
$
 
3,040
$
 
3,202
 
 
(5)%
 
 
4 %
 
 
(6)%
 
 
(3)%
 
 
0 %
Europe, Middle East, and Africa
 
1,170
 
1,148
 
2 %
 
5 %
 
(7)%
 
0 %
 
4 %
Asia Pacific
 
636
 
555
 
15 %
 
20 %
 
(5)%
 
0 %
 
0 %
Latin America
 
474
 
485
 
(2)%
 
12 %
 
(13)%
 
1 %
 
(2)%


 
$
5,320
$
5,390
 
 
 
 
 
 
 
 
 
 


Sales revenue in the United States and Canada for 2002 decreased $162 million compared to 2001 primarily due to lower selling prices. The decline in selling prices, which occurred in all segments, had a negative impact on revenues of $185 million. An unfavorable shift in product mix, primarily in the PCI and Fibers segments, had a negative impact on revenues of $107 million offset by increased sales volumes, which had a positive impact on revenues of $131 million.

Sales revenue in Europe, Middle East, and Africa for 2002 increased $22 million compared to 2001 due to increased sales volumes, which had a positive impact on revenues of $58 million, and the positive effect of foreign currency exchange rates, which had a positive impact on revenues of $43 million. These increases were mostly offset by decreased selling prices, primarily for the Polymers segment, which had a negative impact on revenues of $78 million.

Sales revenue in the Asia Pacific region for 2002 increased $81 million compared to 2001 due to higher sales volumes, primarily for acetyl and intermediates products, which had a positive impact on revenues of $113 million. Lower selling prices had a negative impact on revenues of $27 million.

Sales revenue in Latin America for 2002 decreased $11 million compared to 2001 primarily due to lower selling prices, which had a negative impact on revenues of $61 million. Increased sales volumes had a positive impact on revenues of $58 million. Both the decrease in selling prices and the increase in sales volumes were predominantly attributed to the Polymers segment. Foreign currency exchange rates had a negative impact on revenues of $8 million.

With a substantial portion of sales to customers outside the United States of America, Eastman is subject to the risks associated with operating in international markets. To mitigate its exchange rate risks, the Company frequently seeks to negotiate payment terms in U.S. dollars and euros. In addition, where it deems such actions advisable, the Company engages in foreign currency hedging transactions and requires letters of credit and prepayment for shipments where its assessment of individual customer and country risks indicates their use is appropriate. See Note 8 to the Company’s consolidated financial statements and Part II--Item 7A--"Quantitative and Qualitative Disclosures About Market Risk."

 66

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

LIQUIDITY, CAPITAL RESOURCES, AND OTHER FINANCIAL INFORMATION

(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Net cash provided by (used in)
 
 
 
 
Operating activities
$
244
$
801
$
397
Investing activities
 
(160)
 
(467)
 
(523)
Financing activities
 
397
 
(323)
 
91



Net change in cash and cash equivalents
$
481
$
11
$
(35)



 
 
 
Cash and cash equivalents at end of period
$
558
$
77
$
66



Cash Flows

Cash provided by operating activities in 2003 decreased $557 million compared to 2002 primarily as a result of the changes in liabilities for employee benefits and incentive pay which had a year-over-year impact of $295 million on cash flows from operations. In addition, changes in working capital, which is defined as the net change in trade receivables, inventory and trade payables, had a year-over-year impact of $123 million. The remaining decrease related to a reduction in operating results and other items.
 
The 2003 decrease in liabilities for employee benefits and incentive pay was primarily due to the $238 million contribution to the Company’s U.S. defined benefit pension plans. The Company made no similar contributions to U.S. defined benefit pension plans in 2002 or 2001.

In 2003, increased working capital decreased cash from operating activities by $7 million primarily due to an increase in trade receivables mostly offset by a decrease in inventories. The decrease in working capital for 2002 increased cash flows from operating activities by $116 million as the significant decrease in trade receivables and increase in trade payables was partially offset by increase in inventories.

Cash provided by operating activities in 2002 increased $404 million compared to 2001. The increase was primarily due a $167 million decrease in working capital; an $89 million increase in liabilities for employee benefits and incentive compensation; and receipt of a federal income tax refund of approximately $40 million. Working capital increased cash flows in 2002 by $116 million as described above. Working capital decreased cash flows in 2001 by $51 million primarily as a result of a decrease in trade payables partially offset by a decrease in receivables. Changes in liabilities for employee benefits and incentive compensation increased operating cash flow in 2002 as payments required under the Eastman Performance Plan and the Unit Performance Plan during 2002 were significantly lower than similar payments in 2001 due to the performance under the plans for 2001.

The net decrease in cash used in investing activities in 2003 compared to 2002 reflects a decrease in the addition of properties and equipment, and proceeds from sales of assets in 2003. The decrease in additions of properties and equipment is primarily due to the 2002 purchase of $161 million of certain machinery and equipment previously utilized under an operating lease. The 2003 proceeds from sales of assets of $70 million were due to the sale of the Company’s high-performance crystalline plastics assets and colorant product lines and related assets. In 2001, cash paid for the Hercules Business was approximately $252 million. Cash used in investing activities in 2002 and 2001 also reflects other small acquisitions.

Cash provided by financing activities in 2003 totaled $397 million due primarily to proceeds from long term borrowings of $495 million and an increase in commercial paper borrowings of $39 million. Cash used in financing activities in 2002 reflected a significant decrease in commercial paper and short-term borrowings attributable to the use of proceeds from long-term debt issued during 2002 and the use of cash generated from operations to repay indebtedness. Cash provided by financing activities in 2001 includes the effect of increased commercial paper borrowings and the effect of treasury stock purchases resulting from a reverse/forward stock split from the Company’s common stock approved by the stockholders in 2001. The payment of dividends is also reflected in all periods.

 67

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The significant increase in cash and cash equivalents at the end of 2003 compared to prior years is due to the anticipation of the maturity of $500 million of 6 3/8% notes due January 2004. The debt was paid in January 2004.

In 2004, priorities for use of available cash from operations will be to pay the dividend, reduce outstanding borrowings and fund targeted growth initiatives such as small acquisitions and other ventures.

Liquidity

Eastman has access to a $600 million revolving credit facility (the "Credit Facility") expiring in July 2005. Any borrowings under the Credit Facility are subject to interest at varying spreads above quoted market rates, principally LIBOR. The Credit Facility requires facility fees on the total commitment that vary based on Eastman's credit rating. The rate for such fees was 0.25% and 0.15% as of December 31, 2003 and 2002, respectively. The Credit Facility contains a number of covenants and events of default, including the maintenance of certain financial ratios. Eastman was in compliance with all such covenants for all periods presented.
 
Eastman typically utilizes commercial paper to meet its liquidity needs. The Credit Facility provides liquidity support for commercial paper borrowings and general corporate purposes. Accordingly, outstanding commercial paper borrowings reduce borrowings available under the Credit Facility. Because the Credit Facility expires in July 2005, the commercial paper borrowings supported by the Credit Facility are classified as long-term borrowings because the Company has the ability to refinance such borrowings on a long-term basis. At December 31, 2003, the Company’s commercial paper borrowings were $196 million at an effective interest rate of 1.86%. At December 31, 2002, the Company's commercial paper borrowings were $143 million at an effective interest rate of 1.66%.
 
The Company has an effective registration statement, filed in 1998 with the Securities and Exchange Commission, to issue up to $1 billion of debt or equity securities. On April 3, 2002, Eastman issued notes in the principal amount of $400 million due 2012 and bearing interest at 7% per annum. Net proceeds from the sale of the notes were $394 million and were used to repay portions of outstanding borrowings under the Credit Facility and commercial paper borrowings. On June 16, 2003, the Company issued notes in the principal amount of $250 million due 2008 and bearing interest at 3.25% per annum. Proceeds from the sale of the notes, net of $2 million in transaction fees, were $248 million and were used to repay portions of commercial paper borrowings. On November 12, 2003, the Company issued notes in the principal amount of $250 million due 2018 and bearing interest at 6.3% per annum. Proceeds from the sale of the notes, net of approximately $2 million in transaction fees, were $246 million and were used, along with cash generated from business activities and other borrowings, for the repayment of the Company’s $500 million 6 3/8% notes due on January 15, 2004.
 
On January 15, 2004, the Company retired $500 million of debt bearing interest at 6 3/8% per annum. These notes were reflected in borrowings due within one year in the Consolidated Statements of Financial Position at December 31, 2003. This debt was retired with a combination of cash generated from business activities, new long-term borrowings and available short-term borrowing capacity.

 68

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In the first quarter 2002, the Company entered into interest rate swaps that converted the effective interest rate of the 6 3/8% notes due in 2004 to variable rates.  These original interest rate swaps were settled during the fourth quarter 2002, resulting in $13 million cash proceeds being received by the Company.  The gain resulting from the settlement of the swaps is reflected as an increase in the current portion of long-term borrowings and will be amortized into earnings as a reduction to interest expense through the maturity of the notes in January 2004.  In conjunction with the settlement of the original interest rate swaps, new interest rate swaps were entered into in the fourth quarter 2002, converting the effective interest rate on the notes due in 2004 to variable rates that averaged 3.34% at December 31, 2003 and 4.07% at December 31, 2002.  The recording of the fair value of the interest rate swaps and the corresponding debt resulted in increases of $2 million in other current assets and the current portion of long-term borrowings at December 31, 2003 In the third quarter 2003, the Company entered into interest rate swaps that converted the effective interest rate on $250 million of the $400 million 7% notes due in 2012 to variable rates such that the effective average rate was 5.66% on the variable portion at December 31, 2003. The recording of the fair value of the interest rate swaps and the corresponding debt resulted in a decrease of $3 million for long-term borrowings and an increase in other long term liabilities at December 31, 2003. In the fourth quarter 2003, the Company entered into interest rate swaps that converted the effective interest rate on $150 million of the $250 million 6.3% notes due in 2018 to variable rates such that that the effective average rate was 1.3% on the variable portion at December 31, 2003. The recording of the fair value of the interest rate swaps and the corresponding debt resulted in an increase of $1 million for long-term borrowings and a decrease in other long term liabilities at December 31, 2003.
 
The Company contributed $238 million to its U.S. defined benefit pension plans during 2003. The Company anticipates that additional funding of between $0 and $40 million may be required in 2004. Funding requirements for 2004 are dependent on congressional legislation regarding pension discount rates.

Cash flows from operations and the sources of capital described above are expected to be available and sufficient to meet foreseeable cash flow requirements including those requirements related to the normal seasonal increase in working capital expected in the first half of the year. However, the Company’s cash flows from operations can be affected by numerous factors including risks associated with global operations, raw materials availability and cost, demand for and pricing of Eastman’s products, capacity utilization and other factors described under "Forward-Looking Statements and Risk Factors" below.

Capital Expenditures

Capital expenditures were $230 million, $427 million and $234 million for 2003, 2002 and 2001, respectively. Capital expenditures for 2002 include $161 million related to the purchase of certain machinery and equipment previously utilized under an operating lease. The Company continues its emphasis on cash flow management and, for 2004, expects that capital spending and other directed investments for small acquisitions and other ventures will increase compared to 2003, but be no more than depreciation and amortization.

Other Commitments

At December 31, 2003, the Company’s obligations related to notes and debentures totaled approximately $2.4 billion to be paid over a period of 25 years. Other borrowings, related primarily to commercial paper borrowings, totaled approximately $196 million.

The Company had various purchase obligations at December 31, 2003 totaling approximately $2 billion over a period of approximately 15 years for materials, supplies and energy incident to the ordinary conduct of business. The Company also had various lease commitments for property and equipment under cancelable, noncancelable and month-to-month operating leases totaling approximately $195 million over a period of several years. Of the total lease commitments, approximately 20% relate to machinery and equipment, including computer and communications equipment and production equipment; approximately 40% relate to real property, including office space, storage facilities and land; and approximately 40% relate to railcars.

In addition, the Company had other liabilities at December 31, 2003 totaling approximately $1.2 billion related to pension, retiree medical, and other postemployment obligations.

 69

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The obligations described above are summarized in the following table:

(Dollars in millions)
 
Payments Due For
 
 
 
Period
 
 
 
Notes and Debentures
 
Commercial Paper and Other Borrowings
 
 
 
Purchase Obligations
 
 
 
Operating Leases
 
Other Liabilities (a)
 
 
 
 
Total


 





 
 
 
 
 
 
 
 
 
 
 
 
 
2004
$
504
$
--
$
246
$
45
$
64
$
859
2005
 
--
 
196
 
246
 
40
 
128
 
610
2006
 
5
 
--
 
243
 
33
 
180
 
461
2007
 
--
 
--
 
240
 
24
 
151
 
415
2008
 
250
 
--
 
140
 
13
 
107
 
510
2009 and beyond
 
1,638
 
--
 
902
 
40
 
560
 
3,140
   
  
 
  
 
  
 
  
 
  
 
  
Total
$
2,397
$
196
$
2,017
$
195
$
1,190
$
5,995

 






(a) Amounts represent the current estimated cash payments to be made by the Company in the periods indicated. The amount and timing of such payments is dependent upon interest rates, health care trends, actual returns on plan assets, retirement and attrition rates of employees, continuation or modification of the benefit plans, and other factors. Such factors can significantly impact the amount and timing of any future contributions by the Company. In addition, amounts related to retiree medical do not include the potential effect of the recently enacted Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("the Act"). For further details regarding the implementation of the Act, see Note 9 to the Company’s consolidated financial statements.
 
On January 15, 2004, the Company retired the $500 million of 6 3/8% notes due 2004.
 
The Company also had outstanding guarantees at December 31, 2003. Additional information related to these guarantees is included in Note 10 to the Company’s consolidated financial statements.

Off Balance Sheet and Other Financing Arrangements

If certain operating leases are terminated by the Company, it guarantees a portion of the residual value loss, if any, incurred by the lessors in disposing of the related assets. The Company believes, based on current facts and circumstances, that a material payment pursuant to such guarantees in excess of the payments included above is remote. Under these operating leases, the residual value guarantees at December 31, 2003 totaled $93 million and consisted primarily of leases for railcars, company aircraft, and other equipment.

The Company has long-term commitments relating to joint ventures as described in Note 5 to the Company’s consolidated financial statements. The Company guarantees up to $131 million of the principal amount of the joint ventures’ third-party borrowings, but believes, based on current facts and circumstances and the structure of the ventures, that the likelihood of a payment pursuant to such guarantees is remote.
 
As described in Note 10 to the Company’s consolidated financial statements, Eastman entered into an agreement in 1999 that allows it to generate cash by reducing its working capital through the sale of undivided interests in certain domestic trade accounts receivable under a planned continuous sale program to a third party. Under this agreement, receivables sold to the third party totaled $200 million at December 31, 2003 and 2002. Undivided interests in designated receivable pools were sold to the purchaser with recourse limited to the purchased interest in the receivable pools.

The Company did not have any other material relationships with unconsolidated entities or financial partnerships, including special purpose entities, for the purpose of facilitating off-balance sheet arrangements with contractually narrow or limited purposes. Thus, Eastman is not materially exposed to any financing, liquidity, market, or credit risk related to the above or any other such relationships.

 70

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Treasury Stock Transactions

The Company is currently authorized to repurchase up to $400 million of its common stock. No shares of Eastman common stock were repurchased by the Company during 2003 and 2002. During 2001, 77,069 shares of common stock at a total cost of approximately $4 million, or an average price of $53 per share, were repurchased. A total of 2,746,869 shares of common stock at a cost of approximately $112 million, or an average price of approximately $41 per share, have been repurchased under the authorization. Repurchased shares may be used to meet common stock requirements for compensation and benefit plans and other corporate purposes. In the first quarter 2002, the Company issued 126,614 previously repurchased shares as the annual Company contribution to the Eastman Investment and Employee Stock Ownership Plan.

Dividends      

The Company declared cash dividends of $0.44 per share in the fourth quarters 2003, 2002 and 2001 and a total of $1.76 per share in 2003, 2002 and 2001.
 
ENVIRONMENTAL

Certain Eastman manufacturing sites generate hazardous and nonhazardous wastes, the treatment, storage, transportation, and disposal of which are regulated by various governmental agencies. In connection with the cleanup of various hazardous waste sites, the Company, along with many other entities, has been designated a potentially responsible party ("PRP") by the U.S. Environmental Protection Agency under the Comprehensive Environmental Response, Compensation and Liability Act, which potentially subjects PRPs to joint and several liability for such cleanup costs. In addition, the Company will be required to incur costs for environmental remediation and closure and postclosure under the federal Resource Conservation and Recovery Act. Adequate reserves for environmental contingencies have been established in accordance with Eastman’s policies as described in Note 1 to the Company’s consolidated financial statements. Because of expected sharing of costs, the availability of legal defenses, and the Company’s preliminary assessment of actions that may be required, it does not believe its liability for these environmental matters, individually or in the aggregate, will be material to the Company’s consolidated financial position, results of operations, or cash flows.

The Company accrues environmental costs when it is probable that the Company has incurred a liability and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. This undiscounted accrued amount reflects the Company’s assumptions about remedial requirements at the contaminated site, the nature of the remedy, the outcome of discussions with regulatory agencies and other potentially responsible parties at multi-party sites, and the number and financial viability of other PRPs. Changes in the estimates on which the accruals are based, unanticipated government enforcement action, or changes in health, safety, environmental, chemical control regulations and testing requirements could result in higher or lower costs.

In addition to remediation activities, the Company establishes reserves for closure/postclosure costs associated with the environmental assets it maintains. Environmental assets include but are not limited to land fills, water treatment facilities, and ash ponds. When these types of assets are constructed, a reserve is established for the future environmental remediation anticipated to be associated with the closure of the site based on an expected life of the environmental assets. These future expenses are accreted into earnings over the estimated useful life of the assets. Reserves related to environmental assets accounted for approximately 50% of the total environmental reserve at December 31, 2003. Currently, the Company’s environmental assets are expected to be no longer useable at various different times over the next 50 years. If the Company was to invest in numerous new environmental assets, or, these assets were to require closure a significant number of years before the Company anticipated they would, the amortization on them would increase, and could have a material negative impact on the Company’s financial condition and results of operations. The Company views the likelihood of this occurrence to be remote, and does not anticipate, based on its past experience with this type of planned remediation, that an additional accrual related to environmental assets will be necessary.

 71

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
At December 31, 2003 and 2002, the Company had recognized environmental contingencies of approximately $61 million and $60 million, respectively, representing the minimum or best estimate for remediation costs and, for closure/postclosure costs, the amount accrued to date over the facilities’ estimated useful lives.

The Company's cash expenditures related to environmental protection and improvement were estimated to be approximately $187 million, $195 million and $216 million in 2003, 2002 and 2001, respectively. These amounts pertain primarily to operating costs associated with environmental protection equipment and facilities, but also include expenditures for construction and development. The Company does not expect future environmental capital expenditures arising from requirements of recently promulgated environmental laws and regulations to materially increase the Company's planned level of capital expenditures for environmental control facilities.

INFLATION

In recent years, inflation has not had a material adverse impact on Eastman's costs. The cost of raw materials is generally based on market price, although derivative financial instruments may have been utilized, as appropriate, to mitigate short-term market price fluctuations.

RECENTLY ISSUED ACCOUNTING STANDARDS

In April 2002, the Financial Accounting Standards Board ("FASB") issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections." This Statement, which updates, clarifies and simplifies existing accounting pronouncements, addresses the reporting of debt extinguishments and accounting for certain lease modifications that have economic effects that are similar to sale-leaseback transactions. The provisions of this Statement are generally effective for the Company's 2003 fiscal year, or in the case of specific provisions, for transactions occurring after May 15, 2002 or for financial statements issued on or after May 15, 2002. The provisions of this Statement have not had and are not expected to have a material impact on the Company's financial condition or results of operations.

In July 2002, the FASB issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities." This Statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force ("EITF") Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)." This Statement requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred, and concludes that an entity's commitment to an exit plan does not by itself create a present obligation that meets the definition of a liability. This Statement also establishes that fair value is the objective of initial measurement of the liability. The provisions of this Statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In November 2002, the Emerging Issues Task Force ("EITF") reached a consensus on Issue No. 00-21, "Revenue Arrangements with Multiple Deliverables." EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

 72

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In November 2002, the FASB issued FASB Interpretation No. 45 ("FIN 45"), "Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an interpretation of FASB Statements No. 5, 57 and 107 and Rescission of FASB Interpretation No. 34." FIN 45 clarifies the requirements of SFAS No. 5, "Accounting for Contingencies," relating to the guarantor’s accounting for, and disclosure of, the issuance of certain types of guarantees. The disclosure provisions of FIN 45 are effective for the current fiscal year and the Company has included this information in Note 10 to the Company’s consolidated financial statements. However, the provisions for initial recognition and measurement are effective on a prospective basis for guarantees that are issued or modified after December 31, 2002, irrespective of a guarantor’s year-end. The adoption of FIN 45 did not have a material impact on the Company’s financial position, liquidity or results of operations. See Note 10 to the Company’s consolidated financial statements for additional information regarding the Company’s guarantees.

In December 2002, the FASB issued SFAS No. 148, "Accounting for Stock-Based Compensation – Transition and Disclosure, amendment of FASB Statement No. 123." This Statement provides additional transition guidance for those entities that elect to voluntarily adopt the provisions of SFAS No.123, "Accounting for Stock-Based Compensation." Furthermore, SFAS No. 148 mandates new disclosures in both interim and year-end financial statements within Note 1, "Significant Accounting Policies," to the Company’s consolidated financial statements. The Company has elected not to adopt the recognition provisions of SFAS No. 123, as amended by SFAS No. 148. However, the Company has adopted the disclosure provisions for the current fiscal year and has included this information in Note 1 to the Company’s consolidated financial statements.

Effective July 1, 2003, the Company adopted Emerging Issues Task Force ("EITF") Issue No. 01-08, "Determining Whether an Arrangement Contains a Lease." EITF Issue No. 01-08 provides guidance on how to determine if an arrangement contains a lease that is within the scope of SFAS No. 13, "Accounting for Leases." The provisions of EITF Issue No. 01-08 apply primarily to arrangements agreed to or committed to after the beginning of an entity’s next reporting period beginning after May 28, 2003, or previous arrangements modified after the beginning of an entity’s next reporting period beginning after May 28, 2003. The adoption of EITF Issue No. 01-08 did not have a material impact on the Company’s financial position, liquidity or results of operations.

In January 2003, the FASB issued FASB Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities." FIN 46 clarifies the application of Accounting Research Bulletin No. 51, "Consolidated Financial Statements," to certain entities in which equity investors do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 applies immediately to variable interest entities ("VIE’s") created after January 31, 2003, and to VIE’s in which a public company obtains an interest after that date. In December 2003, the FASB published a revision to FIN 46 ("FIN 46R") to clarify some of the provisions of the interpretation and to defer the effective date of implementation for certain entities. Under the guidance of FIN 46R, public companies that have interests in VIE’s that are commonly referred to as special purpose entities are required to apply the provisions of FIN46R for periods ending after December 15, 2003. A public company that does not have any interests in special purpose entities but does have a variable interest in a VIE created before February 1, 2003, must apply the provisions of FIN 46R by the end of the first interim or annual reporting period ending after March 14, 2004. During the fourth quarter of 2003, the Company assessed certain of its lease arrangements as well as its accounts receivable securitization program according to the provisions of FIN 46R. The Company concluded that such entities did not meet the criteria for consolidation. In addition, the Company has identified certain joint venture partnerships as well as other contractual arrangements created before February 1, 2003 as potential VIE’s. The Company is currently evaluating the effect of these potential VIE’s on its consolidated financial position, liquidity, or results of operations. See Note 10 to the Company’s consolidated financial statements for further discussions about the Company’s potential VIE’s.

 73

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." SFAS No. 149 amends and clarifies accounting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities under SFAS No. 133. SFAS No. 149 amends SFAS No. 133 to require contracts with comparable characteristics be accounted for similarly. SFAS No. 149 clarifies the circumstances under which a contract with an initial net investment qualifies as a derivative and clarifies when a derivative contains a financing component that warrants special reporting in the statement of cash flows. This Statement is effective for contracts entered into or modified after June 30, 2003, except for hedging relationships designated after June 30, 2003, where the guidance should be applied prospectively. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." SFAS No. 150 requires certain financial instruments, which under previous guidance were accounted for as equity, be classified as liabilities or assets in statements of financial position. This Statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise effective at the beginning of the first interim period beginning after June 15, 2003. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In December 2003, the FASB issued a revision to SFAS No. 132 "Employers' Disclosures about Pensions and Other Postretirement Benefits". This statement revises employers' disclosures about pension plans and other postretirement benefit plans. It requires additional disclosures related to the assets, obligations, cash flows, and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. It does not change the measurement or recognition of those plans. The Company has adopted the provisions of this statement. See Note 9 to the consolidated financial statements for more information.

On January 12, 2004, the FASB staff issued FASB Staff Position ("FSP") 106-1 "Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003." FSP 106-1 permits a sponsor of a postretirement health care plan that provides a prescription drug benefit to make a one-time election to defer accounting for the effects of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("the Act") that would be required in accordance with SFAS 106 "Employers Accounting for Postretirement Benefits Other than Pensions." Regardless of whether a sponsor elects that deferral, FSP 106-1 requires certain disclosures in annual or interim financial statements. FSP 106-1 is effective for interim or annual financial statements of fiscal years ending after December 7, 2003. The Company elected to defer accounting for the effects of the Act and has made the required disclosures in Note 9 of the company’s financial statements. The Company is currently evaluating the effect FSP 106-1 will have on its consolidated financial position, liquidity, or results of operations.

 
OUTLOOK

For 2004, the Company expects:
 
·    that historically high raw material and energy costs will continue throughout much of 2004, and that the Company will continue to implement price increases to offset these increases;
 
·    that pension and other postemployment benefit expenses in 2004 will increase compared to 2003 by approximately $15 million;
 
·    to contribute between $0 and $40 million to the Company’s U.S. defined benefit pension plans in 2004;
 
·    net interest expense to decrease compared to 2003 due to lower expected gross interest costs as a result of lower average interest rates on borrowings and anticipated lower average borrowings;
 
·    that depreciation and amortization expense for 2004 will decrease by approximately $30 million;
 
·    priorities for use of available cash from operations will be to pay the quarterly cash dividend, reduce outstanding borrowings and fund targeted growth initiatives such as small acquisitions and other ventures;
 

 74

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
·    capital expenditures to increase in 2004 compared to 2003, but to continue to be no more than depreciation and amortization;
 
·    the effective tax rate to be between 30% and 33%, and certain tax benefits from the extraterritorial income exclusion to continue through 2004;
 
·    combined costs related to selling and general administrative expenses and research and development expenses to be at or below 10% of sales revenue;
 
·    restructuring, divestiture and consolidation activities and continuing cost reduction efforts in the CASPI segment will contribute approximately $50 million to operating results;
 
·    the Polymers segment will maintain its focus on lowering costs and, for its PET polymers product lines, growing along with overall market demand growth; and
 
·    the operating loss in the Developing Businesses Division to be less than $45 million.
 
Longer term, the Company expects:

·    Global demand for PET polymers to grow at an average rate of approximately 10% annually over the next several years; and
 
·    Aggressive management of costs in the PCI segment will help improve margins and position it to take full advantage of the upturn expected in the 2005 through 2006 timeframe and to aggressively identify and implement projects to reduce costs and improve performance.
 
See "Forward-Looking Statements and Risk Factors."
 
FORWARD-LOOKING STATEMENTS AND RISK FACTORS
 
The expectations under "Outlook" and certain other statements in this report may be forward-looking in nature as defined in the Private Securities Litigation Reform Act of 1995. These statements and other written and oral forward-looking statements made by the Company from time to time may relate to, among other things, such matters as planned and expected capacity increases and utilization; anticipated capital spending; expected depreciation and amortization; environmental matters; legal proceedings; exposure to, and effects of hedging of, raw material and energy costs and foreign currencies; global and regional economic, political, and business conditions; competition; growth opportunities; supply and demand, volume, price, cost, margin, and sales; earnings, cash flow, dividends and other expected financial conditions; expectations, strategies, and plans for individual products, businesses, segments and divisions as well as for the whole of Eastman Chemical Company; cash requirements and uses of available cash; financing plans; pension expenses and funding; credit rating; cost reduction and control efforts and targets; integration of acquired businesses; development, production, commercialization and acceptance of new products, services and technologies and related costs; asset and product portfolio changes; and expected tax rate.

 75

     

 
 
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

These plans and expectations are based upon certain underlying assumptions, including those mentioned with the specific statements. Such assumptions are in turn based upon internal estimates and analyses of current market conditions and trends, management plans and strategies, economic conditions and other factors. These plans and expectations and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. In addition to the factors described in this report, the following are some of the important factors that could cause the Company's actual results to differ materially from those in any such forward-looking statements:
 
·    The Company has manufacturing and marketing operations throughout the world, with approximately 45% of the Company's sales revenue attributable to sales outside the United States. Economic factors, including foreign currency exchange rates, could affect the Company's sales revenue, expenses and results. Although the Company utilizes risk management tools, including hedging, as appropriate, to mitigate market fluctuations in foreign currencies, any changes in strategy in regard to risk management tools can also affect sales revenue, expenses and results and there can be no assurance that such measures will result in cost savings or that all market fluctuation exposure will be eliminated. In addition, changes in laws, regulations, or other political factors in any of the countries in which the Company operates could affect business in that country or region, as well as the Company's results of operations and financial condition.
 
·    The Company has made and may continue to make acquisitions, divestitures and investments, and enter into alliances, as part of its strategies for growth and improved profitability. The completion of such transactions is subject to the timely receipt of necessary regulatory and other consents and approvals needed to complete the transactions which could be delayed for a variety of reasons, including the satisfactory negotiation of the transaction documents and the fulfillment of all closing conditions to the transactions. Additionally, there can be no assurance that such transactions will be successfully completed on a timely and cost-efficient basis or that they will achieve projected operating earnings or cost reduction targets.
 
·    The Company has made strategic investments in technology, services businesses, and other ventures in order to build certain Eastman capabilities. There can be no assurance that such investments will achieve their objectives or that they will be beneficial to the Company's results of operations.
 
·    The Company owns assets in the form of equity in other companies, including joint ventures, technology investments and Genencor. Such investments are minority investments in companies which are not managed or controlled by the Company and are subject to all of the risks associated with changes in value of such investments including the market valuation of those companies whose shares are publicly traded.
 
·    The Company has undertaken and will continue to undertake productivity and cost reduction initiatives and organizational restructurings to improve performance and generate cost savings. There can be no assurance that these will be completed as planned or beneficial or that estimated cost savings from such activities will be realized.
 
·    In addition to cost reduction initiatives, the Company is striving to improve margins on its products through price increases, where warranted and accepted by the market; however, the Company's earnings could be negatively impacted should such increases be unrealized, not be sufficient to cover increased raw material and energy costs, or have a negative impact on demand and volume.
 
·    The Company is reliant on certain strategic raw materials for its operations and utilizes risk management tools, including hedging, as appropriate, to mitigate short-term market fluctuations in raw material costs. There can be no assurance, however, that such measures will result in cost savings or that all market fluctuation exposure will be eliminated. In addition, changes in laws or regulations, war or other outbreak of hostilities, or other political factors in any of the countries or regions in which the Company operates or does business, or in countries or regions that are key suppliers of strategic raw materials, could affect availability and costs of raw materials.
 

 76

     

 

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
·    While temporary shortages of raw materials and energy may occasionally occur, these items are generally sufficiently available to cover current and projected requirements. However, their continuous availability and price are subject to unscheduled plant interruptions occurring during periods of high demand, or due to domestic or world market and political conditions, changes in government regulation, war or other outbreak of hostilities. Eastman’s operations or products may, at times, be adversely affected by these factors.
 
·    The Company's competitive position in the markets in which it participates is, in part, subject to external factors. For example, supply and demand for certain of the Company's products is driven by end-use markets and worldwide capacities which, in turn, impact demand for and pricing of the Company's products.
 
·    The Company has an extensive customer base; however, loss of certain top customers could adversely affect the Company's financial condition and results of operations until such business is replaced and no assurances can be made that the Company would be able to regain or replace any lost customers.
 
·    Limitation of the Company's available manufacturing capacity due to significant disruption in its manufacturing operations could have a material adverse affect on sales revenue, expenses and results of operations and financial condition.
 
·    The Company's facilities and businesses are subject to complex health, safety and environmental laws and regulations, which require and will continue to require significant expenditures to remain in compliance with such laws and regulations currently and in the future. The Company's accruals for such costs and associated liabilities are subject to changes in estimates on which the accruals are based. The amount accrued reflects the Company’s assumptions about remedial requirements at the contaminated site, the nature of the remedy, the outcome of discussions with regulatory agencies and other potentially responsible parties at multi-party sites, and the number and financial viability of other potentially responsible parties. Changes in the estimates on which the accruals are based, unanticipated government enforcement action, or changes in health, safety, environmental, chemical control regulations and testing requirements could result in higher or lower costs.
 
·    The Company accesses the capital and credit markets on a regular basis. Access to these markets and the cost of capital is dependent in part upon the Company's credit rating received from independent credit rating agencies. An adverse change in the Company's credit rating could affect the renewal of existing credit facilities or the Company's ability to obtain access to new credit facilities or other debt financing in the future, could adversely affect the terms under which the Company can borrow, and could increase the cost of new borrowings, other debt, or capital.
 
·    The Company’s operations from time to time are parties to or targets of lawsuits, claims, investigations, and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters, which are handled and defended in the ordinary course of business. The Company believes amounts reserved are adequate for such pending matters; however, results of operations could be affected by significant litigation adverse to the Company.
 
The foregoing list of important factors does not include all such factors nor necessarily present them in order of importance. This disclosure, including that under "Outlook" and "Forward-Looking Statements and Risk Factors," and other forward-looking statements and related disclosures made by the Company in this report and elsewhere from time to time, represents management's best judgment as of the date the information is given. The Company does not undertake responsibility for updating any of such information, whether as a result of new information, future events, or otherwise, except as required by law. Investors are advised, however, to consult any further public Company disclosures (such as in filings with the Securities and Exchange Commission or in Company press releases) on related subjects.

 

 77

     

 

ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to changes in financial market conditions in the normal course of its business due to its use of certain financial instruments as well as transacting in various foreign currencies and funding foreign operations. To mitigate the Company's exposure to these market risks, Eastman has established policies, procedures, and internal processes governing its management of financial market risks and the use of financial instruments to manage its exposure to such risks.

The Company determines its market risk utilizing sensitivity analysis, which measures the potential losses in fair value resulting from one or more selected hypothetical changes in interest rates, foreign currency exchange rates, and/or commodity prices.

The Company is exposed to changes in interest rates primarily as a result of its borrowing activities, which include short-term commercial paper and long-term borrowings used to maintain liquidity and to fund its business operations and capital requirements. Currently, these borrowings are predominately U.S. dollar denominated. The nature and amount of the Company's long-term and short-term debt may vary as a result of future business requirements, market conditions, and other factors. For 2003 and 2002, the market risks associated with the fair value of interest-rate-sensitive instruments, assuming an instantaneous parallel shift in interest rates of 10% were approximately $119 million and $100 million, respectively, and an additional $13 million for each one percentage point change in interest rates thereafter. This exposure is primarily related to long-term debt with fixed interest rates.

The Company's operating cash flows denominated in foreign currencies are exposed to changes in foreign currency exchange rates. The Company continually evaluates its foreign currency exposure based on current market conditions and the locations in which the Company conducts business. In order to mitigate the effect of foreign currency risk, the Company enters into forward exchange contracts to hedge certain firm commitments denominated in foreign currencies and currency options to hedge probable anticipated but not yet committed export sales and purchase transactions expected within no more than two years and denominated in foreign currencies. The gains and losses on these contracts offset changes in the value of related exposures. It is the Company's policy to enter into foreign currency transactions only to the extent considered necessary to meet its objectives as stated above. The Company does not enter into foreign currency transactions for speculative purposes. At December 31, 2003, the Company had no outstanding forward exchange contracts or currency options. For 2002, the market risks associated with forward exchange contracts utilizing a modified Black-Scholes option pricing model and a 10% adverse move in the U.S. dollar relative to each foreign currency hedged by the Company were approximately $4 million and an additional $0.4 million for each additional one percentage point adverse change in foreign currency exchange rates. Further adverse movements in foreign currencies would create losses in fair value; however, such losses would not be linear to that disclosed above. This exposure, which is primarily related to foreign currency options purchased by the Company to manage fluctuations in foreign currencies, is limited to the dollar value of option premiums payable by the Company for the related financial instruments. In 2002, the market risks associated with foreign currency options utilizing a modified Black-Scholes option pricing model and a 10% adverse change in the US dollar relative to each foreign currency resulted in a $2 million loss in fair value. Furthermore, since the Company utilizes currency-sensitive derivative instruments for hedging anticipated foreign currency transactions, a loss in fair value for those instruments is generally offset by increases in the value of the underlying anticipated transactions.

The Company is exposed to fluctuations in market prices for certain of its major raw materials. To mitigate short-term fluctuations in market prices for certain commodities, principally propane, ethane, and natural gas, the Company enters into forwards and options contracts. For 2003 and 2002, the market risks associated with feedstock options and natural gas swaps assuming an instantaneous parallel shift in the underlying commodity price of 10% were $4 million and $2 million, respectively, and an additional $0.3 million and $0.1 million for each one percentage point move in closing prices thereafter.

 78

     

 


ITEM 8.       FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

ITEM
Page
 
 
Management's Responsibility for Financial Statements
80
 
 
Report of Independent Auditors
81
 
 
Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss) and Retained Earnings
82
 
 
Consolidated Statements of Financial Position
83
 
 
Consolidated Statements of Cash Flows
84
 
 
Notes to Consolidated Financial Statements
85-133
 
 
Financial Statement Schedules:
 
II - Valuation and Qualifying Accounts
 
 
145


 79

     

 


MANAGEMENT'S RESPONSIBILITY FOR FINANCIAL STATEMENTS

Management is responsible for the preparation and integrity of the accompanying consolidated financial statements of Eastman appearing on pages 82 through 133. Eastman has prepared these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, and the statements of necessity include some amounts that are based on management's best estimates and judgments.

Eastman's accounting systems include extensive internal controls designed to provide reasonable assurance of the reliability of its financial records and the proper safeguarding and use of its assets. Such controls are based on established policies and procedures, are implemented by trained, skilled personnel with an appropriate segregation of duties, and are monitored through a comprehensive internal audit program. The Company's policies and procedures prescribe that the Company and all employees are to maintain the highest ethical standards and that its business practices throughout the world are to be conducted in a manner that is above reproach.

The consolidated financial statements have been audited by PricewaterhouseCoopers LLP, independent accountants, who were responsible for conducting their audits in accordance with auditing standards generally accepted in the United States of America. Their report is included herein.

The Board of Directors exercises its responsibility for these financial statements through its Audit Committee, which consists entirely of nonmanagement Board members. The independent accountants and internal auditors have full and free access to the Audit Committee. The Audit Committee meets periodically with PricewaterhouseCoopers LLP and Eastman's director of internal auditing, both privately and with management present, to discuss accounting, auditing, policies and procedures, internal controls, and financial reporting matters.




/s/ J. Brian Ferguson
 
/s/ Richard A. Lorraine


J. Brian Ferguson
 
Richard A. Lorraine
Chairman of the Board and
 
Senior Vice President and
 
Chief Executive Officer
 
 
Chief Financial Officer
 
 
 
 
 
March 5, 2004
 
 
 


 80

     

 


REPORT OF INDEPENDENT AUDITORS


To the Board of Directors and Stockholders of
Eastman Chemical Company

In our opinion, the consolidated financial statements listed in the index appearing under Item 15(a) (1) on page 137 present fairly, in all material respects, the financial position of Eastman Chemical Company and its subsidiaries at December 31, 2003 and 2002, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2003 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the index appearing under Item 15(a)(2) on page 137 presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. These financial statements and financial statement schedule are the responsibility of the Company's management; our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audits. We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

As discussed in Notes 1, 4 and 23 to the consolidated financial statements, on January 1, 2003 Eastman Chemical Company adopted Statement of Financial Accounting Standard No. 143, "Accounting for Asset Retirement Obligations", and on January 1, 2002, adopted Statement of Financial Accounting Standard No. 142, "Goodwill and Other Intangible Assets."




/s/ PricewaterhouseCoopers LLP

PRICEWATERHOUSECOOPERS LLP
Philadelphia, Pennsylvania
March 3, 2004

 81

     

 

CONSOLIDATED STATEMENTS OF EARNINGS (LOSS),
COMPREHENSIVE INCOME (LOSS) and RETAINED EARNINGS

 
For years ended December 31,
(Dollars in millions, except per share amounts)
 
2003
 
2002
 
2001



Earnings (Loss)
 
 
 
 
 
 
Sales
$
5,800
$
5,320
$
5,390
Cost of sales
 
4,990
 
4,541
 
4,497



Gross profit
 
810
 
779
 
893
 
 
 
 
 
 
 
Selling and general administrative expenses
 
414
 
407
 
407
Research and development expenses
 
173
 
159
 
160
Asset impairments and restructuring charges, net
 
489
 
5
 
396
Goodwill impairments
 
34
 
--
 
--
Other operating income
 
(33)
 
--
 
--
Other operating expense
 
--
 
--
 
50



Operating earnings (loss)
 
(267)
 
208
 
(120)
 
 
 
 
 
 
 
Interest expense, net
 
124
 
122
 
140
Other (income) charges, net
 
(10)
 
2
 
31
Earnings (loss) before income taxes and cumulative effect of change in accounting principles
 
(381)
 
84
 
(291)
Provision (benefit) for income taxes
 
(108)
 
5
 
(116)



 
 
 
 
 
 
 
Earnings (loss) before cumulative effect of change in accounting principles
 
(273)
 
79
 
(175)
Cumulative effect of change in accounting principles, net
 
3
 
(18)
 
--



Net earnings (loss)
$
(270)
$
61
$
(175)



 
 
 
 
 
 
 
Earnings (loss) per share
 
 
 
 
 
 
Basic
 
 
 
 
 
 
Before cumulative effect of change in accounting principles
$
(3.54)
$
1.02
$
(2.28)
Cumulative effect of change in accounting principles, net
 
0.04
 
(0.23)
 
--



Net earnings (loss) per share
$
(3.50)
$
0.79
$
(2.28)



 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
Before cumulative effect of change in accounting principles
$
(3.54)
$
1.02
$
(2.28)
Cumulative effect of change in accounting principles, net
 
0.04
 
(0.23)
 
--



Net earnings (loss) per share
$
(3.50)
$
0.79
$
(2.28)



 
 
 
 
 
 
 
Comprehensive Income (Loss)
 
 
 
 
 
 
Net earnings (loss)
$
(270)
$
61
$
(175)
Other comprehensive income (loss)
 
 
 
 
 
 
Change in cumulative translation adjustment
 
150
 
102
 
(24)
Change in minimum pension liability, net of tax
 
19
 
(145)
 
(106)
Change in unrealized gains (losses) on investments, net of tax
 
--
 
(2)
 
(2)
Change in unrealized gains (losses) on derivative instruments, net of tax
 
5
 
1
 
(2)



Total other comprehensive income (loss)
 
174
 
(44)
 
(134)



Comprehensive income (loss)
$
(96)
$
17
$
(309)



 
 
 
 
 
 
 
Retained Earnings
 
 
 
 
 
 
Retained earnings at beginning of period
$
1,882
$
1,956
$
2,266
Net earnings (loss)
 
(270)
 
61
 
(175)
Cash dividends declared
 
(136)
 
(135)
 
(135)



Retained earnings at end of period
$
1,476
$
1,882
$
1,956




The accompanying notes are an integral part of these financial statements.

 82

     

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Dollars in millions, except per share amounts)
December 31,
Assets
 
2003
 
2002


Current assets
 
 
Cash and cash equivalents
$
558
$
77
Trade receivables, net of allowance of $28 and $32
 
614
 
532
Miscellaneous receivables
 
87
 
142
Inventories
 
698
 
713
Other current assets
 
53
 
83


Total current assets
 
2,010
 
1,547


 
 
 
 
 
Properties
 
 
Properties and equipment at cost
 
9,861
 
9,660
Less: Accumulated depreciation
 
6,442
 
5,907


Net properties
 
3,419
 
3,753


 
 
 
 
 
Goodwill
 
317
 
344
Other intangibles, net of accumulated amortization of $218 and $51
 
33
 
229
Other noncurrent assets
 
451
 
414


Total assets
$
6,230
$
6,287


 
 
 
 
 
Liabilities and Stockholders’ Equity
 
 
 
 
Current liabilities
 
 
 
 
Payables and other current liabilities
$
973
$
1,244
Borrowings due within one year
 
504
 
3


Total current liabilities
 
1,477
 
1,247


 
 
 
 
 
Long-term borrowings
 
2,089
 
2,054
Deferred income tax liabilities
 
316
 
464
Postemployment obligations
 
1,126
 
1,069
Other long-term liabilities
 
179
 
182


Total liabilities
 
5,187
 
5,016


 
 
 
 
 
Commitments and contingencies
 
 
 
 
 
 
 
 
 
Stockholders’ equity
 
 
 
 
Common stock ($0.01 par value– 350,000,000 shares authorized; shares
issued –85,177, 467 and 85,135,117)
 
1
 
1
Additional paid-in capital
 
122
 
119
Retained earnings
 
1,476
 
1,882
Accumulated other comprehensive loss
 
(121)
 
(295)


 
 
1,478
 
1,707
Less: Treasury stock at cost (7,933,646 shares for 2003 and 2002)
 
435
 
436


 
 
 
 
 
Total stockholders’ equity
 
1,043
 
1,271


 
 
 
 
 
Total liabilities and stockholders’ equity
$
6,230
$
6,287











The accompanying notes are an integral part of these financial statements.

 83

     

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 
For years ended December 31,
(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Cash flows from operating activities
 
 
 
 
 
 
Net earnings (loss)
$
(270)
$
61
$
(175)



 
 
 
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities, net of effect of acquisitions
 
 
 
 
 
 
Depreciation and amortization
 
367
 
397
 
435
Cumulative effect of change in accounting principles, net
 
(3)
 
18
 
--
Asset impairments
 
500
 
9
 
373
Gains on sale of assets
 
(33)
 
--
 
--
Write-off of acquired in-process research and development
 
--
 
--
 
5
Provision (benefit) for deferred income taxes
 
(140)
 
95
 
(78)
Changes in operating assets and liabilities, net of effect of acquisitions
 
 
 
 
 
 
(Increase) decrease in trade receivables
 
(46)
 
70
 
79
(Increase) decrease in inventories
 
41
 
(41)
 
(8)
Increase (decrease) in trade payables
 
(2)
 
87
 
(122)
Increase (decrease) in liabilities for employee benefits and incentive pay
 
(214)
 
81
 
(8)
Other items, net
 
44
 
24
 
(104)



 
 
 
 
 
 
 
 
Net cash provided by operating activities
 
244
 
801
 
397



 
 
 
 
 
 
 
Cash flows from investing activities
 
 
 
 
 
 
Additions to properties and equipment
 
(230)
 
(427)
 
(234)
Proceeds from sale of assets
 
71
 
9
 
4
Acquisitions, net of cash acquired
 
--
 
(6)
 
(257)
Additions to capitalized software
 
(15)
 
(18)
 
(28)
Other items, net
 
14
 
(25)
 
(8)



 
 
 
 
 
 
 
Net cash used in investing activities
 
(160)
 
(467)
 
(523)



 
 
 
 
 
 
 
Cash flows from financing activities
 
 
 
 
 
 
Net increase (decrease) in commercial paper and other short-term borrowings
 
39
 
(573)
 
221
Proceeds from long-term borrowings
 
495
 
394
 
--
Repayment of borrowings
 
(5)
 
(8)
 
(11)
Dividends paid to stockholders
 
(136)
 
(135)
 
(135)
Other items
 
4
 
(1)
 
16



Net cash provided by (used in) financing activities
 
397
 
(323)
 
91



 
 
 
 
 
 
 
Net change in cash and cash equivalents
 
481
 
11
 
(35)
 
 
 
 
 
 
 
Cash and cash equivalents at beginning of period
 
77
 
66
 
101



 
 
 
 
 
 
 
Cash and cash equivalents at end of period
$
558
$
77
$
66











The accompanying notes are an integral part of these financial statements.

84
     

 

 

1.    SIGNIFICANT ACCOUNTING POLICIES

Financial Statement Presentation

The consolidated financial statements of Eastman ("Eastman" or the "Company") are prepared in conformity with accounting principles generally accepted in the United States of America and of necessity include some amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The consolidated financial statements include assets, liabilities, revenues and expenses of all majority-owned subsidiaries. Eastman accounts for joint ventures and investments in minority-owned companies where it exercises significant influence on the equity basis. Intercompany transactions and balances are eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents include cash, time deposits and readily marketable securities with maturities of three months or less at the purchase date.

Accounts Receivable Sales

Under a planned continuous sale agreement entered into in 1999, the Company sells to a third party undivided interests in certain domestic accounts receivable. Undivided interests in designated receivable pools are sold to the purchaser with recourse limited to the receivables purchased. The Company's retained interests in the designated receivable pools are measured at fair value, based on expected future cash flows, using management's best estimates of returns and credit losses commensurate with the risks involved. The Company's retained interests in receivables sold are recorded as trade receivables in the consolidated financial statements. Fees paid by the Company under this agreement are based on certain variable market rate indices and are included in other (income) charges, net in the consolidated financial statements.

Allowances for Doubtful Accounts

The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments.

Inventories

Inventories are valued at the lower of cost or market. The Company determines the cost of most raw materials, work in process, and finished goods inventories in the United States by the last-in, first-out ("LIFO") method. The cost of all other inventories, including inventories outside the United States, is determined by the average cost method, which approximates the first-in, first-out ("FIFO") method. The Company writes down its inventories for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions.

Properties

The Company records properties at cost. Maintenance and repairs are charged to earnings; replacements and betterments are capitalized. When Eastman retires or otherwise disposes of assets, it removes the cost of such assets and related accumulated depreciation from the accounts. The Company records any profit or loss on retirement or other disposition in earnings. Asset impairments are reflected as increases in accumulated depreciation.

 85

     

 

Depreciation

Depreciation expense is calculated based on historical cost and the estimated useful lives of the assets (buildings and building equipment 20 to 50 years; machinery and equipment 3 to 33 years), generally using the straight-line method.

Computer Software Costs

Capitalized software costs are amortized primarily on a straight-line basis over three years, the expected useful life of such assets, beginning when the software project is substantially complete and placed in service. In 2003, 2002 and 2001, approximately $15 million, $18 million and $28 million, respectively, were capitalized. During those periods, approximately $24 million, $23 million and $16 million, respectively, of previously capitalized costs were amortized. At December 31, 2003 and 2002, the unamortized capitalized software costs were $33 million and $42 million, respectively.

Goodwill and Other Intangibles

Prior to the adoption of Statement of Financial Accounting Standards ("SFAS") No. 142, "Goodwill and Other Intangible Assets," the Company amortized certain intangible assets on a straight-line basis over the estimated useful lives of such assets , generally 11 to 20 years. The Company adopted the provisions of SFAS No. 142, effective January 1, 2002. The provisions of SFAS No. 142 prohibit the amortization of goodwill and indefinite-lived intangible assets; require that goodwill and indefinite-lived intangible assets be tested at least annually for impairment; require reporting units to be identified for the purpose of assessing potential future impairments of goodwill; and remove the forty-year limitation on the amortization period of intangible assets that have finite lives. The Company performs the annual review for impairment at the reporting unit level, which Eastman has determined to be one level below its operating segment level, and aggregated if appropriate. The tests are performed by determining the fair values of the reporting units using a discounted cash flow model and comparing those fair values to the carrying values of the reporting units, including goodwill. If the fair value of a reporting unit is less than its carrying value, the Company then allocates the fair value of the reporting unit to all the assets and liabilities of that reporting unit, this includes any unrecognized intangible assets, as if the reporting unit’s fair value was the price to acquire the reporting unit. The excess of the fair value of the reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of the goodwill. If the carrying amount of the reporting unit’s goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to that excess. Events or changes in circumstances could occur that may create underperformance relative to projected future cash flows which would create further future impairments. See Note 4 for further discussions regarding the requirements of SFAS 142.

Impaired Assets

The Company evaluates the carrying value of long-lived assets to be held and used, including definite-lived intangible assets, when events or changes in circumstances indicate that the carrying value may not be recoverable. The carrying value of a long-lived asset is considered impaired when the total projected undiscounted cash flows from such asset is separately identifiable and is less than its carrying value.  In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset.  Fair value is determined primarily using the projected cash flows discounted at a rate commensurate with the risk involved or by appraisal.  Losses on long-lived assets to be disposed of are determined in a similar manner, except that fair values are reduced for disposal costs.

 86

     

 

Investments

The consolidated financial statements include the accounts of the Company and all its subsidiaries in which a controlling interest is maintained. For those consolidated subsidiaries in which the Company’s ownership is less than 100%, the outside stockholders’ interests are included in other long-term liabilities.

Investments in affiliates over which the Company has significant influence but not a controlling interest are carried on the equity basis. Under the equity method of accounting, these investments are included in other noncurrent assets. Eastman's negative investment in Primester, described in Note 5 to the Company’s consolidated financial statements, is included in other long-term liabilities. The Company includes its share of earnings and losses of such investments in other income and charges and its share of other comprehensive income (loss) in the appropriate component of other comprehensive income (loss).

Marketable securities held by the Company, currently common or preferred stock, are deemed by management to be available-for-sale and are reported at fair value, with net unrealized gains or losses reported as a component of other comprehensive income (loss) in stockholders' equity. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities. The Company includes these investments in other noncurrent assets.

Other equity investments, for which fair values are not readily determinable, are carried at historical cost and are included in other noncurrent assets.

The Company records an investment impairment charge when it believes a business venture investment, accounted for by the Company as a marketable security or recorded at historical cost, has experienced a decline in value that is other than temporary.

Pension and Other Postemployment Benefits

The Company maintains defined benefit plans that provide eligible employees with retirement benefits. Additionally, Eastman provides life insurance and health care benefits for eligible retirees and health care benefits for retirees’ eligible survivors. The costs and obligations related to these benefits reflect the Company’s assumptions related to general economic conditions (particularly interest rates), expected return on plan assets, rate of compensation increase for employees, and health care cost trends. The cost of providing plan benefits depends on demographic assumptions including retirements, mortality, turnover and plan participation.

Environmental Costs

The Company accrues environmental remediation costs when it is probable that the Company has incurred a liability and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. This undiscounted accrued amount reflects the Company’s assumptions about remediation requirements at the contaminated site, the nature of the remedy, the outcome of discussions with regulatory agencies and other potentially responsible parties at multi-party sites, and the number and financial viability of other potentially responsible parties. Changes in the estimates on which the accruals are based, unanticipated government enforcement action, or changes in health, safety, environmental, and chemical control regulations and testing requirements could result in higher or lower costs.

 87

     

 

In accordance with SFAS No. 143 "Accounting for Asset Retirement Obligations," the Company also establishes reserves for closure/postclosure costs associated with the environmental and other assets it maintains. Environmental assets include but are not limited to land fills, water treatment facilities, and ash ponds. When these types of assets are constructed, a reserve is established for the future environmental remediation anticipated to be associated with the closure of the site based on an expected life of the environmental assets. These future expenses are accreted into earnings over the estimated useful life of the assets. Currently, the Company estimates the useful life of each individual asset up to 50 years. If the Company changes its estimate of the asset retirement obligation costs or its estimate of the useful lives of these assets, the future expenses to be accreted into earnings could increase or decrease.

The Company’s reserve for environmental contingencies was $61 million, $60 million, and $54 million at December 31, 2003, 2002, and 2001, respectively, representing the minimum or best estimate for remediation costs and, for asset retirement obligation costs, the amount accrued to date over the facilities’ estimated useful lives. Accruals for environmental liabilities are included in other long-term liabilities and exclude claims for recoveries from insurance companies or other third parties. Environmental costs are capitalized if they extend the life of the related property, increase its capacity, and/or mitigate or prevent future contamination. The cost of operating and maintaining environmental control facilities is charged to expense.

For additional information see Notes 11 and 23 to the Company’s consolidated financial statements and Schedule II, "Valuation and Qualifying Accounts."

Derivative Financial Instruments

Derivative financial instruments are used by the Company in the management of its exposures to fluctuations in foreign currency, raw materials and energy costs, and interest rates. Such instruments are used to mitigate the risk that changes in exchange rates or raw materials and energy costs will adversely affect the eventual dollar cash flows resulting from the hedged transactions.

The Company enters into forward exchange contracts to hedge certain firm commitments denominated in foreign currencies and currency options to hedge probable anticipated, but not yet committed, export sales and purchase transactions expected within no more than five years and denominated in foreign currencies (principally the British pound, Canadian dollar, euro, and the Japanese yen). To mitigate short-term fluctuations in market prices for propane and natural gas (major raw materials and energy used in the manufacturing process), the Company enters into forwards and options contracts. From time to time, the Company also utilizes interest rate derivative instruments, primarily swaps, to hedge the Company's exposure to movements in interest rates.

The Company's forwards and options contracts are accounted for as hedges because the derivative instruments are designated and effective as hedges and reduce the Company's exposure to identified risks. Gains and losses resulting from effective hedges of existing assets, liabilities, firm commitments, or anticipated transactions are deferred and recognized when the offsetting gains and losses are recognized on the related hedged items and are reported as a component of operating earnings.

Deferred currency option premiums are generally included in other noncurrent assets and are amortized over the life of the contract. The related obligation for payment is generally included in other liabilities and is paid in the period in which the options are exercised or expire and forward exchange contracts mature.


 88

     

 

 
Litigation and Contingent Liabilities

The Company’s operations from time to time are parties to or targets of lawsuits, claims, investigations, and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated.

Revenue Recognition and Customer Incentives

The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price to the customer is fixed or determinable, and collectability is reasonably assured.

The Company records estimated obligations for customer programs and incentive offerings, which consist primarily of revenue or volume-based amounts that a customer must achieve over a specified period of time, as a reduction of revenue to each underlying revenue transaction as the customer progresses toward reaching goals specified in incentive agreements. These estimates are based on a combination of forecast of customer sales and actual sales volumes and revenues against established goals, the customer’s current level of purchases, and Eastman’s knowledge of customer purchasing habits and industry pricing practice. The incentive payment rate may be variable, based upon the customer reaching higher sales volume or revenue levels over a specified period of time in order to receive an agreed upon incentive payment.

Shipping and Handling Fees and Costs

Shipping and handling fees related to sales transactions are billed to customers and are recorded as sales revenue. Shipping and handling costs incurred are recorded in cost of sales.

Restructuring of Operations

The Company records restructuring charges incurred in connection with consolidation of operations, exited business lines, or shutdowns of specific sites. These restructuring charges generally will be substantially completed within 12 months, are based on costs associated with site closure, legal and environmental matters, demolition, contract terminations, severance or other costs directly related to the restructuring. The severance costs relate to charges associated with the actual and probable termination of employees.
 
Stock-based Compensation

As permitted by SFAS No. 123 "Accounting for Stock-Based Compensation," Eastman continues to apply intrinsic value accounting for its stock option plans. Compensation cost for stock options, if any, is measured as the excess of the quoted market price of the stock at the date of grant over the amount an employee must pay to acquire the stock. Eastman has adopted disclosure-only provisions of SFAS No. 123 and SFAS No. 148, "Accounting for Stock-Based Compensation – Transition and Disclosure - an Amendment of FASB Statement No. 123." The Company’s pro forma net earnings and pro forma earnings per share based upon the fair value at the grant dates for awards under Eastman’s plans are disclosed below.

 89

     

 

The Company applies intrinsic value accounting for its stock option plans. If the Company had elected to recognize compensation expense based upon the fair value at the grant dates for awards under these plans, the Company's net earnings (loss) and earnings (loss) per share would have been reduced as follows:

(Dollars and shares in millions, except per share amounts)
2003
 
2002
 
2001



 
 
 
 
 
 
Net earnings (loss), as reported
$
(270)
$
61
$
(175)
Deduct: Total additional stock-based employee Compensation cost, net of tax, that would have been included in net earnings (loss) under fair value method
 
10
 
11
 
8
Pro forma net earnings (loss)
$
(280)
$
50
$
(183)



 
 
 
 
 
 
 
Basic earnings (loss) per share
As reported
(3.50)
 
0.79
 
(2.28)
 
Pro forma
(3.62)
 
0.65
 
(2.38)
 
 
 
 
 
 
 
Shares
 
77.1
 
77.0
 
76.8
 
 
 
 
 
 
 
Diluted earnings (loss) per share
As reported
(3.50)
 
0.79
 
(2.28)
 
Pro forma
(3.62)
 
0.65
 
(2.38)
 
 
 
 
 
 
 
Shares
 
77.1
 
77.2
 
76.8

Compensated Absences

The Company accrues compensated absences and related benefits as current charges to earnings in the period earned.

Recognition of Gains or Losses on Subsidiary or Affiliate Stock Sales

Gains and losses on subsidiary or affiliate stock sales are recorded in other income or other charges and are separately disclosed in the Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss) and Retained Earnings.

Other Income and Other Charges

Included in other income and other charges are results from equity investments, royalty income, gains or losses on foreign exchange transactions, certain litigation costs, fees on securitized receivables and other miscellaneous items.

 90

     

 

Income Taxes

The provision for income taxes has been determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Provision has been made for income taxes on unremitted earnings of subsidiaries and affiliates, except for subsidiaries in which earnings are deemed to be permanently reinvested.

Translation of Non-U.S. Currencies

Where cash flows are primarily denominated in the local currency, foreign consolidated entities of the Company use the local currency as the "functional currency." The effects of those entities remeasuring transactions denominated in currencies other than functional currency are reflected in current earnings in other (income) charges, net. The effects of translating into U.S. dollars the operations of consolidated entities that use a foreign currency as the functional currency are included in comprehensive income (loss) and accumulated other comprehensive income (loss), a component of stockholders' equity.

Comprehensive Income

Components of accumulated other comprehensive income (loss) include cumulative translation adjustments, additional minimum pension liabilities, unrecognized gains or losses on investments, and unrecognized gains or losses on derivative instruments. Accumulated other comprehensive income (loss) is presented net of applicable taxes. Because cumulative translation adjustments are considered a component of permanently invested unremitted earnings of subsidiaries outside the United States, no taxes are provided on such amounts.

Earnings Per Share

Basic earnings (loss) per share reflect reported earnings divided by the weighted average number of common shares outstanding. Diluted earnings per share include the effect of dilutive stock options outstanding during the year.

Reclassifications

The Company has reclassified certain 2002 and 2001 amounts to conform to the 2003 presentation.
 
2.    INVENTORIES

 
December 31
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
At FIFO or average cost (approximates current cost)
 
 
 
 
Finished goods
$
583
$
582
Work in process
 
175
 
175
Raw materials and supplies
 
228
 
229


Total inventories
 
986
 
986
Reduction to LIFO value
 
(288)
 
(273)


Total inventories at LIFO value
$
698
$
713


Inventories valued on the LIFO method were approximately 65% of total inventories in each of the periods.

 91

     

 

 
3.    PROPERTIES AND ACCUMULATED DEPRECIATION

 
December 31
(Dollars in millions)
 
2003
 
2002


Properties at Cost
 
 
 
 
Balance at beginning of year
$
9,660
$
9,302
Additions
 
 
 
 
Capital expenditures
 
230
 
427
Deductions
 
(29)
 
(69)


Balance at end of year
$
9,861
$
9,660


 
 
 
 
 
Properties
 
 
 
 
Land
$
77
$
73
Buildings and building equipment
 
953
 
920
Machinery and equipment
 
8,710
 
8,483
Construction in progress
 
121
 
184


Balance at end of year
$
9,861
$
9,660


 
 
 
 
 
Accumulated Depreciation
 
 
 
 
Balance at beginning of year
$
5,907
$
5,675
Provision for depreciation
 
334
 
358
Fixed asset impairments
 
291
 
4
Deductions
 
(90)
 
(130)


Balance at end of year
$
6,442
$
5,907



Construction-period interest of $347 million and $344 million, reduced by accumulated depreciation of $224 million and $207 million, is included in cost of properties at December 31, 2003 and 2002, respectively. Interest capitalized during 2003, 2002 and 2001 was $3 million, $4 million, and $5 million, respectively.

Depreciation expense was $334 million, $358 million and $385 million, for 2003, 2002 and 2001, respectively.

In accordance with SFAS No. 143, the Company also recorded asset retirement obligations primarily related to closure and post-closure environmental liabilities associated with certain property, plant and equipment. For additional information on the impact to the Company of the adoption of SFAS No. 143, see Note 23 to the Company’s consolidated financial statements.

4.    GOODWILL AND OTHER INTANGIBLE ASSET S

The Company adopted the provisions of SFAS No. 142, "Goodwill and Other Intangible Assets," effective January 1, 2002. The provisions of SFAS No. 142 prohibit the amortization of goodwill and indefinite-lived intangible assets; require that goodwill and indefinite-lived intangible assets be tested at least annually for impairment; require reporting units to be identified for the purpose of assessing potential future impairments of goodwill; and remove the forty-year limitation on the amortization period of intangible assets that have finite lives. For additional information on the impact to the Company of the adoption of SFAS No. 142, see Note 23 to the Company’s consolidated financial statements.
 

 92

     

 

 
Following are the Company’s amortizable intangible assets and indefinite-lived intangible assets. The difference between the gross carrying amount and net carrying amount for each item presented is attributable to impairments and accumulated amortization.

 
As of December 31, 2003
 
As of December 31, 2002
 
 
(Dollars in millions)
Gross Carrying Amount
 
Net Carrying Amount
 
Gross Carrying Amount
 
Net Carrying Amount




 
 
 
 
 
 
 
 
Amortizable intangible assets
 
 
 
 
 
 
 
Developed technology
$
124
$
6
$
124
$
96
Customer lists
62
 
6
 
62
 
48
Other
18
 
2
 
18
 
15




Total
204
 
14
 
204
 
159
 

 
 
 
 

 
 
 
Indefinite-lived intangible assets
 
 
 
 
 
 
 
Trademarks
 
 
19
 
 
 
70


 
 
 
 
 
 
 
 
Other intangible assets
 
$
33
 
 
$
229


As a result of the non-amortization provisions of SFAS No. 142, the Company will no longer record approximately $20 million of annual amortization relating to goodwill and indefinite-lived intangibles, as adjusted for the reclassifications discussed in Note 23 below.
 
Changes in the carrying amount of goodwill follow:

 
 
 
 
(Dollars in millions)
 
 
CASPI
Segment
 
 
 
Other
Segments
 
 
Total
Eastman
Chemical



 
 
 
 
 
 
Reported balance at December 31, 2001
331
 
8
 
339
Intangible assets reclassified into goodwill at January 1, 2002 net of deferred tax liability
7
 
--
 
7
Purchase accounting adjustments and foreign currency translation effect
(5)
 
--
 
(5)
Acquisitions
--
 
3
 
3



Reported balance at December 31, 2002
$
 333
$
 11
$
344



Impairment of goodwill
(34)
 
--
 
(34)
Foreign currency translation effect
7
 
--
 
7



Reported goodwill balance at December 31, 2003
$
306
$
11
$
317



 
 
 
 
 
 


Additional information regarding the impairment of intangibles and goodwill and the adoption of SFAS No. 142 is available in Note 15 and 23 to the Company’s consolidated financial statements
 
The following table presents 2001 earnings and earnings per share as if the nonamortization provisions of SFAS No. 142 had been applied in 2001.
 

 93

     

 

 

(Dollars in millions, except per share amounts)
 
2001

 
 
 
Reported net earnings (loss)
$
(175)
Add back goodwill amortization
 
15
Add back assembled workforce and trademark amortization
 
3

Adjusted net earnings (loss)
$
(157)

 
 
 
Basic earnings (loss) per share before cumulative effect of change in accounting principle:
 
 
Reported basic earnings (loss) per share
$
(2.28)
Add back goodwill amortization
 
.20
Add back assembled workforce and trademark amortization
 
.03

Adjusted net earnings (loss) per share
$
(2.05)

 
 
 
Diluted earnings (loss) per share before cumulative effect of change in accounting principle:
 
 
Reported diluted earnings (loss) per share
$
(2.28)
Add back goodwill amortization
 
.20
Add back assembled workforce and trademark amortization
 
.03

Adjusted net earnings (loss) per share
$
(2.05)

 
 
 

Amortization expense for definite-lived intangible assets was approximately $10 million, $12 million, and $16 million, respectively, for 2003, 2002, and 2001. If the non-amortization provisions of SFAS No. 142 had been applied in the prior years, amortization expense would have been $14 million in 2001. Estimated amortization expense for the five succeeding years is approximately $2 million per year.
 
5.    EQUITY INVESTMENTS AND OTHER NONCURRENT ASSETS AND LIABILITIES

Eastman owns 25 million shares, or approximately 42%, of the outstanding common shares of Genencor International, Inc. ("Genencor") a company engaged in the discovery, development, manufacture and marketing of biotechnology products for the industrial chemicals, agricultural and health care markets. This investment is accounted for under the equity method and is included in other noncurrent assets. At December 31, 2003 and 2002, the Company’s investment in Genencor, including preferred stock and accumulated dividends receivable, was $221 million and $196 million, respectively. At December 31, 2003, the fair market value of the Company’s common stock portion of that investment in Genencor was $15.70 per share or $393 million.

Eastman has a 50% interest in and serves as the operating partner in Primester, a joint venture engaged in the manufacture of cellulose acetate at its Kingsport, Tennessee plant. This investment is accounted for under the equity method. The Company guarantees up to $125 million of the principal amount of the joint venture's third-party borrowings; however, management believes, based on current facts and circumstances and the structure of the venture, that the likelihood of a payment pursuant to such guarantee is remote. Eastman had a negative investment in the joint venture of approximately $40 million at December 31, 2003 and 2002, representing the recognized portion of the venture's accumulated deficits that it has a commitment to fund as necessary. Such amounts are included in other long-term liabilities. The Company provides certain utilities and general plant services to the joint venture. In return for Eastman providing those services, the joint venture paid Eastman a total of $39 million in three equal installments in 1991, 1992 and 1993. Eastman is amortizing the deferred credit to earnings over the 10-year period of the utilities and plant services contract, which concludes at the end of 2004.

 94

     

 

Eastman owns a 50% interest in Nanjing Yangzi Eastman Chemical Ltd. ("Nanjing"), a company engaged in the manufacture of Eastotac Ô hydrocarbon tackifying resins for the adhesives market. This joint venture is accounted for under the equity method and is included in other noncurrent assets. The Company guarantees up to $6 million of the principal amount of the joint venture's third-party borrowings; however, management believes, based on current facts and circumstances and the structure of the venture, that the likelihood of a payment pursuant to such guarantee is remote. At December 31, 2003 and 2002, the Company’s investment in Nanjing was approximately $7 million.

In 2002, Eastman entered into a joint venture in Qilu Eastman Specialty Chemical Ltd. ("Qilu"), a company engaged in the manufacture of Texanol Ô ester alcohol coalescing aid for the paint market and TXIB Ô plasticizer for the glove and flooring markets. Eastman holds a 51% share in the joint venture, which is located in Zibo City, China. The Company’s investment in Qilu was approximately $4 million at December 31, 2003.
 
6.    PAYABLES AND OTHER CURRENT LIABILITIES

 
December 31
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Trade creditors
$
478
$
471
Accrued payrolls, vacation, and variable-incentive compensation
 
135
 
194
Accrued taxes
 
63
 
61
Interest payable
 
45
 
48
Current portion of U.S. defined benefit pension plan liabilities
 
--
 
220
Bank overdrafts
 
22
 
39
Other
 
230
 
211


Total
$
973
$
1,244


The current portion of U.S. defined benefit pension plan liabilities is an estimate of the Company’s anticipated funding through December 31, 2004.
 
7.    BORROWINGS

 
December 31
(Dollars in millions)
2003
 
2002


 
 
 
 
Borrowings consisted of:
 
 
 
6 3/8% notes due 2004
$
504
$
513
3 1/4% notes due 2008
250
 
--
6.30% notes due 2018
249
 
--
7% notes due 2012
394
 
397
7 1/4% debentures due 2024
496
 
496
7 5/8% debentures due 2024
200
 
200
7.60% debentures due 2027
297
 
297
Commercial paper borrowings
196
 
143
Other
7
 
11


Total borrowings
2,593
 
2,057
Borrowings due within one year
(504)
 
(3)


Long-term borrowings
$
2,089
$
2,054



 95

     

 

Eastman has access to a $600 million revolving credit facility (the "Credit Facility") expiring in July 2005. Any borrowings under the Credit Facility are subject to interest at varying spreads above quoted market rates, principally LIBOR. The Credit Facility requires facility fees on the total commitment that vary based on Eastman's credit rating. The rate for such fees was 0.25% and 0.15% as of December 31, 2003 and December 31, 2002, respectively. The Credit Facility contains a number of covenants and events of default, including the maintenance of certain financial ratios.
 
Eastman typically utilizes commercial paper, generally with maturities of 90 days or less, to meet its liquidity needs. The Credit Facility provides liquidity support for commercial paper borrowings and general corporate purposes. Accordingly, outstanding commercial paper borrowings reduce borrowings available under the Credit Facility. Because the Credit Facility expires in July 2005, the commercial paper borrowings supported by the Credit Facility are classified as long-term borrowings because the Company has the ability to refinance such borrowings on a long-term basis. At December 31, 2003, the Company’s commercial paper borrowings were $196 million at an effective interest rate of 1.85%. At December 31, 2002, the Company's commercial paper borrowings were $143 million at an effective interest rate of 1.66%.
 
On April 3, 2002, the Company issued notes in the principal amount of $400 million due 2012 and bearing interest at 7% per annum. Proceeds from the sale of the notes, net of $3 million in transaction fees, were $394 million and were used to repay portions of outstanding borrowings under the Credit Facility and commercial paper borrowings.
 
On June 16, 2003, the Company issued notes in the principal amount of $250 million due 2008 and bearing interest at 3 1/4% per annum. Proceeds from the sale of the notes, net of $2 million in transaction fees, were $248 million and were used to repay portions of commercial paper borrowings.
 
On November 12, 2003, the Company issued notes in the principal amount of $250 million due 2018 and bearing interest at 6.30% per annum. Proceeds from the sale of the notes, net of approximately $2 million in transaction fees, were $246 million and were used, along with cash generated from business activities and other borrowings, for the repayment of the Company’s outstanding $500 million 6 3/8% notes due on January 15, 2004.
 
On January 15, 2004, the Company retired $500 million of debt bearing interest at 6 3/8% per annum. These bonds were reflected in borrowings due within one year in the Consolidated Statements of Financial Position at December 31, 2003. This debt was retired with cash accumulated from a combination of sources including cash generated from business activities, new long-term borrowings and available short-term borrowing capacity.

In the first quarter 2002, the Company entered into interest rate swaps that converted the effective interest rate of the notes due in 2004 to a variable rate.  These original interest rate swaps were settled during the fourth quarter 2002, resulting in $13 million cash proceeds being received by the Company.  The gain resulting from the settlement of the swaps is reflected as an increase in the current portion of long-term borrowings and is being amortized into earnings as a reduction to interest expense through the maturity of the notes in January 2004.  In conjunction with the settlement of the original interest rate swaps, new interest rate swaps were entered into in the fourth quarter 2002, converting the effective interest rate on the notes due in 2004 to variable rates that averaged 3.37% at December 31, 2003 and 4.07% at December 31, 2002.  
 
In the third quarter 2003, the Company entered into interest rate swaps that converted the effective interest rate of a portion of the notes due in 2012 to variable rates such that the average rate was 6.26% at December 31, 2003. The recording of the fair value of the interest rate swaps and the corresponding debt resulted in increases of approximately $1 million in other current assets and the current portion of long-term borrowings at December 31, 2003.
 

 96

     

 

 
8.    FAIR VALUE OF FINANCIAL INSTRUMENTS

  December 31, 2003      December 31, 2002     
 
     

     
 
(Dollars in millions)
 
Recorded Amount
 
Fair Value
 
Recorded
Amount
 
Fair Value




 
 
 
 
 
 
 
 
 
Long-term borrowings
$
2,089
$
2,247
$
2,054
$
2,220

The fair value for fixed-rate borrowings is based on current interest rates for comparable securities. The Company's floating-rate borrowings approximate fair value.

Hedging Programs

Financial instruments held as part of the hedging programs discussed below are recorded at fair value based upon comparable market transactions as quoted by the broker.
The Company is exposed to market risk, such as changes in currency exchange rates, raw material and energy costs and interest rates. The Company uses various derivative financial instruments pursuant to the Company's hedging policies to mitigate these market risk factors and their effect on the cash flows of the underlying transactions. Designation is performed on a specific exposure basis to support hedge accounting. The changes in fair value of these hedging instruments are offset in part or in whole by corresponding changes in the cash flows of the underlying exposures being hedged. The Company does not hold or issue derivative financial instruments for trading purposes.
 
·    Currency Rate Hedging
 
The Company manufactures and sells its products in a number of countries throughout the world and, as a result, is exposed to movements in foreign currency exchange rates. To manage the volatility relating to these exposures, the Company nets the exposures on a consolidated basis to take advantage of natural offsets. To manage the remaining exposure, the Company enters into forward exchange contracts to hedge certain firm commitments denominated in foreign currencies and currency options and forwards to hedge probable anticipated, but not yet committed, export sales transactions expected within no more than five years and denominated in foreign currencies (principally the British pound, Canadian dollar, euro and the Japanese yen). These contracts are designated as cash flow hedges. The mark-to-market gains or losses on qualifying hedges are included in accumulated other comprehensive income (loss) to the extent effective, and reclassified into cost of sales in the period during which the hedged transaction affects earnings.
 
·    Commodity Hedging
 
Raw materials and energy sources used by the Company are subject to price volatility caused by weather, supply conditions, economic variables and other unpredictable factors. To mitigate short-term fluctuations in market prices for propane, ethane and natural gas, the Company enters into forwards and options contracts. These contracts are designated as cash flow hedges. The mark-to-market gains or losses on qualifying hedges are included in accumulated other comprehensive income (loss) to the extent effective, and reclassified into cost of sales in the period during which the hedged transaction affects earnings.

 97

     

 

 
·    Interest Rate Hedging
 
The Company's policy is to manage interest cost using a mix of fixed and variable rate debt. To manage this mix in a cost-efficient manner, the Company enters into interest rate swaps in which the Company agrees to exchange the difference between fixed and variable interest amounts calculated by reference to an agreed upon notional principal amount. These swaps are designated to hedge the fair value of underlying debt obligations with the interest rate differential reflected as an adjustment to interest expense over the life of the swaps. As these instruments are 100% effective, there is no impact on earnings due to hedge ineffectiveness.

From time to time, the Company also utilizes interest rate derivative instruments, primarily swaps, to hedge the Company’s exposure to movements in interest rates on anticipated debt offerings. These instruments are designated as cash flow hedges and are typically 100% effective. As a result, there is no current impact on earnings due to hedge ineffectiveness. The mark-to-market gains or losses on these hedges are included in accumulated other comprehensive income (loss) to the extent effective, and are reclassified into interest expense over the period of the related debt instruments.

The fair value for fixed-rate borrowings is based upon current interest rates for comparable securities. The Company’s floating-rate instruments have carrying values that approximate fair value.

At December 31, 2002, the remaining mark-to-market gains from currency, commodity and certain interest rate hedges that were included in accumulated other comprehensive loss totaled approximately $1 million. If realized, substantially all of this balance will be reclassified into earnings during the next 12 months. The mark-to-market gains or losses on non-qualifying, excluded and ineffective portions of hedges are recognized in cost of sales or other income and charges immediately. Such amounts did not have a material impact on earnings during 2002.

At December 31, 2003, mark-to-market gains from raw material, energy and certain interest rate hedges that were included in accumulated other comprehensive income (loss) totaled approximately $4 million. If realized, approximately $1 million of this balance will be reclassified into earnings during the next 12 months. The mark-to-market gains or losses on non-qualifying, excluded and ineffective portions of hedges are recognized in cost of sales or other income and charges immediately. Such amounts did not have a material impact on earnings for all periods presented.
 
9.    RETIREMENT PLANS

Eastman maintains defined benefit plans that provide eligible employees with retirement benefits. Prior to 2000, benefits were calculated using a defined benefit formula based on age, years of service and employee's final average compensation as defined in the plans. Effective January 1, 2000, the defined benefit pension plan, the Eastman Retirement Assistance Plan, was amended. Employees' accrued pension benefits earned prior to January 1, 2000 are calculated based on previous plan provisions using the employee's age, years of service and final average compensation as defined in the plans. The amended defined benefit pension plan uses a pension equity formula based on age, years of service and final average compensation to calculate an employee's retirement benefit from January 1, 2000 forward. Benefits payable will be the combined pre-2000 and post-1999 benefits.

Benefits are paid to employees from trust funds. Contributions to the plan are made as permitted by laws and regulations. The pension trust fund does not directly own any of the Company’s common stock.
 
Pension coverage for employees of Eastman's international operations is provided, to the extent deemed appropriate, through separate plans. The Company systematically provides for obligations under such plans by depositing funds with trustees, under insurance policies or by book reserves.

 98

     

 

Below is a summary balance sheet of the change in plan assets during 2003 and 2002, the funded status of the plans, amounts recognized in the Statements of Financial Position, and a Summary of Benefit Costs. The assumptions used to develop the projected benefit obligation for the Company's significant defined benefit pension plans are also provided in the following tables.

Summary Balance Sheet
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Change in benefit obligation:
 
 
 
 
Benefit obligation, beginning of year
$
1,222
$
1,062
Service cost
 
42
 
36
Interest cost
 
84
 
80
Actuarial loss
 
94
 
72
New plans
 
28
 
72
Effect of currency exchange
 
10
 
--
Benefits paid
 
(134)
 
(100)


Benefit obligation, end of year
$
1,346
$
1,222


 
 
 
 
 
Change in plan assets:
 
 
 
 
Fair value of plan assets, beginning of year
$
574
$
697
Actual return (loss) on plan assets
 
189
 
(96)
New plans
 
19
 
70
Effect of currency exchange
 
6
 
--
Company contributions
 
249
 
3
Benefits paid
 
(134)
 
(100)


Fair value of plan assets, end of year
$
903
$
574


 
 
 
 
 
Benefit obligation in excess of plan assets
$
443
$
648
Unrecognized actuarial loss
 
(535)
 
(564)
Unrecognized prior service credit
 
73
 
96
   
  
 
  
Net amount recognized, end of year
$
(19)
$
180


 
 
 
 
 
Amounts recognized in the Statements of Financial Position consist of:
 
 
 
 
Prepaid benefit cost
$
(33)
$
--
Accrued benefit cost
 
14
 
180
Additional minimum liability
 
386
 
417
Accumulated other comprehensive loss
 
(386)
 
(417)


Net amount recognized, end of year
$
(19)
$
180


 
 
 
 
 


The accumulated benefit obligation basis at the end of 2003 and 2002 was $1,283 million and $1,179 million, respectively. The Company uses a measurement date of December 31 for the majority of its pension plans.
 

 99

     

 

 
A summary of the components of net periodic benefit cost recognized for Eastman's significant defined benefit pension plans follows:

Summary of Benefit Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Components of net periodic benefit cost:
 
 
 
 
 
 
Service cost
$
42
$
36
$
32
Interest cost
 
84
 
80
 
72
Expected return on assets
 
(82)
 
(77)
 
(72)
Amortization of:
 
 
 
 
 
 
Transition asset
 
--
 
(4)
 
(4)
Prior service credit
 
(11)
 
(12)
 
(12)
Actuarial loss
 
19
 
9
 
4



Net periodic benefit cost
$
52
$
32
$
20




 
2003
 
2002
 
2001



 
 
 
 
 
 
Weighted-average assumptions used to determine benefit obligations for years ended December 31:
 
 
 
 
 
Discount rate
6.18%
 
6.72%
 
7.25%
Expected return on assets
8.88%
 
8.94%
 
9.50%
Rate of compensation increase
3.77%
 
4.00%
 
4.00%
 
 
 
 
 
 
Weighted-average assumptions used to determine net periodic pension cost for years ended December 31:
 
 
 
 
 
Discount rate
6.72%
 
7.25%
 
7.75%
Expected return on assets
8.94%
 
9.50%
 
9.50%
Rate of compensation increase
4.00%
 
4.00%
 
4.25%


The fair value of plan assets for the US plans at December 31, 2003 and 2002 was $835 million and $540 million, respectively, while the fair value of plan assets at December 31, 2003 and 2002 for non-U.S. plans was $68 million and $34 million, respectively. At December 31, 2003 and 2002, the expected long-term rate of return on the US plan assets was 9.00%, while the expected long-term rate of return on non-U.S. plan assets was 7.36% and 8% at December 31, 2003 and 2002, respectively. The asset allocation for the Company’s U.S. pension plans at December 31, 2003 and 2002, and the target allocation for 2004, by asset category, is as follows:

(Dollars in millions)
Target allocation for 2004
Plan assets at December 31, 2003
Plan assets at December 31, 2002



Asset category
 
 
 
 
 
 
 
Equity securities
75%
80%
79%
Debt securities
10%
11%
8%
Real estate
5%
4%
5%
Other Investments
10%
5%
8%



Total
100%
100%
100%


 100

     

 

The Company’s investment strategy for the U.S. defined benefit pension plan is to maximize long-term rate of return on plan assets within an acceptable level of risk in order to minimize the cost of providing pension benefits. The investment policy establishes a target allocation range for each asset class and the fund is managed within those ranges. The plan uses a number of investment approaches including equity, real estate, and fixed income funds in which the underlying securities are marketable in order to achieve this target allocation. The plan also invests in private equity and other funds.

The expected rate of return was determined by modeling the expected long-term rates of return for broad categories of investments held by the plan against a number of various potential economic scenarios.

The Company anticipates pension contributions to its U.S. defined-benefit plans for 2004 to be between $0 and $40 million, reflecting quarterly contributions as required by the IRS code section 412.
 
As a result of the partial settlement of pension liabilities, the Company recorded a charge of $7 million in 2001.

DEFINED CONTRIBUTION PLANS

The Company sponsors a defined contribution employee stock ownership plan (the "ESOP"), a qualified plan under Section 401(a) of the Internal Revenue Code, which is a component of the Eastman Investment and Employee Stock Ownership Plan ("EIP/ESOP"). Eastman anticipates that it will make annual contributions for substantially all U.S. employees equal to 5% of eligible compensation to the ESOP, or for employees who have five or more prior ESOP contributions, to either the Eastman Stock Fund or other investment funds within the EIP. Employees may diversify to other investment funds within the EIP from the ESOP at anytime without restrictions. Allocated shares in the ESOP totaled 2,582,229 shares, 2,774,676 shares and 2,814,730 shares as of December 31, 2003, 2002 and 2001, respectively. Dividends on shares held by the EIP/ESOP are charged to retained earnings. All shares held by the EIP/ESOP are treated as outstanding in computing earnings per share.

Charges for contributions to the EIP/ESOP were $38 million, $37 million and $38 million for 2003, 2002 and 2001, respectively.

POSTRETIREMENT WELFARE PLANS

Eastman provides life insurance and health care benefits for eligible retirees, and health care benefits for retirees' eligible survivors. In general, Eastman provides those benefits to retirees eligible under the Company's U.S. pension plans. Similar benefits are also provided to retirees of Holston Defense Corporation ("HDC"), a wholly-owned subsidiary of the Company that, prior to January 1, 1999, operated a government-owned ammunitions plant. HDC’s contract with the Department of Army ("DOA") provided for reimbursement of allowable costs incurred by HDC including certain postretirement welfare costs, for as long as HDC operated the plant. After the contract was terminated at the end of 1998, the Army has not contributed further to these costs. The Company continues to accrue for the costs related to HDC retirees while pursuing extraordinary relief from the DOA for reimbursement of these and other previously expensed employee benefit costs. Given the uncertain outcome of discussions with the DOA, the Company will recognize the impact of any reimbursement in the period settled.

A few of the Company's non-U.S. operations have supplemental health benefit plans for certain retirees, the cost of which is not significant to the Company.

The following tables set forth the status of the Company's U.S. plans at December 31, 2003 and 2002:

 101

     

 

 

Summary Balance Sheet
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Change in benefit obligation:
 
 
 
 
Benefit obligation, beginning of year
$
896
$
779
Service cost
 
8
 
6
Interest cost
 
58
 
57
Plan participants’ contributions
 
4
 
2
Actuarial loss
 
70
 
97
Plan amendments
 
(10)
 
--
Benefits paid
 
(49)
 
(45)


Benefit obligation, end of year
$
977
$
896


 
 
 
 
 
Change in plan assets:
 
 
 
 
Fair value of plan assets, beginning of year
$
26
$
35
Actual return on plan assets
 
--
 
2
Company contributions
 
38
 
32
Plan participants’ contributions
 
4
 
2
Benefits paid
 
(49)
 
(45)


Fair value of plan assets, end of year
$
19
$
26


 
 
 
 
 
Benefit obligation in excess of plan assets
$
958
$
870
Unrecognized actuarial loss
 
(338)
 
(280)
Unrecognized prior service credit
 
36
 
30


Net amount recognized, end of year
$
656
$
620


 
 
 
 
 
Amounts recognized in the Statements of Financial Position consist of:
 
 
 
 
Accrued benefit cost
$
656
$
620


Net amount recognized, end of year
$
656
$
620


 
 
 
 
 



Weighted-average assumptions used to determine end of year benefit obligations:
2003
 
2002
 
2001



 
 
 
 
 
 
Discount rate
6.25%
 
6.75%
 
7.25%
Rate of compensation increase
3.75%
 
4.00%
 
4.00%
Health care cost trend
 
 
 
 
 
Initial
10.00%
 
10.00%
 
10.00%
Decreasing to ultimate trend of
5.00%
 
5.25%
 
5.00%
In year
2009
 
2007
 
2006

 

Weighted-average assumptions used to determine end of year net benefit cost:
2003
 
2002
 
2001



 
 
 
 
 
 
Discount rate
6.75%
 
7.25%
 
7.75%
Rate of compensation increase
4.00%
 
4.00%
 
4.25%
Health care cost trend
 
 
 
 
 
Initial
10.00%
 
10.00%
 
7.00%
Decreasing to ultimate trend of
5.25%
 
5.00%
 
5.00%
In year
2007
 
2006
 
2006


 102

     

 

 
The net periodic postretirement benefit cost follows:

Summary of Benefit Costs
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Components of net periodic benefit cost:
 
 
 
 
 
 
Service cost
$
8
$
6
$
6
Interest cost
 
58
 
57
 
52
Expected return on assets
 
(1)
 
(2)
 
(2)
Amortization of:
 
 
 
 
 
 
Prior service cost
 
(4)
 
(3)
 
(3)
Actuarial loss
 
13
 
9
 
5



Net periodic benefit cost
$
74
$
67
$
58



 
 
 
 
 
 
 


A 10% rate of increase in the per capita cost of covered health care benefits is assumed for 2004. The rate is assumed to decrease gradually to 5% for 2009 and remain at that level thereafter. A 1% increase in health care cost trend would have increased the 2003 service and interest costs by $3 million, and the 2003 benefit obligation by $54 million. A 1% decrease in health care cost trend would have decreased the 2003 service and interest costs by $3 million, and the 2003 accumulated post-retirement benefit obligation by $46 million.

The Company anticipates its payments for other post-retirement benefits will be $40 million in 2004.

On December 7, 2003, Congress passed the Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("the Act"). As permitted by FASB Staff Position ("FSP") 106-1, "Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003," the Company elected to defer accounting for the effects of the Act. Accordingly, the Company’s accumulated post-retirement benefit obligation and net periodic postretirement benefit cost disclosed above do not reflect the effects of the Act. Specific authoritative guidance on the accounting for the federal subsidy is pending and that guidance, when issued, could require the sponsor to change previously reported information.
 
10.    COMMITMENTS

Purchase Obligations and Lease Commitments


At December 31, 2003, the Company had various purchase obligations totaling approximately $2 billion over a period of approximately 15 years for materials, supplies and energy incident to the ordinary conduct of business. The Company also had various lease commitments for property and equipment under cancelable, noncancelable and month-to-month operating leases totaling approximately $195 million over a period of several years. Of the total lease commitments, approximately 20% relate to machinery and equipment, including computer and communications equipment and production equipment; approximately 40% relate to real property, including office space, storage facilities and land; and approximately 40% relate to railcars. The obligations described above are summarized in the following table:
 

 103

     

 


(Dollars in millions)
 
Payments Due For

 
 
 
Period
 
 
 
Notes and Debentures
 
Commercial Paper and Other Borrowings
 
 
 
Purchase Obligations
 
 
 
Operating Leases
 
 
 
 
Total






 
 
 
 
 
 
 
 
 
 
 
2004
$
504
$
--
$
246
$
45
$
795
2005
 
--
 
196
 
246
 
40
 
482
2006
 
5
 
--
 
243
 
33
 
281
2007
 
--
 
--
 
240
 
24
 
264
2008
 
250
 
--
 
140
 
13
 
403
2009-2013
 
396
 
--
 
643
 
29
 
1,068
Beyond 2013
 
1,242
 
--
 
259
 
11
 
1,512





Total
$
2,397
$
196
$
2,017
$
195
$
4,805






If certain operating leases are terminated by the Company, it guarantees a portion of the residual value loss, if any, incurred by the lessors in disposing of the related assets. The Company believes, based on current facts and circumstances, that a material payment pursuant to such guarantees in excess of the payments included above is remote. Under these operating leases, the residual value guarantees at December 31, 2003 totaled $93 million and consisted primarily of leases for railcars, company aircraft, and other equipment.
Rental expense, net of sublease income, was approximately $64 million, $80 million and $83 million in 2003, 2002 and 2001, respectively.

Accounts Receivable Securitization Program

In 1999, the Company entered into an agreement that allows the Company to sell certain domestic accounts receivable under a planned continuous sale program to a third party. The agreement permits the sale of undivided interests in domestic trade accounts receivable. Receivables sold to the third party totaled $200 million at December 31, 2003, 2002, and 2001. Undivided interests in designated receivable pools were sold to the purchaser with recourse limited to the purchased interest in the receivable pools. Fees paid by the Company under this agreement are based on certain variable market rate indices and totaled approximately $3 million, $4 million, and $9 million in 2003, 2002 and 2001, respectively. Average monthly proceeds from collections reinvested in the continuous sale program were approximately $249 million, $250 million, and $239 million, in 2003, 2002, and 2001, respectively. The portion that continues to be recognized in the Statements of Financial Position is domestic trade receivables of $91 million, $93 million and $124 million at December 31, 2003, 2002 and 2001, respectively.
 
Guarantees

In November 2002, the Financial Accounting Standards Board ("FASB") issued FASB Interpretation No. 45 ("FIN 45"), "Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others," an interpretation of FASB Statements No. 5, 57 and 107 and Rescission of FASB Interpretation No. 34." FIN 45 clarifies the requirements of SFAS No. 5, "Accounting for Contingencies," relating to the guarantor’s accounting for, and disclosure of, the issuance of certain types of guarantees. The Company has adopted the disclosure requirements of the interpretation as of December 31, 2002. Disclosures about each group of similar guarantees are provided below and summarized in the following table:

 104

     

 


(Dollars in millions)
 
 
 
 
 
Obligations of equity affiliates
$
131
Residual value guarantees
 
93

Total
$
224

Obligations of Equity Affiliates

Eastman has long-term commitments relating to joint ventures as described in Note 5 to the Company’s consolidated financial statements. The Company guarantees up to $131 million of the principal amount of the joint ventures’ third-party borrowings, but believes, based on current facts and circumstances and the structure of the ventures, that the likelihood of a payment pursuant to such guarantees is remote.

Residual Value Guarantees

If certain operating leases are terminated by the Company, it guarantees a portion of the residual value loss, if any, incurred by the lessors in disposing of the related assets. Under these operating leases, the residual value guarantees at December 31, 2003 totaled $93 million and consisted primarily of leases for railcars, company aircraft, and other equipment. The Company believes, based on current facts and circumstances, that a material payment pursuant to such guarantees is remote.

Equity Investment Guarantees

In addition, the Company has committed to funding obligations related to certain venture capital investments. If required, the Company’s commitment could total $26 million over the next five years.

Other Guarantees

Guarantees and claims arise during the ordinary course of business from relationships with suppliers, customers and non-consolidated affiliates when the Company undertakes an obligation to guarantee the performance of others if specified triggering events occur. Non-performance under a contract could trigger an obligation of the Company. These potential claims include actions based upon alleged exposures to products, intellectual property and environmental matters, and other indemnifications. The ultimate effect on future financial results is not subject to reasonable estimation because considerable uncertainty exists as to the final outcome of these claims. However, while the ultimate liabilities resulting from such claims may be significant to results of operations in the period recognized, management does not anticipate they will have a material adverse effect on the Company's consolidated financial position or liquidity.

Product Warranty Liability

The Company warrants to the original purchaser of its products that it will repair or replace without charge products if they fail due to a manufacturing defect. However, the Company’s historical claims experience has not been material. The estimated product warranty liability for the Company's products as of December 31, 2003 is less than $1 million. The Company accrues for product warranties when it is probable that customers will make claims under warranties relating to products that have been sold and a reasonable estimate of the costs can be made.

 105

     

 

11.    ENVIRONMENTAL MATTERS

Certain Eastman manufacturing sites generate hazardous and nonhazardous wastes, the treatment, storage, transportation, and disposal of which are regulated by various governmental agencies. In connection with the cleanup of various hazardous waste sites, the Company, along with many other entities, has been designated a potentially responsible party ("PRP"), by the U.S. Environmental Protection Agency under the Comprehensive Environmental Response, Compensation and Liability Act, which potentially subjects PRPs to joint and several liability for such cleanup costs. In addition, the Company will be required to incur costs for environmental remediation and closure and postclosure under the federal Resource Conservation and Recovery Act. Adequate reserves for environmental contingencies have been established in accordance with Eastman’s policies described in Note 1 and 23 to the Company’s consolidated financial statements. Because of expected sharing of costs, the availability of legal defenses, and the Company’s preliminary assessment of actions that may be required, it does not believe its liability for these environmental matters, individually or in the aggregate, will be material to the Company’s consolidated financial position, results of operations or cash flows. The Company’s reserve for environmental contingencies was $61 million and $60 million at December 31, 2003 and 2002, respectively, representing the minimum or best estimate for remediation costs and, for asset retirement obligation costs, the amount accrued to date over the facilities’ estimated useful lives.
 
12.    LEGAL MATTERS

General

From time to time, the Company and its operations are parties to, or targets of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety and employment matters, which are being handled and defended in the ordinary course of business. While the Company is unable to predict the outcome of these matters, it does not believe, based upon currently available facts, that the ultimate resolution of any such pending matters, including the sorbates litigation and the asbestos litigation described in the following paragraphs, will have a material adverse effect on its overall financial condition, results of operations or cash flows. However, adverse developments could negatively impact earnings or cash flows in a particular future period.
 
Sorbates Litigation

As previously reported, on September 30, 1998, the Company entered into a voluntary plea agreement with the U.S. Department of Justice and agreed to pay an $11 million fine to resolve a charge brought against the Company for violation of Section One of the Sherman Act. Under the agreement, the Company entered a plea of guilty to one count of price-fixing for sorbates, a class of food preservatives, from January 1995 through June 1997. The plea agreement was approved by the United States District Court for the Northern District of California on October 21, 1998. The Company recognized the entire fine as a charge against earnings in the third quarter of 1998 and paid the fine in installments over a period of five years. On October 26, 1999, the Company pleaded guilty in a Federal Court of Canada to a violation of the Competition Act of Canada and was fined $780,000 (Canadian). The plea in Canada admitted that the same conduct that was the subject of the United States guilty plea had occurred with respect to sorbates sold in Canada, and prohibited repetition of the conduct and provides for future monitoring. The Canadian fine has been paid and was recognized as a charge against earnings in the fourth quarter of 1999.
 

 106

     

 

 
Following the September 30, 1998 plea agreement, the Company, along with other defendants, was sued in federal, state and Canadian courts in more than twenty putative class action lawsuits filed on behalf of purchasers of sorbates and products containing sorbates, claiming those purchasers paid more for sorbates and for products containing sorbates than they would have paid in the absence of the defendants’ price-fixing. Only two of these lawsuits have not been resolved via settlement. One of the cases has been inactive for more than a year.  In the other case, the trial court decided in October 2002 that the case would not proceed as a class action, though that decision has been appealed by the plaintiff.
 
In addition, six states have sued the Company and other defendants in connection with the sorbates matter, seeking damages, restitution and civil penalties on behalf of consumers of sorbates in those respective states. One of those six cases has been settled; defense motions to dismiss were granted in four state cases; one of those dismissals has been appealed and none of the other three are yet final.  Seven other states have advised the Company that they intend to bring similar actions against the Company and others. A settlement with those seven states has tentatively been reached.
 
The Company has recognized charges to earnings for estimated and actual costs, including legal fees and expenses, related to the sorbates fine and litigation. While the Company intends to continue to defend vigorously the remaining sorbates actions unless they can be settled on acceptable terms, the ultimate outcome of the matters still pending and of additional claims that could be made is not expected to have a material impact on the Company's financial condition, results of operations, or cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses and charges against earnings in particular periods.
 
Asbestos Litigation      

Over the years, Eastman has been named as a defendant, along with numerous other defendants, in lawsuits in various state courts in which plaintiffs alleged injury due to exposure to asbestos at Eastman’s manufacturing sites and sought unspecified monetary damages and other relief. Historically, these cases were dismissed or settled without a material effect on Eastman’s financial condition, results of operations, or cash flows.
 
In recently filed cases, plaintiffs allege exposure to asbestos-containing products allegedly made by Eastman.  Based on its investigation to date, the Company has information that it manufactured limited amounts of an asbestos-containing plastic product between the mid-1960's and the early 1970's.  The Company's investigation has found no evidence that any of the plaintiffs worked with or around any such product alleged to have been manufactured by the Company.
 
The Company recently reached an agreement with plaintiffs' counsel to resolve many of these claims. The Company intends to defend vigorously the approximately 2000 remaining claims or to settle them on acceptable terms.
 
The Company continues to evaluate the allegations and claims made in recent asbestos-related lawsuits and its insurance coverages. Based on such evaluation to date, the Company continues to believe that the ultimate resolution of asbestos cases will not have a material impact on the Company’s financial condition, results of operations, or cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses and charges against earnings in particular periods. To date, costs incurred by the Company related to the recent asbestos-related lawsuits have not been material.
 

 107

     

 

 
13.    STOCKHOLDERS’ EQUITY

A reconciliation of the changes in stockholders’ equity for 2001, 2002 and 2003 is provided below:

 
 
 
($ = dollars in millions)
Common
Stock at
Par Value
$
Paid-in
Capital
$
Retained
Earnings
$
Accumulated
Other
Comprehensive
Income (Loss)
$
Treasury
Stock At
Cost
$
Total
Stockholders’
Equity
$






 
 
 
 
 
 
 
Balance at January 1, 2001
1
100
2,266
(117)
(438)
1,812
 
 
 
 
 
 
 
Net Earnings (Loss)
 
 
(175)
 
 
(175)
Cash Dividends
 
 
(135)
 
 
(135)
Other Comprehensive Income (Loss)
 
 
 
(134)
 
(134)
Other Items
 
18
 
 
(4)
14






Balance at December 31, 2001
1
118
1,956
(251)
(442)
1,382
 
 
 
 
 
 
 
Net Earnings
 
 
61
 
 
61
Cash Dividends
 
 
(135)
 
 
(135)
Other Comprehensive Income (Loss)
 
 
 
(44)
 
(44)
Other Items
 
1
 
 
6
7






Balance at December 31, 2002
1
119
1,882
(295)
(436)
1,271
 
 
 
 
 
 
 
Net Earnings (Loss)
 
 
(270)
 
 
(270)
Cash Dividends
 
 
(136)
 
 
(136)
Other Comprehensive Income (Loss)
 
 
 
174
 
174
Other Items
 
3
 
 
1
4






Balance at December 31, 2003
1
122
1,476
(121)
(435)
1,043







ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

 
 
 
 
(Dollars in millions)
 
 
 
Cumulative Translation Adjustment
 
 
Unfunded Minimum Pension
Liability
 
 
Unrealized
Gains
(Losses) on Investments
 
Unrealized
Gains
(Losses) on
Cash Flow
Hedges
 
 
Accumulated
Other
Comprehensive
Income (Loss)





 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2001
$
(133)
$
(116)
$
--
$
(2)
$
(251)
Period change
 
102
 
(145)
 
(2)
 
1
 
(44)





Balance at December 31, 2002
 
(31)
 
(261)
 
(2)
 
(1)
 
(295)
Period change
 
150
 
19
 
--
 
5
 
174





Balance at December 31, 2003
$
119
$
(242)
$
(2)
$
4
$
(121)






 108

     

 

 
Except for cumulative translation adjustment, amounts of other comprehensive income (loss) are presented net of applicable taxes. Because cumulative translation adjustment is considered a component of permanently invested unremitted earnings of subsidiaries outside the United States, no taxes are provided on such amounts.

The Company is authorized to issue 400 million shares of all classes of stock, of which 50 million may be preferred stock, par value $0.01 per share, and 350 million may be common stock, par value $0.01 per share. The Company declared dividends of $1.76 per share in 2003, 2002 and 2001.

The Company established a benefit security trust in 1997 to provide a degree of financial security for unfunded obligations under certain plans and contributed to the trust a warrant to purchase up to 1,000,000 shares of common stock of the Company for par value. The warrant, which remains outstanding, is exercisable by the trustee if the Company does not meet certain funding obligations, which obligations would be triggered by certain occurrences, including a change in control or potential change in control, as defined, or failure by the Company to meet its payment obligations under covered unfunded plans. Such warrant is excluded from the computation of diluted earnings per share because the conditions upon which the warrant is exercisable have not been met.

The additions to paid-in capital for 2003 primarily reflect the vesting of restricted stock. The additions to paid-in-capital for 2002 and 2001 are primarily the result of exercises of stock options by employees.

The Company is currently authorized to repurchase up to $400 million of its common stock. No shares of Eastman common stock were repurchased by the Company during 2003 and 2002. During 2001, 77,069 shares of common stock at a total cost of approximately $4 million, or an average price of $53 per share, were repurchased. The repurchase in 2001 was the result of a reverse/forward stock split of the Company's common stock which was approved by the stockholders on May 3, 2001 in order to consolidate small shareholdings and reduce administrative costs. Repurchased shares may be used to meet common stock requirements for compensation and benefit plans and other corporate purposes. In the first quarter 2002, the Company issued 126,614 previously repurchased shares as the annual Company contribution to the Eastman Investment and Employee Stock Ownership Plan.

The Company's charitable foundation held 144,825 shares of Eastman common stock at December 31, 2003 and 2002 and 158,424 shares at December 31, 2001.

For 2003, 2002 and 2001, the weighted average number of common shares outstanding used to compute basic earnings per share was 77.1 million, 77.1 million and 76.8 million, respectively, and for diluted earnings per share was 77.1 million, 77.2 million and 76.8 million, respectively, reflecting the effect of dilutive options outstanding only in 2002. As a result of the net loss reported for 2003, common shares underlying options to purchase 10,338,100 shares of common stock at a range of prices from $29.90 to $73.94 have been excluded from the calculation of diluted earnings (loss) per share. Excluded from the 2002 calculation were shares underlying options to purchase 8,208,355 shares of common stock at a range of prices from $42.75 to $73.94, because the exercise price of the options was greater than the average market price of the underlying common shares. As a result of the net loss reported for 2001, common shares underlying options to purchase 7,006,410 shares of common stock at a range of prices from $33.01 to $73.94 were excluded from the calculation of diluted earnings (loss) per share.

In 1999, several key executive officers were awarded performance-based stock options to further align their compensation with the return to Eastman's stockholders and to provide additional incentive and opportunity for reward to individuals in key positions having direct influence over corporate actions that are expected to impact the market price of Eastman's common stock. As a result of the net loss reported for 2001, 156,060 shares underlying such options were excluded from the calculation of diluted earnings (loss) per share because their effect would be anti-dilutive.

 109

     

 

 
Additionally, 200,000 shares underlying an option issued to the former Chief Executive Officer in 1997 were excluded from diluted earnings per share calculations for 2001 because the stock price conditions to exercise had not been met as to any of the shares as of December 31, 2001. The entire option was cancelled and forfeited on September 16, 2002, as none of the price vesting conditions had been met.

Shares of common stock issues (1)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Balance at beginning of year
 
85,135,117
 
85,053,349
 
84,739,902
Issued for employee compensation and benefit plans
 
42,350
 
81,768
 
313,447



Balance at end of year
 
85,177,467
 
85,135,117
 
85,053,349



 
 
 
 
 
 
 
(1) Includes shares held in treasury
 
 
 
 
 
 

14.    STOCK OPTION AND COMPENSATION PLANS

Omnibus Plans

Eastman's 2002 Omnibus Long-Term Compensation Plan (the "2002 Omnibus Plan"), which is substantially similar to and intended to replace the 1997 Omnibus Long-Term Compensation Plan (the "1997 Omnibus Plan"), which formerly replaced the 1994 Omnibus Long-Term Compensation Plan (the "1994 Omnibus Plan"), provides for grants to employees of nonqualified stock options, incentive stock options, tandem and freestanding stock appreciation rights ("SAR’s"), performance shares and various other stock and stock-based awards. Certain of these awards may be based on criteria relating to Eastman performance as established by the Compensation and Management Development Committee of the Board of Directors. No new awards have been made under the 1994 Omnibus Plan or the 1997 Omnibus Plan following the effectiveness of the 2002 Omnibus Plan. Outstanding grants and awards under the 1994 Omnibus Plan or the 1997 Omnibus Plan are unaffected by the replacement of the 1997 Omnibus Plan (and 1994 Omnibus Plan) with the 2002 Omnibus Plan. The 2002 Omnibus Plan provides that options can be granted through May 2, 2007, for the purchase of Eastman common stock at an option price not less than 100% of the per share fair market value on the date of the stock option's grant. Substantially all grants awarded under the 1994 Omnibus Plan, the 1997 Omnibus Plan, and the 2002 Omnibus Plan have been at option prices equal to the fair market value on the date of grant. Options typically vest in 50% increments on the first two anniversaries of the grant date and expire ten years after grant. There is a maximum of 7.5 million shares of common stock available for option grants and other awards during the term of the 2002 Omnibus Plan. The maximum number of shares of common stock with respect to one or more options and/or SAR’s that may be granted during any one calendar year under the 2002 Omnibus Plan to the Chief Executive Officer or to any of the next four most highly compensated executive officers (each a "Covered Employee") is 300,000. The maximum fair market value of any awards (other than options and SAR’s) that may be received by a Covered Employee during any one calendar year under the 2002 Omnibus Plan is the equivalent value of 200,000 shares of common stock as of the first business day of such calendar year.

 110

     

 

 
Director Long-Term Compensation Plan

Eastman's 2002 Director Long-Term Compensation Plan (the "2002 Director Plan"), which is substantially similar to and intended to replace the 1999 Director Long-Term Compensation Plan (the "1999 Director Plan"), which formerly replaced the 1994 Director Long-Term Compensation Plan (the "1994 Director Plan"), provides for grants of nonqualified stock options and restricted shares to nonemployee members of the Board of Directors. No new awards have been made under the 1994 Director Plan or the 1999 Director Plan, following the effectiveness of the 2002 Director Plan. Outstanding grants and awards under the 1994 Director Plan or the 1999 Director Plan are unaffected by the replacement of the 1999 Director Plan (and the 1994 Director Plan) with the 2002 Director Plan. Shares of restricted stock are granted upon the first day of the directors' initial term of service and nonqualified stock options and shares of restricted stock are granted each year following the annual meeting of stockholders. The 2002 Director Plan provides that options can be granted through the later of May 1, 2007, or the date of the annual meeting of stockholders in 2007 for the purchase of Eastman common stock at an option price not less than the stock's fair market value on the date of the grant. The options vest in 50% increments on the first two anniversaries of the grant date and expire ten years after grant. The maximum number of shares of common stock that shall be available for grant of awards under the 2002 Director Plan during its term is 200,000.

Nonemployee Director Stock Option Plan

Eastman's 1996 Nonemployee Director Stock Option Plan provides for grants of nonqualified stock options to nonemployee members of the Board of Directors in lieu of all or a portion of each member's annual retainer. The Nonemployee Director Stock Option Plan provides that options may be granted for the purchase of Eastman common stock at an option price not less than the stock's fair market value on the date of grant. The options become exercisable six months after the grant date. The maximum number of shares of Eastman common stock available for grant under the Plan is 150,000.

Stock Option Balances and Activity

The fair value of each option is estimated on the grant date using the Black-Scholes option-pricing model, which requires input of highly subjective assumptions. Some of these assumptions used for grants in 2003, 2002 and 2001, respectively, include: average expected volatility of 27.90%, 27.57% and 27.07%; average expected dividend yield of 5.90%, 3.71% and 3.67%; and average risk-free interest rates of 3.50%, 5.06% and 4.72%. An expected option term of six years for all periods was developed based on historical experience information. The expected term for reloads was considered as part of this calculation and is equivalent to the remaining term of the original grant at the time of reload.

Because the Company's employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options.

 111

     

 

 
A summary of the status of the Company's stock option plans is presented below:

 
2003
 
2002
 
2001



 
 
 
 
Options
 
Weighted-Average Exercise
Price
 
 
 
 
Options
 
Weighted-
Average
Exercise
Price
 
 
 
 
Options
 
Weighted-Average Exercise
Price






 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at beginning of year
 
8,511,597
$
 
49
 
 
7,006,410
$
 
50
 
 
5,801,348
$
 
50
Granted
1,987,100
 
30
 
1,860,360
 
47
 
1,608,793
 
48
Exercised
--
 
--
 
(64,384)
 
39
 
(330,989)
 
42
Forfeited or canceled
(160,597)
 
45
 
(290,789)
 
57
 
(72,742)
 
52






Outstanding at end of year
10,338,100
$
45
 
8,511,597
$
49
 
7,006,410
$
50



 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at year-end
 
7,412,800
 
 
 
 
5,965,433
 
 
 
 
4,773,210
 
 



 
 
 
 
 
 
 
 
 
 
 
 
 
Available for grant at end of year
 
5,778,900
 
 
 
 
7,766,204*
 
 
 
 
1,911,557
 
 



 
 
 
 
 
 
 
 
 
 
 
 

*Increased number of shares available for grant is the result of new plans adopted during 2002 as discussed above.

The weighted average fair value of options granted during 2003, 2002 and 2001 were $4.55, $11.16 and $10.95, respectively.

The following table summarizes information about stock options outstanding at December 31, 2003:

 
 
Options Outstanding
 
Options Exercisable


 
 
Range of Exercise Prices
 
 
Number Outstanding at 12/31/03
 
Weighted-Average Remaining Contractual Life
 
 
Weighted-Average Exercise Price
 
 
Number Exercisable at 12/31/03
 
Weighted-Average Exercise Price









 
 
 
 
 
 
 
 
 
 
 
$30-42
 
2,276,900
 
8.8
Years
$
31
 
295,500
$
38
$43-46
 
2,807,600
 
3.5
"
 
45
 
2,799,600
 
45
$47-49
 
3,133,100
 
7.7
"
 
48
 
2,197,200
 
48
$50-74
 
2,120,500
 
3.2
"
 
58
 
2,120,500
 
58


 
 
10,338,100
 
5.9
"
$
45
 
7,412,800
$
49


Eastman Performance Plan

Eligible Company employees participated in the Eastman Performance Plan (the "EPP"), a variable pay program which made a portion of each employee's total annual compensation dependent upon the Company's financial performance. Effective with the 2003 performance year, the executive officers of the Company were excluded from participation in the EPP. Following the 2003 performance year, the Company terminated the EPP. The amount anticipated to be paid under the EPP for 2003 is $14 million. For 2002, the amount paid under the EPP was $15 million. No amounts were paid under the EPP for 2001.

 112

     

 

Unit Performance Plan

Eastman managers and executive officers participate in the Unit Performance Plan (the "UPP"), a variable pay program which makes a portion of each participant’s total annual cash compensation dependent upon organizational and individual performance. The amount anticipated to be paid under the UPP for 2003 is $5 million. For 2002, the amount paid under the UPP was $5 million. No amounts were paid under the UPP for 2001.
 
15.    IMPAIRMENTS AND RESTRUCTURING CHARGES, NET

Impairments and restructuring charges totaled $523 million during 2003, with non-cash asset impairments of $500 million and restructuring charges of $23 million. The following table summarizes the 2003, 2002 and 2001 charges:

(Dollars in millions)
 
2003
 
2002
 
2001



Eastman Division Segments:
 
 
 
 
 
 
Coatings, Adhesives, Specialty Polymers, and Inks ("CASPI") Segment:
 
 
 
 
 
 
Fixed asset impairments
$
195
$
2
$
59
Intangible asset impairments
 
175
 
--
 
--
Goodwill impairments
 
34
 
--
 
--
Severance charges
 
13
 
--
 
8
Site closure costs
 
3
 
3
 
10
 
 
 
 
 
 
Performance Chemicals and Intermediates ("PCI") Segment:
 
 
 
 
 
 
Fixed asset impairments
 
95
 
(1)
 
69
Severance charges
 
4
 
--
 
3
Site closure costs
 
--
 
--
 
1
 
 
 
 
 
 
 
Specialty Plastics ("SP") Segment
 
 
 
 
 
 
Fixed asset impairments
 
--
 
--
 
15
Severance charges
 
1
 
--
 
--



 
 
 
 
 
 
 
Total Eastman Division
 
520
 
4
 
165
 
 
 
 
 
 
 
Voridian Division Segments:
 
 
 
 
 
 
Polymers Segment:
 
 
 
 
 
 
Fixed asset impairments
 
1
 
1
 
123
Severance charges
 
1
 
--
 
--
Termination of raw material supply agreement
 
--
 
--
 
108
 
 
 
 
 
 
 
Fibers Segment:
 
 
 
 
 
 
Severance charges
 
1
 
--
 
--



 
 
 
 
 
 
 
Total Voridian Division
 
3
 
1
 
231



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
523
$
5
$
396



 
 
 
 
 
 
 
Total asset impairments and restructuring charges, net
 
489
 
5
 
396
Total goodwill impairments
 
34
 
--
 
--



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
523
$
5
$
396



 113

     

 

 
·    CASPI Segment
 
2003

In the third quarter, the Company reorganized the operating structure within its CASPI segment and changed the segment’s business strategy in response to the financial performance of certain underlying product lines. Those product lines include: acrylate ester monomers; composites (unsaturated polyester resins); inks and graphic arts raw materials; liquid resins; powder resins; and textile chemicals. Prior to the third quarter, management was pursuing growth strategies aimed at significantly improving the financial performance of these product lines. However, due to the continued operating losses and deteriorating market conditions, management decided to pursue alternative strategies including restructuring, divestiture, and consolidation. This change affected both the manner in which certain assets are used and the financial outlook for these product lines, thus triggering the impairments and certain restructuring charges.

The third quarter fixed asset impairments charges of $194 million primarily relate to assets associated with the above mentioned product lines, and primarily impact manufacturing sites in the North American and European regions that were part of the Lawter International, Inc. ("Lawter"), McWhorter Technologies, Inc ("McWhorter"), and Chemicke Zavody Sokolov ("Sokolov") acquisitions. Within these product lines, nine sites in North America and six sites in Europe were impaired. As the undiscounted future cash flows could not support the carrying value of the assets, the fixed assets were written down to fair value, as established primarily by appraisal.

The third quarter intangible asset impairments charges relate to definite-lived intangible assets of approximately $128 million and indefinite-lived intangibles of approximately $47 million. The definite-lived intangibles relate primarily to developed technology and customer lists, and the indefinite-lived intangibles primarily relate to trademarks. These intangible assets were primarily associated with the acquisitions of Lawter and McWhorter. As the undiscounted future cash flows could not support the carrying value of the definite-lived intangible assets, these assets were written down to fair value, as established primarily by appraisal. Indefinite-lived intangible assets were written down to fair value, as established by appraisal.

Upon adoption of SFAS No. 142, "Goodwill and Other Intangible Assets," the Company defined reporting units as one level below the operating segment level and considered the criteria set forth in SFAS No. 142 in aggregating the reporting units. This resulted in the CASPI segment being deemed a single reporting unit. In the third quarter 2003, the reorganization of the operating structure within the CASPI segment resulted in new reporting units one level below the operating segment. Due to the change in strategy and lack of similar economic characteristics, these reporting units did not meet the criteria necessary for aggregation. As a result, the goodwill associated with the CASPI segment was reassigned to the new reporting units based upon relative fair values. The reporting unit that contained the above-mentioned product lines was assigned $34 million of goodwill out of the total CASPI segment goodwill of $333 million. Because the Company determined that this reporting unit could no longer support the carrying value of its assigned goodwill, the full amount of that goodwill was impaired. The fair value of the other reporting unit within CASPI was sufficient to support the carrying value of the remainder of the goodwill.

In the fourth quarter, the Company recognized fixed asset impairments and site closure costs of $1 million and $3 million, respectively. The fixed asset impairments relate to additional impairments associated with the CASPI reorganization procedures, as discussed above.

Severance charges of $13 million for 2003 are discussed in further detail below.

 114

     

 

2002

A change in estimate for site closure costs for Philadelphia, Pennsylvania and Portland, Oregon resulted in a $1 million credit to earnings in the third quarter. In the fourth quarter, the Company recognized restructuring charges of approximately $4 million related to closure of plants in Duesseldorf, Germany; Rexdale, Canada; and LaVergne, Tennessee; and additionally recognized an asset impairment charge of approximately $2 million related to certain other European assets.

2001

In the second quarter, the Company recognized a charge of approximately $20 million related to the closure of plants in Philadelphia, Pennsylvania and Portland, Oregon that were obtained in the acquisition of McWhorter Technologies, Inc. ("McWhorter"). In the third quarter, the Company recognized a charge of approximately $21 million related to the closure of a Moundville, Alabama plant that was obtained in the acquisition of Lawter International, Inc.

In the fourth quarter, the Company recognized a charge of approximately $27 million related to the closure of an operating site in Duesseldorf, Germany. Also in the fourth quarter, charges of approximately $6 million and $3 million, respectively, were recognized related to the impairment of other operating assets in Savannah, Georgia and Banbury, England.

The restructuring charges include write-downs of the fixed assets at these facilities, severance accruals for employees impacted by the plant shutdowns, and other costs associated with closing the facilities. The Philadelphia and Portland facilities were closed in 2001, and the Moundville, Duesseldorf and Banbury sites closed in 2002. The Savannah site closed in 2003. The fair value of the impacted assets was determined using the discounted estimated net cash flows related to the products produced by the impacted assets.
 
·    PCI Segment

2003

In the second quarter, the Company recorded an asset impairment charge of approximately $15 million related to the impairment of certain fixed assets used in the PCI segment’s fine chemicals product lines that are located in Llangefni, Wales. In response to industry conditions, during the second quarter 2003 the Company revised its strategy and the earnings forecast for the products manufactured by these assets. As the undiscounted future cash flows could not support the carrying value of the asset, the fixed assets were written down to fair value, as established primarily by discounted future cash flows of the impacted assets.

In the third and fourth quarter, the PCI segment incurred charges of $80 million related to the impairment of fixed assets used in certain commodity and performance chemicals product lines as a result of increased competition and changes in business strategy in response to a change in market conditions and the financial performance of these product lines. Within the commodity product lines, the fixed asset impairments charge relates to assets at the Sokolov, Czech Republic facility. Within the specialty organic chemicals product lines, the fixed asset impairments charge relates to assets located at the Kingsport, Tennessee facility.
 
Severance charges of $4 million for 2003 are discussed in further detail below.

2002

In the fourth quarter, a net $1 million credit to earnings was recorded due to a $2 million credit associated with previously impaired fine chemicals product lines assets, and a charge of $1 million related to impaired assets used in certain research and development activities.

 115

     

 

2001

As a part of the 2001 restructuring of the Company's fine chemicals product lines, Eastman recorded restructuring charges, including related asset write-downs, totaling approximately $70 million. These charges resulted from the Company's on-going restructuring of its fine chemicals product lines to reduce costs, and from the write-down of assets determined to be impaired. The restructuring initiative and related asset impairments involve manufacturing sites within the United States at Tennessee and Arkansas, Llangefni, Wales, and Hong Kong.

Charges in the fourth quarter and the third quarter of $1 million and $6 million, respectively, pertained primarily to severance accruals for employees impacted by the plant shutdowns, closure costs and write-downs of fixed assets. Charges totaling approximately $63 million recorded during the second quarter related to certain fine chemicals product lines that did not fit the Company’s long-term strategic objectives and for assets determined to be impaired.

The impairments at the foreign sites included the write-down of fixed assets and other long-term deposits. The restructuring and asset impairments at the domestic sites primarily pertained to write-downs of fixed assets, net of the effect of a reversal of a customer deposit, related to a custom synthesis product contract. In 2001, the Company reported that a large customer of the PCI segment did not intend to renew its contract for a custom synthesis product beyond June 30, 2002. As a consequence, impairment charges totaling approximately $70 million related to the impacted assets were recorded during 2001 as part of the restructuring of the fine chemicals product lines. These assets were written down to fair value in the second quarter of 2001 using discounted estimated net cash flows from contracts that were currently in effect. Subsequently, the customer initiated discussions with the Company which resulted in two amendments to the agreement to extend the custom synthesis product contract through June 2004 based on renegotiated terms. Effective July 1, 2003, Eastman and the customer entered into a multi-year agreement in which the Company will remain the sole global supplier for the customer's custom synthesis product.

Also during 2001, PCI incurred asset impairment charges of $3 million for certain European assets. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.
 
·    SP Segment

During 2001, Specialty Plastics incurred a $15 million asset impairment charge related to deterioration of demand for certain specialty plastics products produced in Kingsport, Tennessee. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.

Severance charges of $1 million for 2003 are discussed in further detail below.
 
·    Polymers Segment

2003

In the fourth quarter, an asset impairment charge of $1 million was recorded related to assets classified as held for sale at the Company’s Kirkby manufacturing site. The fair value of these assets was determined using the estimated proceeds from sale less cost to sell.

Severance charges of $1 million for 2003 are discussed in further detail below.

 116

     

 

2002

In 2002, the Company recorded charges related to the write-down of underperforming polyethylene assets totaling approximately $1 million.

2001

During the second quarter, Eastman terminated an agreement with a supplier that guaranteed the Company’s right to buy a specified quantity of a certain raw material annually through 2007 at prices determined by the pricing formula specified in the agreement. In prior years, the Company paid a total of $239 million to the supplier and deferred those costs to be amortized over the 15-year period during which the product was to be received. The Company began amortizing those costs in 1993 and had recorded accumulated amortization of $131 million at March 31, 2001. As a result of the termination of this agreement, a charge of $108 million, representing unamortized deferred cost, was charged to the Polymers segment's earnings during the second quarter 2001 as no continuing economic benefits will be received pertaining to this contract.

Also during the second quarter, management identified and announced certain assets that were intended to be spun off at year-end 2001 related to the Company’s efforts to spin off the specialty chemicals and plastics businesses. An indirect result of these decisions would have been that the continuing operations would have been required to purchase certain raw materials and utilities that were historically produced internally for use in the manufacture of polyethylene. Considering the purchase price of these raw materials and utilities, the carrying value of certain assets used to consume ethylene at the Longview, Texas facility in the manufacture of polyethylene exceeded the expected future cash flows attributable to such assets.

Subsequent to the second quarter, the spin-off was canceled. However, management determined that the continued operation of these assets was not economically attractive. Based upon the resulting cash flows from the probable future use of these assets, an impairment loss of $103 million was charged to the Polymers segment’s earnings during the second quarter 2001. The impairment represents the excess of the carrying value over the discounted estimated future cash flows related to the products produced by the impacted assets.

Also during 2001, the Company recorded asset impairment charges related to under-utilized assets including $10 million related to the discontinuation of the precolored-green PET polymers product line in Kingsport, Tennessee; and $10 million related to cessation of production at the Company’s solid-stating facility in Toronto, Ontario. The fair value of these assets was determined using the discounted estimated cash flows related to the products produced by these assets.

Severance Charges - 2003

In the first half of the year, severance costs of $3 million were incurred within the CASPI segment related primarily to consolidation and restructuring activities and changes in previously accrued amounts. In the third quarter 2003, the Company recognized $14 million in restructuring charges related to the actual and probable involuntary separations of approximately 300 employees. These workforce reductions are the result of decisions made as part of the restructuring of the CASPI segment discussed above, the Company’s annual budgeting process, and site closure costs associated with the PCI segment. During the fourth quarter, severance charges were recorded in the CASPI and Fibers segment totaling $2 million and $1 million, respectively, due to the ongoing restructuring of the CASPI segment and the annual budgeting process discussed above.

During 2003, terminations related to actual and probable involuntary separations totaled approximately 500 employees. As of the end of 2003, approximately 350 of these terminations had been incurred, with the remaining primarily relating to previously announced consolidation and restructuring activities of certain European CASPI manufacturing sites that will be completed in early 2004.


 117

     

 

 

 
 
Balance at
January 1, 2001
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2001





 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
373
$
(373)
$
--
$
--
Severance costs
 
--
 
16
 
--
 
(6)
 
10
Site closure costs
 
10
 
10
 
--
 
(7)
 
13





Total
$
10
$
399
$
(373)
$
(13)
$
23





 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in millions)
 
Balance at
January 1, 2002
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2002
   
  
 
  
 
  
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
2
$
(2)
$
--
$
--
Severance costs
 
10
 
2
 
--
 
(10)
 
2
Site closure costs
 
13
 
3
 
--
 
(9)
 
7





Total
$
23
$
7
$
(2)
$
(19)
$
9





 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at
January 1, 2003
 
Provision/ Adjustments
 
Noncash Reductions
 
Cash Reductions
 
Balance at
December 31, 2003





 
 
 
 
 
 
 
 
 
 
 
Noncash charges
$
--
$
500
$
(500)
$
--
$
--
Severance costs
 
2
 
20
 
--
 
(12)
 
10
Site closure costs
 
7
 
3
 
--
 
(5)
 
5





Total
$
9
$
523
$
(500)
$
(17)
$
15





Substantially all severance and site closure costs are expected to be applied to the reserves within one year.
 
16.    OTHER OPERATING (INCOME) EXPENSE AND OTHER (INCOME) CHARGES, NET


(Dollars in millions)
2003
 
2002
 
2001



 
 
 
 
 
 
Other operating income
(33)
 
--
 
--
Other operating expense
--
 
--
 
50

Other operating income for 2003 totaled approximately $33 million and reflected gains of approximately $20 million on the sale of the Company’s high-performance crystalline plastic assets in the first quarter, and approximately $13 million on the sale of the Company’s colorant product lines and related assets in the fourth quarter. These items were reflected within the SP and CASPI segments, respectively.

Other operating expense of $50 million was recognized in 2001. This amount consisted of approximately $20 million in charges associated with efforts to spin off the specialty chemicals and plastics businesses; an $18 million write-down of accounts receivable for credit risks resulting from the devaluation of the Argentine peso; a $7 million pension settlement charge; and a $5 million write-off of acquired in-process research and development related to the acquisition of the hydrocarbon resins and select portions of the rosin-based resins business from Hercules Incorporated ("Hercules Businesses"). Approximately $26 million of these items were reflected in the Polymers segment, $11 million in the CASPI segment, $7 million in the PCI segment, $4 million in the SP segment, and $2 million in the Fibers segment.

 118

     

 


 (Dollars in millions)  

2003  

 

2002  

 

2001  

   
  
 
  
 
  
Other income
$
(28)
$
(14)
$
(11)
Other charges
 
18
 
16
 
42



Other (income) charges, net
$
(10)
$
2
$
31



Included in other income are the Company’s portion of earnings from its equity investments, royalty income, net gains on foreign exchange transactions and other miscellaneous items. Included in other charges are net losses on foreign exchange transactions, the Company’s portion of losses from its equity investments, fees on securitized receivables and other miscellaneous items.

Other income for 2003 primarily reflects net gains on foreign exchange transactions of $13 million and the Company’s portion of earnings from its equity investment in Genencor of $10 million. Other charges for 2003 consist primarily of write downs to fair value of certain technology business venture investments due to other than temporary declines in value of $4 million, fees on securitized receivables of $3 million, and other miscellaneous charges.

Other income for 2002 primarily reflected $9 million of earnings from the Company’s equity investment in Genencor, net of a restructuring charge of $5 million. Additionally, other income included a net gain on foreign exchange transactions of $4 million. Other charges for 2002 primarily reflected a write-down to fair value of certain technology business venture investments due to other than temporary declines in value of $8 million and fees on securitized receivables of $4 million.

Other income for 2001 primarily reflected the Company’s portion of earnings from its equity investment in Genencor. Other charges for 2001 included a $12 million charge for currency losses resulting from the devaluation of the Argentine peso, an $8 million charge for sorbates civil litigation settlement costs, and other miscellaneous items.

For more information on the Company’s equity investment in Genencor, refer to Notes 1 and 5.
 
17.    ACQUISITIONS

Ariel Research Corporation
 
In January 2002, Eastman acquired Ariel Research Corporation ("Ariel") for approximately $8 million, including $6 million cash paid at closing and a $2 million promissory note to be paid in 2003, subject to certain post-closing adjustments. Ariel is a provider of worldwide regulatory information, software products and services that enable corporations to manage product safety and stewardship functions, including requirements for workplace, environmental and dangerous goods compliance.
 
The transaction, which was financed with available cash and commercial paper borrowings, was accounted for by the purchase method of accounting and, accordingly, the results of Ariel for the period from the acquisition date are included in the accompanying consolidated financial statements and reported in the Developing Businesses segment. Tangible assets acquired were recorded at their fair values. Definite-lived intangible assets of approximately $7 million are being amortized on a straight-line basis over 3 to 10 years. Assuming this transaction had been made at January 1, 2001, the consolidated pro forma results for 2001 would not be materially different from reported results.
 

 119

     

 

 
Certain Businesses of Hercules Incorporated
 
On May 1, 2001, the Company completed the asset acquisition of the Hercules Businesses for approximately $252 million. The facilities acquired are located in the United States, the Netherlands and Mexico. Additionally, certain assets acquired are operated under contracts with Hercules at a shared facility in the United States.
 
The transaction, which was financed with available cash and commercial paper borrowings, was accounted for by the purchase method of accounting and, accordingly, the results of the Hercules Businesses for the period from the acquisition date are included in the accompanying consolidated financial statements and reported in the CASPI segment. Tangible assets acquired were recorded at their fair values. Goodwill and other intangible assets of approximately $33 million, which represents the excess of cost over the fair value of net tangible assets acquired, were being amortized on a straight-line basis over 17 to 40 years. Effective January 1, 2002, in connection with the adoption of SFAS No. 142, "Goodwill and Other Intangible Assets," definite-lived intangible assets of approximately $2 million are being amortized on a straight-line basis over 17 years. Acquired in-process research and development of approximately $8 million was written off during the second quarter 2001, and subsequently revised to $5 million with a $3 million credit to earnings in the third quarter 2001. Assuming this transaction had been made at January 1, 2001, the consolidated pro forma results for 2001 would not be materially different from reported results.

The below table details the acquisitions of Ariel and Hercules that occurred in 2002 and 2001. The Company made no acquisitions in 2003.

(Dollars in millions)
 
2002
 
2001


 
 
 
 
 
Details of acquisitions are as follows:
 
 
 
 
Fair value of assets acquired
$
8
$
261
Liabilities assumed
 
2
 
4


Net cash paid for acquisitions
 
6
 
257
Cash acquired in acquisitions
 
--
 
--


Cash paid for acquisitions
$
6
$
257



 120

     

 

 
18.    INCOME TAXES

Components of earnings (loss) before income taxes and the provision (benefit) for U.S. and other income taxes follow:

(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Earnings (loss) before income taxes
 
 
 
 
 
 
United States
$
(309)
$
98
$
(293)
Outside the United States
 
(72)
 
(14)
 
2



Total
$
(381)
$
84
$
(291)



 
 
 
 
 
 
 
Provision (benefit) for income taxes
 
 
 
 
 
 
United States
 
 
 
 
 
 
Current
$
16
$
(113)
$
(44)
Deferred
 
(102)
 
100
 
(68)
Non-United States
 
 
 
 
 
 
Current
 
10
 
16
 
9
Deferred
 
(29)
 
(7)
 
(3)
State and other
 
 
 
 
 
 
Current
 
3
 
7
 
(3)
Deferred
 
(6)
 
2
 
(7)



Total
$
(108)
$
5
$
(116)



The following represents deferred tax charge (benefit) recorded as a component of accumulated other comprehensive income (loss) in stockholders’ equity.

(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Minimum pension liability
$
(12)
$
86
$
65
Unrealized losses on investments
 
--
 
1
 
1
Net unrealized gains (losses) on derivative instruments
 
(3)
 
(1)
 
1



Total
$
(15)
$
86
$
67



Differences between the provision (benefit) for income taxes and income taxes computed using the U.S. federal statutory income tax rate follow:

(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Amount computed using the statutory rate
$
(133)
$
29
$
(102)
State income taxes, net
 
(4)
 
6
 
(6)
Foreign rate variance
 
27
 
2
 
(6)
Foreign sales corporation/extraterritorial income exclusion
 
(9)
 
(14)
 
(4)
ESOP dividend payout
 
(2)
 
(2)
 
(1)
Change in reserves for tax contingencies
 
--
 
(17)
 
--
Goodwill Impairment
 
12
 
--
 
--
Other
 
1
 
1
 
3



Provision (benefit) for income taxes
$
(108)
$
5
$
(116)



 121

     

 

 
The significant components of deferred tax assets and liabilities follow:

 
December 31,
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Deferred tax assets
 
 
 
 
Postemployment obligations
$
393
$
398
Payroll and related items
 
33
 
64
Miscellaneous reserves
 
41
 
36
Net operating loss carry forwards
 
195
 
133
Other
 
93
 
92


Total deferred tax assets
 
755
 
723
Less valuation allowance
 
(175)
 
(132)


Deferred tax assets less valuation allowance
$
580
$
591


 
 
 
 
 
Deferred tax liabilities
 
 
 
 
Depreciation
$
( 694)
$
( 774)
Inventories
 
(31)
 
(27)
Purchase accounting adjustments
 
(7)
 
(76)
Other
 
(121)
 
(99)


Total deferred tax liabilities
$
(853)
$
(976)


 
 
 
 
 
Net deferred tax liabilities
$
(273)
$
(385)


 
 
 
 
 
As recorded in the Consolidated Statements of Financial Position:
 
 
 
 
Other current assets
$
8
$
32
Other noncurrent assets
 
42
 
47
Payables and other current liabilities
 
(7)
 
--
Deferred income tax liabilities
 
(316)
 
(464)


Net deferred tax liabilities
$
(273)
$
(385)


Unremitted earnings of subsidiaries outside the United States, considered to be reinvested indefinitely, totaled $414 million at December 31, 2003. It is not practicable to determine the deferred tax liability for temporary differences related to those unremitted earnings.

For certain consolidated foreign subsidiaries, income and losses directly flow through to taxable income in the United States. These entities are also subject to taxation in the foreign tax jurisdictions. Net operating loss carryforwards exist to offset future taxable income in foreign tax jurisdictions and valuation allowances are provided to reduce deferred related tax assets if it is more likely than not that this benefit will not be realized. Changes in the estimated realizable amount of deferred tax assets associated with net operating losses for these entities could result in changes in the deferred tax asset valuation allowance in the foreign tax jurisdiction. At the same time, because these entities are also subject to tax in the United States, a deferred tax liability for the expected future taxable income will be established concurrently. Therefore, the impact of any reversal of valuation allowances on consolidated income tax expense will only be to the extent that there are differences between the United States statutory tax rate and the tax rate in the foreign jurisdiction.

At December 31, 2003, net operating loss carryforwards totaled $442 million. Of this total, $94 million will expire in 3 to 15 years; $348 million will never expire.

 122

     

 

 
Amounts due to and from tax authorities as recorded in the Consolidated Statements of Financial Position:

 
December 31,
(Dollars in millions)
 
2003
 
2002


 
 
 
 
 
Miscellaneous receivables
$
--
$
(63)
Other noncurrent assets
 
--
 
(6)
Payables and other current liabilities
 
23
 
21
Other long-term liabilities
 
36
 
45
   
  
 
  
Total income taxes payable (receivable)
$
59
$
(3)


 
19.    SUPPLEMENTAL CASH FLOW INFORMATION

(Dollars in millions)
2003
 
2002
 
2001



 
 
 
 
 
Cash paid for interest and income taxes is as follows:
 
 
Interest (net of amounts capitalized)
$
 133
$
 125
$
 152
Income taxes paid (received)
(43)
 
(40)
 
(7)
The Company’s portion of earnings from its equity investments included in cash flows from operating activities
12
 
11
 
6

Derivative financial instruments and related gains and losses are included in cash flows from operating activities. The effect on cash of foreign currency transactions and exchange rate changes for all years presented was insignificant.
 
20.    SEGMENT INFORMATION

The Company’s products and operations are managed and reported in three divisions comprising six operating segments. Eastman Division consists of the CASPI segment, the PCI segment and the SP segment. Voridian Division contains the Polymers segment and the Fibers segment. The Developing Businesses Division consists of the Developing Businesses Segment. The divisional structure has allowed the Company to align costs more directly with the activities and businesses that generate them.

Goods and services are transferred between the divisions at predetermined prices that may be in excess of cost. Accordingly, the divisional structure results in the recognition of interdivisional sales revenue and operating earnings. Such interdivisional transactions are eliminated in the Company’s consolidated financial statements. Prior to 2002, segment sales revenue reflected only actual sales to third parties and the intersegment transfer of goods and services, recorded at cost, had no impact on segment earnings.

The CASPI segment manufactures raw materials, additives and specialty polymers, primarily for the paints and coatings, inks and graphic arts, adhesives and other markets. The CASPI segment's products consist of binders and resins, liquid vehicles, additives, unsaturated polyester resins and polyester and acrylic emulsions. Binders and resins, such as alkyd and polyester resins, hydrocarbon resins and rosins and rosin esters, are used in adhesives and as key components in paints and inks to form a protective coating or film, and bind color to the substrate. Liquid vehicles, such as ester, ketone and alcohol solvents, maintain the binders in liquid form for ease of application. Additives, such as cellulosic polymers, Texanol Ô ester alcohol and chlorinated polyolefins, provide different properties or performance enhancements to the end product. Unsaturated polyester resins are used primarily in gel coats and fiberglass reinforced plastics. Polyester and acrylic emulsions are traditionally used as textile sizes to protect fibers during processing in textile manufacturing, and the technology is also used in water-based paints, coatings and inks. Additional products are developed in response to, or in anticipation of, new applications where the Company believes significant value can be achieved.

 123

     

 

 
The PCI segment manufactures diversified products that are used in a variety of markets and industrial and consumer applications, including chemicals for agricultural intermediates, fibers, food and beverage ingredients, photographic chemicals, pharmaceutical intermediates, polymer compounding and chemical manufacturing intermediates. The PCI segment also offers custom manufacturing services through its custom synthesis business.

The SP segment produces highly specialized copolyesters, cellulosic plastics and compounded polyethylene plastics that possess unique performance properties for value-added end uses such as appliances, store fixtures and displays, building and construction, electronics and electronic packaging, medical packaging, personal care and cosmetics, performance films, tape and labels, biodegradeables, cups and lids, fiber and strapping, photographic and optical film, graphic arts and general packaging. The SP segment’s key products include engineering and specialty polymers, specialty film and sheet products, and packaging film and fiber products.

The Polymers segment manufactures and supplies PET polymers for use in beverage and food packaging and other applications such as custom-care and cosmetics packaging, health care and pharmaceutical uses, household products and industrial. PET polymers serve as source products for packaging a wide variety of products including carbonated soft drinks, water, beer and personal care items and food containers that are suitable for both conventional and microwave oven use. The Polymers segment also manufactures low-density polyethylene and linear low-density polyethylene, which are used primarily for packaging and film applications and in extrusion coated containers such as milk and juice cartons.

The Fibers segment manufactures Estron Ô acetate tow and Estrobond Ô triacetin plasticizers which are used primarily in cigarette filters; Estron Ô and Chromspun Ô acetate yarns for use in apparel, home furnishings and industrial fabrics; and acetyl chemicals.

The Developing Businesses segment includes new businesses and certain investments in non-traditional growth opportunities that leverage the Company’s technology expertise, intellectual property and know-how into business models that extend to new customers and markets. The segment includes, among other new and developing businesses, Cendian Corporation ("Cendian"), a logistics provider for chemical companies; Ariel Research Corporation ("Ariel"), a provider of international chemical and regulatory compliance solutions for environmental, health and safety operations; and Eastman’s gasification services.

Effective January 1, 2003, sales, operating results and assets for the Developing Businesses Division were moved from the CASPI, PCI and SP segments to the Developing Businesses segment. During 2002, these amounts were included within the CASPI, PCI, and SP segments. During 2001, these amounts had been split among all segments. Accordingly, the prior year amounts for sales and operating earnings have been reclassified for all periods presented, while asset amounts for 2001 have not been revised because of the implementation date of the divisional structure. In addition, during the second quarter of 2003, the Company revised the Assets by Division and Segment as of December 31, 2002 to appropriately reflect the allocation of certain assets shared by the segments comprising Eastman Division. These revisions had no effect on the consolidated financial statements.

 124

     

 

 

(Dollars in millions)
 
2003

 
 
 
 
 
 
 
Sales by Division and Segment
 
External Sales
 
Interdivisional Sales
 
Total Sales
Eastman Division Segments
 
 
 
CASPI Segment
$
1,597
$
--
$
1,597
PCI Segment
 
1,184
 
495
 
1,679
SP segment
 
559
 
49
 
608



Total
 
3,340
 
544
 
3,884



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
Polymers
 
1,756
 
68
 
1,824
Fibers
 
635
 
80
 
715



Total
 
2,391
 
148
 
2,539



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
69
 
396
 
465



Total
 
69
 
396
 
465



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
5,800
$
1,088
$
6,888



(Dollars in millions)
 
2002

 
 
 
 
 
 
 
Sales by Division and Segment
 
External Sales
 
Interdivisional Sales
 
Total Sales
Eastman Division Segments
 
 
 
CASPI Segment
$
1,540
$
--
$
1,540
PCI Segment
 
1,084
 
383
 
1,467
SP segment
 
528
 
45
 
573



Total
 
3,152
 
428
 
3,580



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
Polymers
 
1,510
 
55
 
1,565
Fibers
 
642
 
72
 
714



Total
 
2,152
 
127
 
2,279



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
16
 
330
 
346



Total
 
16
 
330
 
346



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
5,320
$
885
$
6,205



 


 125

     

 


(Dollars in millions)
 
2001

 
 
 
 
 
 
 
Sales by Division and Segment
 
External Sales
 
Interdivisional Sales
 
Total Sales
Eastman Division Segments
 
 
 
CASPI Segment
$
1,508
$
--
$
1,508
PCI Segment
 
1,132
 
--
 
1,132
SP segment
 
535
 
--
 
535



Total
 
3,175
 
--
 
3,175



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
Polymers
 
1,587
 
--
 
1,587
Fibers
 
628
 
--
 
628



Total
 
2,215
 
--
 
2,215



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
--
 
110
 
110



Total
 
--
 
110
 
110



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
5,390
$
110
$
5,500




(Dollars in millions)
 
2003
 
2002
 
2001
Operating Earnings (Loss) (1)



Eastman Division Segments
 
 
 
CASPI Segment
$
(358)
$
58
$
(25)
PCI Segment
 
(89)
 
14
 
(60)
SP segment
 
63
 
34
 
51



Total
 
(384)
 
106
 
(34)



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
 
Polymers
 
62
 
35
 
(187)
Fibers
 
125
 
133
 
147



Total
 
187
 
168
 
(40)



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
(65)
 
(70)
 
(46)



Total
 
(65)
 
(70)
 
(46)



 
 
 
 
 
 
 
Eliminations
 
(5)
 
4
 
--



Total Eastman Chemical Company
$
(267)
$
208
$
(120)



(1)     Operating earnings (loss) includes the impact of asset impairments and restructuring charges, goodwill impairments, and other operating income and expense as described in Notes 15 and 16.
 

 126

     

 

 

(Dollars in millions)
 
2003
 
2002
 
2001



 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
Eastman Division Segments
 
 
 
CASPI Segment
$
1,644
$
1,975
$
1,916
PCI Segment
 
1,753
 
1,655
 
1,249
SP segment
 
821
 
795
 
925



Total
 
4,218
 
4,425
 
4,090



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
 
Polymers
 
1,441
 
1,269
 
1,379
Fibers
 
520
 
551
 
596



Total
 
1,961
 
1,820
 
1,975



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
51
 
42
 
27



Total
 
51
 
42
 
27



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
6,230
$
6,287
$
6,092



 
 
 
 
 
 
 
Depreciation Expense
 
 
 
 
 
 
Eastman Division Segments
 
 
 
 
CASPI Segment
$
79
$
98
$
101
PCI Segment
 
94
 
97
 
78
SP segment
 
41
 
49
 
63



Total
 
214
 
244
 
242



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
 
Polymers
 
69
 
69
 
94
Fibers
 
37
 
37
 
43



Total
 
106
 
106
 
137



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
14
 
8
 
6



Total
 
14
 
8
 
6



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
334
$
358
$
385



 
 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
 
Eastman Division Segments
 
 
 
 
CASPI Segment
$
77
$
147
$
35
PCI Segment
 
56
 
140
 
53
SP segment
 
7
 
61
 
43



Total
 
140
 
348
 
131



 
 
 
 
 
 
 
Voridian Division Segments
 
 
 
 
Polymers
 
52
 
49
 
67
Fibers
 
34
 
24
 
30



Total
 
86
 
73
 
97



 
 
 
 
 
 
 
Developing Businesses Division
 
 
 
 
 
 
Developing Businesses
 
4
 
6
 
6



Total
 
4
 
6
 
6



 
 
 
 
 
 
 
Total Eastman Chemical Company
$
230
$
427
$
234




 127

     

 

 

(Dollars in millions)
 
2003
 
2002
 
2001
Geographic Information
 
 
 
 
 
 
Revenues
 
 
 
United States
$
3,074
$
2,887
$
2,990
All foreign countries
 
2,726
 
2,433
 
2,400



Total
$
5,800
$
5,320
$
5,390



 
 
 
 
 
 
 
Long-Lived Assets, Net
 
 
 
 
United States
$
2,542
$
2,805
$
2,760
All foreign countries
 
877
 
948
 
867



Total
$
3,419
$
3,753
$
3,627



21.    QUARTERLY SALES AND EARNINGS DATA – UNAUDITED

 
(Dollars in millions, except per share amounts)
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter




 
 
 
 
 
 
 
 
 
2003
 
 
 
 
 
 
 
 
Sales
$
1, 441
$
1, 481
$
1, 444
$
1,434
Gross profit
 
184
 
241
 
200
 
185
Asset impairments and restructuring charges
 
2
 
16
 
462
 
9
Goodwill impairments
 
--
 
--
 
34
 
--
Other operating income
 
(20)
 
--
 
--
 
(13)
Operating earnings (loss)
 
59
 
75
 
(440)
 
39
Earnings (loss) before income taxes and cumulative effect of change in accounting principles
 
29
 
49
 
(471)
 
12
Provision (benefit) for income taxes
 
11
 
14
 
(135)
 
2
Earnings (loss) before cumulative effect of change in accounting principles
 
18
 
35
 
(336)
 
10
Cumulative effect of change in accounting principles, net
 
3
 
--
 
--
 
--
Net earnings (loss)
 
21
 
35
 
(336)
 
10
 
 
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
 
 
Earnings (loss) per share before cumulative effect of change in accounting principles
$
0.23
$
0.46
$
(4.35)
$
0.13
Cumulative effect of change in accounting principles, net
 
0.04
 
--
 
--
 
--




Net earnings (loss) per share (2)
$
0.27
$
0.46
$
(4.35)
$
0.13




 
 
 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
 
 
Earnings (loss) per share before cumulative effect of change in accounting principles
$
0.23
$
0.46
$
(4.35)
$
0.13
Cumulative effect of change in accounting principles, net
 
0.04
 
--
 
--
 
--




Net earnings (loss) per share (2)
$
0.27
$
0.46
$
(4.35)
$
0.13




 
 
 
 
 
 
 
 
 


 128

     

 

 

 
(Dollars in millions, except per share amounts)
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
 
 
 
 
 
 
 
 
2002 (1)
 
 
 
 
 
 
 
 
Sales
$
1, 236
$
1, 395
$
1, 374
$
1, 315
Gross profit
 
205
 
229
 
202
 
143
Asset impairment and restructuring charges
 
--
 
--
 
(1)
 
6
Operating earnings (loss)
 
77
 
81
 
61
 
(11)
Earnings (loss) before income taxes and cumulative effect of change in accounting principles
 
33
 
60
 
28
 
(37)
Provision (benefit) for income taxes
 
9
 
16
 
4
 
(24)
Earnings (loss) before cumulative effect of change in accounting principles
 
24
 
44
 
24
 
(13)
Cumulative effect of change in accounting principles, net
 
(18)
 
-
 
-
 
-
Net earnings (loss)
 
6
 
44
 
24
 
(13)
 
 
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
 
 
Earnings (loss) per share before cumulative effect of change in accounting principles
$
0.30
$
0.58
$
0.31
$
(0.16)
Cumulative effect of change in accounting principles, net
 
(0.23)
 
--
 
--
 
--




Net earnings (loss) per share (2)
$
0.07
$
0.58
$
0.31
$
(0.16)




 
 
 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
 
 
Earnings (loss) per share before cumulative effect of change in accounting principles
$
0.30
$
0.58
$
0.31
$
(0.16)
Cumulative effect of change in accounting principles, net
 
(0.23)
 
--
 
--
 
--




Net earnings (loss) per share (2)
$
0.07
$
0.58
$
0.31
$
(0.16)




 
 
 
 
 
 
 
 
 

(1) Results for the first quarter 2002 included a $5 million charge related to the previously announced restructuring of Genencor.

(2) Each quarter is calculated as a discrete period; the sum of the four quarters may not equal the calculated full-year amount.
 
22.    RECENTLY ISSUED ACCOUNTING STANDARDS

In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections." This Statement, which updates, clarifies and simplifies existing accounting pronouncements, addresses the reporting of debt extinguishments and accounting for certain lease modifications that have economic effects that are similar to sale-leaseback transactions. The provisions of this Statement are generally effective for the Company's 2003 fiscal year, or in the case of specific provisions, for transactions occurring after May 15, 2002 or for financial statements issued on or after May 15, 2002. The provisions of this Statement have not had and are not expected to have a material impact on the Company's financial condition or results of operations.

 129

     

 

In July 2002, the FASB issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities." This Statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force ("EITF") Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)." This Statement requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred, and concludes that an entity's commitment to an exit plan does not by itself create a present obligation that meets the definition of a liability. This Statement also establishes that fair value is the objective of initial measurement of the liability. The provisions of this Statement are effective for exit or disposal activities that are initiated after December 31, 2002, with early application encouraged. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In November 2002, the Emerging Issues Task Force ("EITF") reached a consensus on Issue No. 00-21, "Revenue Arrangements with Multiple Deliverables." EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In November 2002, the FASB issued FASB Interpretation No. 45 ("FIN 45"), "Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an interpretation of FASB Statements No. 5, 57 and 107 and Rescission of FASB Interpretation No. 34." FIN 45 clarifies the requirements of SFAS No. 5, "Accounting for Contingencies," relating to the guarantor’s accounting for, and disclosure of, the issuance of certain types of guarantees. The disclosure provisions of FIN 45 are effective for the current fiscal year and the Company has included this information in Note 10 to the Company’s consolidated financial statements. However, the provisions for initial recognition and measurement are effective on a prospective basis for guarantees that are issued or modified after December 31, 2002, irrespective of a guarantor’s year-end. The adoption of FIN 45 did not have a material impact on the Company’s financial position, liquidity or results of operations. See Note 10 to the Company’s consolidated financial statements for additional information regarding the Company’s guarantees.

In December 2002, the FASB issued SFAS No. 148, "Accounting for Stock-Based Compensation – Transition and Disclosure, amendment of FASB Statement No. 123." This Statement provides additional transition guidance for those entities that elect to voluntarily adopt the provisions of SFAS No.123, "Accounting for Stock-Based Compensation." Furthermore, SFAS No. 148 mandates new disclosures in both interim and year-end financial statements within Note 1, "Significant Accounting Policies," to the Company’s consolidated financial statements. The Company has elected not to adopt the recognition provisions of SFAS No. 123, as amended by SFAS No. 148. However, the Company has adopted the disclosure provisions for the current fiscal year and has included this information in Note 1 to the Company’s consolidated financial statements.

Effective July 1, 2003, the Company’s method of accounting for arrangements containing a lease changed as a result of the adoption of Emerging Issues Task Force ("EITF") Issue No. 01-08, "Determining Whether an Arrangement Contains a Lease." EITF Issue No. 01-08 provides guidance on how to determine if an arrangement contains a lease that is within the scope of SFAS No. 13, "Accounting for Leases." The provisions of EITF Issue No. 01-08 apply primarily to arrangements agreed to or committed to after the beginning of an entity’s next reporting period beginning after May 28, 2003, or previous arrangements modified after the beginning of an entity’s next reporting period beginning after May 28, 2003. The adoption of EITF Issue No. 01-08 did not have a material impact on the Company’s financial position, liquidity or results of operations.

 130

     

 

In January 2003, the FASB issued FASB Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities." FIN 46 clarifies the application of Accounting Research Bulletin No. 51, "Consolidated Financial Statements," to certain entities in which equity investors do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 applies immediately to variable interest entities ("VIE’s") created after January 31, 2003, and to VIE’s in which a public company obtains an interest after that date. In December 2003, the FASB published a revision to FIN 46 ("FIN 46R") to clarify some of the provisions of the interpretation and to defer the effective date of implementation for certain entities. Under the guidance of FIN 46R, public companies that have interests in VIE’s that are commonly referred to as special purpose entities are required to apply the provisions of FIN 46R for periods ending after December 15, 2003. A public company that does not have any interests in special purpose entities but does have a variable interest in a VIE created before February 1, 2003, must apply the provisions of FIN 46R by the end of the first interim or annual reporting period ending after March 14, 2004. During the fourth quarter of 2003, the Company assessed certain of its lease arrangements as well as its accounts receivable securitization program according to the provisions of FIN 46R. The Company concluded that such entities did not meet the criteria for consolidation under FIN 46R. In addition, the Company has identified certain joint venture partnerships as well as other contractual arrangements created before February 1, 2003 as potential VIE’s. The Company is currently evaluating the effect of these potential VIE’s on its financial position, liquidity, or results of operations. See Note 10 to the Company’s consolidated financial statements for further discussions about the Company’s potential VIE’s.

In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." SFAS No. 149 amends and clarifies accounting for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities under SFAS No. 133. SFAS No. 149 amends SFAS No. 133 to require contracts with comparable characteristics be accounted for similarly. SFAS No. 149 clarifies the circumstances under which a contract with an initial net investment qualifies as a derivative and clarifies when a derivative contains a financing component that warrants special reporting in the statement of cash flows. This Statement is effective for contracts entered into or modified after June 30, 2003, except for hedging relationships designated after June 30, 2003, where the guidance should be applied prospectively. The adoption of this statement did not have a material impact on the Company’s financial position, liquidity, or results of operations.

In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." SFAS No. 150 requires certain financial instruments, which under previous guidance were accounted for as equity, be classified as liabilities or assets in statements of financial position. This Statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise effective at the beginning of the first interim period beginning after June 15, 2003. The adoption of this statement did not have a material impact on the Company’s consolidated financial position, liquidity, or results of operations.

In December 2003, the FASB issued a revision to SFAS No. 132 "Employers' Disclosures about Pensions and Other Postretirement Benefits". This statement revises employers' disclosures about pension plans and other postretirement benefit plans. It requires additional disclosures related to the assets, obligations, cash flows, and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. It does not change the measurement or recognition of those plans. The Company has adopted the provisions of this statement. See Note 9 to the consolidated financial statements for more information.

 131

     

 

On January 12, 2004, the FASB staff issued FSP 106-1 "Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003." FSP 106-1 permits a sponsor of a postretirement health care plan that provides a prescription drug benefit to make a one-time election to defer accounting for the effects of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("the Act") that would be required in accordance with SFAS 106 "Employers Accounting for Postretirement Benefits Other than Pensions." Regardless of whether a sponsor elects that deferral, FSP 106-1 requires certain disclosures in annual or interim financial statements. FSP 106-1 is effective for interim or annual financial statements of fiscal years ending after December 7, 2003. The Company elected to defer accounting for the effects of the Act and has made the required disclosures in Note 9 to the Company’s consolidated financial statements. The Company is currently evaluating the effect FSP 106-1 will have on its financial position, liquidity, and results of operations.
 
23.    CUMULATIVE EFFECT OF CHANGES IN ACCOUNTING PRINCIPLES, NET OF TAX

SFAS No. 143
 
Effective January 1, 2003, the Company’s method of accounting for environmental closure and postclosure costs changed as a result of the adoption of Statement of Financial Accounting Standards ("SFAS") No. 143, "Accounting for Asset Retirement Obligations." Upon the initial adoption of the provision, entities are required to recognize a liability for any existing asset retirement obligations adjusted for cumulative accretion to the date of adoption of this Statement, an asset retirement cost capitalized as an increase to the carrying amount of the associated long-lived asset, and accumulated depreciation on that capitalized cost. In accordance with SFAS No. 143, the Company recorded asset retirement obligations primarily related to closure and postclosure environmental liabilities associated with certain property plant and equipment. This resulted in the Company recording asset retirement obligations of $28 million and an after-tax credit to earnings of $3 million.

If the asset retirement obligation measurement and recognition provisions of SFAS No. 143 had been in effect on January 1, 2002 and 2001, the aggregate carrying amount of those obligations on that date would have been $27 million and $26 million, respectively. If the amortization of asset retirement cost and accretion of asset retirement obligation provisions of SFAS No. 143 had been in effect during 2002 and 2001, the impact on "Earnings before cumulative effect of changes in accounting principle" would have been immaterial.
 
SFAS No. 142
 
The Company adopted the provisions of SFAS No. 142, "Goodwill and Other Intangible Assets," effective January 1, 2002. The provisions of SFAS No. 142 prohibit the amortization of goodwill and indefinite-lived intangible assets; require that goodwill and indefinite-lived intangible assets be tested at least annually for impairment; require reporting units to be identified for the purpose of assessing potential future impairments of goodwill; and remove the forty-year limitation on the amortization period of intangible assets that have finite lives.

 132

     

 

In connection with the adoption of SFAS No. 142, the Company completed in the first quarter 2002 the impairment test for intangible assets with indefinite useful lives other than goodwill. As a result of this impairment test, it was determined that the fair value of certain trademarks related to the CASPI segment, as established by appraisal and based on discounted future cash flows, was less than the recorded value. Accordingly, the Company recognized an after-tax impairment charge of approximately $18 million in the first quarter of 2002 to reflect lower than previously expected cash flows from certain related products. This charge is reported in the Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss), and Retained Earnings as the cumulative effect of a change in accounting principle. Additionally, the Company reclassified $12 million of its intangible assets related to assembled workforce and the related deferred tax liabilities of approximately $5 million to goodwill. During the second quarter 2002, the Company performed the transitional impairment test on its goodwill as required upon adoption of this Statement, and determined that no impairment of goodwill existed as of January 1, 2002. The Company completed its annual testing of goodwill and indefinite-lived intangible assets for impairment in the third quarter 2002 and determined that no impairment existed as of September 30, 2002. The Company plans to continue its annual testing of goodwill and indefinite-lived intangible assets for impairment in the third quarter of each year, unless events warrant more frequent testing.

In the third quarter 2003, the Company impaired certain goodwill and indefinite-lived intangible assets in the CASPI segment as discussed in Note 15 above. Additionally, the Company completed its annual impairment review of the remaining goodwill and indefinite-lived intangible assets. No further impairment of goodwill or indefinite-lived intangible assets was required due to this review.
 
24.    SUBSEQUENT EVENTS

On January 15, 2004, the Company retired $500 million of 6 3/8% coupon debt. These bonds were reflected in borrowings due within one year in the Consolidated Statements of Financial Position at December 31, 2003. This debt was retired with a combination of cash generated from business activities, new long-term borrowings and available short-term borrowing capacity.

 133

     

 

 
ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.    CONTROLS AND PROCEDURES

The Company maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the Company’s disclosure controls and procedures. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective as of December 31, 2003.

There has been no change in the Company's internal control over financial reporting that occurred during the fourth quarter of 2003 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 134

     

 

PART III

ITEM 10.    DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

The material under the heading "Proposals to be Voted Upon at the Annual Meeting--Item 1--Election of Directors" (except for the material under the subheading "Board Committees--Audit Committee--Audit Committee Report", which is not incorporated by reference herein) and in Note (12) to the Summary Compensation Table under the heading "Executive Compensation--Compensation Tables" to be filed in the 2004 definitive Proxy Statement is incorporated by reference herein in response to this Item. Certain information concerning executive officers of the Company is set forth under the heading "Executive Officers of the Company" in Part I of this Annual Report.

The Company has adopted a code of ethics and business conduct applicable to the chief executive officer, chief financial officer and the controller of the Company. See "Part I – Item 1. Business – Available Information – SEC Filings and Corporate Governance Materials".

ITEM 11.    EXECUTIVE COMPENSATION

The material under the headings "Proposals to be Voted Upon at the Annual Meeting--Item 1--Election of Directors--Director Compensation" to be filed in the 2004 definitive Proxy Statement is incorporated by reference herein in response to this Item. In addition, the material under the heading "Executive Compensation" to be filed in the 2004 definitive Proxy Statement is incorporated by reference herein in response to this Item, except for the material under the subheadings " -- Compensation and Management Development Committee Report on Executive Compensation" and " -- Performance Graph," which are not incorporated by reference herein.

ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The material under the headings "Stock Ownership of Directors and Executive Officers--Common Stock" and "Stock Ownership of Certain Beneficial Owners" to be filed in the 2004 definitive Proxy Statement is incorporated by reference herein in response to this Item.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

Equity Compensation Plans Approved by Stockholders

Stockholders approved the Company’s 1994, 1997, and 2002 Omnibus Long-Term Compensation Plans; the 1994, 1999, and 2002 Director Long-Term Compensation Plans; and the 1996 Non-Employee Director Stock Option Plan. Although stock and stock-based awards are still outstanding under the 1994 and 1997 Omnibus Long-Term Compensation Plans, as well as the 1994 and 1999 Director Long-Term Compensation Plans, no new shares are available under these plans for future grants.

Equity Compensation Plans Not Approved by Stockholders                                                                        
Stockholders have approved all compensation plans under which shares of Eastman common stock may be issued.

 135

     

 

Summary Equity Compensation Plan Information Table

The following table sets forth certain information as of December 31, 2003 with respect to compensation plans under which shares of Eastman common stock may be issued.

Plan Category
 
Number of Securities to be Issued upon Exercise of Outstanding Options
(a)
 
Weighted-Average Exercise Price of Outstanding Options
(b)
 
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding securities reflected in Column (a))
(c)
 




 
 
 
 
 
 
 
 
Equity compensation plans approved by stockholders
 
10,338,100
(1)
$45
 
5,778,900
(2)
 
 
 
 
 
 
 
 
Equity compensation plans not approved by stockholders
 
--
 
--
 
--
 



 
 
 
 
 
 
 
 
TOTAL
 
10,338,100
 
$45
 
5,778,900
 



 
(1) Represents shares of common stock issuable upon exercise of outstanding options granted under Eastman Chemical Company’s 1994, 1997, and 2002 Omnibus Long-Term Compensation Plans; the 1994, 1999, and 2002 Director Long-Term Compensation Plans; and the 1996 Non-Employee Director Stock Option Plan.

(2) Includes shares of common stock available for future grants under the Company’s 2002 Omnibus Long-Term Compensation Plan, the 2002 Director Long-Term Compensation Plan, and the 1996 Non-Employee Director Stock Option Plan.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

There are no transactions or relationships since the beginning of the last completed fiscal year required to be reported in response to this Item.


ITEM 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES

The information concerning amounts billed for professional services rendered by the principal accountant and pre-approval of such services by the Audit Committee of the Company’s Board of Directors under the heading "Item 2 – Ratification of Appointment of Independent Accountants" to be filed in the 2004 definitive Proxy Statement is incorporated by reference herein in response to this Item.






 136

     

 

PART IV

ITEM 15.       EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

 
 
 
 
Page
(a)
1.
Consolidated Financial Statements:
 
79
 
 
 
 
 
 
 
Management's Responsibility for Financial Statements
 
80
 
 
 
 
 
 
 
Report of Independent Auditors
 
81
 
 
 
 
 
 
 
Consolidated Statements of Earnings (Loss), Comprehensive Income (Loss), and Retained Earnings
 
 
82
 
 
 
 
 
 
 
Consolidated Statements of Financial Position
 
83
 
 
 
 
 
 
 
Consolidated Statements of Cash Flows
 
84
 
 
 
 
 
 
 
Notes to Company’s Consolidated Financial Statements
 
85-133
 
 
 
 
 
 
2.
Financial Statement Schedule
 
 
 
 
II - Valuation and Qualifying Accounts
 
145
 
 
 
 
 
 
3.
Exhibits filed as part of this report are listed in the Exhibit Index beginning at page 140
 
 
 
 
 
 
 
(b)
Reports on Form 8-K during fourth quarter 2003
 
 
 
 
 
 
 
On October 9, 2003, the Company furnished under Item 12 of Form 8-K the text of its public release updating efforts to improve CASPI segment profitability and disclosing expected results of operations for the third quarter of 2003.
 
On October 23, 2003, the Company furnished under Item 12 of Form 8-K the text of its public release of financial results for the third quarter of 2003.
 
On December 5, 2003, the Company filed under Item 5 of Form 8-K the Agreement of Substitution and Amendment of Stockholder Protection Rights Agreement, dated as of April 23, 2003, and the amendment, dated as of December 4, 2003, to the Stockholder Protection Rights Agreement, dated as of December 13, 1993 .
 
 
 
 
 
 
(c)
The Exhibit Index and required Exhibits to this report are included beginning at page 140
 
 
 
 
 
 
(d)
II - Valuation and Qualifying Accounts
 
145


 137

     

 

SI GNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
Eastman Chemical Company
 
 
 
 
 
 
By:
/s/ J. Brian Ferguson

 
J. Brian Ferguson
 
Chairman of the Board and Chief Executive Officer
 
 
Date:
March 5, 2004
 


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

SIGNATURE
 
TITLE
 
DATE



 
 
 
 
 
PRINCIPAL EXECUTIVE OFFICER:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/s/ J. Brian Ferguson
 
Chairman of the Board of Directors
 
March 5, 2004

J. Brian Ferguson
 
and Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRINCIPAL FINANCIAL OFFICER:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/s/ Richard A. Lorraine
 
Senior Vice President and
 
March 5, 2004

Richard A. Lorraine
 
Chief Financial Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRINCIPAL ACCOUNTING OFFICER:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/s/ Curtis E. Espeland
 
Controller
 
March 5, 2004

Curtis E. Espeland
 
 
 
 
 
 
 
 
 


 138

     

 


SIGNATURE
 
TITLE
 
DATE



 
 
 
 
 
DIRECTORS:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/s/ H. Jesse Arnelle
 
Director      
 
March 5, 2004

H. Jesse Arnelle
 
 
 
 
 
 
 
 
 
/s/ Calvin A. Campbell, Jr.
 
Director      
 
March 5. 2004

Calvin A. Campbell, Jr.
 
 
 
 
 
 
 
 
 
/s/ Stephen R. Demeritt
 
Director      
 
March 5, 2004

Stephen R. Demeritt
 
 
 
 
 
 
 
 
 
/s/ Donald W. Griffin
 
Director      
 
March 5, 2004

Donald W. Griffin
 
 
 
 
 
 
 
 
 
/s/ Robert M. Hernandez
 
Director      
 
March 5, 2004

Robert M. Hernandez
 
 
 
 
 
 
 
 
 
/s/ Renee J. Hornbaker
 
Director
 
March 5, 2004

Renee J. Hornbaker
 
 
 
 
 
 
 
 
 
/s/ Thomas H. McLain
 
Director      
 
March 5, 2004

Thomas H. McLain
 
 
 
 
 
 
 
 
 
/s/ David W. Raisbeck
 
Director      
 
March 5, 2004

David W. Raisbeck
 
 
 
 
 
 
 
 
 
/s/ John A. White
 
Director      
 
March 5, 2004

John A. White
 
 
 
 
 
 
 
 
 
/s/ Peter M. Wood
 
Director      
 
March 5, 2004

Peter M. Wood
 
 
 
 

 

 139

     

 

 

 
 
 
 
 
 
 
EXHIBIT INDEX
 
Sequential
Exhibit
 
 
 
Page
Number
 
Description
 
Number



 
 
 
 
 
3.01
 
Amended and Restated Certificate of Incorporation of Eastman Chemical Company, as amended (incorporated by reference to Exhibit 3.01 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2001)
 
 
 
 
 
 
 
3.02
 
Amended and Restated Bylaws of Eastman Chemical Company, as amended December 4, 2003
 
 
146-161
 
 
 
 
 
4.01
 
Form of Eastman Chemical Company Common Stock certificate as amended February 1, 2001 (incorporated herein by reference to Exhibit 4.01 to Eastman Chemical Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2001 (the "March 31, 2001 10-Q"))
 
 
 
 
 
 
 
4.02
 
Stockholder Protection Rights Agreement dated as of December 13, 1993, between Eastman Chemical Company and First Chicago Trust Company of New York, as Rights Agent (incorporated herein by reference to Exhibit 4.4 to Eastman Chemical Company's Registration Statement on Form S-8 relating to the Eastman Investment Plan, File No. 33-73810)
 
 
 
 
 
 
 
4.03
 
Indenture, dated as of January 10, 1994, between Eastman Chemical Company and The Bank of New York, as Trustee (the "Indenture") (incorporated herein by reference to Exhibit 4(a) to Eastman Chemical Company's current report on Form 8-K dated January 10, 1994 (the "8-K"))
 
 
 
 
 
 
 
4.04
 
Form of 6 3/8% Notes due January 15, 2004 (incorporated herein by reference to Exhibit 4(c) to the 8-K)
 
 
 
 
 
 
 
4.05
 
Form of 7 1/4% Debentures due January 15, 2024 (incorporated herein by reference to Exhibit 4(d) to the 8-K)
 
 
 
 
 
 
 
4.06
 
Officers’ Certificate pursuant to Sections 201 and 301 of the Indenture (incorporated herein by reference to Exhibit 4(a) to Eastman Chemical Company's Current Report on Form 8-K dated June 8, 1994 (the "June 8-K"))
 
 
 
 
 
 
 
4.07
 
Form of 7 5/8% Debentures due June 15, 2024 (incorporated herein by reference to Exhibit 4(b) to the June 8-K)
 
 
 
 
 
 
 
4.08
 
Form of 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.08 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 1996 (the "1996 10-K"))
 
 
 
 
 
 
 
4.09
 
Form of 7% Notes due April 15, 2012 (incorporated herein by reference to Exhibit 4.09 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2002)
 
 
 
 
 
 
 
4.10
 
Officer's Certificate pursuant to Sections 201 and 301 of the Indenture related to 7.60% Debentures due February 1, 2027 (incorporated herein by reference to Exhibit 4.09 to the 1996 10-K)
 
 

 

 140

     

 


 
 
 
 
 
 
 
EXHIBIT INDEX
 
Sequential
Exhibit
 
 
 
Page
Number
 
Description
 
Number



 
 
 
 
 
4.11
 
$200,000,000 Accounts Receivable Securitization agreement dated April 13, 1999 (amended April 11, 2000), between the Company and Bank One, N.A., as agent. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, in lieu of filing a copy of such agreement, the Company agrees to furnish a copy of such agreement to the Commission upon request.
 
 
 
 
 
 
 
4.12
 
Credit Agreement, dated as of July 13, 2000 (the "Credit Agreement") among Eastman Chemical Company, the Lenders named therein, and Citibank, N.A. as Agent (incorporated herein by reference to Exhibit 4.11 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2000)
 
 
 
 
 
 
 
4.13
 
Form of 3 ¼% Notes due June 16, 2008 (incorporated herein by reference to Exhibit 4.13 to Eastman Chemical Company’s Quarterly Report on Form 10-Q for the quarter ending June 30, 2003)
 
 
 
 
 
 
 
4.14
 
Form of 6.30% notes due 2018 (incorporated herein by reference to Exhibit 4.14 to Eastman Chemical Company’s Quarterly Report on Form 10-Q for the quarter ending September 30, 2003)
 
 
 
 
 
 
 
4.15
 
Amendments to Stockholder Protection Rights Agreement (incorporated herein by reference to Exhibits 4.1 and 4.2 to Eastman Chemical Company’s current report on Form 8-K dated December 4, 2003).
 
 
 
 
 
 
 
10.01*
 
Eastman Chemical Company Benefit Security Trust dated January 2, 2002 (incorporated herein by reference to Exhibit 10.04 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
 
 
 
 
 
 
 
10.02*
 
Amended Eastman Performance Plan (incorporated herein by referenced to Exhibit 10.02 to Eastman Chemical Company’s Annual Report on Form 10-K for the year ended December 31, 2002, as initially filed on March 12, 2003.)
 
 
 
 
 
 
 
10.03*
 
2002 Director Long-Term Compensation Plan, as amended (incorporated herein by reference to Appendix A to Eastman Chemical Company’s definitive 2002 Annual Meeting Proxy Statement filed pursuant to Regulation 14A)
 
 
 
 
 
 
 
10.04*
 
Eastman 2001-2003 Long-Term Performance Subplan of 1997 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.03 to the June 30, 2001 10-Q)
 
 
 
 
 
 
 
10.05*
 
Amended Eastman Executive Deferred Compensation Plan (incorporated herein by referenced to Exhibit 10.02 to Eastman Chemical Company’s Annual Report on Form 10-K for the year ended December 31, 2002, as initially filed on March 12, 2003.)
 
 
 
 
 
 
 
10.06*
 
Eastman Excess Retirement Income Plan, amended and restated effective January 1, 2002 (incorporated herein by reference to Exhibit 10.10 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 2001, as initially filed on March 12, 2002.)
 
 

 141

     

 

 

 
 
 
 
 
 
 
EXHIBIT INDEX
 
Sequential
Exhibit
 
 
 
Page
Number
 
Description
 
Number



 
 
 
 
 


10.07*
 
Eastman Unfunded Retirement Income Plan, amended and restated effective January 1, 2002 (incorporated herein by reference to Exhibit 10.11 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 2001, as initially filed on March 12, 2002.)
 
 
 
 
 
 
 
10.08*
 
Form of Executive Severance Agreements (incorporated herein by reference to Exhibit 10.12 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 2001, as initially filed on March 12, 2002.)
 
 
 
 
 
 
 
10.09*
 
Eastman Unit Performance Plan as amended January 1, 2004
 
162-167
 
 
 
 
 
10.10*
 
2002 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Appendix A to Eastman Chemical Company’s definitive 2002 Annual Meeting Proxy Statement filed pursuant to Regulation 14A)
 
 
 
 
 
 
 
10.11*
 
1996 Non-Employee Director Stock Option Plan (incorporated herein by reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 1996)
 
 
 
 
 
 
 
10.12*
 
Amended Director Deferred Compensation Plan (incorporated herein by referenced to Exhibit 10.02 to Eastman Chemical Company’s Annual Report on Form 10-K for the year ended December 31, 2002, as initially filed on March 12, 2003.)
 
 
 
 
 
 
 
10.13*
 
Employment Agreement between Eastman Chemical Company and James P. Rogers (incorporated herein by reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 1999)
 
 


10.14*
 
Eastman 2000-2002 Long-Term Performance Subplan of 1997 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.20 to Eastman Chemical Company's Annual Report on Form 10-K for the year ended December 31, 1999 (the "1999 10-K"))
 
 
 
 
 
 
 
10.15*
 
Form of Award Notice for Stock Options Granted to Managers under Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit 10.21 to the 1999 10-K)
 
 
 
 
 
 
 
10.16*
 
Form of Indemnification Agreements between Theresa K. Lee, Gregory O. Nelson, James P. Rogers and Eastman Chemical for service as directors of Genencor International, Inc. (incorporated herein by reference to Exhibit 10.01 to the June 30, 2000 10-Q)
 
 

 

 142

     

 



 
 
 
 
 
 
 
EXHIBIT INDEX
 
Sequential
Exhibit
 
 
 
Page
Number
 
Description
 
Number



 
 
 
 
 
10.17
 
Imaging Chemicals License Agreement, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.13 to the S-1)
 
 
 
 
 
 
 
10.18
 
Contribution Agreement, dated as of December 9, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.07 to the S-1)
 
 
 
 
 
 
 
10.19
 
General Assignment, Assumption and Agreement Regarding Litigation, Claims and Other Liabilities, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.08 to the S-1)
 
 
 
 
 
 
 
10.20
 
Tax Sharing and Indemnification Agreement, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.09 to the S-1)
 
 
 
 
 
 
 
10.21
 
Intellectual Property Agreement Non-Imaging, dated as of December 31, 1993, between Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.12 to the S-1)
 
 
 
 
 
 
 
10.22*
 
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated October 7, 2002 (incorporated herein by reference to Exhibit 10.01 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
 
 
 
 
 
 
 
10.23*
 
Amended and Restated Warrant to Purchase Shares of Common Stock of Eastman Chemical Company, dated January 2, 2002 (incorporated herein by reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
 
 
 
 
 
 
 
10.24*
 
Amended and Restated Registration Rights Agreement, dated January 2, 2002 (incorporated herein by reference to Exhibit 10.03 to Eastman Chemical Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2002)
 
 
 
 
 
 
 
10.25*
 
Form of Indemnification Agreements with Directors and Executive Officers
 
168-186
 
 
 
 
 
10.26*
 
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated February 5, 2004
 
187-188
 
 
 
 
 
10.27*
 
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
 
189-191





 143

     

 




 
 
 
 
 
 
 
EXHIBIT INDEX
 
Sequential
Exhibit
 
 
 
Page
Number
 
Description
 
Number



 
 
 
 
 
10.28*
 
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
 
192-194
 
 
 
 
 
10.29*
 
Notice of Restricted Stock Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated December 3, 2003
 
195-196
 
 
 
 
 
10.30*
 
Notice of Performance Shares Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
 
197-200
 
 
 
 
 
10.31*
 
Notice of Performance Shares Granted Pursuant to the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan, dated January 1, 2004
 
201-203
 
 
 
 
 
10.32*
 
Eastman 2004-2005 Performance Share Award Subplan of the 2002 Omnibus Long-Term Compensation Plan
 
204-213
 
 
 
 
 
10.33*
 
Eastman 2004-2006 Performance Share Award Subplan of the 2002 Omnibus Long-Term Compensation Plan
 
214-223
 
 
 
 
 
12.01
 
Statement re: Computation of Ratios of Earnings (Loss) to Fixed Charges
 
224
 
 
 
 
 
21.01
 
Subsidiaries of the Company
 
225-229
 
 
 
 
 
23.01
 
Consent of Independent Accountants
 
230
 
 
 
 
 
31.01
 
Rule 13a – 14(a) Certification by J. Brian Ferguson, Chairman of the Board and Chief Executive Officer, for the year ended December 31, 2003
 
231
 
 
 
 
 
31.02
 
Rule 13a – 14(a) Certification by Richard A. Lorraine, Senior Vice President and Chief Financial Officer, for the year ended December 31, 2003
 
232
 
 
 
 
 
32.01
 
Section 1350 Certification by J. Brian Ferguson, Chairman of the Board and Chief Executive Officer, for the year ended December 31, 2003
 
233
 
 
 
 
 
32.02
 
Section 1350 Certification by Richard A. Lorraine, Senior Vice President and Chief Financial Officer, for the year ended December 31, 2003
 
234
 
 
 
 
 
 
 
 
 
 
* Management contract or compensatory plan or arrangement filed pursuant to Item 601(b) (10) (iii) of Regulation S-K.

 

 144

     

 

SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS


 
 
 
 
Additions
 
 
 
 

 
 
(Dollars in millions)
 
 
Balance at January 1, 2001
 
 
Charged to Cost and Expense
 
 
Charged to Other Accounts
 
 
 
 
Deductions
 
 
Balance at December 31, 2001





Reserve for:
 
 
 
 
 
 
 
 
 
 
Doubtful accounts and returns
$
16
$
25
$
--
$
6
$
35
Environmental contingencies
 
49
 
5
 
--
 
--
 
54
Deferred tax valuation allowance
 
159
 
(4)
 
--
 
--
 
155





 
$
224
$
26
$
--
$
6
$
244





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2002
 
 
 
 
 
Balance at December 31, 2002


 
 
 
 
 
 
 
 
 
 
 
Reserve for:
 
 
 
 
 
 
 
 
 
 
Doubtful accounts and returns
$
35
$
18
$
--
$
21
$
32
Environmental contingencies
 
54
 
6
 
--
 
--
 
60
Deferred tax valuation allowance
 
155
 
(23)
 
--
 
--
 
132





 
$
244
$
1
$
--
$
21
$
224





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2003
 
 
 
 
 
Balance at December 31, 2003


 
 
 
 
 
 
 
 
 
 
 
Reserve for:
 
 
 
 
 
 
 
 
 
 
Doubtful accounts and returns
$
32
$
8
$
--
$
12
$
28
Environmental contingencies
 
60
 
1
 
--
 
--
 
61
Deferred tax valuation allowance
 
132
 
43
 
--
 
--
 
175





 
$
224
$
52
$
--
$
12
$
264





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 





145
     

 


Exhibit 3.02

EASTMAN CHEMICAL COMPANY BYLAWS

AMENDED AND RESTATED AS OF DECEMBER 4, 2003


SECTION I

Capital Stock

Section 1.1. Certificates . Every holder of stock in the Corporation shall be entitled to have a certificate signed in the name of the Corporation by the Chairman of the Board of Directors or the Vice Chairman or a Vice President, and by the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary of the Corporation certifying the number of shares in the Corporation owned by such holder. Any or all of the signatures on the certificate may be a facsimile. In case any officer, transfer agent, or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent, or registrar at the date of issue.

Section 1.2. Record Ownership . A record of the name and address of the holder of each certificate, the number of shares represented thereby and the date of issue thereof shall be made on the Corporation's books. The Corporation shall be entitled to treat the holder of record of any share of stock as the holder in fact thereof, and accordingly shall not be bound to recognize any equitable or other claim to or interest in any share on the part of any other person, whether or not it shall have express or other notice thereof, except as required by the laws of the State of Delaware.

Section 1.3. Transfer of Record Ownership . Transfers of stock shall be made on the books of the Corporation only by direction of the person named in the certificate or such person's attorney, lawfully constituted in writing, and only upon the surrender of the certificate therefor and a written assignment of the shares evidenced thereby, which certificate shall be canceled before the new certificate is issued.

Section 1.4. Lost Certificates . Any person claiming a stock certificate in lieu of one lost, stolen or destroyed shall give the Corporation an affidavit as to such person's ownership of the certificate and of the facts which go to prove its loss, theft or destruction. Such person shall also, if required by policies adopted by the Board of Directors, give the Corporation a bond, in such form as may be approved by the Corporation, sufficient to indemnify the Corporation against any claim that may be made against it on account of the alleged loss of the certificate or the issuance of a new certificate.

146
     

Exhibit 3.02

Section 1.5. Transfer Agents; Registrars; Rules Respecting Certificates. The Board of Directors may appoint, or authorize any officer or officers to appoint, one or more transfer agents and one or more registrars. The Board of Directors may make such further rules and regulations as it may deem expedient concerning the issue, transfer and registration of stock certificates of the Corporation.

Section 1.6. Record Date . The Board of Directors may fix in advance a future date, not exceeding 60 days (nor, in the case of a stockholders' meeting, less than ten days) preceding the date of any meeting of stockholders, payment of dividend or other distribution, allotment of rights, or change, conversion or exchange of capital stock or for the purpose of any other lawful action, as the record date for determination of the stockholders entitled to notice of and to vote at any such meeting and any adjournment thereof, or to receive any such dividend or other distribution or allotment of rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, or to participate in any such other lawful action, and in such case such stockholders and only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to such notice of and to vote at such meeting and any adjournment thereof, or to receive such dividend or other distribution or allotment of rights, or to exercise such rights, or to participate in any such other lawful action, as the case may be, notwithstanding any transfer of any stock on the books of the Corporation after any such record date fixed as aforesaid.


SECTION II

Meetings of Stockholders

Section 2.1. Annual . The annual meeting of stockholders for the election of directors and the transaction of such other proper business shall be held on the first Thursday in May, unless otherwise specified by resolution adopted by the Board of Directors, and at the time and place, within or without the State of Delaware, as determined by the Board of Directors.

Section 2.2. Special . Special meetings of stockholders for any purpose or purposes may be called only by the Board of Directors, pursuant to a resolution adopted by a majority of the members of the Board of Directors then in office. Special meetings may be held at any place, within or without the State of Delaware, as determined by the Board of Directors. The only business which may be conducted at such a meeting, other than procedural matters and matters relating to the conduct of the meeting, shall be the matter or matters described in the notice of the meeting.

147
     

Exhibit 3.02

Section 2.3. Notice . Notice of each meeting of stockholders, shall be made in writing, or electronically to such stockholders as have consented to the receipt of such notice by electronic means, or by any such other means permitted by the Delaware General Corporation Law. Such notice shall state the date, time, place and, in the case of a special meeting, the purpose thereof, shall be given as provided by law by the Secretary or an Assistant Secretary not less than ten days nor more than 60 days before such meeting (unless a different time is specified by law) to every stockholder entitled by law to notice of such meeting.

Section 2.4. List of Stockholders. A complete list of the stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder, shall be prepared by the Secretary. Such list shall be available for examination of any stockholder, for any purpose germane to the meeting, either on a reasonably accessible electronic network or, during normal business hours, at the Corporation’s principal place of business, for at least ten days before the meeting and at the place of the meeting during the whole time of the meeting. In the event that such list is to be made available on an electronic network, the notice of meeting given under Section 2.3 hereof shall provide the information required to gain access to such list.

Section 2.5. Quorum . The holders of shares of stock entitled to cast a majority of the votes on the matters at issue at a meeting of stockholders, present in person or represented by proxy, shall constitute a quorum, except as otherwise required by the Delaware General Corporation Law. In the event of a lack of a quorum, the chairman of the meeting or a majority in interest of the stockholders present in person or represented by proxy may adjourn the meeting from time to time without notice other than announcement at the meeting, until a quorum shall be obtained. At any such adjourned meeting at which there is a quorum, any business may be transacted that might have been transacted at the meeting originally called.

148
     

Exhibit 3.02

Section 2.6. Organization and Procedure. (a) The Chairman of the Board, or such other officer of the Corporation designated by a majority of the directors that the Corporation would have if there were no vacancies on the Board of Directors (the "Whole Board"), will call meetings of the stockholders to order and will act as presiding officer thereof. Unless otherwise determined prior to the meeting by a majority of the Whole Board, the presiding officer of the meeting of the stockholders will have the right and the authority to determine and maintain the rules, regulations and procedures for the proper conduct of the meeting, including, without limitation, restricting entry to the meeting after it has commenced, maintaining order and the safety of those in attendance, opening and closing the polls for voting, dismissing business or proposals not properly submitted, limiting the time allowed for discussion of the business of the meeting, restricting the persons (other than stockholders of the Corporation or their duly appointed proxies) that may attend the meeting, and ascertaining whether any stockholder or proxy holder may be excluded from the meeting based upon any determination by the presiding officer, in his or her sole discretion, that the stockholder or proxy holder is unduly disruptive or is likely to disrupt the meeting. The Secretary of the Corporation shall act as secretary, but in the absence of the Secretary, the presiding officer may appoint a secretary.

(b) At an annual meeting of the stockholders, only such business will be conducted or considered as is properly brought before the meeting. To be properly brought before an annual meeting, business must be (i) specified in the notice of meeting (or any supplement thereto) given in accordance with these bylaws, (ii) brought before the meeting by the presiding officer or by or at the direction of a majority of the Whole Board, or (iii) otherwise properly requested to be brought before the meeting by a stockholder of the Corporation in accordance with these bylaws.
 
(c) At a special meeting of stockholders, only such business may be conducted or considered as is properly brought before the meeting. To be properly brought before a special meeting, business must be (i) specified in the notice of the meeting (or any supplement thereto) given in accordance with these bylaws or (ii) brought before the meeting by the presiding officer or by or at the direction of a majority of the Whole Board. The determination of whether any business sought to be brought before any annual or special meeting of the stockholders is properly brought before such meeting will be made by the presiding officer of the meeting. If the presiding officer determines that any business is not properly brought before such meeting, he or she will so declare at the meeting and any such business will not be conducted or considered.
149
     

Exhibit 3.02

Section 2.7. Stockholder Nominations and Proposals. (a) No proposal for a stockholder vote shall be submitted by a stockholder (a "Stockholder Proposal") to the Corporation's stockholders unless the stockholder submitting such proposal (the "Proponent") shall have filed a written notice setting forth with particularity (i) the names and business addresses of the Proponent and all Persons (as such term is defined in Article V of the Certificate of Incorporation) acting in concert with the Proponent; (ii) the name and address of the Proponent and the Persons identified in clause (i), as they appear on the Corporation's books (if they so appear); (iii) the class and number of shares of the Corporation beneficially owned by the Proponent and the Persons identified in clause (i); (iv) a description of the Stockholder Proposal containing all material information relating thereto; and (v) such other information as the Board of Directors reasonably determines is necessary or appropriate to enable the Board of Directors and stockholders of the Corporation to consider the Stockholder Proposal. The presiding officer at any stockholders' meeting may determine that any Stockholder Proposal was not made in accordance with the procedures prescribed in these Bylaws or is otherwise not in accordance with law, and if it is so determined, such officer shall so declare at the meeting and the Stockholder Proposal shall be disregarded.
150
     

Exhibit 3.02


(b) Only persons who are selected and recommended by the Board of Directors or the committee of the Board of Directors designated to make nominations, or who are nominated by stockholders in accordance with the procedures set forth in this Section 2.7, shall be eligible for election, or qualified to serve, as directors. Nominations of individuals for election to the Board of Directors of the Corporation at any annual meeting or any special meeting of stockholders at which directors are to be elected may be made by any stockholder of the Corporation entitled to vote for the election of directors at that meeting by compliance with the procedures set forth in this Section 2.7. Nominations by stockholders shall be made by written notice (a "Nomination Notice"), which shall set forth (i) as to each individual nominated, (A) the name, date of birth, business address and residence address of such individual; (B) the business experience during the past five years of such nominee, including his or her principal occupations and employment during such period, the name and principal business of any corporation or other organization in which such occupations and employment were carried on, and such other information as to the nature of his or her responsibilities and level of professional competence as may be sufficient to permit assessment of his or her prior business experience; (C) whether the nominee is or has ever been at any time a director, officer or owner of 5% or more of any class of capital stock, partnership interests or other equity interest of any corporation, partnership or other entity; (D) any directorships held by such nominee in any company with a class of securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, or subject to the requirements of Section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940, as amended; (E) whether, in the last five years, such nominee has been convicted in a criminal proceeding or has been subject to a judgment, order, finding or decree of any federal, state or other governmental entity, concerning any violation of federal, state or other law, or any proceeding in bankruptcy, which conviction, order, finding, decree or proceeding may be material to an evaluation of the ability or integrity of the nominee; and (F) all information relevant to a determination of the nominee's status as to "independence," including references to the criteria established by the New York Stock Exchange (or any other exchange or quotation system on which the Corporation's equity securities are then listed or quoted) and the Corporation's Corporate Governance Guidelines, in each case as in effect at the time of such Stockholder Nomination; and (ii) as to the Person submitting the Nomination Notice and any Person acting in concert with such Person, (x) the name and business address of such Person, (y) the name and address of such Person as they appear on the Corporation's books (if they so appear), and (z) the class and number of shares of the Corporation that are beneficially owned by such Person. A written consent to being named in a proxy statement as a nominee, and to serve as a director if elected, signed by the nominee, shall be filed with any Nomination Notice. If the presiding officer at any stockholders' meeting determines that a nomination was not made in accordance with the procedures prescribed by these Bylaws, he shall so declare to the meeting and the defective nomination shall be disregarded.

151

     

  Exhibit 3.02

 

 
(c) In the case of an annual meeting of stockholders, Nomination Notices and Stockholder Proposals shall be delivered to the Secretary at the principal executive office of the Corporation not less than 45 days prior to the date on which the notice of the immediately preceding year's annual meeting of stockholders was first sent to the stockholders of the Corporation. In the case of a special meeting of stockholders, Nomination Notices and Stockholder Proposals shall be delivered to the Secretary at the principal executive office of the Corporation no later than the close of business on the 15th day following the day on which notice of the date of a special meeting of stockholders was given.

Section 2.8. Voting . Unless otherwise provided in a resolution or resolutions providing for any class or series of Preferred Stock pursuant to Article IV of the Certificate of Incorporation or by the Delaware General Corporation Law, each stockholder shall be entitled to one vote, in person or by proxy, for each share held of record by such stockholder who is entitled to vote generally in the election of directors. Each stockholder voting by proxy shall grant such authority in writing, by electronic or telephonic transmission or communication, or by any such other means permitted by the Delaware General Corporation Law. All elections for the Board of Directors shall be decided by a plurality of the votes cast and all other questions shall be decided by a majority of the votes cast, except as otherwise required by the Delaware General Corporation Law or as provided for in the Certificate of Incorporation or these Bylaws. Abstentions shall not be considered to be votes cast.

Section 2.9. Inspectors. The Board of Directors by resolution shall, in advance of any meeting of stockholders, appoint one or more inspectors, which inspector or inspectors may include individuals who serve the Corporation in other capacities, including, without limitation, as officers, employees, agents or representatives of the Corporation, to act at the meeting and make a written report thereof. One or more persons may be designated by the Board of Directors as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before discharging his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors shall have the duties prescribed by the Delaware General Corporation Law.

SECTION III

Board of Directors

152
     

Exhibit 3.02

Section 3.1. Number and Qualifications . The business and affairs of the Corporation shall be managed by or under the direction of its Board of Directors. The number of directors constituting the Board of Directors shall be as authorized from time to time exclusively by a vote of a majority of the members of the Board of Directors then in office. The maximum number of consecutive three-year terms of office that may be served by any director is three, and for purposes of calculating such maximum number of terms there shall not be counted as a three-year term any service during a partial term for which such director is serving or during any initial term; provided, however, that the Board of Directors is authorized in circumstances it deems appropriate to nominate and thereby render eligible a person for a fourth or subsequent consecutive three-year term. Notwithstanding the foregoing, (i) a person who is not serving as a director shall not be eligible for nomination, appointment, or election if such person has or will have reached age 70 on the date of his or her appointment or election; and (ii) any director reaching the age of 70 during any term of office shall continue to be qualified to serve as a director only until the next annual meeting of stockholders following his or her 70th birthday, provided, however, that the Board of Directors is authorized, in circumstances it deems appropriate and by unanimous approval of all of the directors then in office (excepting the director whose qualification is the subject of the action), to render a director then in office eligible to serve until the next annual meeting of stockholders following his or her 71st birthday.

Section 3.2. Resignation . A director may resign at any time by giving notice, in writing, by electronic transmission or by any other means permitted by the Delaware General Corporation Law, to the Chairman of the Board or to the Secretary. Unless otherwise stated in such notice of resignation, the acceptance thereof shall not be necessary to make it effective; and such resignation shall take effect at the time specified therein or, in the absence of such specification, it shall take effect upon the receipt thereof.

Section 3.3. Regular Meetings . Regular meetings of the Board of Directors may be held without further notice at such time as shall from time to time be determined by the Board of Directors. Unless otherwise determined by the Board of Directors, the locations of the regular meetings of the Board of Directors shall be in Kingsport, Tennessee. A meeting of the Board of Directors for the election of officers and the transaction of such other business as may come before it may be held without notice immediately following the annual meeting of stockholders.

Section 3.4. Special Meetings . Special meetings of the Board of Directors may be called by the Chairman of the Board, or the Vice Chairman or at the request in writing of one third of the members of the Board of Directors then in office.
153
     

Exhibit 3.02


Section 3.5. Notice of Special Meetings . Notice of the date, time and place of each special meeting shall be mailed by regular mail to each director at his designated address at least six days before the meeting; or sent by overnight courier to each director at his designated address at least two days before the meeting (with delivery scheduled to occur no later than the day before the meeting); or given orally by telephone or other means, or by telegraph or telecopy, or by any other means comparable to any of the foregoing, to each director at his designated address at least 24 hours before the meeting; provided, however, that if less than five days' notice is provided and one third of the members of the Board of Directors then in office object in writing prior to or at the commencement of the meeting, such meeting shall be postponed until five days after such notice was given pursuant to this sentence (or such shorter period to which a majority of those who objected in writing agree), provided that notice of such postponed meeting shall be given in accordance with this Section 3.5. The notice of the special meeting shall state the general purpose of the meeting, but other routine business may be conducted at the special meeting without such matter being stated in the notice.

Section 3.6. Place of Meetings . The Board of Directors may hold their meetings and have an office or offices inside or outside of the State of Delaware.

Section 3.7. Telephonic Meeting and Participation . Any or all of the directors may participate in a meeting of the Board of Directors or any committee thereof by conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation shall constitute presence in person at the meeting.

Section 3.8. Action by Directors Without a Meeting . Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted to be taken at any meeting of the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the Board or of such committee, as the case may be, consent thereto in writing, by electronic transmission, or by any other means permitted by the Delaware General Corporation Law, and the writing or writings or, if the consent action is taken by electronic transmission, paper reproductions of such electronic transmissions, are filed with the minutes of proceedings of the Board or committee.
154
     

Exhibit 3.02

Section 3.9. Quorum and Adjournment . A majority of the directors then holding office shall constitute a quorum. The vote of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. Whether or not a quorum is present to conduct a meeting, any meeting of the Board of Directors (including an adjourned meeting) may be adjourned by a majority of the directors present, to reconvene at a specific time and place. It shall not be necessary to give to the directors present at the adjourned meeting notice of the reconvened meeting or of the business to be transacted, other than by announcement at the meeting that was adjourned; provided, however, notice of such reconvened meeting, stating the date, time, and place of the reconvened meeting, shall be given to the directors not present at the adjourned meeting in accordance with the requirements of Section 3.5 hereof.

Section 3.10. Organization . The Chairman of the Board, or, in the absence of the Chairman of the Board, the Vice Chairman, or in the absence of the Vice Chairman, a member of the Board selected by the members present, shall preside at meetings of the Board. The Secretary of the Corporation shall act as secretary, but in the absence of the Secretary, the presiding officer may appoint a secretary.

Section 3.11. Compensation of Directors . Directors shall receive such compensation for their services as the Board of Directors may determine. Any director may serve the Corporation in any other capacity and receive compensation therefor.

Section 3.12. Presumption of Assent . A director of the Corporation who is present at a meeting of the Board of Directors when a vote on any matter is taken is deemed to have assented to the action taken unless he votes against or abstains from the action taken, or unless at the beginning of the meeting or promptly upon arrival the director objects to the holding of the meeting or transacting specified business at the meeting. Any such dissenting votes, abstentions or objections shall be entered in the minutes of the meeting.


SECTION IV

Committees

155
     

Exhibit 3.02

Section 4.1. Committees . The Board of Directors may, by resolutions passed by a majority of the members of the Board of Directors, designate members of the Board of Directors to constitute other committees which shall in each case consist of such number of directors, and shall have and may execute such powers as may be determined and specified in the respective resolutions appointing them. Any such committee may fix its rules of procedure, determine its manner of acting and the time and place, whether within or without the State of Delaware, of its meetings and specify what notice thereof, if any, shall be given, unless the Board of Directors shall otherwise by resolution provide. Unless otherwise provided by the Board of Directors or such committee, the quorum, voting and other procedures shall be the same as those applicable to actions taken by the Board of Directors. A majority of the members of the Board of Directors then in office shall have the power to change the membership of any such committee at any time, to fill vacancies therein and to discharge any such committee or to remove any member thereof, either with or without cause, at any time.


SECTION V

Officers

Section 5.1. Designation. The officers of the Corporation shall be a Chairman of the Board of Directors, a Chief Executive Officer, a Chief Financial Officer, a Treasurer, a Controller, and a Secretary, and such other officers as the Board of Directors may elect or appoint, or provide for the appointment of, as may from time to time appear necessary or advisable in the conduct of the business and affairs of the Corporation. Any number of offices may be held by the same persons, except that the Chairman of the Board must be a director of the Corporation and may also be the Chief Executive Officer.

Section 5.2. Election Term. At its first meeting after each annual meeting of stockholders, the Board of Directors shall elect the officers or provide for the appointment thereof. Subject to Section 5.3 and Section 5.4 hereof, the term of each officer elected by the Board of Directors shall be until the first meeting of the Board of Directors following the next annual meeting of stockholders and until such officer’s successor is chosen and qualified.

Section 5.3. Resignation. Any officer may resign at any time by giving written notice to the Secretary. Unless otherwise stated in such notice of resignation, the acceptance thereof shall not be necessary to make it effective; and such resignation shall take effect at the time specified therein or, in the absence of such specification, it shall take effect upon the receipt thereof.

156
     

Exhibit 3.02

Section 5.4. Removal. Any officer may be removed at any time with or without cause by affirmative vote of a majority of the members of the Board of Directors then in office. Any officer appointed by another officer may be removed with or without cause by such officer or the Chief Executive Officer.

Section 5.5. Vacancies. A vacancy in any office may be filled for the unexpired portion of the term by the Board of Directors or, in the case of offices held by officers who may be appointed by other officers, by any officer authorized to appoint such officer.

Section 5.6. Chief Executive Officer. The Chief Executive Officer shall be responsible for carrying out the policies adopted by the Board of Directors.

Section 5.7. Chairman of the Board. The Chairman of the Board shall have such powers and perform such duties as may be provided for herein and as may be incident to the office and as may be assigned by the Board of Directors.

Section 5.8. Chief Financial Officer. The Chief Financial Officer shall act in an executive financial capacity, and assist the Chief Executive Officer in the general supervision of the Corporation’s financial policies and affairs, and shall perform all acts incident to the position of Chief Financial Officer, subject to the control of the Board of Directors.

Section 5.9. Treasurer. The Treasurer shall have charge of all funds of the Corporation and shall perform all acts incident to the position of Treasurer, subject to the control of the Board of Directors.

Section 5.10. Controller. The Controller shall serve as principal accounting officer of the Corporation, having the custody and operation of the accounting books and records of the Corporation, and shall perform all acts incident to the position of Controller, subject to the control of the Board of Directors.

Section 5.11. Secretary. The Secretary shall keep the minutes, and give notices, of all meetings of stockholders and directors and of such committees as directed by the Board of Directors. The Secretary shall have charge of such books and papers as the Board of Directors may require. The Secretary (or any Assistant Secretary) is authorized to certify copies of extracts from minutes and of documents in the Secretary’s charge and anyone may rely on such certified copies to the same effect as if such copies were originals and may rely upon any statement of fact concerning the Corporation certified by the Secretary (or any Assistant Secretary). The Secretary shall perform all acts incident to the office of Secretary, subject to the control of the Board of Directors.

157
     

Exhibit 3.02

Section 5.12. Compensation of Officers. The officers of the Corporation shall receive such compensation for their services as the Board of Directors or the appropriate committee thereof may determine. The Board of Directors may delegate its authority to determine compensation to designated officers of the Corporation.

Section 5.13. Execution of Instruments. Checks, notes, drafts, other commercial instruments, assignments, guarantees of signatures and contracts (except as otherwise provided herein or by law) shall be executed by the Chief Executive Officer or other officers or employees or agents, in any such case as the Board of Directors may direct or authorize.

Section 5.14. Mechanical Endorsements. The Chief Executive Officer, the Secretary, or other authorized officers may authorize any endorsement on behalf of the Corporation to be made by such mechanical means or stamps as any of such officers may deem appropriate.


SECTION VI

Indemnification

Section 6.1. Indemnification Provisions in Certificate of Incorporation . The provisions of this Section VI are intended to supplement Article VII of the Certificate of Incorporation pursuant to Sections 7.2 and 7.3 thereof. To the extent that this Section VI contains any provisions inconsistent with said Article VII, the provisions of the Certificate of Incorporation shall govern. Terms defined in such Article VII shall have the same meaning in this Section VI.

Section 6.2. Indemnification of Employees . The Corporation shall indemnify and advance expenses to its employees to the same extent as to its directors and officers, as set forth in the Certificate of Incorporation and in this Section VI of the Bylaws of the Corporation.

Section 6.3. Undertakings for Advances of Expenses . If and to the extent the Delaware General Corporation Law requires, an advancement by the Corporation of expenses incurred by an indemnitee pursuant to clause (iii) of the last sentence of Section 7.1 of the Certificate of Incorporation (hereinafter an "advancement of expenses") shall be made only upon delivery to the Corporation of an undertaking (hereinafter an "undertaking"), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter a "final adjudication") that such indemnitee is not entitled to be indemnified for such expenses under Article VII of the Certificate of Incorporation or otherwise.
158
     

Exhibit 3.02


Section 6.4. Claims for Indemnification . If a claim for indemnification under Section 7.1 of the Certificate of Incorporation is not paid in full by the Corporation within 60 days after it has been received in writing by the Corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be 20 days, the indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and in any suit by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking the Corporation shall be entitled to recover such expenses only upon a final adjudication that, the indemnitee has not met the applicable standard of conduct set forth in Section 145 of the Delaware General Corporation Law (or any successor provision or provisions). Neither the failure of the Corporation (including the Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in Section 145 of the Delaware General Corporation Law (or any successor provision or provisions), nor an actual determination by the Corporation (including the Board of Directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to have or retain such advancement of expenses, under Article VII of the Certificate of Incorporation or this Section VI or otherwise, shall be on the Corporation.

Section 6.5. Insurance . The Corporation may maintain insurance, at its expense, to protect itself and any director, trustee, officer, employee or agent of the Corporation or another enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law.

Section 6.6. Severability . In the event that any of the provisions of this Section VI (including any provision within a single section, paragraph or sentence) is held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, the remaining provisions are severable and shall remain enforceable to the full extent permitted by law.
159
     

Exhibit 3.02



SECTION VII

Miscellaneous

Section 7.1. Seal . The Corporation shall have a suitable seal, containing the name of the Corporation. The Secretary shall be in charge of the seal and may authorize one or more duplicate seals to be kept and used by any other officer or person.

Section 7.2. Waiver of Notice . Whenever any notice is required to be given, a waiver thereof in writing, signed by the person or persons entitled to the notice, whether before or after the time stated therein shall be deemed equivalent thereto. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened.

Section 7.3. Voting of Stock Owned by the Corporation . Powers of attorney, proxies, waivers of notice of meeting, consents and other instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chairman of the Board, the Vice Chairman, any Vice President or such officers or employees or agents as the Board of Directors or any of such designated officers may direct. Any such officer may, in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by proxy at any meeting of security holders of any corporation in which the Corporation may own securities and at any such meeting shall possess and may exercise any and all rights and powers incident to the ownership of such securities and which, as the owner thereof, the Corporation might have exercised and possessed if present. The Board of Directors may from time to time confer like powers upon any other person or persons.


SECTION VIII

Amendment of Bylaws

160
     

Exhibit 3.02

Section 8.1. Power to Amend. Except as otherwise provided by law or by the certificate of incorporation or these bylaws, these bylaws or any of them may be amended in any respect or repealed at any time, either (i) at any meeting of stockholders, subject to these bylaws, provided that any amendment or supplement proposed to be acted upon at any such meeting has been described in reasonable detail in the notice of such meeting, or (ii) at any meeting of the Board of Directors, provided in all events that any action relating to the last sentence of Section 3.1 hereof concerning the age 70 qualification limitation on Board service shall require the vote of 100% of the directors then in office, and provided further in all events that no amendment to any by-law that conflicts or varies with, or frustrates the purposes or effect of, any provision of the certificate of incorporation or other provisions of these bylaws may be adopted (including, without limitation, any bylaw the purpose or effect of which is to require approvals of matters by supermajority vote of the Board of Directors or a committee) without amendment of such provision of the certificate of incorporation or other provision of the bylaws in accordance with applicable law and, to the extent otherwise applicable, these bylaws.

Section 8.2. Approval of Amendments. Notwithstanding the foregoing and anything contained in these bylaws to the contrary, these bylaws may not be amended, supplemented, or repealed by the stockholders, and no provision inconsistent in intent, operation, or effect therewith may be adopted by the stockholders, without the affirmative vote of the holders of at least 80% of the stock of the Corporation of any class or series entitled to vote generally in the election of the directors of the Board of Directors, voting together as a single class. Notwithstanding anything contained in these bylaws to the contrary, the affirmative vote of the holders of at least 80% of the stock of the Corporation of any class or series entitled to vote generally in the election of the directors of the Board of Directors, voting together as a single class, is required to amend, supplement or repeal, or to adopt any provisions inconsistent with, this section.

161
     

Exhibit 10.09
 
EASTMAN CHEMICAL COMPANY

EASTMAN UNIT PERFORMANCE PLAN
(amended and restated effective January 1, 2004)


ARTICLE 1. PURPOSE

Total cash compensation for all Company employees, including Plan participants, is intended to be competitive with pay in the applicable labor market and in the chemical industry for similar jobs when target levels of performance are achieved. The Eastman Unit Performance Plan ("UPP", or the "Plan") is a variable compensation plan for management level individuals at Eastman Chemical Company (the "Company") and subsidiaries of the Company, as recommended by the Chief Executive Officer ("CEO")) and as designated by the Compensation and Management Development Committee (the "Committee") of the Board of Directors. It is designed to deliver a portion of annual cash compensation according to corporate and organizational unit performance and the attainment of individual objectives and expectations. The UPP is intended to provide an incentive for superior business and individual performance, and to tie the interests of management-level individuals to the performance of the Company's businesses and, thereby, the interests of the Company and its shareowners.

ARTICLE 2. SUMMARY OF PLAN DESIGN

The UPP is designed so that a pool of dollars ("Award Pool") is generated for each major functional organization (a "Unit") within the Company. For purposes of this plan, the CEO shall be a participant in the CEO Unit Award Pool, and the Committee shall be the "head" and "management" of the CEO Unit.

A Unit Award Pool will be determined by multiplying, for each participant in a Unit:

  1. Each participant’s annual base pay rate on December 31 of the year in which Company and Unit performance is measured (the "Performance Year"), times

  1. The participant’s "UPP Target Award Percentage", which is a target award percentage, expressed as a percentage of annual base rate, and determined by the participant’s salary grade, times

  1. A "Unit Performance Factor", expressed as a percentage and determined by pre-set corporate and/or specified organizational unit ("Business Group Units") performance goals. Generally, the Performance Factor can range from 0%, if performance goals are not met, up to the maximum performance factor of 250% for each UPP measure.

The Unit Award Pool is then determined by summing the result of 1) multiplied by 2) multiplied by 3) for each participant in the Unit.

The performance goals and correlative Performance Factors for each Unit will be established as soon as practicable, either prior to the beginning of each Performance Year or as soon as reasonably determinable at the beginning of the Performance Year. The performance goals and correlative Performance Factors are established by the Committee, based (in all cases except for the CEO) upon the recommendation of the CEO.

162

     

Exhibit 10.09
 
At the end of each Performance Year, the Committee will certify performance in relation to the pre-established performance goals, thereby determining the Performance Factor and Award Pool for each Unit. The CEO, after consultation with the Company executive officers with management responsibility for the affected Units, will determine whether, in his discretion, any adjustments to the amounts of any of the Unit Award Pools is appropriate. Once the amount of each Unit Award Pool has been determined within each Unit, management will exercise discretion in allocating the Award Pool for individual payouts. The payouts will be based on the attainment of individual objectives and expectations established at the beginning of such Performance Year by Unit management for each individual participant. Maximum potential for an individual award could exceed an individual’s assigned UPP Target Award Percentage multiplied by the Unit Performance Factor, based on management's assessment of individual performance. However, except in the case of the CEO Unit Award Pool and the Unit Award Pool for the executive officers, the sum of all individual awards cannot exceed the sum of all Unit Award Pools. As the Committee approves executive officer awards and determines the CEO award, it may, in its discretion, adjust the CEO Unit Award Pool and the Unit Award Pool for the executive officers. Any adjustment to these Unit Award Pools will result in an adjustment to the sum of all Unit Award Pools for the Company.

ARTICLE 3. ELIGIBILITY AND PARTICIPATION

3.01 General Eligibility

The UPP is designed for management-level individuals who have an impact on the financial performance of the Company. Prior to or at the time performance goals are established for a Performance Year, the Committee, upon the recommendation of the CEO, will confirm in writing the eligibility criteria for participation in the UPP for such Performance Year and the portion of each participant's total annual compensation that is variable under the Plan.

3.02 New Participants and Job Changes During the Performance Year

Individuals who are appointed to positions eligible for UPP participation during the Performance Year become eligible for participation on the first day of the month of the appointment. Individuals who become participants during the Performance Year will be eligible to receive a UPP award based on the discretion of Unit management. Each participant's "Target UPP Variable Pay", (for each participant, 1) his or her annual base pay rate, 2) multiplied by his or her UPP Target Award Percentage, 3) multiplied by the Unit Performance Factor(s)) will be allocated to a Unit Award Pool based upon the following process:

I.       The Performance Year will be divided into four, three-month (quarterly) intervals (January 1 to March 31; April 1 to June 30; July 1 to September 30; and October 1 to December 31)

II.       Anyone promoted into UPP, who changes UPP participation level, or who moves between Units at any time during one of these three-month intervals will have a portion of his/her Target UPP Variable Pay allocated to a Unit Award Pool as follows:

Table 1. Promotion into UPP
 
Quarter
 
Date of Promotion
 
Prorated Percent of Target UPP Variable Pay Allocated to Unit Award Pool



1st
January 1 - March 31
100%



2nd
April 1 - June 30
75%



3rd
July 1 - September 30
50%



4th
October 1 - December 31
25%




163

     

Exhibit 10.09
 
Table 2. Change in UPP participation level
 
Quarter
 
Date of Change in UPP participation level
Percent of Target UPP Variable Pay Prior to Change Allocated to Unit Award Pool
Percent of New Target UPP Variable Pay After the Change Allocated to Unit Award Pool




1st
January 1 - March 31
0%
100%




2nd
April 1 - June 30
25%
75%




3rd
July 1 - September 30
50%
50%




4th
October 1 - December 31
75%
25%





Table 3. Terminations
 
Quarter
 
Date of Termination
 
Prorated Percent of Target UPP Variable Pay Allocated to Unit Award Pool



1st
January 1 - March 31
25%



2nd
April 1 - June 30
50%



3rd
July 1 - September 30
75%



4th
October 1 - December 31
100%





3.03 Terminations

In the event an eligible participant (1) retires, (2) dies, (3) becomes disabled under the Eastman Long-Term Disability Plan, or (4) terminates employment as a result of, pursuant to, or in connection with layoff, special separation, divestiture, or similar circumstances, such person's Target UPP Variable Pay will be allocated to his or her Unit's Award Pool for such Performance Year in accordance with the process outlined in Section 3.02, Part II, Table 3, under the column " Prorated Percent of Target UPP Variable Pay Allocated to Unit Award Pool ." He/she will be eligible to receive a UPP award for such Performance Year at the sole discretion of the Unit management.

Participants who terminate employment with the Company for reasons other than those specified under this Section 3.03 will be credited to a Unit Award Pool and be eligible to receive an award under the UPP only if they were actively employed on the last scheduled workday of the Performance Year.

ARTICLE 4. PERFORMANCE YEAR AND PERFORMANCE GOALS

4.01 Performance Year

The Plan's Performance Year shall be the calendar year beginning on January 1 and ending on December 31.

4.02 Performance Goals

Each year, the CEO will recommend to the Committee performance goals for each Unit for a given Performance Year. Such performance goals may be for one or more Units, for the Company as a whole, or for a combination of one or more Units and the Company. Either by the first day of the Performance Year, or such later date as is practicable, the Committee shall establish in writing, with respect to the Performance Year, a target objective(s) with respect to such performance goals and formulae or methods for computing the applicable Performance Factor(s) based on the extent to which such performance goals are attained. Performance Factors can range from 0%, if performance goals are not met, to the maximum performance factors for each UPP measure. Performance goals for each measure may be based upon any quantitative and objectively determinable business or financial criteria, alone or in combination, as the CEO and the Unit heads shall deem appropriate.

Once established, performance goals for a particular Performance Year cannot be changed during the Performance Year.

164

     

Exhibit 10.09
 
ARTICLE 5. AWARD DETERMINATION

5.01       Certification of Performance

As soon as practicable following the availability of performance results for the completed Performance Year, the Committee shall certify performance in relation to the pre-established goals, thereby determining the Performance Factor(s) and Award Pools for each Unit. To the extent the performance goals are expressed in standard accounting terms, they shall be measured according to generally accepted accounting principles as in existence on the date on which the performance goals are established and without regard to any changes in such principles after such date.

In determining whether the performance goals have been met, to the extent that such goals are expressed in terms of financial performance, the Committee may adjust the financial results for a Performance Year to exclude the effect of unusual charges or income items or other events which are distortive of financial results for the Performance Year. Notwithstanding actual performance, the Committee may, in its sole discretion, adjust the amounts of the Unit Award Pools to reflect overall Company performance and business and financial conditions.

5.02       Calculation of Unit Award Pool and Individual Awards; Report to Committee

Based upon Company and/or Unit performance against the performance goals, the Performance Factors are determined as provided in Sections 4.02 and 5.01. The amount generated for each Unit Award Pool will equal the aggregate of the Target UPP Variable Pay for each eligible participant in the Unit. The CEO, after consultation with the Company executive officers with management responsibility for the affected Units, will determine whether, in his discretion, any adjustments to the amounts of any of the Unit Award Pools is appropriate. Once the amount of each Unit Award Pool has been determined within each Unit, management shall have the sole discretion to allocate the Unit Award Pool among eligible participants, based on objective or subjective assessments of the participants' achievement of pre­established goals and expectations for the Performance Year. If the sum of individual awards as allocated by the Unit management within a particular Unit exceeds the Award Pool amount for that Unit, the Unit management shall make adjustments to individual awards to account for the difference. In certain circumstances (e.g. participants transferring between Units), however, awards in a Unit may exceed the Unit Award Pool. As a result, corresponding adjustments must be made to another Unit Award Pool. The sum of all individual awards shall not exceed the sum of all Unit Award Pools for the Company. Final allocations of the Unit Award Pools shall be reported to the CEO, who shall report the UPP results to the Committee. The Committee shall approve the UPP award amounts for all executive officers of the Company, and shall determine the UPP Award amount for the CEO. As the Committee approves executive officer awards and determines the CEO award, it may, in its discretion, adjust the CEO Unit Award Pool and the Unit Award Pool for the executive officers. Any adjustment to these Unit Award Pools will result in an adjustment to the sum of all Unit Award Pools for the Company.

ARTICLE 6. PAYMENT OF AWARDS

UPP awards shall be paid by the' Company in March for performance in the previous Performance Year, based upon the Unit management's allocation of awards from the Unit Award Pools. The Committee has the authority, in its discretion, to defer payment of a participant's award into the Executive Deferred Compensation Plan until the participant retires or otherwise terminates employment, if the Committee determines that payment of the award could result in the participant receiving compensation in excess of the maximum amount deductible by the Company for Federal income tax purposes.

165

     

Exhibit 10.09
 
ARTICLE 7. SALARY ADJUSTMENTS AND BENEFITS

7.01       Salary Adjustment Upon Entry Into the UPP

The UPP is a variable compensation program whereby participants may earn compensation based upon corporate, organizational, and individual performance. New participants to the Plan are immediately administered on the appropriate rate schedule for their assigned salary grade. This may reduce or eliminate promotional increases, depending upon the person's pay position in the rate range of the new salary grade. Subsequent salary treatment will depend upon pay/performance relationships for their assigned grade.

7.02       Salary Conversion Upon Withdrawal From the UPP

In unusual circumstances when it is necessary for an individual to be removed from the Plan, the individual's base salary and target annual cash compensation will be reviewed to ensure competitiveness with pay in the applicable labor market and in the chemical industry for similar jobs when target levels of performance are achieved. Should the removal from the Plan involve a reduction in salary grade, base salary in the new salary grade will be selected based upon the individual's applicable training and experience.

7.03       Relationship to Benefits

The UPP award payout is considered in calculating the basis for calculation of certain benefits. For participants who are U. S.-based employees, base salary, the actual UPP payout (if applicable), the actual Annual Performance Plan ("APP") payout (if applicable), and the actual Eastman Performance Plan ("EPP") payout (if applicable), are included in calculating retirement benefits. For, Participants who are non-U.S.-based employees, generally retirement benefits are calculated using only base salary plus amounts earned under the UPP, and APP, and EPP; however, some countries have different rules concerning the pay that must be counted in calculating retirement benefits, and non-U.S. based employees should contact their human resources representatives if they have questions.

ARTICLE 8. OTHER TERMS AND CONDITIONS

8.01 Claims

No person shall have any legal claim to be granted an award under the Plan. Except as may be otherwise required by law, payouts under the Plan shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, charge, garnishment, execution, or levy of any kind, either voluntary or involuntary. Plan payouts shall be payable from the general assets of the Company and no participant shall have any claim with respect to any specific assets of the Company.

8.02       No Employment Rights

Neither the UPP nor any action taken under the UPP shall be construed as giving any employee the right to be retained in the employ of the Company or to maintain any participant's compensation at any level.

8.03 Withholding

For Participants who are U.S.-based employees, the Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy Federal, state, and local taxes (including the participant's OASDI and MEDI obligation) required by law to be withheld. For Participants who are non-U. S. based employees, the Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy all applicable foreign and local taxes required by law to be withheld.

166

     

Exhibit 10.09
 

ARTICLE 9. ADMINISTRATION

9.01       Power and Authority of the Committee

The Committee shall have full power and authority to administer and interpret the provisions of the Plan and to adopt such rules, regulations, agreements, guidelines, and instruments for the administration of the Plan and for conduct of its business as the Committee deems appropriate or advisable. The Committee sets and interprets policy, confirms the individual participants in the UPP and the amounts of variable pay under the UPP, establishes annual performance measures and performance goals, certifies the extent to which performance goals were satisfied under the Plan, and approves the UPP award amounts to participants who are executive officers of the Company.

9.02       Committee's Delegation of Authority

The Committee shall have full power to delegate to any officer or employee of the Company the authority to administer and interpret the procedural aspects of the Plan, subject to the Plan's terms, including adopting and enforcing rules to decide procedural and administrative issues.

9.03       Amending or Terminating the Plan

By action of the Committee, the Plan may be amended, modified, suspended, or terminated, in whole or in part, at any time for any reason.

ARTICLE 10. PLAN AUDIT

The Senior Vice President, Human Resources, has responsibility for monitoring and reporting on the administration and effectiveness of the Plan. The Senior Vice President's role is to provide independent, objective appraisal and guidance to both the Committee and the CEO, in the administration of the UPP. Each year, the Senior Vice President will provide a formal review to the Committee end the CEO on the overall effectiveness of the UPP.
 

167


Exhibit 10.25
 

DIRECTOR/OFFICER INDEMNIFICATION AGREEMENT
 
This [Director] [Officer] Indemnification Agreement, dated as of ___________ , 200__ (this " Agreement "), is made by and between Eastman Chemical Company, a Delaware corporation (the " Company "), and _____________________ (" Indemnitee ").
RECITALS :
 
A.    Section 141 of the Delaware General Corporation Law provides that the business and affairs of a corporation shall be managed under the direction of its board of directors.
 
B.    Pursuant to Sections 141 and 142 of the Delaware General Corporation Law, significant authority with respect to the management of the Company has been delegated to the officers of the Company.
 
C.    By virtue of the managerial prerogatives vested in the directors and officers of a Delaware corporation, directors and officers act as fiduciaries of the corporation and its stockholders.
 
D.    Thus, it is critically important to the Company and its stockholders that the Company be able to attract and retain the most capable persons reasonably available to serve as directors and officers of the Company.
 
E.    In recognition of the need for corporations to be able to induce capable and responsible persons to accept positions in corporate management, Delaware law authorizes (and in some instances requires) corporations to indemnify their directors and officers, and further authorizes corporations to purchase and maintain insurance for the benefit of their directors and officers.
 
F.    The Delaware courts have recognized that indemnification by a corporation serves the dual policies of (1) allowing corporate officials to resist unjustified lawsuits, secure in the knowledge that, if vindicated, the corporation will bear the expense of litigation and (2) encouraging capable women and men to serve as corporate directors and officers, secure in the knowledge that the corporation will absorb the costs of defending their honesty and integrity.
 
G.    The number of lawsuits challenging the judgment and actions of directors and officers of Delaware corporations, the costs of defending those lawsuits and the threat to directors’ and officers’ personal assets have all materially increased over the past several years, chilling the willingness of capable women and men to undertake the responsibilities imposed on corporate directors and officers.
 
H.    Recent federal legislation and rules adopted by the Securities and Exchange Commission and the national securities exchanges have exposed such directors and officers to new and substantially broadened civil liabilities.
 

168

     

Exhibit 10.25
 
I.    Under Delaware law, a director’s and officer’s right to be reimbursed for the costs of defense of criminal actions, whether such claims are asserted under state or federal law, does not depend upon the merits of the claims asserted against the director or officer and is separate and distinct from any right to indemnification the director or officer may be able to establish.
 
J.    Indemnitee is, or will be, a director and officer of the Company and his/her willingness to serve in such capacity is predicated, in substantial part, upon the Company’s willingness to indemnify him/her in accordance with the principles reflected above, to the fullest extent permitted by the laws of the state of Delaware, and upon the other undertakings set forth in this Agreement.
 
K.    Therefore, in recognition of the need to provide Indemnitee with substantial protection against personal liability, in order to procure Indemnitee’s continued service as a director and officer of the Company and to enhance Indemnitee’s ability to serve the Company in an effective manner, and in order to provide such protection pursuant to express contract rights (intended to be enforceable irrespective of, among other things, any amendment to the Company’s certificate of incorporation or bylaws (collectively, the " Constituent Documents "), any change in the composition of the Company’s Board of Directors (the " Board ") or any change-in-control or business combination transaction relating to the Company), the Company wishes to provide in this Agreement for the indemnification of and the advancement of Expenses to Indemnitee as set forth in this Agreement and for the continued coverage of Indemnitee under the Company’s directors’ and officers’ liability insurance policies.
 
L.    In light of the considerations referred to in the preceding recitals, it is the Company’s intention and desire that the provisions of this Agreement be construed liberally, subject to their express terms, to maximize the protections to be provided to Indemnitee hereunder.
 
AGREEMENT :
 
NOW, THEREFORE, the parties hereby agree as follows:  
 
1.  Certain Definitions. In addition to terms defined elsewhere herein, the following terms have the following meanings when used in this Agreement with initial capital letters:
 

 169

     

Exhibit 10.25
 
   (a)  "Change in Control" means the occurrence after the date of this Agreement of any of the following events:
 
     (i)    the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person" ) of Beneficial Ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) ("Beneficial Ownership") of 15% or more of the combined voting power of the then-outstanding Voting Stock of the Company; provided , however , that:
 
       (A)   for purposes of this Section 1(a)(i), the following acquisitions shall not constitute a Change in Control: (1) any acquisition of Voting Stock of the Company directly from the Company that is approved by a majority of the Incumbent Directors, (2) any acquisition of Voting Stock of the Company by the Company or any Subsidiary, (3) any acquisition of Voting Stock of the Company by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary, and (4) any acquisition of Voting Stock of the Company by any Person pursuant to a Business Combination that complies with clauses (1), (2) and (3) of Section 1(a)(iii) below;
 
    (B)    if any Person acquires Beneficial Ownership of 15% or more of combined voting power of the then-outstanding Voting Stock of the Company as a result of a transaction described in clause (A)(1) of Section 1(a)(i) and such Person thereafter becomes the Beneficial Owner of any additional shares of Voting Stock of the Company representing 1% or more of the then-outstanding Voting Stock of the Company, other than in an acquisition directly from the Company that is approved by a majority of the Incumbent Directors or other than as a result of a stock dividend, stock split or similar transaction effected by the Company in which all holders of Voting Stock are treated equally, such subsequent acquisition shall be deemed to constitute a Change in Control;
 
     (C) a Change in Control will not be deemed to have occurred if a Person acquires Beneficial Ownership of 15% or more of the Voting Stock of the Company as a result of a reduction in the number of shares of Voting Stock of the Company outstanding unless and until such Person thereafter becomes the Beneficial Owner of any additional shares of Voting Stock of the Company representing 1% or more of the then-outstanding Voting Stock of the Company, other than in an acquisition directly from the Company that is approved by a majority of the Incumbent Directors or other than as a result of a stock dividend, stock split or similar transaction effected by the Company in which all holders of Voting Stock are treated equally; and

170

     

Exhibit 10.25
 
   (D) if at least a majority of the Incumbent Directors determine that a Person has acquired Beneficial Ownership of 15% or more of the Voting Stock of the Company inadvertently, and such Person divests as promptly as practicable a sufficient number of shares so that such Person Beneficially Owns less than 15% of the Voting Stock of the Company, then no Change in Control shall have occurred as a result of such Person’s acquisition; or
 
     (ii)    a majority of the Directors are not Incumbent Directors; or
 
     (iii)    the consummation of a reorganization, merger or consolidation, or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets of another corporation, or other transaction (each, a "Business Combination" ), unless, in each case, immediately following such Business Combination (A) all or substantially all of the individuals and entities who were the Beneficial Owners of Voting Stock of the Company immediately prior to such Business Combination Beneficially Own, directly or indirectly, more than 60% of the combined voting power of the then outstanding shares of Voting Stock of the entity resulting from such Business Combination (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries), (B) no Person (other than the Company, such entity resulting from such Business Combination, or any employee benefit plan (or related trust) sponsored or maintained by the Company, any Subsidiary or such entity resulting from such Business Combination) Beneficially Owns 15% or more of the combined voting power of the then outstanding shares of Voting Stock of the entity resulting from such Business Combination, and (C) a majority of the members of the Board of Directors of the entity resulting from such Business Combination were Incumbent Directors at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
 
     (iv)    approval by the stockholders of the Company of a complete liquidation or dissolution of the Company, except pursuant to a Business Combination that complies with clauses (A), (B) and (C) of Section 1(a)(iii).
 

171

     

  Exhibit 10.25

 

 
     (v)    For purposes of this Section 1(a), the following terms shall have the following meanings when used herein with initial capital letters:
(A)    " Exchange Act " shall mean the Securities Exchange Act of 1934, as amended.
 
(B)    "Incumbent Directors" means the individuals who, as of the date hereof, are directors of the Company and any individual becoming a director subsequent to the date hereof (including other Incumbent Directors who first became directors after the date hereof) whose election, nomination for election by the Company’s stockholders, or appointment, was approved by a vote of at least two-thirds of the then Incumbent Directors (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without objection to such nomination); provided , however , that an individual shall not be an Incumbent Director if such individual’s election or appointment to the Board occurs as a result of an actual or threatened election contest (as described in Rule 14a-12(c) of the Exchange Act) with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board.
 
(C)    "Subsidiary" means an entity in which the Company directly or indirectly Beneficially Owns 50% or more of the outstanding Voting Stock.
 
(D)    "Voting Stock" means securities entitled to vote generally in the election of directors (or similar governing bodies).
 
(b)   " Claim " means (i) any threatened, asserted, pending or completed claim, demand, action, suit or proceeding, whether civil, criminal, administrative, arbitrative, investigative or other, and whether made pursuant to federal, state or other law; and (ii) any inquiry or investigation, whether threatened, asserted, pending or completed, by the Company or any other Person, including without limitation any federal, state or other governmental entity, that Indemnitee determines might lead to the institution of any such claim, demand, action, suit or proceeding. For the avoidance of doubt, the Company intends indemnity to be provided hereunder in respect of acts or failure to act prior to, on or after the date hereof.
 
(c) "Controlled Affiliate" means any corporation, limited liability company, partnership, joint venture, trust or other entity or enterprise, whether or not for profit, that is directly or indirectly controlled by the Company. For purposes of this definition, "control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of an entity or enterprise, whether through the ownership of voting securities, through other voting rights, by contract or otherwise; provided that direct or indirect Beneficial Ownership of capital stock or other interests in an entity or enterprise entitling the holder to cast 15% or more of the total number of votes generally entitled to be cast in the election of directors (or persons performing comparable functions) of such entity or enterprise shall be deemed to constitute control for purposes of this definition.
 
 

172

     

  Exhibit 10.25

 

 
(d) " Disinterested Director " means a director of the Company who is not and was not a party to the Claim in respect of which indemnification is sought by Indemnitee.
 
(e) " Expenses " means attorneys’ and experts’ fees and expenses and all other costs and expenses paid or payable in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to investigate, defend, be a witness in or participate in (including on appeal), any Claim.
 
(f) " Indemnifiable Claim " means any Claim based upon, arising out of or resulting from (i) any threatened, asserted, pending or completed claim, demand, action, suit, proceeding, inquiry or investigation regarding the act or failure to act by Indemnitee in his or her capacity as a director, officer, employee or agent of the Company or as a director, officer, employee, member, manager, trustee or agent of any other corporation, limited liability company, partnership, joint venture, trust or other entity or enterprise, whether or not for profit, as to which Indemnitee is or was serving at the request of the Company as a director, officer, employee, member, manager, trustee or agent, (ii) any threatened, asserted, pending or completed claim, demand, action, suit, proceeding, inquiry or investigation regarding the act or failure to act by Indemnitee in respect of any business, transaction, communication, filing, disclosure or other activity of the Company or any other entity or enterprise referred to in clause (i) of this sentence, or (iii) Indemnitee’s status as a current or former director, officer, employee or agent of the Company or as a current or former director, officer, employee, member, manager, trustee or agent of the Company or any other entity or enterprise referred to in clause (i) of this sentence or any actual, alleged or suspected act or failure to act by Indemnitee in connection with any obligation or restriction imposed upon Indemnitee by reason of such status. In addition to any service at the actual request of the Company, for purposes of this Agreement, Indemnitee shall be deemed to be serving or to have served at the request of the Company as a director, officer, employee, member, manager, trustee or agent of another entity or enterprise if Indemnitee is or was serving as a director, officer, employee, member, manager, trustee or agent of such entity or enterprise and (i) such entity or enterprise is or at the time of such service was a Controlled Affiliate, (ii) such entity or enterprise is or at the time of such service was an employee benefit plan (or related trust) sponsored or maintained by the Company or a Controlled Affiliate, or (iii) the Company or a Controlled Affiliate (by action of the Board, any committee thereof or the Company's Chief Executive Officer (" CEO ") (other than as the CEO him or herself)) caused or authorized Indemnitee to be nominated, elected, appointed, designated, employed, engaged or selected to serve in such capacity.
 
(g) " Indemnifiable Losses" means any and all Losses relating to, arising out of or resulting from any Indemnifiable Claim.

173

     

Exhibit 10.25
 
(h) " Independent Counsel " means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company (or any Subsidiary) or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements) or (ii) any other named (or, as to a threatened matter, reasonably likely to be named) party to the Indemnifiable Claim giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term "Independent Counsel" shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.
 
(i) " Losses " means any and all Expenses, damages, losses, liabilities, judgments, fines, penalties (whether civil, criminal or other) and amounts paid or payable in settlement, including without limitation all interest, assessments and other charges paid or payable in connection with or in respect of any of the foregoing.
 
2.  Indemnification Obligation. Subject only to Section 7 and to the proviso in this Section, the Company shall indemnify, defend and hold harmless Indemnitee, to the fullest extent permitted or required by the laws of the State of Delaware in effect on the date hereof or as such laws may from time to time hereafter be amended to increase the scope of such permitted indemnification, against any and all Indemnifiable Claims and Indemnifiable Losses; provided , however , that, except as provided in Sections 5 and 20, Indemnitee shall not be entitled to indemnification pursuant to this Agreement in connection with any Claim initiated by Indemnitee against the Company or any director or officer of the Company unless the Company has joined in or consented to the initiation of such Claim. The Company acknowledges that the foregoing obligation is substantially broader than that now provided by applicable law and the Company’s Constituent Documents and intends that it be interpreted consistently with this Section and the recitals to this Agreement.

174

     

Exhibit 10.25
 
3.  Advancement of Expenses. Indemnitee shall have the right to advancement by the Company prior to the final disposition of any Indemnifiable Claim of any and all Expenses relating to, arising out of or resulting from any Indemnifiable Claim paid or incurred by Indemnitee or which Indemnitee determines are reasonably likely to be paid or incurred by Indemnitee. Without limiting the generality or effect of any other provision hereof, Indemnitee’s right to such advancement is not subject to the satisfaction of any standard of conduct. Without limiting the generality or effect of the foregoing, within five business days after any request by Indemnitee, the Company shall, in accordance with such request (but without duplication), (a) pay such Expenses on behalf of Indemnitee, (b) advance to Indemnitee funds in an amount sufficient to pay such Expenses, or (c) reimburse Indemnitee for such Expenses; provided that Indemnitee shall repay, without interest any amounts actually advanced to Indemnitee that, at the final disposition of the Indemnifiable Claim to which the advance related, were in excess of amounts paid or payable by Indemnitee in respect of Expenses relating to, arising out of or resulting from such Indemnifiable Claim. In connection with any such payment, advancement or reimbursement, at the request of the Company, Indemnitee shall execute and deliver to the Company an undertaking, which need not be secured and shall be accepted without reference to Indemnitee’s ability to repay the Expenses, by or on behalf of the Indemnitee, to repay any amounts paid, advanced or reimbursed by the Company in respect of Expenses relating to, arising out of or resulting from any Indemnifiable Claim in respect of which it shall have been determined, following the final disposition of such Indemnifiable Claim and in accordance with Section 7, that Indemnitee is not entitled to indemnification hereunder.
 
4.  Indemnification for Additional Expenses. Without limiting the generality or effect of the foregoing, the Company shall indemnify and hold harmless Indemnitee against and, if requested by Indemnitee, shall reimburse Indemnitee for, or advance to Indemnitee, within five business days of such request, any and all Expenses paid or incurred by Indemnitee or which Indemnitee determines are reasonably likely to be paid or incurred by Indemnitee in connection with any Claim made, instituted or conducted by Indemnitee for (a) indemnification or reimbursement or advance payment of Expenses by the Company under any provision of this Agreement, or under any other agreement or provision of the Constituent Documents now or hereafter in effect relating to Indemnifiable Claims, and/or (b) recovery under any directors’ and officers’ liability insurance policies maintained by the Company, regardless in each case of whether Indemnitee ultimately is determined to be entitled to such indemnification, reimbursement, advance or insurance recovery, as the case may be; provided , however , that Indemnitee shall return, without interest, any such advance of Expenses (or portion thereof) which remains unspent at the final disposition of the Claim to which the advance related.
 

175

     

   Exhibit 10.25

 

 
5.  Partial Indemnity. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of any Indemnifiable Loss but not for all of the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.
 
6.  Procedure for Notification . To obtain indemnification under this Agreement in respect of an Indemnifiable Claim or Indemnifiable Loss, Indemnitee shall submit to the Company a written request therefor, including a brief description (based upon information then available to Indemnitee) of such Indemnifiable Claim or Indemnifiable Loss. If, at the time of the receipt of such request, the Company has directors’ and officers’ liability insurance in effect under which coverage for such Indemnifiable Claim or Indemnifiable Loss is potentially available, the Company shall give prompt written notice of such Indemnifiable Claim or Indemnifiable Loss to the applicable insurers in accordance with the procedures set forth in the applicable policies. The Company shall provide to Indemnitee a copy of such notice delivered to the applicable insurers, and copies of all subsequent correspondence between the Company and such insurers regarding the Indemnifiable Claim or Indemnifiable Loss, in each case substantially concurrently with the delivery or receipt thereof by the Company. The failure by Indemnitee to timely notify the Company of any Indemnifiable Claim or Indemnifiable Loss shall not relieve the Company from any liability hereunder unless, and only to the extent that, the Company did not otherwise learn of such Indemnifiable Claim or Indemnifiable Loss and such failure results in forfeiture by the Company of substantial defenses, rights or insurance coverage.
 
7.  Determination of Right to Indemnification .
 
     (a)  To the extent that Indemnitee shall have been successful on the merits or otherwise in defense of any Indemnifiable Claim or any portion thereof or in defense of any issue or matter therein, including without limitation dismissal without prejudice, Indemnitee shall be indemnified against all Indemnifiable Losses relating to, arising out of or resulting from such Indemnifiable Claim in accordance with Section 2 and no Standard of Conduct Determination (as defined in Section 7(b)) shall be required. Without limiting the generality or effect of the foregoing, any Claim that is settled in whole or in part or withdrawn will be deemed to be subject to this Section 7(a).

176

     

Exhibit 10.25
 
 
     (b)  To the extent that the provisions of Section 7(a) are inapplicable to an Indemnifiable Claim that shall have been finally disposed of, any determination of whether Indemnitee has satisfied any applicable standard of conduct under Delaware law that is a legally required condition precedent to indemnification of Indemnitee hereunder against Indemnifiable Losses relating to, arising out of or resulting from such Indemnifiable Claim (a " Standard of Conduct Determination ") shall be made as follows: (i) if a Change of Control shall not have occurred, or if a Change of Control shall have occurred but Indemnitee shall have requested that the Standard of Conduct Determination be made pursuant to this clause (i), (A) by a majority vote of the Disinterested Directors, even if less than a quorum of the Board, (B) if such Disinterested Directors so direct, by a majority vote of a committee of Disinterested Directors designated by a majority vote of all Disinterested Directors, or (C) if there are no such Disinterested Directors, by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee; and (ii) if a Change in Control shall have occurred and Indemnitee shall not have requested that the Standard of Conduct Determination be made pursuant to clause (i), by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee. Upon reasonable advance request, Indemnitee shall cooperate with reasonable requests of the individual or firm making such Standard of Conduct Determination, including providing to such Person documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination without incurring any unreimbursed cost in connection therewith. The Company shall indemnify and hold harmless Indemnitee against and, if requested by Indemnitee, shall reimburse Indemnitee for, or advance to Indemnitee, within five business days of such request, any and all costs and expenses (including attorneys’ and experts’ fees and expenses) incurred by Indemnitee in so cooperating with the Person making such Standard of Conduct Determination.
 
     (c)  The Company shall use its best efforts to cause any Standard of Conduct Determination required under Section 7(b) to be made as promptly as practicable. If (i) the Person empowered or selected under Section 7 to make the Standard of Conduct Determination shall not have made a determination within 30 calendar days after the later of (A) receipt by the Company of written notice from Indemnitee advising the Company of the final disposition of the applicable Indemnifiable Claim (the date of such receipt being the " Notification Date ") and (B) the selection of an Independent Counsel, if such determination is to be made by Independent Counsel, that is permitted under the provisions of Section 7(e) to make such determination and (ii) Indemnitee shall have fulfilled his/her obligations set forth in the second sentence of Section 7(b), then Indemnitee shall be deemed to have satisfied the applicable standard of conduct; provided that such 30-day period may be extended for a reasonable time, not to exceed an additional 30 calendar days, if the Person making such determination in good faith requires such additional time for the obtaining or evaluation or documentation and/or information relating thereto.

177

     

Exhibit 10.25
 
 
     (d)  If (i) Indemnitee shall be entitled to indemnification hereunder against any Indemnifiable Losses pursuant to Section 7(a), (ii) no determination of whether Indemnitee has satisfied any applicable standard of conduct under Delaware law is a legally required condition precedent to indemnification of Indemnitee hereunder against any Indemnifiable Losses, or (iii) Indemnitee has been determined or deemed pursuant to Section 7(b) or (c) to have satisfied any applicable standard of conduct under Delaware law which is a legally required condition precedent to indemnification of Indemnitee hereunder against any Indemnifiable Losses, then the Company shall pay to Indemnitee, within five business days after the later of (x) the Notification Date in respect of the Indemnifiable Claim or portion thereof to which such Indemnifiable Losses are related, out of which such Indemnifiable Losses arose or from which such Indemnifiable Losses resulted and (y) the earliest date on which the applicable criterion specified in clause (i), (ii) or (iii) above shall have been satisfied, an amount equal to the amount of such Indemnifiable Losses.

178

     

Exhibit 10.25
 
 
     (e)  If a Standard of Conduct Determination is required to be, but has not been, made by Independent Counsel pursuant to Section 7(b)(i), the Independent Counsel shall be selected by the Board or a Board Committee, and the Company shall give written notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Standard of Conduct Determination is required to be, or to have been, made by Independent Counsel pursuant to Section 7(b)(ii), the Independent Counsel shall be selected by Indemnitee, and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either case, Indemnitee or the Company, as applicable, may, within five business days after receiving written notice of selection from the other, deliver to the other a written objection to such selection; provided , however , that such objection may be asserted only on the ground that the Independent Counsel so selected does not satisfy the criteria set forth in the definition of "Independent Counsel" in Section 1(h), and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the Person so selected shall act as Independent Counsel. If such written objection is properly and timely made and substantiated, (i) the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit and (ii) the non-objecting party may, at its option, select an alternative Independent Counsel and give written notice to the other party advising such other party of the identity of the alternative Independent Counsel so selected, in which case the provisions of the two immediately preceding sentences and clause (i) of this sentence shall apply to such subsequent selection and notice. If applicable, the provisions of clause (ii) of the immediately preceding sentence shall apply to successive alternative selections. If no Independent Counsel that is permitted under the foregoing provisions of this Section 7(e) to make the Standard of Conduct Determination shall have been selected within 30 calendar days after the Company gives its initial notice pursuant to the first sentence of this Section 7(e) or Indemnitee gives its initial notice pursuant to the second sentence of this Section 7(e), as the case may be, either the Company or Indemnitee may petition the Court of Chancery of the State of Delaware for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person or firm selected by the Court or by such other person as the Court shall designate, and the person or firm with respect to whom all objections are so resolved or the person or firm so appointed will act as Independent Counsel. In all events, the Company shall pay all of the reasonable fees and expenses of the Independent Counsel incurred in connection with the Independent Counsel’s determination pursuant to Section 7(b).

179

     

Exhibit 10.25
 
 
   8.  Presumption of Entitlement.

(a)  Notwithstanding any other provision hereof, in making any Standard of Conduct Determination, the Person making such determination shall presume that Indemnitee has satisfied the applicable standard of conduct, and the Company may overcome such presumption only by its adducing clear and convincing evidence to the contrary. Any Standard of Conduct Determination that is adverse to Indemnitee may be challenged by the Indemnitee in the Court of Chancery of the State of Delaware. No determination by the Company (including by its directors or any Independent Counsel) that Indemnitee has not satisfied any applicable standard of conduct shall be a defense to any Claim by Indemnitee for indemnification or reimbursement or advance payment of Expenses by the Company hereunder or create a presumption that Indemnitee has not met any applicable standard of conduct.

   9.  No Other Presumption. For purposes of this Agreement, the termination of any Claim by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere or its equivalent, will not create a presumption that Indemnitee did not meet any applicable standard of conduct or that indemnification hereunder is otherwise not permitted.

   10.   Non-Exclusivity. The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee may have under the Constituent Documents, or the substantive laws of the Company’s jurisdiction of incorporation, any other contract or otherwise (collectively, " Other Indemnity Provisions "); provided , however , that (a) to the extent that Indemnitee otherwise would have any greater right to indemnification under any Other Indemnity Provision, Indemnitee will without further action be deemed to have such greater right hereunder and (b) to the extent that any change is made to any Other Indemnity Provision which permits any greater right to indemnification than that provided under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right hereunder. The Company may not adopt any amendment to any of the Constituent Documents the effect of which would be to deny, diminish or encumber Indemnitee’s right to indemnification under this Agreement or any Other Indemnity Provision.

180

     

Exhibit 10.25
 
 
   11.  Liability Insurance and Funding. For the duration of Indemnitee’s service as a director and/or officer of the Company and for not less than six years thereafter, the Company shall cause to be maintained in effect policies of directors’ and officers’ liability insurance providing coverage for directors and/or officers of the Company that is at least as favorable in scope and amount to that provided by the Company’s current policies of directors’ and officers’ liability insurance. Upon request, the Company shall provide Indemnitee or his or her counsel with a copy of all directors’ and officers’ liability insurance applications, binders, policies, declarations, endorsements and other related materials, and shall provide Indemnitee with a reasonable opportunity to review and comment on the same. Without limiting the generality or effect of the two immediately preceding sentences, the Company shall not discontinue or significantly reduce the scope or amount of coverage from one policy period to the next (i)  without the prior approval thereof by a majority vote of the Incumbent Directors, even if less than a quorum, or (ii) if at the time that any such discontinuation or significant reduction in the scope or amount of coverage is proposed there are no Incumbent Directors, without the prior written consent of Indemnitee in his or her sole discretion. In all policies of directors’ and officers’ liability insurance obtained by the Company, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits, subject to the same limitations, as are accorded to the Company’s directors and officers most favorably insured by such policy. Notwithstanding the foregoing, (i) the Company may, but shall not be required to, create a trust fund, grant a security interest or use other means, including without limitation a letter of credit, to ensure the payment of such amounts as may be necessary to satisfy its obligations to indemnify and advance expenses pursuant to this Agreement and (ii) in renewing or seeking to renew any insurance hereunder, the Company will not be required to expend more than 2.0 times the premium amount of the immediately preceding policy period (equitably adjusted if necessary to reflect differences in policy periods).
 
   12.  Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the related rights of recovery of Indemnitee against other Persons (other than Indemnitee’s successors), including any entity or enterprise referred to in clause (i) of the definition of "Indemnifiable Claim" in Section 1(f). Indemnitee shall execute all papers reasonably required to evidence such rights (all of Indemnitee’s reasonable Expenses, including attorneys’ fees and charges, related thereto to be reimbursed by or, at the option of Indemnitee, advanced by the Company).
 
   13.  No Duplication of Payments. The Company shall not be liable under this Agreement to make any payment to Indemnitee in respect of any Indemnifiable Losses to the extent Indemnitee has otherwise already actually received payment (net of Expenses incurred in connection therewith) under any insurance policy, the Constituent Documents and Other Indemnity Provisions or otherwise (including from any entity or enterprise referred to in clause (i) of the definition of "Indemnifiable Claim" in Section 1(f)) in respect of such Indemnifiable Losses otherwise indemnifiable hereunder.
 

181

     

  Exhibit 10.25

 

 
   14.  Defense of Claims. The Company shall be entitled to participate in the defense of any Indemnifiable Claim or to assume the defense thereof with counsel reasonably satisfactory to the Indemnitee; provided that if Indemnitee determines, after consultation with counsel selected by Indemnitee, that (a) the use of counsel chosen by the Company to represent Indemnitee would present such counsel with an actual or potential conflict, (b) the named parties in any such Indemnifiable Claim (including any impleaded parties) include both the Company and Indemnitee and Indemnitee shall conclude that there may be one or more legal defenses available to him or her that are different from or in addition to those available to the Company, (c) any such representation by such counsel would be precluded under the applicable standards of professional conduct then prevailing, or (d) Indemnitee has interests in the claim or underlying subject matter that are different from or in addition to those of other Persons against whom the Claim has been made or might reasonably be expected to be made, then Indemnitee shall be entitled to retain separate counsel (but not more than one law firm plus, if applicable, local counsel in respect of any particular Indemnifiable Claim for all indemnitees in Indemnitee's circumstances) at the Company’s expense. The Company shall not be liable to Indemnitee under this Agreement for any amounts paid in settlement of any threatened or pending Indemnifiable Claim effected without the Company’s prior written consent. The Company shall not, without the prior written consent of the Indemnitee, effect any settlement of any threatened or pending Indemnifiable Claim which the Indemnitee is or could have been a party unless such settlement solely involves the payment of money and includes a complete and unconditional release of the Indemnitee from all liability on any claims that are the subject matter of such Indemnifiable Claim. Neither the Company nor Indemnitee shall unreasonably withhold its consent to any proposed settlement; provided that Indemnitee may withhold consent to any settlement that does not provide a complete and unconditional release of Indemnitee.
 
   15.  Successors and Binding Agreement.
 
(a)  The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business or assets of the Company, by agreement in form and substance satisfactory to Indemnitee and its counsel, expressly to assume and agree to perform this Agreement in the same manner and to the same extent the Company would be required to perform if no such succession had taken place. This Agreement shall be binding upon and inure to the benefit of the Company and any successor to the Company, including without limitation any person acquiring directly or indirectly all or substantially all of the business or assets of the Company whether by purchase, merger, consolidation, reorganization or otherwise (and such successor will thereafter be deemed the " Company " for purposes of this Agreement), but shall not otherwise be assignable or delegatable by the Company.
 
(b)  This Agreement shall inure to the benefit of and be enforceable by the Indemnitee’s personal or legal representatives, executors, administrators, heirs, distributees, legatees and other successors.
 

182

     

  Exhibit 10.25

 

 
(c)  This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the other, assign or delegate this Agreement or any rights or obligations hereunder except as expressly provided in Sections 15(a) and 15(b). Without limiting the generality or effect of the foregoing, Indemnitee’s right to receive payments hereunder shall not be assignable, whether by pledge, creation of a security interest or otherwise, other than by a transfer by the Indemnitee’s will or by the laws of descent and distribution, and, in the event of any attempted assignment or transfer contrary to this Section 15(c), the Company shall have no liability to pay any amount so attempted to be assigned or transferred.
 
   16.  Notices. For all purposes of this Agreement, all communications, including without limitation notices, consents, requests or approvals, required or permitted to be given hereunder must be in writing and shall be deemed to have been duly given when hand delivered or dispatched by electronic facsimile transmission (with receipt thereof orally confirmed), or one business day after having been sent for next-day delivery by a nationally recognized overnight courier service, addressed to the Company (to the attention of the Secretary of the Company) and to Indemnitee at the applicable address shown on the signature page hereto, or to such other address as any party may have furnished to the other in writing and in accordance herewith, except that notices of changes of address will be effective only upon receipt.
 
   17.  Governing Law. The validity, interpretation, construction and performance of this Agreement shall be governed by and construed in accordance with the substantive laws of the State of Delaware, without giving effect to the principles of conflict of laws of such State. The Company and Indemnitee each hereby irrevocably consent to the jurisdiction of the Chancery Court of the State of Delaware for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement, waive all procedural objections to suit in that jurisdiction, including without limitation objections as to venue or inconvenience, agree that service in any such action may be made by notice given in accordance with Section 16 and also agree that any action instituted under this Agreement shall be brought only in the Chancery Court of the State of Delaware.
 
   18.  Validity. If any provision of this Agreement or the application of any provision hereof to any Person or circumstance is held invalid, unenforceable or otherwise illegal, the remainder of this Agreement and the application of such provision to any other person or circumstance shall not be affected, and the provision so held to be invalid, unenforceable or otherwise illegal shall be reformed to the extent, and only to the extent, necessary to make it enforceable, valid or legal. In the event that any court or other adjudicative body shall decline to reform any provision of this Agreement held to be invalid, unenforceable or otherwise illegal as contemplated by the immediately preceding sentence, the parties thereto shall take all such action as may be necessary or appropriate to replace the provision so held to be invalid, unenforceable or otherwise illegal with one or more alternative provisions that effectuate the purpose and intent of the original provisions of this Agreement as fully as possible without being invalid, unenforceable or otherwise illegal.
 

183

     

  Exhibit 10.25

 

 
   19.  Miscellaneous. No provision of this Agreement may be waived, modified or discharged unless such waiver, modification or discharge is agreed to in writing signed by Indemnitee and the Company. No waiver by either party hereto at any time of any breach by the other party hereto or compliance with any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, expressed or implied with respect to the subject matter hereof have been made by either party that are not set forth expressly in this Agreement.
 
   20.  Legal Fees and Expenses. It is the intent of the Company that Indemnitee not be required to incur legal fees and or other Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to Indemnitee hereunder. Accordingly, without limiting the generality or effect of any other provision hereof, if it should appear to Indemnitee that the Company has failed to comply with any of its obligations under this Agreement or in the event that the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, the Company irrevocably authorizes the Indemnitee from time to time to retain counsel of Indemnitee’s choice, at the expense of the Company as hereafter provided, to advise and represent Indemnitee in connection with any such interpretation, enforcement or defense, including without limitation the initiation or defense of any litigation or other legal action, whether by or against the Company or any director, officer, stockholder or other person affiliated with the Company, in any jurisdiction. Notwithstanding any existing or prior attorney-client relationship between the Company and such counsel, the Company irrevocably consents to Indemnitee’s entering into an attorney-client relationship with such counsel, and in that connection the Company and Indemnitee agree that a confidential relationship shall exist between Indemnitee and such counsel. Without limiting the generality or effect of any other provision hereof or respect to whether Indemnitee prevails, in whole or in part, in connection with any of the foregoing, the Company will pay and be solely financially responsible for any and all attorneys’ and related fees and expenses incurred by Indemnitee in connection with any of the foregoing.

184

     

Exhibit 10.25
 
 
   21.  Certain Interpretive Matters. Unless the context of this Agreement otherwise requires, (1) "it" or "its" or words of any gender include each other gender, (2) words using the singular or plural number also include the plural or singular number, respectively, (3) the terms "hereof," "herein," "hereby" and derivative or similar words refer to this entire Agreement, (4) the terms "Article," "Section," "Annex" or "Exhibit" refer to the specified Article, Section, Annex or Exhibit of or to this Agreement, (5) the terms "include," "includes" and "including" will be deemed to be followed by the words "without limitation" (whether or not so expressed), and (6) the word "or" is disjunctive but not exclusive. Whenever this Agreement refers to a number of days, such number will refer to calendar days unless business days are specified and whenever action must be taken (including the giving of notice or the delivery of documents) under this Agreement during a certain period of time or by a particular date that ends or occurs on a non-business day, then such period or date will be extended until the immediately following business day. As used herein, "business day" means any day other than Saturday, Sunday or a United States federal holiday .
 
   22.  Entire Agreement . This Agreement and the Constituent Documents constitute the entire agreement, and supersede all prior agreements and understandings, both written and oral, between the parties hereto with respect to the subject matter of this Agreement. Any prior agreements or understandings between the parties hereto with respect to indemnification are hereby terminated and of no further force or effect.
 
   23.  Counterparts. This Agreement may be executed in one or more counterparts, each of which will be deemed to be an original but all of which together shall constitute one and the same agreement.

185

     

Exhibit 10.25
 
IN WITNESS WHEREOF, Indemnitee has executed and the Company has caused its duly authorized representative to execute this Agreement as of the date first above written.

EASTMAN CHEMICAL COMPANY
100 N. Eastman Road
Kingsport, TN 37660


By:      _________________________                                   

[INDEMNITEE]
___________________________
___________________________
 
___________________________________________
     [Indemnitee Name]

 
  186  


Exhibit 10.26

AWARD NOTICE

NOTICE OF RESTRICTED STOCK
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: Theresa K. Lee

Number of Shares: 5,000

Date of Grant: February 5, 2004

  1. Award of Restricted Stock . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Eastman Chemical Company ("Company") has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of shares ("Restricted Stock") of its $.01 par value Common Stock ("Common Stock") set forth above, to be held, subject to the terms of the Plan and this Award Notice, as restricted stock. This Award recognizes your significant contribution to the Company and provides additional incentive for your continued service with the Company. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.
  2. Lapse of Restrictions . The restrictions described below with respect to the Restricted Stock will lapse upon the earlier of: (1) as to 2,500 shares, on December 31, 2005; as to 2,500 shares, on December 31, 2006; in each case if and only if you are still an employee of the Company or a Subsidiary on date, or (2) termination of your employment with the Company and its Subsidiaries, if and only if such termination is by reason of death, disability, or for another approved reason, as determined by the Committee (the dates and time described in clause (1) or (2), as applicable, are referred to herein as the "Vesting Dates").
  3. Book-Entry Registration . The Restricted Stock awarded pursuant to this Award Notice initially will be evidenced by book-entry registration only, without the issuance of certificates representing such shares.
  4. Issuance of Shares . Subject to the other terms of this Award Notice, the Company will either issue a certificate or certificates representing the Restricted Stock as promptly as practicable following the Vesting Dates or place the shares in the Automatic Dividend Reinvestment Plan maintained for stockholders of the Company as directed by the grantee. The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.
 
You may elect to defer the Award until after you retire or otherwise terminate employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If you choose to defer the Award, the Award shall be converted into the right to receive a cash payment.

If payment of the Award would, or could in the reasonable estimation of the Committee, result in you receiving compensation in excess of the Maximum Deductible Amount in a given year, then such portion (or all, as applicable) of the Award as would, or could in the reasonable estimation of the Committee, cause you to receive compensation from the Company in excess of the Maximum Deductible Amount shall be converted into the right to receive a cash payment, which shall be deferred until after you retire or otherwise terminate employment with the Company and its Subsidiaries.

 187

     

Exhibit 10.26

If any portion of an Award is converted into a right to receive a cash payment as described above, an amount representing the Fair Market Value of the deferred portion of the Award will be credited to the Stock Account of the Eastman EDCP and hypothetically invested in units of Common Stock. Thereafter, such amount will be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.

  1. Restrictions on Transfer of Shares . The Restricted Stock, and the right to vote such shares and to receive dividends thereon, may not, except as otherwise provided in the Plan, be sold, assigned, transferred, pledged or encumbered in any way prior to the Vesting Dates, whether by operation of law or otherwise. After the Vesting Dates, certificates for the Restricted Stock may be issued during your lifetime only to you, except in the case of a permanent disability involving mental incapacity.
  2. Limitation of Rights . Except as otherwise provided in this Award Notice or the Plan, prior to the Vesting Dates, you will have no rights of a stockholder with respect to the Restricted Stock, except for the right to receive such cash dividends, if any, as may be declared on the shares of Common Stock subject thereto from time to time, and the right to vote (in person or by proxy) such shares at any meeting of stockholders of the Company. Neither the Plan, this Award nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.
  3. Termination . Upon termination of your employment with the Company and its Subsidiaries, prior to a Vesting Date, other than by reason of death, disability, or for another approved reason, as determined by the Committee, all of the unvested shares of Restricted Stock will be canceled and forfeited by you to the Company without the payment of any consideration by the Company. In such event, neither you nor any of your successors, heirs, assigns or personal representatives will thereafter have any further rights or interest in such shares or otherwise in this Award.
  4. Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.
  5. Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits prior to the Vesting Date, the shares of Common Stock subject to this Award automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company) prior to the Vesting Dates, the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.
  6. Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.
  7. Noncompetition; Confidentiality . You will forfeit all rights to this Award if you violate the noncompetition and confidentiality provisions contained in Section 20 of the Plan.
  8. Performance of Job Duties . Payment of shares pursuant to this award is contingent upon meeting minimally acceptable performance expectations, such as progress toward business objectives as detailed in the Annual Business Plan and completion of other assignments requested from time to time by the Chief Executive Officer. Shortfalls in performance levels will be communicated as soon as possible to allow time for correction. Final appraisal of performance for purposes of this award is at the sole discretion of the Chief Executive Officer with the approval of the Committee.
  9. Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.


188
     


Exhibit 10.27
 

AWARD NOTICE

NOTICE OF RESTRICTED STOCK
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: Allan R. Rothwell

Number of Shares: 20,000

Date of Grant: January 1, 2004


  1. Award of Restricted Stock . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of Eastman Chemical Company ("Company") has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of shares ("Restricted Stock") of its $.01 par value Common Stock ("Common Stock") set forth above, to be held, subject to the terms of the Plan and this Award Notice, as restricted stock. This Award recognizes your significant contribution to the Company and provides additional incentive for your continued exemplary performance. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.
  1. Lapse of Restrictions . The restrictions described below with respect to the Restricted Stock will lapse upon the earlier of: (1) as to 10,000 shares, on November 30, 2004; as to 10,000 shares, on November 30, 2005; in each case if and only if you are still an employee of the Company or a Subsidiary on date, or (2) termination of your employment with the Company and its Subsidiaries, if and only if such termination is by reason of death, disability, or for another approved reason, as determined by the Committee (the dates and time described in clause (1) or (2), as applicable, are referred to herein as the "Vesting Dates").
  1. Book-Entry Registration . The Restricted Stock awarded pursuant to this Award Notice initially will be evidenced by book-entry registration only, without the issuance of certificates representing such shares.

 189

     

  Exhibit 10.27

 

 
  1. Issuance of Shares . Subject to the other terms of this Award Notice, the Company will either issue a certificate or certificates representing the Restricted Stock as promptly as practicable following the Vesting Dates or place the shares in the Automatic Dividend Reinvestment Plan maintained for shareowners of the Company as directed by the grantee. The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

You may elect to defer the Award until after you retire or otherwise terminate employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If you choose to defer the Award, the Award shall be converted into the right to receive a cash payment.

If any portion of an Award is converted into a right to receive a cash payment as described above, an amount representing the Fair Market Value of the deferred portion of the Award will be credited to the Stock Account of the Eastman EDCP and hypothetically invested in units of Common Stock. Thereafter, such amount will be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.

  1. Restrictions on Transfer of Shares . The Restricted Stock, and the right to vote such shares and to receive dividends thereon, may not, except as otherwise provided in the Plan, be sold, assigned, transferred, pledged or encumbered in any way prior to the Vesting Dates, whether by operation of law or otherwise. After the Vesting Dates, certificates for the Restricted Stock may be issued during your lifetime only to you, except in the case of a permanent disability involving mental incapacity.
  1. Limitation of Rights . Except as otherwise provided in this Award Notice or the Plan, prior to the Vesting Dates, you will have no rights of a shareowner with respect to the Restricted Stock, except for the right to receive such cash dividends, if any, as may be declared on the shares of Common Stock subject thereto from time to time, and the right to vote (in person or by proxy) such shares at any meeting of shareowners of the Company. Neither the Plan, this Award nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.
  1. Termination . Upon termination of your employment with the Company and its Subsidiaries, prior to the Vesting Dates, other than by reason of death, disability, or for another approved reason, as determined by the Committee, all of the Restricted Stock will be canceled and forfeited by you to the Company without the payment of any consideration by the Company. In such event, neither you nor any of your successors, heirs, assigns or personal representatives will thereafter have any further rights or interest in such shares or otherwise in this Award.

 190

     

  Exhibit 10.27

 

 
  1. Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.
  2. Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits prior to the Vesting Dates, the shares of Common Stock subject to this Award automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company) prior to the Vesting Dates, the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.
  3. Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.
  4. Non-competition; Confidentiality . You will forfeit all rights to this Award if you violate the non-competition and confidentiality provisions contained in Section 20 of the Plan.
  5. Performance of Job Duties . Payment of shares pursuant to this award is contingent upon meeting minimally acceptable performance expectations, such as progress toward business objectives as detailed in the Annual Business Plan and completion of other assignments requested from time to time by the Chief Executive Officer. Shortfalls in performance levels will be communicated as soon as possible to allow time for correction. Final appraisal of performance for purposes of this award is at the sole discretion of the Chief Executive Officer with the approval of the Committee.
  6. Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.




191
     


Exhibit 10.28
 
AWARD NOTICE

NOTICE OF RESTRICTED STOCK
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: Roger K. Mowen

Number of Shares: 4,000

Date of Grant: January 1, 2004


  1. Award of Restricted Stock . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of Eastman Chemical Company ("Company") has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of shares ("Restricted Stock") of its $.01 par value Common Stock ("Common Stock") set forth above, to be held, subject to the terms of the Plan and this Award Notice, as restricted stock. This Award recognizes your significant contribution to the Company and provides additional incentive for your continued exemplary performance. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.
  2. Lapse of Restrictions . The restrictions described below with respect to the Restricted Stock will lapse as to 4,000 shares upon the earlier of: (1) May 31, 2004, if and only if you are still an employee of the Company or a Subsidiary on date, or (2) termination of your employment with the Company and its Subsidiaries, if and only if such termination is by reason of death, disability, or for another approved reason, as determined by the Committee (the dates and time described in clause (1) or (2), as applicable, are referred to herein as the "Vesting Dates").
  3. Book-Entry Registration . The Restricted Stock awarded pursuant to this Award Notice initially will be evidenced by book-entry registration only, without the issuance of certificates representing such shares.

 192

     

  Exhibit 10.28

 

 
  1. Issuance of Shares . Subject to the other terms of this Award Notice, the Company will either issue a certificate or certificates representing the Restricted Stock as promptly as practicable following the Vesting Dates or place the shares in the Automatic Dividend Reinvestment Plan maintained for shareowners of the Company as directed by the grantee. The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.
You may elect to defer the Award until after you retire or otherwise terminate employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If you choose to defer the Award, the Award shall be converted into the right to receive a cash payment.

If any portion of an Award is converted into a right to receive a cash payment as described above, an amount representing the Fair Market Value of the deferred portion of the Award will be credited to the Stock Account of the Eastman EDCP and hypothetically invested in units of Common Stock. Thereafter, such amount will be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.

  1. Restrictions on Transfer of Shares . The Restricted Stock, and the right to vote such shares and to receive dividends thereon, may not, except as otherwise provided in the Plan, be sold, assigned, transferred, pledged or encumbered in any way prior to the Vesting Dates, whether by operation of law or otherwise. After the Vesting Dates, certificates for the Restricted Stock may be issued during your lifetime only to you, except in the case of a permanent disability involving mental incapacity.
  2. Limitation of Rights . Except as otherwise provided in this Award Notice or the Plan, prior to the Vesting Dates, you will have no rights of a shareowner with respect to the Restricted Stock, except for the right to receive such cash dividends, if any, as may be declared on the shares of Common Stock subject thereto from time to time, and the right to vote (in person or by proxy) such shares at any meeting of shareowners of the Company. Neither the Plan, this Award nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.

 193

     

 
Exhibit 10.28
 
 
  1. Termination . Upon termination of your employment with the Company and its Subsidiaries, prior to the Vesting Dates, other than by reason of death, disability, or for another approved reason, as determined by the Committee, all of the Restricted Stock will be canceled and forfeited by you to the Company without the payment of any consideration by the Company. In such event, neither you nor any of your successors, heirs, assigns or personal representatives will thereafter have any further rights or interest in such shares or otherwise in this Award.
  2. Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.
  3. Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits prior to the Vesting Dates, the shares of Common Stock subject to this Award automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company) prior to the Vesting Dates, the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.
  4. Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.
  5. Non-competition; Confidentiality . You will forfeit all rights to this Award if you violate the non-competition and confidentiality provisions contained in Section 20 of the Plan.
  6. Performance of Job Duties . Payment of shares pursuant to this award is contingent upon meeting minimally acceptable performance expectations, such as progress toward business objectives as detailed in the Annual Business Plan and completion of other assignments requested from time to time by the Chief Executive Officer. Shortfalls in performance levels will be communicated as soon as possible to allow time for correction. Final appraisal of performance for purposes of this award is at the sole discretion of the Chief Executive Officer with the approval of the Committee.
  7. Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.




194
     

Exhibit 10.29

AWARD NOTICE

NOTICE OF RESTRICTED STOCK
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: Richard A. Lorraine

Number of Shares: 20,000

Date of Grant: December 3, 2003

1.    Award of Restricted Stock . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Eastman Chemical Company ("Company") has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of shares ("Restricted Stock") of its $.01 par value Common Stock ("Common Stock") set forth above, to be held, subject to the terms of the Plan and this Award Notice, as restricted stock. This Award recognizes your significant contribution to the Company and provides additional incentive for your continued service with the Company. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.

2.    Lapse of Restrictions . The restrictions described below with respect to the Restricted Stock will lapse upon the earlier of (1) December 3, 2006, if and only if you are still an employee of the Company or a Subsidiary on that date, or (2) termination of your employment with the Company and its Subsidiaries, if and only if such termination is by reason of death, disability, or for another approved reason, as determined by the Committee (the date described in clause (1) or (2), as applicable, is referred to herein as the "Vesting Date").

3.    Book-Entry Registration . The Restricted Stock awarded pursuant to this Award Notice initially will be evidenced by book-entry registration only, without the issuance of certificates representing such shares.

4.    Issuance of Shares . Subject to the other terms of this Award Notice, the Company will either issue a certificate or certificates representing the Restricted Stock as promptly as practicable following the Vesting Dates or place the shares in the Automatic Dividend Reinvestment Plan maintained for stockholders of the Company as directed by the grantee. The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

You may elect to defer the Award until after you retire or otherwise terminate employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If you choose to defer the Award, the Award shall be converted into the right to receive a cash payment.

 195

     

Exhibit 10.29

If any portion of an Award is converted into a right to receive a cash payment as described above, an amount representing the Fair Market Value of the deferred portion of the Award will be credited to the Stock Account of the Eastman EDCP and hypothetically invested in units of Common Stock. Thereafter, such amount will be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.

5.    Restrictions on Transfer of Shares . The Restricted Stock, and the right to vote such shares and to receive dividends thereon, may not, except as otherwise provided in the Plan, be sold, assigned, transferred, pledged or encumbered in any way prior to the Vesting Dates, whether by operation of law or otherwise. After the Vesting Dates, certificates for the Restricted Stock may be issued during your lifetime only to you, except in the case of a permanent disability involving mental incapacity.

6.    Limitation of Rights . Except as otherwise provided in this Award Notice or the Plan, prior to the Vesting Dates, you will have no rights of a stockholder with respect to the Restricted Stock, except for the right to receive such cash dividends, if any, as may be declared on the shares of Common Stock subject thereto from time to time, and the right to vote (in person or by proxy) such shares at any meeting of stockholders of the Company. Neither the Plan, this Award nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.

7.    Termination . Upon termination of your employment with the Company and its Subsidiaries, prior to a Vesting Date, other than by reason of death, disability, or for another approved reason, as determined by the Committee, all of the unvested shares of Restricted Stock will be canceled and forfeited by you to the Company without the payment of any consideration by the Company. In such event, neither you nor any of your successors, heirs, assigns or personal representatives will thereafter have any further rights or interest in such shares or otherwise in this Award.

8.    Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.
 

  9.        Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits prior to the Vesting Date, the shares of Common Stock subject to this Award automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company) prior to the Vesting Dates, the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.

10.    Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.

      11.    Noncompetition; Confidentiality . You will forfeit all rights to this Award if you violate the noncompetition and confidentiality provisions contained in Section 20 of the Plan.

   12.    Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.

196
     

Exhibit 10.30
 
AWARD NOTICE

NOTICE OF PERFORMANCE SHARES
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: James P. Rogers

Number of Shares: 12,000

Date of Grant: January 1, 2004


1.    Grant of Performance Shares . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of the Eastman Chemical Company ("Company") Board of Directors has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of performance shares ("Performance Shares") of its $.01 par value Common Stock ("Common Stock") set forth above. The Performance Shares are rights to receive Awards in the form of shares of Common Stock, subject to the attainment of specified performance conditions. Subject to satisfaction of the minimum performance conditions and the other terms of the Award Notice, the award will be paid in the form of unrestricted shares of Common Stock, except for deferrals as described in Section 4 of this Award Notice. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.

2.      Performance Measures . The performance measures for the Performance Shares are based: (1) 75% on achievement of divestitures and/or restructuring of the businesses comprising the resins, inks, and monomers business organization in the Coatings, Adhesives, Specialty Polymers, and Inks (CASPI) segment; and (2) 25% on development and execution of a business plan, approved by the Chief Executive Officer, that will result in specific structural changes that will result in improved financial performance (measured by earnings from operations for Eastman Division, excluding the impact of divestitures and/or restructuring of the resins, inks, and monomers business organization in (1) above), as compared to the 2004 annual business plan. The specific terms of the performance measures are summarized in Schedule A attached to this Award Notice. Successful execution relative to the performance measures for purposes of this Award will be certified by the Chief Executive Officer and approved by the Committee.

 197

     

Exhibit 10.30
 
3.    Number of Performance Shares Awarded . The number of Performance Shares that you have been awarded is 12,000 shares. This is hereafter referred to as the "Target Grant Amount". However, the actual number of shares of Common Stock, hereafter referred to as the "Actual Award Amount", to which you will be entitled pursuant to this Award Notice, if any, may be less than the Target Grant Amount, depending on the degree of execution relative to the performance measures outlined in Section 2 of this Award Notice, and summarized in Schedule A .

4.    Payment of Award . Performance will be measured at the close of fiscal year 2004, and payment will be made as soon as possible thereafter, provided, however, that if payment of the Award could, in the reasonable estimation of the Committee, result in your receiving compensation in the year of scheduled payment in excess of the amount deductible by the Company under Section 162(m) of the Internal Revenue Code, then such portion (or all, as applicable) of the Award as could, in the reasonable estimation of the Committee, create such excess compensation, will be converted into the right to receive a cash payment, which will be deferred until after you terminate employment with the Company and its Subsidiaries.

You may elect to defer the Award until after you retire or otherwise terminate employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If you choose to defer the Award, the Award shall be converted into the right to receive a cash payment.

The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

5.    Restrictions on Transfer of Shares . Unless and until unrestricted shares of Common Stock are delivered or, if applicable, cash is distributed under the EDCP to you in payment of an earned Award of the Performance Shares, the Performance Shares are not transferable except by will or by the laws of descent and distribution, and may not be sold, assigned, pledged or encumbered in any way, whether by operation of law or otherwise.

 198

     

Exhibit 10.30
 
6.    Limitation of Rights . Except as otherwise provided in this Award Notice or in the Plan, you will have no rights of a stockholder with respect to the Performance Shares unless and until certificates for shares of Common Stock have been issued to you. No such certificates will be issued until the Actual Grant Amount has been determined and you have otherwise become entitled to payment of an Award under the terms of the Plan. However, if payment of all or any portion of the Award is deferred, but the Award has otherwise become payable, the deferred Award will be credited with additional shares of Common Stock based on any dividends declared on the Common Stock, in accordance with the terms of the EDCP. Neither the Plan, the granting of these Performances Shares, nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.

7.    Termination . Upon termination of your employment with the Company and its Subsidiaries by reason of death, disability, or for another approved reason, as determined by the Committee, you will receive, subject to the terms and conditions of the Plan, an Award representing a prorated portion of the Target Grant Amount to which you otherwise would be entitled, based on the number of full calendar months from January 1, 2004 through the effective date of such termination. For these purposes, if the effective date of your termination occurs prior to the last business day of a particular calendar month, then that month will not be counted as a full month. Upon termination of your employment with the Company or a Subsidiary for reason other than death, disability, or another approved reason prior to the date the shares of Common Stock covered by the Award Notice are delivered to you, you will not be eligible or entitled to receive any Performance Shares under this Award Notice.

8.    Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.

   9.    Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits, the number of shares subject to the Performance Shares automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company), the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.

 199

     

Exhibit 10.30
 
10.    Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.

   11.    Non-competition; Confidentiality . You will forfeit all rights to this Award if you violate the non-competition and confidentiality provisions contained in Section 20 of the Plan.

   12.    Performance of Job Duties . Payment of shares pursuant to this award is contingent upon meeting minimally acceptable performance expectations, such as progress toward business objectives as detailed in the Annual Business Plan and completion of other assignments requested from time to time by the Chief Executive Officer. Shortfalls in performance levels will be communicated as soon as possible to allow time for correction. Final appraisal of performance for purposes of this award is at the sole discretion of the Chief Executive Officer with the approval of the Committee.

   13.    Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.


200
     

Exhibit 10.31
 
AWARD NOTICE

NOTICE OF PERFORMANCE SHARES
GRANTED PURSUANT TO THE
EASTMAN CHEMICAL COMPANY
2002 OMNIBUS LONG-TERM COMPENSATION PLAN


Grantee: Roger K. Mowen

Number of Shares: 4,000

Date of Grant: January 1, 2004


1.    Grant of Performance Shares . This Award Notice serves to notify you that the Compensation and Management Development Committee (the "Committee") of the Eastman Chemical Company ("Company") Board of Directors has granted to you, under the 2002 Omnibus Long-Term Compensation Plan ("Plan"), the number of performance shares ("Performance Shares") of its $.01 par value Common Stock ("Common Stock") set forth above. The Performance Shares are rights to receive Awards in the form of shares of Common Stock, subject to the attainment of specified performance conditions. Subject to satisfaction of the minimum performance conditions and the other terms of the Award Notice, the award will be paid in the form of unrestricted shares of Common Stock, except for deferrals as described in Section 4 of this Award Notice. The Plan is incorporated herein by reference and made a part of this Award Notice. Capitalized terms not otherwise defined herein have the respective meanings set forth in the Plan.

2.      Performance Measures . The performance measures for the Performance Shares are based: (1) 50% on achievement of specified milestones related to growth of the Coal Gasification Services business, and (2) 50% on achievement of specified milestones related to restructuring the Company’s investment in Cendian. The specific terms of the performance measures are summarized in Schedule A attached to this Award Notice. Successful execution relative to the performance measures for purposes of this award will be certified by the Chief Executive Officer and approved by the Committee.

3.    Number of Performance Shares Awarded . The number of Performance Shares that you have been awarded is 4,000 shares. This is hereafter referred to as the "Target Grant Amount". However, the actual number of shares of Common Stock, hereafter referred to as the "Actual Award Amount", to which you will be entitled pursuant to this Award Notice, if any, may be less than the Target Grant Amount, depending on the degree of execution relative to performance measures outlined in Section 2 of this Award Notice, and summarized in Schedule A .
 

 201

     

  Exhibit 10.31

 

 
4.    Payment of Award . Performance will be measured as of May 31, 2004, and payment will be made as soon as possible thereafter, provided, however, that if payment of the Award could, in the reasonable estimation of the Committee, result in your receiving compensation in the year of scheduled payment in excess of the amount deductible by the Company under Section 162(m) of the Internal Revenue Code, then such portion (or all, as applicable) of the Award as could, in the reasonable estimation of the Committee, create such excess compensation, will be converted into the right to receive a cash payment, which will be deferred until after you terminate employment with the Company and its Subsidiaries.

The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the Participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

5.    Restrictions on Transfer of Shares . Unless and until unrestricted shares of Common Stock are delivered, the Performance Shares are not transferable except by will or by the laws of descent and distribution, and may not be sold, assigned, pledged or encumbered in any way, whether by operation of law or otherwise.

6.    Limitation of Rights . Except as otherwise provided in this Award Notice or in the Plan, you will have no rights of a stockholder with respect to the Performance Shares unless and until certificates for shares of Common Stock have been issued to you. No such certificates will be issued until the Actual Grant Amount has been determined and you have otherwise become entitled to payment of an Award under the terms of the Plan. Neither the Plan, the granting of these Performances Shares, nor this Award Notice gives you any right to remain employed by the Company or a Subsidiary.

7.    Termination . Upon termination of your employment with the Company and its Subsidiaries by reason of death, disability, or for another approved reason, as determined by the Committee, you will receive, subject to the terms and conditions of the Plan, an Award representing a prorated portion of the Target Grant Amount to which you otherwise would be entitled, based on the number of full calendar months from January 1, 2004 through the effective date of such termination. For these purposes, if the effective date of your termination occurs prior to the last business day of a particular calendar month, then that month will not be counted as a full month. Upon termination of your employment with the Company or a Subsidiary for reason other than death, disability, or another approved reason prior to the date the shares of Common Stock covered by the Award Notice are delivered to you, you will not be eligible or entitled to receive any Performance Shares under this Award Notice.

 202

     

  Exhibit 10.31

 

 
8.    Change in Ownership; Change in Control . Sections 25 and 26 of the Plan contain certain special provisions that will apply to this Award in the event of a Change in Ownership or Change in Control, respectively.

   9.    Adjustment of Shares . If the number of outstanding shares of Common Stock changes through the declaration of stock dividends or stock splits, the number of shares subject to the Performance Shares automatically will be adjusted. If there is a change in the number of outstanding shares of Common Stock or any change in the outstanding stock of the Company (or any successor to the Company), the Committee will make any adjustments and modifications to this Award that it deems appropriate. In the event of any other change in the capital structure or in the Common Stock of the Company, the Committee is authorized to make appropriate adjustments to this Award.

10.    Restrictions on Issuance of Shares . If at any time the Company determines that listing, registration or qualification of the shares of Common Stock subject to this Award upon any securities exchange or under any state or federal law, or the approval of any governmental agency, is necessary or advisable as a condition to the award or issuance of certificate(s) for the shares of Common Stock subject to this Award, such award or issuance may not be made in whole or in part unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to the Company.

   11.    Non-competition; Confidentiality . You will forfeit all rights to this Award if you violate the non-competition and confidentiality provisions contained in Section 20 of the Plan.

   12.    Performance of Job Duties . Payment of shares pursuant to this award is contingent upon meeting minimally acceptable performance expectations, such as progress toward business objectives as detailed in the Annual Business Plan and completion of other assignments requested from time to time by the Chief Executive Officer. Shortfalls in performance levels will be communicated as soon as possible to allow time for correction. Final appraisal of performance for purposes of this award is at the sole discretion of the Chief Executive Officer with the approval of the Committee.

   13.    Plan Controls . In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of this Award Notice, the provisions of the Plan will be controlling and determinative.


203
     

Exhibit 10.32
PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2005 PERFORMANCE PERIOD












EASTMAN CHEMICAL COMPANY


204
     

Exhibit 10.32

 


PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2005 PERFORMANCE PERIOD



TABLE OF CONTENTS

Section
Title
Page
 
 
 
Section 1.
Background
1
 
 
 
Section 2.
Definitions
1
 
 
 
Section 3.
Administration
2
 
 
 
Section 4.
Eligibility
3
 
 
 
Section 5.
Form of Awards
3
 
 
 
Section 6.
Size of Awards
3
 
 
 
Section 7.
Composition of Comparison Group
4
 
 
 
Section 8.
Preconditions to Receipt of an Award
4
 
 
 
Section 9.
Manner and Timing of Award Payments
5
 
 
 
Section 10.
No Rights as Stockholder
6
 
 
 
Section 11.
Application of Plan
6
 
 
 
Section 12.
Adjustment of Actual Grant Amount
6
 
 
 
Section 13.
Amendments
6
 
 
 
Exhibit A.
 
7
 
 
 
Exhibit B.
 
8

205
     

Exhibit 10.32

 


EASTMAN CHEMICAL COMPANY
PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2005 PERFORMANCE PERIOD



Section 1. Background . Under Section 11 of the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan (the "Plan"), the "Committee" (as defined in the Plan), may, among other things, award shares of the $.01 par value common stock ("Common Stock") of Eastman Chemical Company (the "Company") to "Employees" (as defined in the Plan), and such awards may take the form of performance shares, which are contingent upon the attainment of certain performance objectives during a specified period, and subject to such other terms, conditions, and restrictions as the Committee deems appropriate. The purpose of this Performance Share Award Subplan (this "Subplan") is to set forth the terms of the grant of performance shares for the 2004-2005 Performance Period specified herein, effective as of January 1, 2004 (the "Effective Date").

Section 2. Definitions .

(a)    The following definitions shall apply to this Subplan:
 
     (i)    "Actual Grant Amount" means the number of shares of Common Stock to which a participant is entitled under this Subplan, calculated in accordance with Section 6 of this Subplan.
 
     (ii)    "Award Amount" means the performance shares awarded to the participant under this Subplan at the beginning of the Performance Period.
 
     (iii)     "Award Payment Date" means the date the Compensation Committee approves the payout of Common Stock covered by an award under this Subplan to a participant.
 
     (iv)    "Comparison Group" is the group of companies comprising the "Materials Sector" from Standard and Poor’s Super Composite 1500 Index, identified as Global Industry Classification Standard ("GICS") 15.
 
     (v)    "Cost of Capital" reflects the cost of debt and the cost of equity, expressed as a percentage, reflecting the percentage of interest charged on debt and the percentage of expected return on equity.
 
     (vi)    "Earnings from Continuing Operations" shall be defined as the total sales of the Company minus the costs of all operations of any nature used to produce such sales, including taxes, plus after-tax interest associated with the Company's capital debt.
 
     (vii)    "Maximum Deductible Amount" means the maximum amount deductible by the Company under Section 162(a), taking into consideration the limitations under Section 162(m), of the Internal Revenue Code of 1986, as amended, or any similar or successor provisions thereto.
 
 

 1

 

 206

     

 Exhibit 10.32

 

 
     (viii)    "Participation Date" means April 2, 2004.
 
     (ix)    Performance Period" means January 1, 2004 through December 31, 2005.
 
     (x)    "       "Performance Year" means one of the two calendar years in the Performance Period.
 
     (xi)    "Return on Capital" shall mean the return produced by funds invested in the Company and shall be determined as Earnings from Continuing Operations, as defined in Section 2.a.(vi), divided by the Average Capital Employed. Average Capital Employed shall be derived by adding the Company's capital debt plus equity at the close of the last day of the year preceding the Performance Year, to the Company's capital debt plus equity at the close of the last day of the present Performance Year, with the resulting sum being divided by two. Capital debt is defined as the sum of borrowing by the Company due within one year and long-term borrowing, as designated on the Company's balance sheet. The resulting ratio shall be multiplied by One Hundred (100) in order to convert such to a percentage. Such percentage shall be calculated to the third place after the decimal point (i.e., xx.xxx%), and then rounded to the second place after the decimal point (i.e., xx.xx%).
 
     (xii)    "Target Award Range" means, with respect to any eligible Employee, the number of performance shares within the range specified on Exhibit A hereto for the Salary Grade applicable to such Employee.
 
     (xiii)    "TSR" means total stockholder return, as reflected by the sum of (A) change in stock price (measured as the difference between (I) the average of the closing prices of a company’s common stock on the New York Stock Exchange, or of the last sale prices or closing prices of such stock on another national trading exchange, as applicable, in the period beginning on the tenth trading day preceding the beginning of the Performance Period and ending on the tenth trading day of the Performance Period and (II) the average of such closing or last sale prices for such stock in the period beginning on the tenth trading day preceding the end of the Performance Period and ending on the tenth trading day following the end of the Performance Period) plus (B) dividends declared, assuming reinvestment of dividends, and expressed as a percentage return on a stockholder’s hypothetical investment.

(b)    Any capitalized terms used but not otherwise defined in this Subplan shall have the respective meanings set forth in the Plan.

Section 3. Administration . This Subplan shall be administered by the Committee. The Committee shall have authority to interpret this Subplan, to prescribe rules and regulations relating to this Subplan, and to take any other actions it deems necessary or advisable for the administration of this Subplan, and shall retain all general authority granted to it under Section 3 of the Plan. At the end of the Performance Period, the Committee shall approve Actual Grant Amounts awarded to participants under this Subplan.
 

2

 

 207

     

Exhibit 10.32

Section 4. Eligibility . The Employees who are eligible to participate in this Subplan are those Employees who, as of the Participation Date, are at Salary Grade 53 and above. These Salary Grades generally include Employees who, as of the Participation Date, have been designated as "officers" of the Company for purposes of Section 16 of the Exchange Act, and held positions with the Company considered carrying responsibilities and functions generally associated with a vice-president-level position. Employees who are promoted during the Performance Period to a position that would meet the above criteria, but who do not hold such position as of the Participation Date, are not eligible to participate in this Subplan.

Section 5. Form of Awards . Subject to the terms and conditions of the Plan and this Subplan, Awards under this Subplan shall be paid in the form of unrestricted shares of Common Stock, except for conversions to cash and deferrals under Section 9 of this Subplan, and except that if a participant is entitled to any fraction of a share of Common Stock, as a result of Section 10 of this Subplan or otherwise, then in lieu of receiving such fraction of a share, the participant shall be paid a cash amount representing the market value, as determined by the Committee, of such fraction of a share at the time of payment.

Section 6. Size of Awards .

(a)    Target Award Range. Exhibit A hereto shows by Salary Grade the Target Award Range. The Salary Grade to be used in determining the size of any Award Amount to a participant under this Subplan shall be the Salary Grade applicable to the position held by the participant on the Participation Date. The actual size of the Award Amount to the participant shall be determined based on an assessment by his or her senior management, of the participant’s past performance and potential for contributions to the Company’s future long term success. Based on this assessment, the participant may receive no award, the target award amount, or any amount within the Target Award Range to the nearest 10 performance shares. Each member of senior management will have a performance share budget, based on the cumulative award targets for their reports, which must be balanced for their organizations.
 
(b)    Actual Grant Amount. Subject to the Committee’s authority to adjust the Actual Grant Amount described in Section 12, the Actual Grant Amount awarded to the participant at the end of the Performance Period is determined by applying a multiplier to the participant’s Award Amount. The multiplier shall be determined by comparing Company performance relative to two measures:
 
     (i)    The Company's TSR during the Performance Period relative to the TSRs of the companies in the Comparison Group during the Performance Period. The Company and each company in the Comparison Group shall be ranked by TSR, in descending order, with the company having the highest TSR during the Performance Period being ranked number one. The Comparison Group shall further be separated into quintiles (first 20%, second 20%, etc.) and the Company's position, in relation to the Comparison Group, shall be expressed as a position in the applicable quintile ranking; and
 
     (ii)    The arithmetic average, for each of the Performance Years during the Performance Period, of the Company’s average Return on Capital minus a Return on Capital target. The Return on Capital target will be determined by the Committee.
 
 

 3

 

 208

     

 Exhibit 10.32

 

 
  An award multiplier table is shown in Exhibit B. The award multiplier is based on the Company’s performance relative to its quintile ranking relative to the Comparison Group, and its average Return on Capital relative to a target during the Performance Period. The award multipliers range from 3.0 (i.e. 300%), if the Company's TSR is in the top performing quintile (top 20%) of companies in the Comparison Group, and the average Return on Capital minus the target Return on Capital is greater than 10 percentage points, to 0.0 (with no shares of Common Stock being delivered to participants under this Subplan), if the Company does not meet certain levels of performance relative to the two measures.

Section 7. Composition of Comparison Group . The Comparison Group is composed of companies relevant for purposes of TSR comparisons under this Subplan. However, during the Performance Period, a company in the Comparison Group may be dropped from the Comparison Group if a company's common stock ceases to be publicly traded on a national stock exchange or market; or a company is a party to a significant merger, acquisition, or other reorganization. Under these, or similar circumstances, the company or companies may be removed from the Comparison Group, and may be replaced with another company or companies by Standard & Poor’s, consistent with their established criteria for selection of companies for the Comparison Group. In any case where the Comparison Group ceases to exist, or is otherwise determined to no longer be appropriate as the basis for a measure under this Subplan, the Committee may designate a replacement Comparison Group. In any such case, the Committee shall have authority to determine the appropriate method of calculating the TSR of such former and/or replacement Comparison Group, whether by complete substitution of the replacement Comparison Group (and disregard of the former Comparison Group) over the entire Performance Period or by pro rata calculations for each Comparison Group or otherwise.

Section 8. Preconditions to Receipt of an Award .

(a)    Continuous Employment . Except as specified in paragraph (b) below, to remain eligible for an Award under this Subplan, an eligible Employee must remain continuously employed with the Company or a Subsidiary at all times from the Effective Date through the Award Payment Date.

(b)    Death, Disability, Retirement, or Termination for an Approved Reason Before the Award Payment Date. If a participant's employment with the Company or a Subsidiary is terminated due to death, disability, retirement, or any approved reason prior to the Award Payment Date, the participant shall receive, subject to the terms and conditions of the Plan and this Subplan, an Award representing a prorated portion of the Actual Grant Amount to which such participant otherwise would be entitled, with the precise amount of such Award to be determined by multiplying the Actual Grant Amount by a fraction, the numerator of which is the number of full calendar months employed in the Performance Period from the Effective Date through and including the effective date of such termination, and the denominator of which is 24 (the total number of months in the Performance Period).
 
 

 4

 

 209

     

Exhibit 10.32

Section 9. Manner and Timing of Award Payments .

(a)    Timing of Award Payment . Except for deferrals under Sections 9(c) and 9(d), if any Awards are payable under this Subplan, the payment of such Awards to eligible Employees shall be made as soon as is administratively practicable after the end of the Performance Period and final approval by the Committee.

(b)    Tax Withholding . The company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a F air M arket V alue on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

(c)    Deferral of Award in Excess of the Maximum Deductible Amount . If payment of the Award would, or could in the reasonable estimation of the Committee, result in the participant's receiving compensation in excess of the Maximum Deductible Amount in a given year, then such portion (or all, as applicable) of the Award as would, or could in the reasonable estimation of the Committee, cause such participant to receive compensation from the Company in excess of the Maximum Deductible Amount shall be converted into the right to receive a cash payment, which shall be deferred until after the participant retires or otherwise terminates employment with the Company and its Subsidiaries.

(d)     Election to Defer the Award . Any participant in this Subplan may elect to defer the Award until after the participant retires or otherwise terminates employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If the participant chooses to defer the Award, the Award shall be converted into the right to receive a cash payment.

(e)     Award Deferral to the EDCP . In the event that all or any portion of an Award is converted into a right to receive a cash payment pursuant to Sections 9(c) or 9(d), except as otherwise provided in this Section with respect to Section 16 insiders, an amount representing the Fair Market Value, as of the date the Common Stock covered by the Award otherwise would be delivered to the participant, of the Actual Grant Amount (or the deferred portion thereof) will be credited to the Stock Account of the EDCP, and hypothetically invested in units of Common Stock. Notwithstanding the foregoing, for each Section 16 insider electing to defer the Award, the deferrable amount, when initially credited to the participant's EDCP Account, shall be held in a participant's Interest Account until the next date that dividends are paid on Common Stock, and on such date the deferrable amount that would have been initially credited to the participant's Stock Account but for this sentence shall be transferred, together with allocable interest thereon, to the participant's Stock Account, subject to provisions set forth in the EDCP. Thereafter, such amount shall be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.
 
 

5

 

 210

     

Exhibit 10.32

Section 10. No Rights as Stockholder . No certificates for shares of Common Stock shall be issued under this Subplan nor shall any participant have any rights as a stockholder as a result of participation in this Subplan, until the Actual Grant Amount has been determined and such participant has otherwise become entitled to an Award under the terms of the Plan and this Subplan. In particular, no participant shall have any right to vote or to receive dividends on any shares of Common Stock under this Subplan, until certificates for such shares have been issued as described above; provided, however, that if payment of all or any portion of an Award under this Subplan has been deferred pursuant to Section 9 of this Subplan or otherwise, but such Award otherwise has become payable hereunder, then during the period during which payment is deferred, the deferred Award shall be credited with additional units of Common Stock, and (if applicable) fractions thereof, based on any dividends declared on the Common Stock, in accordance with the terms of the EDCP.

Section 11. Application of Plan . The provisions of the Plan shall apply to this Subplan, except to the extent that any such provisions are inconsistent with specific provisions of this Subplan. In particular, and without limitation, Section 11 (relating to performance shares), Section 12 (relating to qualification of Awards as "performance-based" under Code Section 162(m)), Section 17 (relating to nonassignability), Section 18 (relating to adjustment of shares available), Section 19 (relating to withholding taxes), Section 20 (relating to noncompetition and confidentiality), Section 21 (relating to regulatory approvals and listings), Section 24 (relating to the governing law), Section 25 (relating to changes in ownership), Section 26 (relating to changes in control), Section 27 (relating to no rights to employment or participation), Section 28 (relating to no rights, title, or interest in Company assets), and Section 29 (relating to securities laws) shall apply to this Subplan.

Section 12. Adjustment of Actual Grant Amount . The Committee may, in its sole discretion, adjust the Actual Grant Amount to reflect overall Company performance and business and financial conditions.

Section 13. Amendments . The Committee may, from time to time, amend this Subplan in any manner.
 
 

 6

 
211
     

Exhibit 10.32

 


EXHIBIT A


Eastman Chemical Company
Performance Share Award Grant Table
2004-2005 Cycle


















 

7

 

 212

     

Exhibit 10.32





EXHIBIT B


Award Multiplier Table

Eastman TSR Relative to Comparison Companies
 
Differential from Target Return on Capital


 
<-7%
-5% to
-7%
-3 to
-5%
-1 to
-3%
-1 to +1%
+1 to +3%
+3 to +5%
+5 to +7%
+7 to +10%
>10%











0-19%( 5 th quintile)
0.0
0.0
0.0
0.0
0.6
0.8
1.0
1.3
1.6
1.9











20-39%(4 th quintile)
0.0
0.0
0.0
0.4
0.8
1.0
1.3
1.6
1.9
2.2











40-59%(3 rd quintile)
0.0
0.0
0.4
0.6
1.0
1.3
1.6
1.9
2.2
2.5











60-79%(2 nd quintile)
0.0
0.4
0.6
1.0
1.3
1.6
1.9
2.2
2.5
2.8











80-99%(1 st quintile)
0.0
0.6
0.8
1.3
1.6
1.9
2.2
2.5
2.8
3.0












 

8

 

213
     

Exhibit 10.33
 
PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2006 PERFORMANCE PERIOD











EASTMAN CHEMICAL COMPANY


214
     

Exhibit 10.33

 


PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2006 PERFORMANCE PERIOD



TABLE OF CONTENTS

Section
Title
Page
 
 
 
Section 1.
Background
1
 
 
 
Section 2.
Definitions
1
 
 
 
Section 3.
Administration
2
 
 
 
Section 4.
Eligibility
3
 
 
 
Section 5.
Form of Awards
3
 
 
 
Section 6.
Size of Awards
3
 
 
 
Section 7.
Composition of Comparison Group
4
 
 
 
Section 8.
Preconditions to Receipt of an Award
4
 
 
 
Section 9.
Manner and Timing of Award Payments
5
 
 
 
Section 10.
No Rights as Stockholder
6
 
 
 
Section 11.
Application of Plan
6
 
 
 
Section 12.
Adjustment of Actual Grant Amount
6
 
 
 
Section 13.
Amendments
6
 
 
 
Exhibit A.
 
7
 
 
 
Exhibit B.
 
8


215
     

Exhibit 10.33

 



EASTMAN CHEMICAL COMPANY
PERFORMANCE SHARE AWARD SUBPLAN
OF THE 2002 OMNIBUS LONG-TERM COMPENSATION PLAN
2004-2006 PERFORMANCE PERIOD



Section 1. Background . Under Section 11 of the Eastman Chemical Company 2002 Omnibus Long-Term Compensation Plan (the "Plan"), the "Committee" (as defined in the Plan), may, among other things, award shares of the $.01 par value common stock ("Common Stock") of Eastman Chemical Company (the "Company") to "Employees" (as defined in the Plan), and such awards may take the form of performance shares, which are contingent upon the attainment of certain performance objectives during a specified period, and subject to such other terms, conditions, and restrictions as the Committee deems appropriate. The purpose of this Performance Share Award Subplan (this "Subplan") is to set forth the terms of the grant of performance shares for the 2004-2006 Performance Period specified herein, effective as of January 1, 2004 (the "Effective Date").

Section 2. Definitions .

(a)    The following definitions shall apply to this Subplan:
 
     (i)    "Actual Grant Amount" means the number of shares of Common Stock to which a participant is entitled under this Subplan, calculated in accordance with Section 6 of this Subplan.
 
     (ii)    "Award Amount" means the performance shares awarded to the participant under this Subplan at the beginning of the Performance Period.
 
     (iii)    "Award Payment Date" means the date the Compensation Committee approves the payout of Common Stock covered by an award under this Subplan to a participant.
 
     (iv)    "Comparison Group" is the group of companies comprising the "Materials Sector" from Standard and Poor’s Super Composite 1500 Index, identified as Global Industry Classification Standard ("GICS") 15.
 
     (v)    "Cost of Capital" reflects the cost of debt and the cost of equity, expressed as a percentage, reflecting the percentage of interest charged on debt and the percentage of expected return on equity.
 
     (vi)    "Earnings from Continuing Operations" shall be defined as the total sales of the Company minus the costs of all operations of any nature used to produce such sales, including taxes, plus after-tax interest associated with the Company's capital debt.
 
     (vii)    "Maximum Deductible Amount" means the maximum amount deductible by the Company under Section 162(a), taking into consideration the limitations under Section 162(m), of the Internal Revenue Code of 1986, as amended, or any similar or successor provisions thereto.

 1

 

 216

     

 Exhibit 10.33

 

     (viii)    "Participation Date" means April 2, 2004.
 
     (ix)    "Performance Period" means January 1, 2004 through December 31, 2006.
 
     (x)    "Performance Year" means one of the three calendar years in the Performance Period.
 
     (xi)    "Return on Capital" shall mean the return produced by funds invested in the Company and shall be determined as Earnings from Continuing Operations, as defined in Section 2.a.(vi), divided by the Average Capital Employed. Average Capital Employed shall be derived by adding the Company's capital debt plus equity at the close of the last day of the year preceding the Performance Year, to the Company's capital debt plus equity at the close of the last day of the present Performance Year, with the resulting sum being divided by two. Capital debt is defined as the sum of borrowing by the Company due within one year and long-term borrowing, as designated on the Company's balance sheet. The resulting ratio shall be multiplied by One Hundred (100) in order to convert such to a percentage. Such percentage shall be calculated to the third place after the decimal point (i.e., xx.xxx%), and then rounded to the second place after the decimal point (i.e., xx.xx%).
 
     (xii)    "Target Award Range" means, with respect to any eligible Employee, the number of performance shares within the range specified on Exhibit A hereto for the Salary Grade applicable to such Employee.
 
     (xiii)    "TSR" means total stockholder return, as reflected by the sum of (A) change in stock price (measured as the difference between (I) the average of the closing prices of a company’s common stock on the New York Stock Exchange, or of the last sale prices or closing prices of such stock on another national trading exchange, as applicable, in the period beginning on the tenth trading day preceding the beginning of the Performance Period and ending on the tenth trading day of the Performance Period and (II) the average of such closing or last sale prices for such stock in the period beginning on the tenth trading day preceding the end of the Performance Period and ending on the tenth trading day following the end of the Performance Period) plus (B) dividends declared, assuming reinvestment of dividends, and expressed as a percentage return on a stockholder’s hypothetical investment.

(b)    Any capitalized terms used but not otherwise defined in this Subplan shall have the respective meanings set forth in the Plan.

Section 3. Administration . This Subplan shall be administered by the Committee. The Committee shall have authority to interpret this Subplan, to prescribe rules and regulations relating to this Subplan, and to take any other actions it deems necessary or advisable for the administration of this Subplan, and shall retain all general authority granted to it under Section 3 of the Plan. At the end of the Performance Period, the Committee shall approve Actual Grant Amounts awarded to participants under this Subplan.

 2


 217

     

 Exhibit 10.33

 

Section 4. Eligibility . The Employees who are eligible to participate in this Subplan are those Employees who, as of the Participation Date, are at Salary Grade 53 and above. These Salary Grades generally include Employees who, as of the Participation Date, have been designated as "officers" of the Company for purposes of Section 16 of the Exchange Act, and held positions with the Company considered carrying responsibilities and functions generally associated with a vice-president-level position. Employees who are promoted during the Performance Period to a position that would meet the above criteria, but who do not hold such position as of the Participation Date, are not eligible to participate in this Subplan.

Section 5. Form of Awards . Subject to the terms and conditions of the Plan and this Subplan, Awards under this Subplan shall be paid in the form of unrestricted shares of Common Stock, except for conversions to cash and deferrals under Section 9 of this Subplan, and except that if a participant is entitled to any fraction of a share of Common Stock, as a result of Section 10 of this Subplan or otherwise, then in lieu of receiving such fraction of a share, the participant shall be paid a cash amount representing the market value, as determined by the Committee, of such fraction of a share at the time of payment.

Section 6. Size of Awards .

(a)    Target Award Range. Exhibit A hereto shows by Salary Grade the Target Award Range. The Salary Grade to be used in determining the size of any Award Amount to a participant under this Subplan shall be the Salary Grade applicable to the position held by the participant on the Participation Date. The actual size of the Award Amount to the participant shall be determined based on an assessment by his or her senior management of the participant’s past performance and potential for contributions to the Company’s future long term success. Based on this assessment, the participant may receive no award, the target award amount, or any amount within the Target Award Range to the nearest 10 performance shares. Each member of senior management will have a performance share budget, based on the cumulative award targets for their reports, which must be balanced for their organizations.
 
(b)    Stock Option Grants for Employees Named After the Participation Date. Employees who are hired into, or promoted to a Salary Grade 53 or above position after the Participation Date but prior to, subject to final approval by the Compensation Committee, an October 2004 option grant, will be eligible to receive an additional number of options to purchase Company stock as of the next scheduled meeting of the Compensation Committee following their hire or promotion. The additional grant of options will be determined based on several factors, including timing of the promotion or hire, number of options received in the previous assignment, stock option target ranges for the employee’s new salary grade, and considerations of performance assessment. The amount of the award will be recommended by the Company’s Chief Executive Officer for approval by the Compensation Committee. The option grant price will be the closing price of Company common stock on the New York Stock Exchange on the meeting date of the Compensation Committee.
 
(c)    Actual Grant Amount. Subject to the Committee’s authority to adjust the Actual Grant Amount described in Section 12, the Actual Grant Amount awarded to the participant at the end of the Performance Period is determined by applying a multiplier to the participant’s Award Amount. The multiplier shall be determined by comparing Company performance relative to two measures:
 
 

 3

 

 218

     

 Exhibit 10.33

 

   (i)    The Company's TSR during the Performance Period relative to the TSRs of the companies in the Comparison Group during the Performance Period. The Company and each company in the Comparison Group shall be ranked by TSR, in descending order, with the company having the highest TSR during the Performance Period being ranked number one. The Comparison Group shall further be separated into quintiles (first 20%, second 20%, etc.) and the Company's position, in relation to the Comparison Group, shall be expressed as a position in the applicable quintile ranking; and
   (ii)    The arithmetic average, for each of the Performance Years during the Performance Period, of the Company’s average Return on Capital minus a Return on Capital target. The Return on Capital target will be determined by the Committee.
 
   An award multiplier table is shown in Exhibit B. The award multiplier is based on the Company’s performance relative to its quintile ranking relative to the Comparison Group, and its average Return on Capital relative to a target during the Performance Period. The award multipliers range from 3.0 (i.e. 300%), if the Company's TSR is in the top performing quintile (top 20%) of companies in the Comparison Group, and the average Return on Capital minus the target Return on Capital is greater than 10 percentage points, to 0.0 (with no shares of Common Stock being delivered to participants under this Subplan), if the Company does not meet certain levels of performance relative to the two measures.

Section 7. Composition of Comparison Group . The Comparison Group is composed of companies relevant for purposes of TSR comparisons under this Subplan. However, during the Performance Period, a company in the Comparison Group may be dropped from the Comparison Group if a company's common stock ceases to be publicly traded on a national stock exchange or market; or a company is a party to a significant merger, acquisition, or other reorganization. Under these, or similar circumstances, the company or companies may be removed from the Comparison Group, and may be replaced with another company or companies by Standard & Poor’s, consistent with their established criteria for selection of companies for the Comparison Group. In any case where the Comparison Group ceases to exist, or is otherwise determined to no longer be appropriate as the basis for a measure under this Subplan, the Committee may designate a replacement Comparison Group. In any such case, the Committee shall have authority to determine the appropriate method of calculating the TSR of such former and/or replacement Comparison Group, whether by complete substitution of the replacement Comparison Group (and disregard of the former Comparison Group) over the entire Performance Period or by pro rata calculations for each Comparison Group or otherwise.

Section 8. Preconditions to Receipt of an Award .

(a)    Continuous Employment . Except as specified in paragraph (b) below, to remain eligible for an Award under this Subplan, an eligible Employee must remain continuously employed with the Company or a Subsidiary at all times from the Effective Date through the Award Payment Date.

4



 219

     

 Exhibit 10.33

 

(b)    Death, Disability, Retirement, or Termination for an Approved Reason Before the Award Payment Date. If a participant's employment with the Company or a Subsidiary is terminated due to death, disability, retirement, or any approved reason prior to the Award Payment Date, the participant shall receive, subject to the terms and conditions of the Plan and this Subplan, an Award representing a prorated portion of the Actual Grant Amount to which such participant otherwise would be entitled, with the precise amount of such Award to be determined by multiplying the Actual Grant Amount by a fraction, the numerator of which is the number of full calendar months employed in the Performance Period from the Effective Date through and including the effective date of such termination, and the denominator of which is 36 (the total number of months in the Performance Period).

Section 9. Manner and Timing of Award Payments .

(a)    Timing of Award Payment . Except for deferrals under Sections 9(c) and 9(d), if any Awards are payable under this Subplan, the payment of such Awards to eligible Employees shall be made as soon as is administratively practicable after the end of the Performance Period and final approval by the Committee.

(b)    Tax Withholding . The Company may withhold or require the grantee to remit a cash amount sufficient to satisfy federal, state, and local taxes (including the participant’s FICA obligation) required by law to be withheld. Further, either the Company or the grantee may elect to satisfy the withholding requirement by having the Company withhold shares of common stock having a F air M arket V alue on the date the tax is to be determined equal to the minimum statutory total tax which could be imposed on the transaction.

(c)    Deferral of Award in Excess of the Maximum Deductible Amount . If payment of the Award would, or could in the reasonable estimation of the Committee, result in the participant's receiving compensation in excess of the Maximum Deductible Amount in a given year, then such portion (or all, as applicable) of the Award as would, or could in the reasonable estimation of the Committee, cause such participant to receive compensation from the Company in excess of the Maximum Deductible Amount shall be converted into the right to receive a cash payment, which shall be deferred until after the participant retires or otherwise terminates employment with the Company and its Subsidiaries.

(d)    Election to Defer the Award . Any participant in this Subplan may elect to defer the Award until after the participant retires or otherwise terminates employment with the Company and its Subsidiaries under the terms and subject to the conditions of the Eastman Executive Deferred Compensation Plan, as the same now exists or may be amended hereafter (the "EDCP"). If the participant chooses to defer the Award, the Award shall be converted into the right to receive a cash payment.

 

 5

 

 220

     

 Exhibit 10.33

 

(e)    Award Deferral to the EDCP . In the event that all or any portion of an Award is converted into a right to receive a cash payment pursuant to Sections 9(c) or 9(d), except as otherwise provided in this Section with respect to Section 16 insiders, an amount representing the Fair Market Value, as of the date the Common Stock covered by the Award otherwise would be delivered to the participant, of the Actual Grant Amount (or the deferred portion thereof) will be credited to the Stock Account of the EDCP, and hypothetically invested in units of Common Stock. Notwithstanding the foregoing, for each Section 16 insider electing to defer the Award, the deferrable amount, when initially credited to the participant's EDCP Account, shall be held in a participant's Interest Account until the next date that dividends are paid on Common Stock, and on such date the deferrable amount that would have been initially credited to the participant's Stock Account but for this sentence shall be transferred, together with allocable interest thereon, to the participant's Stock Account, subject to provisions set forth in the EDCP. Thereafter, such amount shall be treated in the same manner as other investments in the EDCP and shall be subject to the terms and conditions thereof.

Section 10. No Rights as Stockholder . No certificates for shares of Common Stock shall be issued under this Subplan nor shall any participant have any rights as a stockholder as a result of participation in this Subplan, until the Actual Grant Amount has been determined and such participant has otherwise become entitled to an Award under the terms of the Plan and this Subplan. In particular, no participant shall have any right to vote or to receive dividends on any shares of Common Stock under this Subplan, until certificates for such shares have been issued as described above; provided, however, that if payment of all or any portion of an Award under this Subplan has been deferred pursuant to Section 9 of this Subplan or otherwise, but such Award otherwise has become payable hereunder, then during the period during which payment is deferred, the deferred Award shall be credited with additional units of Common Stock, and (if applicable) fractions thereof, based on any dividends declared on the Common Stock, in accordance with the terms of the EDCP.

Section 11. Application of Plan . The provisions of the Plan shall apply to this Subplan, except to the extent that any such provisions are inconsistent with specific provisions of this Subplan. In particular, and without limitation, Section 11 (relating to performance shares), Section 12 (relating to qualification of Awards as "performance-based" under Code Section 162(m)), Section 17 (relating to nonassignability), Section 18 (relating to adjustment of shares available), Section 19 (relating to withholding taxes), Section 20 (relating to noncompetition and confidentiality), Section 21 (relating to regulatory approvals and listings), Section 24 (relating to the governing law), Section 25 (relating to changes in ownership), Section 26 (relating to changes in control), Section 27 (relating to no rights to employment or participation), Section 28 (relating to no rights, title, or interest in Company assets), and Section 29 (relating to securities laws) shall apply to this Subplan.
 
Section 12. Adjustment of Actual Grant Amount . The Committee may, in its sole discretion, adjust the Actual Grant Amount to reflect overall Company performance and business and financial conditions.

Section 13. Amendments . The Committee may, from time to time, amend this Subplan in any manner.



 6



221
     

Exhibit 10.33

 




EXHIBIT A


Eastman Chemical Company
Performance Share Award Grant Table
2004-2006 Cycle



















 7

 

 222

     

 Exhibit 10.33

 





EXHIBIT B


Award Multiplier Table

Eastman TSR Relative to Comparison Companies
 
Differential from Target Return on Capital


 
<-7%
-5% to
-7%
-3 to
-5%
-1 to
-3%
-1 to +1%
+1 to +3%
+3 to +5%
+5 to +7%
+7 to +10%
>10%











0-19%( 5 th quintile)
0.0
0.0
0.0
0.0
0.6
0.8
1.0
1.3
1.6
1.9











20-39%(4 th quintile)
0.0
0.0
0.0
0.4
0.8
1.0
1.3
1.6
1.9
2.2











40-59%(3 rd quintile)
0.0
0.0
0.4
0.6
1.0
1.3
1.6
1.9
2.2
2.5











60-79%(2 nd quintile)
0.0
0.4
0.6
1.0
1.3
1.6
1.9
2.2
2.5
2.8











80-99%(1 st quintile)
0.0
0.6
0.8
1.3
1.6
1.9
2.2
2.5
2.8
3.0











 

 

8



223
     

EXHIBIT 12.01

EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

COMPUTATION OF RATIOS OF EARNINGS (LOSS) TO FIXED CHARGES


Dollars in millions)
 
2003
 
2002
 
2001
 
2000
 
1999
 
 

 
 

 
 

 
 

 
 

 
Earnings (loss) before income taxes and cumulative effect of change in accounting principle
$
 
 
(381)
$
 
 
84
$
 
 
(291)
$
 
 
452
$
 
 
72
Add:
 
 
 
 
 
 
 
 
 
 
Interest expense
 
130
 
128
 
146
 
142
 
126
Appropriate portion of rental expense (1)
 
21
 
28
 
28
 
28
 
28
Amortization of capitalized interest
 
12
 
13
 
15
 
15
 
16





Earnings (loss) as adjusted
$
(218)
$
253
$
(102)
$
637
$
242





 
 
 
 
 
 
 
 
 
 
 
Fixed charges:
 
 
 
 
 
 
 
 
 
 
Interest expense
$
130
$
128
$
146
$
142
$
126
Appropriate portion of rental expense (1)
 
21
 
28
 
28
 
28
 
28
Capitalized interest
 
3
 
4
 
5
 
6
 
13





Total fixed charges
$
154
$
160
$
179
$
176
$
167





 
 
 
 
 
 
 
 
 
 
 
Ratio of earnings (loss) to fixed charges
 
(B)
 
1.6x
 
(A)
 
3.6x
 
1.5x





 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   (1)    For all periods presented, the interest component of rental expense is estimated to equal one-third of such expense.

   (A)    Due to the net loss reported, the coverage ratio was less than 1x. To achieve a coverage ratio of 1x, additional pre-tax earnings of $281 million would have been required for 2001.

   (B)    Due to the net loss reported, the coverage ratio was less than 1x. To achieve a coverage ratio of 1x, additional pre-tax earnings of $372 million would have been required for 2003.

 

 224


EXHIBIT 21.01
 
EASTMAN CHEMICAL COMPANY
SUBSIDIARIES

 
JURISDICTION OF
 
INCORPORATION
NAME OF SUBSIDIARY
OR ORGANIZATION



Altovar Ltd.
United Kingdom
Air Products Liquid Phase Conversion Company, L.P
Delaware
Ariel Research Corporation
Delaware
Ariel Research Corporation – Europe ApS
Denmark
Cendian Corporation
Delaware
Diagnostics Acquisition Corp.
Delaware
Eastman (Shanghai) Chemical Trading Co., Ltd.
China
Eastman (Tianjin) Chemical Company
China
Eastman Belgium B.V.B.A.
Belgium (Kallo)
Eastman Cayman Financial Services Limited
Cayman Islands
Eastman Chemical (Malaysia) Sdn. Bhd.
Malaysia
Eastman Chemical Asia Pacific Pte. Ltd.
Singapore
Eastman Chemical B.V.
Netherlands
Eastman Chemical Canada, Inc.
Canada
Eastman Chemical Company Foundation, Inc.
Delaware
Eastman Chemical Company Investments, Inc.
Delaware
Eastman Chemical Deutschland GmbH
Germany
Eastman Chemical Espana, Inc.
Delaware
Eastman Chemical, Europe, Middle East, and Africa, Ltd.
Delaware
Eastman Chemical Financial Corporation
Delaware

 

 225

     

EXHIBIT 21.01
 
EASTMAN CHEMICAL COMPANY
SUBSIDIARIES

 
JURISDICTION OF
 
INCORPORATION
NAME OF SUBSIDIARY
OR ORGANIZATION



Eastman Chemical Finland Oy
Finland
Eastman Chemical GmbH & Co KG
Germany
Eastman Chemical Holding GmbH
Germany
Eastman Chemical Holdings, S.A. de C.V.
Mexico
Eastman Chemical Hong Kong Limited
Hong Kong
Eastman Chemical Italia S.r.l.
Italy
Eastman Chemical Japan Limited
Japan
Eastman Chemical Korea Ltd.
Korea
Eastman Chemical Latin America, Inc.
Delaware
Eastman Chemical Ltd.
New York
Eastman Chemical Luxembourg S.a.r.l.
Luxembourg
Eastman Chemical Middelburg, B.V.
Netherlands
Eastman Chemical Resins, Inc.
Delaware
Eastman Chemical Singapore Pte. Ltd.
Singapore
Eastman Chemical Sweden AB
Sweden
Eastman Chemical The Hague B.V.
Netherlands
Eastman Chemical Uruapan, S.A. de C.V.
Mexico
Eastman Cogen Management L.L.C.
Texas
Eastman Cogeneration L.P.
Texas

 

226

     

EXHIBIT 21.0 1
 
EASTMAN CHEMICAL COMPANY
SUBSIDIARIES

 
JURISDICTION OF
 
INCORPORATION
NAME OF SUBSIDIARY
OR ORGANIZATION



Eastman Company
Delaware
Eastman Company UK Limited
United Kingdom
Eastman do Brasil Ltda.
Brazil
Eastman Espana S. L.
Spain
Eastman Gasification Services Company
Delaware
Eastman International Management Company
Tennessee
Eastman Malta Limited
Malta
Eastman Netherlands B.V.
Netherlands
Eastman Resins, Inc.
Delaware
Eastman Servicios Corporativos, S.A. de C.V.
Mexico
Eastman Sokolov, a.s.
Czech Republic
Enterprise Genetics, Inc.
Nevada
Fujian Nanping Eastman Company
China
GLC Associates
Nevada
Hartlepet Limited
United Kingdom
Holston Defense Corporation
Virginia
Industrias Voridian, S.A. de C.V.
Mexico
Jager Chemie France S.A.R.L.
France
Jager Chemie i.L., Basel
Switzerland

 

227

     

EXHIBIT 21.01
 
EASTMAN CHEMICAL COMPANY
SUBSIDIARIES

 
JURISDICTION OF
 
INCORPORATION
NAME OF SUBSIDIARY
OR ORGANIZATION



Jager Verwaltungs-GmbH
Germany
Jiangsu Funing Eastman Chemical Co., Ltd.
China
Kingsport Hotel, L.L.C.
Tennessee
Lawter International (Canada) Company
Canada
Lawter International (Hong Kong) Limited
Hong Kong
Lawter International Products, Pte. Ltd.
Singapore
Lawter International, A.p.S
Denmark
Lawter International, B.V.B.A.
Belgium
Lawter International, S.A.
Spain
McWhorter Holdings AB
Sweden
McWhorter Holdings Ltd.
United Kingdom
Mustang Pipeline Company
Texas
Nanjing Yangzi Eastman Chemical Ltd.
China
Peroxides s.r.o.
Czech Republic
Pinto Pipeline Company of Texas
Texas
Primester
New York
Qilu Eastman Specialty Chemicals, Ltd
China
Shanghai Eastman Consulting Company Ltd
China
Union-Chemie Singapore Pte. Ltd.
Singapore
Voridian (Gibraltar) Limited
United Kingdom

 

228

     

EXHIBIT 21.01
 
EASTMAN CHEMICAL COMPANY
SUBSIDIARIES

 
JURISDICTION OF
 
INCORPORATION
NAME OF SUBSIDIARY
OR ORGANIZATION



Voridian (U.K.)
United Kingdom
Voridian AG
Switzerland
Voridian Argentina S.R.L.
Argentina
Voridian B.V.
Netherlands
Voridian Canada Company
Nova Scotia
Voridian Company
Delaware
Voridian de Mexico, S.A. de C.V.
Mexico
Voridian do Brasil Ltda.
Brazil - partnership
Voridian England Ltd.
United Kingdom
Voridian Espana S.A.
Spain
Voridian Europoort B.V.
Netherlands
Voridian Holdings B.V.
Netherlands
Voridian Holdings S.L.
Spain
Voridian Hong Kong Limited
Hong Kong
Voridian International, Limited
United Kingdom
Voridian Polymer Ltd.
United Kingdom
Voridian Singapore Pte. Ltd.
Singapore
Voridian Spain L.L.C.
Delaware
Workington Investments Limited
United Kingdom

 
229
     


 

EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

EXHIBIT 23.01

CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-62597) of Eastman Chemical Company of our report dated March 3, 2004, relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10-K. We also consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 33-73808, No. 33-73810, No. 33-73812 and No. 33-77844) of Eastman Chemical Company of our report dated March 3, 2004 relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

PRICEWATERHOUSECOOPERS LLP
Philadelphia, Pennsylvania
March 4, 2004

230
     


Exhibit 31.01

 
EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES
 
Rule 13a – 14(a)/15d – 14(a) Certifications


I, J. Brian Ferguson, certify that:
 
1. I have reviewed this annual report on Form 10-K of Eastman Chemical Company;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date: March 5, 2004
 
/s/ J. Brian Ferguson
_________________________________
J. Brian Ferguson
Chairman of the Board and Chief Executive Officer
 
231
     

Exhibit 31.02
 
EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES
 
Rule 13a – 14(a) /15d – 14(a) Certifications


I, Richard A. Lorraine, certify that:
 
1. I have reviewed this annual report on Form 10-K of Eastman Chemical Company;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date: March 5, 2004
 
/s/ Richard A. Lorraine
_________________________________
Richard A. Lorraine
Senior Vice President and Chief Financial Officer
 
232
     

Exhibit 32.01


 
EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES
 
Section 1350 Certifications


In connection with the Annual Report of Eastman Chemical Company (the "Company") on Form 10-K for the year ending December 31, 2003, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:
 
1.    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
 
A signed original of this written statement required by Section 906 has been provided to Eastman Chemical Company and will be retained by Eastman Chemical Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: March 5, 2004



/s/ J. Brian Ferguson
___________________________________
J. Brian Ferguson
Chairman of the Board and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.

233
     

Exhibit 32.02


EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

Section 1350 Certifications


In connection with the Annual Report of Eastman Chemical Company (the "Company") on Form 10-K for the year ending December 31, 2003, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:
 
1.    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.
 
A signed original of this written statement required by Section 906 has been provided to Eastman Chemical Company and will be retained by Eastman Chemical Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: March 5, 2004



/s/ Richard A. Lorraine
_________________________________
Richard A. Lorraine
Senior Vice President and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.

234